Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.8564419134430752,-1.9901268667491523,0.0,0.0,0.0,38/81,8.07%,IFI44L;VCAM1;CD74;EPSTI1;RSAD2;MX1;PARP14;DDX60;SAMD9L;LAP3;IFIH1;PARP12;XAF1;PSMB9;SOD2;ISG15;TDRD7;STAT1;IRF2;IFI27;HLA-B;IRF1;RNF213;HERC6;TNFSF10;TAP1;EIF2AK2;LY6E;NLRC5;OAS3;GBP4;SAMHD1;LCP2;NFKBIA;WARS1;B2M;NFKB1;TRIM25
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.8238321025416679,-1.7510827596726097,0.0,0.21648093424003986,0.3,28/47,8.07%,IFI44L;CD74;EPSTI1;RSAD2;MX1;PARP14;DDX60;SAMD9L;LAP3;IFIH1;PARP12;PSMB9;ISG15;TDRD7;IRF2;IFI27;IRF1;HLA-C;HERC6;TAP1;NUB1;EIF2AK2;LY6E;GBP4;WARS1;B2M;LPAR6;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.848857650161472,-1.7342545561413143,0.0,0.20768089626280248,0.35,2/17,1.12%,CX3CL1;GBP1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7293026646047662,1.7263358279987495,0.02564102564102564,0.5648530890403307,0.38,8/43,8.90%,GRIK2;NOVA1;SLC12A6;GRM5;GRIA2;SNAP25;NRXN1;HOMER1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.9487557485427037,-1.7211872396566703,0.0,0.19008082030832768,0.42,2/7,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7370990735627456,1.7160747059675483,0.0,0.37186161695155107,0.48,6/49,8.87%,TRIM5;AFF3;NOVA1;UTY;NOVA2;REST
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.9068331765796638,-1.6954083206764576,0.0,0.3041293124933243,0.69,6/20,4.75%,IFI44L;RSAD2;MX1;BTG2;PRKN;SLC38A3
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7257964706315925,-1.6905931151487343,0.0,0.286881238057939,0.71,26/67,14.87%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;RPL23;RPL30;LARS1;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37;PPA2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.9668377800120097,-1.6898278254847836,0.0,0.24740678198861699,0.72,2/11,0.21%,CD74;RSAD2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.8565989400926449,-1.6843399162437955,0.0,0.24288104817175205,0.74,8/16,6.29%,CD74;CX3CL1;GBP1;STAT1;SP100;NUB1;CALCOCO2;GBP4
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8606616133245956,-1.681922251897089,0.01639344262295082,0.20486488411008652,0.74,14/23,6.91%,RSAD2;MX1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8606616133245956,-1.681922251897089,0.01639344262295082,0.20486488411008652,0.74,14/23,6.91%,RSAD2;MX1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;SAMHD1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7454643393805591,-1.6783055649484833,0.0,0.19680084930912717,0.75,19/70,8.92%,HES1;NR4A1;BTG2;SAT1;IFIH1;SOD2;PLK2;IRF1;TNIP1;TAP1;SERPINE1;SMAD3;NFKBIA;SLC2A3;NFKB1;FOS;BHLHE40;TANK;JUN
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.8641935084559358,-1.678054418364095,0.0,0.18304078992653777,0.76,6/17,6.99%,MX1;GBP1;FN1;TNFSF10;LY6E;LCP2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.8721182014523325,-1.6723995471379822,0.022222222222222223,0.19739162108941724,0.8,5/18,6.99%,CD74;HLA-B;HLA-C;LGALS3;LCP2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.720756789156382,-1.659623252983723,0.0,0.2315667136295897,0.85,23/60,14.63%,RPS12;RPL31;RPS18;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;UPF3A;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7182546918738105,-1.6552163306641827,0.0,0.24076903905721508,0.87,32/54,22.68%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14;RPL11;RPS27;RPL27A;RPLP1;TRAM1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.8829974491208292,-1.6541997354621059,0.0,0.23034099405418879,0.87,8/20,6.19%,RSAD2;MX1;IFIH1;ISG15;TNIP1;ZC3HAV1;EIF2AK2;OAS3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8787266720755866,-1.6514374837234753,0.0,0.230457465145064,0.87,1/14,0.13%,CD74
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7343513823327633,-1.650147162726173,0.0,0.22410763382031226,0.87,25/60,14.63%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;DMD;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9612042115927966,-1.6430460967398357,0.0,0.2349610139922384,0.93,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9612042115927966,-1.6430460967398357,0.0,0.2349610139922384,0.93,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8996740447304685,-1.6373690857110654,0.0,0.25545253099637694,0.95,2/12,2.79%,CD74;CXCL12
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7247602707790639,-1.6338175973822255,0.0,0.2587211165307794,0.96,22/51,15.88%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.7566583229689703,-1.631207188138939,0.017543859649122806,0.2571141530740665,0.96,10/40,8.31%,NR4A1;BTG2;SOD2;HLA-F;IRF1;CHKA;TAP1;NFKBIA;FOS;TFRC
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.9836900924269338,-1.6295206111344331,0.0,0.2538810956432988,0.98,2/5,1.30%,CD74;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8435029501364766,-1.6281297023951773,0.021739130434782608,0.24963947733827038,0.98,6/15,6.91%,PARP14;PPARG;ISG15;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.907040509934207,-1.6227501550620487,0.0,0.27171809569716077,0.99,2/16,0.27%,HES1;TBX3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.720048993688792,-1.6188331221613015,0.0,0.27377895929183,0.99,21/51,14.63%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.7629018591440193,-1.6176665296408266,0.02040816326530612,0.27003545107294175,0.99,11/30,8.63%,SAT1;IFIH1;PARP12;IRF2;HLA-C;TNIP1;LGALS3;TNFSF10;OAS3;NFKBIA;BHLHE40
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.8457212424171522,-1.6166205547649484,0.019230769230769232,0.2665501158346664,0.99,3/13,7.28%,CD74;TNFSF10;DSP
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9656746309255211,-1.6150499764520594,0.0,0.26470514235530074,0.99,1/7,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.8105183500423336,-1.6143895438022442,0.0,0.25923208647784474,0.99,2/28,0.32%,CD74;CX3CL1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.9771325150148912,-1.613796734775432,0.020833333333333332,0.25311109232029055,0.99,2/5,2.23%,CD74;PLCG2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.7661191991388914,-1.6127527165468856,0.03508771929824561,0.25056108131552285,0.99,8/30,8.07%,CYLD;IFIH1;ISG15;IRF1;NLRC5;NFKB1;LRRFIP1;TRIM25
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6913039592588979,-1.6127037280724081,0.0,0.24319163774741923,0.99,31/89,14.63%,RPS12;RPL31;TNIP1;RPS18;RFC3;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;MEF2A;WARS1;RPL23;RPL30;TOPBP1;RPS28;RPS19;POLR2A;PTMA;RPS7;RPS14;RPS15;RPL28;RPL10;ATM;RPL9;EEF1A1;GCNT1;RPL24;RPL37
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7890619326410696,-1.61204926252845,0.016666666666666666,0.2392604611182601,0.99,12/32,10.73%,VCAM1;RSAD2;HLA-F;HLA-B;IRF1;HLA-C;SAMHD1;B2M;ERAP1;HLA-E;SPPL2A;APPL2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.8926361901263273,-1.6112451669164924,0.017241379310344827,0.23613435238920338,0.99,2/19,0.93%,HES1;KIAA1217
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.7606112464722504,-1.6070322528727652,0.02,0.24630592781694713,1.0,4/29,5.37%,CD74;CYLD;STAT1;CDC37
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8309105728529528,-1.6068960857706347,0.0,0.2401020888105192,1.0,9/25,6.19%,RSAD2;MX1;IFIH1;ISG15;TNIP1;ZC3HAV1;PABPC1;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.8895295586791514,-1.6062341987060147,0.0,0.23638255858856136,1.0,4/14,5.82%,CD74;PARP14;PRKN;NLRC5
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.6657361350090601,1.6045905600872836,0.022727272727272728,1.0,0.96,8/48,6.45%,HDAC9;ANKH;SNAP25;DUSP6;ITGA2;IGFBP3;EVI5;MAP7
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.9478351222522609,-1.597011711272548,0.0,0.2679611564068786,1.0,2/8,0.53%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.8918198028409043,-1.596409523217385,0.02040816326530612,0.26400113931712177,1.0,1/17,0.27%,TBX3
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7167733500996104,-1.593678266323287,0.0,0.2722983179813742,1.0,22/55,15.88%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.8659753722197916,1.5935819890962892,0.0,1.0,0.98,3/12,5.95%,CRY1;CALR;CNOT2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.7355585285972914,1.5909106204361962,0.0,1.0,0.98,7/29,8.37%,RBM20;NOVA1;PTBP3;MBNL1;YTHDF2;NOVA2;HNRNPLL
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.7776240019421166,1.5908148939757685,0.0,1.0,0.98,1/22,0.08%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9300745659939915,-1.5879093477218373,0.02040816326530612,0.28782263746945747,1.0,2/8,4.01%,CD74;PRKN
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.8971276184762785,-1.5853664648333599,0.0,0.2937612677492337,1.0,7/15,6.99%,CD74;PARP14;PPARG;LGALS3;CPM;SLCO2B1;LCP2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.9291499112227286,-1.5822041478429143,0.020833333333333332,0.30154796802000133,1.0,1/6,1.01%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.8959222603649183,-1.5787892395411491,0.018518518518518517,0.30287109429743,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.8959222603649183,-1.5787892395411491,0.018518518518518517,0.30287109429743,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.8336991132501248,-1.5784475349939568,0.021739130434782608,0.29788128552948573,1.0,1/15,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.7264780203797914,-1.5782701454012924,0.0,0.2928796312914029,1.0,5/47,3.53%,CD74;CX3CL1;GBP1;FN1;TNIP1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.962542244139416,-1.5780946510379912,0.0,0.2880780432228433,1.0,1/6,0.08%,VCAM1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.9623239545392904,-1.5775300901875031,0.0,0.2855353498967145,1.0,1/7,0.08%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.682596458151316,-1.577026429700974,0.0,0.2818719856708962,1.0,9/101,3.24%,CD74;HES1;TBX3;CX3CL1;STAT1;FN1;CNOT8;GRK5;UFL1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.9283448797123227,-1.5761524560062887,0.0196078431372549,0.2799408307475895,1.0,2/9,0.32%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.9359033800743781,-1.576139885464531,0.0,0.27475674128930083,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.8595204292981294,-1.5759358753708916,0.037037037037037035,0.27168117246089263,1.0,1/12,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.7841562857392874,-1.571417473897704,0.0392156862745098,0.28436694149301406,1.0,5/22,7.30%,CYLD;SP100;LGALS3;TNFSF10;BCL2L14
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.9148666453489722,-1.5712264886484932,0.0,0.28048963152710343,1.0,2/11,0.56%,CX3CL1;CYLD
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.8884576027333086,-1.571117353810858,0.0,0.2761998126510854,1.0,6/13,4.49%,IFIH1;PARP12;HLA-F;IRF1;HLA-C;TAP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.8132579836411864,-1.5679072257787146,0.019230769230769232,0.28279444076003557,1.0,2/21,0.66%,NR4A1;BTG2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9629407983614988,1.5659686427751511,0.0,1.0,1.0,1/8,0.08%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.8256878413739492,-1.5641699147327779,0.0,0.29392126843972893,1.0,5/22,7.01%,CYLD;TMSB4X;UFL1;NLRC5;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.8723705158094482,-1.5641321159031298,0.0,0.28944911799228046,1.0,2/12,2.12%,PPARG;STAT1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.8623121920662927,-1.5624386916956334,0.0196078431372549,0.2909122231958994,1.0,1/10,0.21%,RSAD2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6929183547211692,-1.560938266713994,0.03225806451612903,0.2918260213022915,1.0,11/57,9.46%,CYLD;BTG2;SAT1;SOD2;IRF1;LGALS3;TNFSF10;TAP1;IGF2R;JUN;PMAIP1
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.9330559294665144,-1.5598524283496917,0.02040816326530612,0.2910612560971268,1.0,1/9,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.8997249741372162,-1.556789989650385,0.0,0.30055514322256943,1.0,2/10,2.39%,CD74;FN1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8049294229608398,1.553706192223756,0.024390243902439025,1.0,1.0,5/13,8.90%,GRIK2;GRM5;GRIA2;PLCB1;HOMER1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.9431846957882446,-1.5527992822630328,0.0,0.31328135198965124,1.0,2/7,2.34%,PLK2;CENATAC
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.30593073203219406,1.0,1/6,0.85%,OMD
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.30593073203219406,1.0,1/6,0.85%,OMD
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6793251033904407,-1.5508196605438942,0.017241379310344827,0.306700454024065,1.0,28/52,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RIOK3;RPL24;RPL37;RPL11;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.957221649247591,-1.550634920308747,0.0,0.3030733079360558,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.7699956469823828,-1.5504427617725751,0.0,0.29538794143593516,1.0,8/29,8.31%,SLC22A5;SLC6A6;SLC16A2;SLC5A6;SLC38A3;SLCO2B1;SLC2A3;TFRC
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.7699956469823828,-1.5504427617725751,0.0,0.29538794143593516,1.0,8/29,8.31%,SLC22A5;SLC6A6;SLC16A2;SLC5A6;SLC38A3;SLCO2B1;SLC2A3;TFRC
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.8407916664959011,-1.5501390340407746,0.038461538461538464,0.2920648220719282,1.0,6/20,8.74%,CX3CL1;OPTN;TNIP1;SERPINE1;NFKBIA;CD47
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.8289557837979686,1.549519667470018,0.02,1.0,1.0,3/9,3.56%,PNP;BCL6;ZBTB1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.8680980994386015,-1.548211613562114,0.0,0.29610938599082576,1.0,3/10,2.79%,CX3CL1;NR4A1;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.846139148529072,-1.5456610160601352,0.019230769230769232,0.3013133003406083,1.0,6/19,9.75%,CX3CL1;TNIP1;SERPINE1;NFKBIA;CD47;RPS19
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.7514309086125452,-1.5430773697654137,0.058823529411764705,0.3116602923622654,1.0,3/33,2.55%,VCAM1;FN1;ITGB5
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.7542891393537096,-1.5425274090607208,0.037037037037037035,0.3106299119757303,1.0,5/36,2.79%,VCAM1;CX3CL1;SLC6A6;FN1;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9433912396405595,-1.5416407464750863,0.022222222222222223,0.3105736479966551,1.0,2/7,4.01%,CD74;PRKN
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.8997412647794684,-1.541177312983176,0.0,0.30838006501498727,1.0,2/13,0.27%,HES1;TBX3
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.8258223531245881,1.5366201724456843,0.02127659574468085,1.0,1.0,3/13,3.13%,BMP6;PRKD1;IL6R
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.7576203519925264,-1.5363765653714627,0.03389830508474576,0.3268334104745968,1.0,9/27,13.23%,CX3CL1;IFIH1;PLCG2;OAS3;CD47;HLA-E;VSIR;CLU;JAK2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.9177925195266471,-1.5363466020773628,0.0425531914893617,0.32305917196435946,1.0,2/8,2.79%,CD74;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.8092764396076682,-1.5363076158106612,0.05263157894736842,0.31924820700836337,1.0,3/16,3.43%,VCAM1;CD74;VAV3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.8747507667356356,-1.5362735677278032,0.016666666666666666,0.3154018430685036,1.0,4/11,4.01%,CX3CL1;SOD2;SNX6;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.768257599415724,-1.5349401977286314,0.0425531914893617,0.3178070858065162,1.0,5/26,8.31%,CX3CL1;LGALS3;SMAD3;WARS1;TFRC
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.9309252435641535,-1.533304848778625,0.0,0.32077691374908635,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.9389296414704005,-1.5329233954677908,0.06976744186046512,0.3181520706840291,1.0,2/5,4.01%,IFI27;PRKN
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.8378476645099073,-1.53277331595771,0.018867924528301886,0.31534480917052066,1.0,3/10,7.73%,CX3CL1;CXCL12;STK39
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.9165431575617295,-1.5310866117974375,0.0425531914893617,0.3195613790915888,1.0,3/7,4.01%,HES1;PPARG;PRKN
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.8709989642079766,-1.5279052795342347,0.0,0.33092097867660797,1.0,5/20,2.95%,CD74;CX3CL1;IFIH1;PLCG2;HLA-B
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.9251990311450431,-1.5271747316352797,0.023255813953488372,0.32935608802807154,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.9007677799535504,-1.5271463564414496,0.10909090909090909,0.32585283481427607,1.0,2/7,2.12%,MX1;STAT1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.8582231171594226,-1.5234602441135912,0.04,0.3398727710947816,1.0,2/9,4.75%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7317795111486743,1.5229390895719548,0.02127659574468085,1.0,1.0,8/18,17.18%,ITPR3;STIM1;ATP2A2;ITPR2;SLC8A1;ANK2;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.7985522258069275,-1.5212800652947036,0.03773584905660377,0.3451885864619571,1.0,3/17,4.75%,SLC6A6;SLC16A2;SLC38A3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.8039429746200332,-1.52126840883063,0.019230769230769232,0.34151636745704267,1.0,2/17,0.32%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.8375118815067955,-1.5212109755766017,0.018867924528301886,0.3380326167003652,1.0,1/8,0.08%,VCAM1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.8315113561375538,-1.5197916261815747,0.023809523809523808,0.3397914663960789,1.0,1/13,2.82%,OPTN
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.9500619855231086,1.519129542788546,0.0,1.0,1.0,2/7,2.02%,MMRN1;SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.9608227440589907,-1.5179527877061265,0.0,0.3362147842939668,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.9608227440589907,-1.5179527877061265,0.0,0.3362147842939668,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.9608227440589907,-1.5179527877061265,0.0,0.3362147842939668,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.8738403950489623,-1.5174904402380622,0.0,0.3348590451098373,1.0,5/14,6.40%,CX3CL1;ULK4;CTNNA2;NTNG1;SRGAP2C
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9455915873942498,-1.5158199345735062,0.0,0.3387578975791979,1.0,2/11,0.27%,HES1;TBX3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.8418005150752377,-1.515275561327048,0.02040816326530612,0.3373002791745815,1.0,2/13,2.44%,CYLD;ULK4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.7049345135104967,-1.5133496053260909,0.0,0.3441754658980885,1.0,1/32,0.08%,VCAM1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.8275369135143062,-1.5119328739880662,0.07547169811320754,0.34614610920464167,1.0,7/18,8.37%,HES1;KIAA1217;LGALS3;NR3C2;ARHGEF37;DSP;ACER2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.8370498377432164,-1.5119129448725417,0.0,0.3430506233183628,1.0,6/17,8.92%,HES1;PPARG;SP100;PRKN;NFKBIA;JUN
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6752462575135614,-1.510807076777381,0.017241379310344827,0.34310185804081794,1.0,27/49,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;RPL11;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.7588467475123666,-1.5074028964443376,0.038461538461538464,0.356475557089138,1.0,8/30,9.27%,CX3CL1;DDX60;OPTN;TNIP1;SERPINE1;NFKBIA;CD47;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.8842432418589662,-1.506456600066241,0.02040816326530612,0.35708598547634396,1.0,3/13,3.43%,CD74;SHLD1;VAV3
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.983603572645922,-1.5063466157930034,0.0,0.3542943730211796,1.0,1/5,0.08%,VCAM1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.9390202508828793,1.5059586228714619,0.0,1.0,1.0,1/5,4.59%,NAA50
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.7730597653539706,-1.5058236208970652,0.05555555555555555,0.35385752709924034,1.0,1/20,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.6490690153825512,1.5055355929434333,0.04878048780487805,1.0,1.0,3/38,1.51%,PDK4;ABL2;INSIG1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.8266539214751476,-1.5029801959019002,0.0,0.3618004802965817,1.0,2/15,1.57%,MX1;RIMS1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.8924080286929665,-1.5026931551586542,0.04,0.3596072661983938,1.0,4/10,6.99%,EPSTI1;ITGB5;SP100;LCP2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.8716021889988814,1.50240991818139,0.05357142857142857,1.0,1.0,1/9,0.08%,PDK4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.7407127763817003,-1.500366434809402,0.0196078431372549,0.3632099885131349,1.0,13/37,6.91%,IFI44L;RSAD2;MX1;IFIH1;ISG15;STAT1;IRF2;IFI27;IRF1;EIF2AK2;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.7407127763817003,-1.500366434809402,0.0196078431372549,0.3632099885131349,1.0,13/37,6.91%,IFI44L;RSAD2;MX1;IFIH1;ISG15;STAT1;IRF2;IFI27;IRF1;EIF2AK2;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.8067938867135498,1.5003113872357632,0.0,1.0,1.0,2/13,2.12%,TEAD4;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.9460596706503005,-1.4996825345526743,0.0,0.3637247001165633,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.9705830043846827,-1.4993362943201956,0.0,0.36186363061571003,1.0,1/7,0.24%,HES1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.9004935774031085,-1.4993212470960708,0.017543859649122806,0.358770779071986,1.0,1/10,0.24%,HES1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.6641806468838364,-1.4989760906483856,0.0,0.3565357759455638,1.0,14/52,8.07%,CD74;MX1;CYLD;PPARG;IFIH1;ISG15;PLCG2;IFI27;SP100;NUB1;CALCOCO2;NLRC5;B2M;TRIM25
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.9121284923184465,-1.4975524789071093,0.03571428571428571,0.36028390777395447,1.0,2/6,4.49%,SLC5A6;TAP1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.8847975400046062,1.49610599960763,0.01694915254237288,1.0,1.0,3/9,9.83%,PDK4;PIK3CA;ITGA5
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.8447564536818462,-1.495980009069165,0.05660377358490566,0.36370556959922146,1.0,1/10,0.24%,HES1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.752757535638136,-1.495900637535163,0.0784313725490196,0.3609615577572283,1.0,5/23,3.61%,BTG2;PLK2;CNOT8;NDRG1;SP100
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.763336187722397,-1.495612519259926,0.06,0.3592146649724772,1.0,3/15,12.32%,PSMB9;SERPINE1;VSIR
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.7655769020898947,-1.4943604834251516,0.018867924528301886,0.362304002575042,1.0,1/26,0.13%,CD74
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.9441516086628806,-1.4921831619042025,0.021739130434782608,0.3698570800175032,1.0,2/6,3.53%,VCAM1;TNIP1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6454192686574373,-1.491748471858045,0.016129032258064516,0.3688412717627372,1.0,29/53,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;RPL11;DHX29;RPS27;RPL27A;RPLP1;CUL4A;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.686426400007833,1.4915436819258123,0.0,1.0,1.0,6/32,8.39%,CREB5;GRM5;GRIA2;ST18;PEX5L;NRXN1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6576297236578078,1.4912792626997788,0.022222222222222223,1.0,1.0,11/37,11.61%,ATRNL1;NOVA1;SOX5;CADM2;GRIA2;SNAP25;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.9024624974112331,-1.4907030768204745,0.08695652173913043,0.37010445435695555,1.0,2/6,6.27%,DOK5;ZDHHC17
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.8851626246714044,1.4906536114961324,0.017543859649122806,1.0,1.0,3/8,9.83%,PDK4;PIK3CA;ITGA5
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6856368239645521,1.489411270319424,0.07142857142857142,1.0,1.0,13/27,12.06%,SMAD9;NOVA1;CADM2;GRIA2;SNAP25;MAPK10;FGF12;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1;CNTN1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.6417430077515192,-1.4883913940316182,0.0,0.3759209923945536,1.0,9/91,5.74%,CD74;HES1;CX3CL1;RIMS1;HGSNAT;FN1;CXCL12;SPG7;GEMIN5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.9344187177565042,-1.4880524538291993,0.0,0.3739741139139104,1.0,1/7,0.21%,RSAD2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.8873802062385018,-1.4878185193777622,0.021739130434782608,0.3723030020509364,1.0,1/11,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.781268908885403,1.487468922309859,0.05,1.0,1.0,6/15,13.31%,ITPR3;SNAP25;CHD7;CACNA1C;ITPR2;PPP3CB
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.829951248208982,-1.4874475691275248,0.07692307692307693,0.3709825240803985,1.0,5/11,14.13%,PPARG;LCP2;NFKB1;RORA;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.8758381461791815,-1.4873284204859438,0.017857142857142856,0.36871487366000466,1.0,3/13,2.23%,CD74;IFIH1;PLCG2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.9033459176697471,-1.4871808265768671,0.0425531914893617,0.36672158261505644,1.0,1/9,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.8887685608017072,-1.485234979630693,0.017241379310344827,0.3705543811106789,1.0,2/10,1.30%,RSAD2;IFIH1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.6289865306144298,-1.4833952657724514,0.016666666666666666,0.37582729355323996,1.0,27/85,14.93%,RPS12;CNOT8;RPL31;RPS18;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;NBDY;RPS14;RPS15;UPF3A;RPL28;RPL10;ATM;RPL9;RPL24;RPL37;PARN
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.8315521187662593,-1.4832797829396096,0.09615384615384616,0.3739820583926398,1.0,1/12,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.8974539948753113,-1.483254930138737,0.037037037037037035,0.3713098377101401,1.0,1/8,0.53%,CEMIP
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.7022473119773311,-1.48317424987477,0.016666666666666666,0.3689849500470254,1.0,6/42,2.12%,CX3CL1;PSMA1;GBP1;PSMB9;TMSB4X;STAT1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.8887157908962502,1.4783544861128257,0.020833333333333332,1.0,1.0,2/8,1.62%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.7036537235562189,-1.4772523549271828,0.01818181818181818,0.3927877820622569,1.0,4/50,1.41%,HES1;TBX3;PPARG;ABCA5
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6917859703319382,-1.4771864271286632,0.05172413793103448,0.39026585688404447,1.0,7/49,4.99%,VCAM1;NR4A1;FN1;ITIH5;CXCL12;LAMA4;COL8A1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8903409093804955,1.4771735327511286,0.02040816326530612,1.0,1.0,1/7,0.48%,GRIK2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.7919237400620969,-1.4768608000706105,0.08333333333333333,0.38876053486869877,1.0,2/17,2.39%,CD74;FN1
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.7052152135281522,-1.4764222423378939,0.04838709677419355,0.38832508010192246,1.0,7/34,8.42%,KIAA1217;TMEM117;ARHGEF37;SUN1;DSP;TMEM50B;COL18A1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.9411323715214402,-1.4753313596843034,0.020833333333333332,0.3903498535987528,1.0,1/6,0.24%,HES1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.7925643820176193,-1.474426928813634,0.09615384615384616,0.390943225606949,1.0,4/26,4.97%,VCAM1;CXCL12;LAMA4;MMRN2
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.7122548264993611,-1.4742184652997752,0.08771929824561403,0.3890350122437031,1.0,5/19,8.74%,CX3CL1;GBP1;NFKB1;TANK;CD47
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7306052747469973,1.4739020766955144,0.023809523809523808,1.0,1.0,15/34,12.03%,ZNF385D;NOVA1;NREP;PRKG1;CADM2;GRIA2;MAPK10;NTM;SGIP1;ROBO2;NRXN1;ADGRB3;CACNA1C;RBFOX1;FGF14
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.9412237374544292,-1.4736931230442833,0.02040816326530612,0.3889738165773096,1.0,2/7,0.53%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.9553031289915503,-1.4727425257763425,0.02127659574468085,0.3902877117137505,1.0,2/6,1.59%,SLC6A6;SLC16A2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.7818512122711381,-1.4724341946817534,0.07017543859649122,0.38892576007153673,1.0,4/23,7.22%,HES1;STAT1;PLXND1;MAML3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7045155272331429,1.4716678872066482,0.021739130434782608,1.0,1.0,8/28,14.48%,PDK4;GRM5;GRIA2;NRXN1;RTN1;LRRK2;BAALC;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8480344254199399,-1.4716503060975694,0.11363636363636363,0.3900795212558662,1.0,2/6,8.31%,SHLD1;TFRC
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.9022635094850535,-1.4708573675119652,0.04081632653061224,0.39100517734565393,1.0,1/9,0.13%,CD74
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8479844045026109,1.4703663396098714,0.02,1.0,1.0,2/8,4.67%,CRY1;HECTD4
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.8877782529417599,-1.4684719939799113,0.0392156862745098,0.39839531930549127,1.0,1/8,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8714033471830881,-1.4681750002293859,0.08,0.3968758849336864,1.0,2/5,9.46%,PPARG;PMAIP1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8910468831879386,-1.4676134763087962,0.07407407407407407,0.3966269748319601,1.0,2/9,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.8021802901370237,-1.467585440854985,0.03389830508474576,0.3941036615688276,1.0,1/12,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.8703469231762759,1.4658114308461743,0.0392156862745098,1.0,1.0,2/9,4.57%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9628917128184479,-1.4653408508525858,0.03773584905660377,0.4010760165885313,1.0,3/5,3.61%,MX1;ISG15;SP100
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.924930761942867,-1.4649199254544598,0.04081632653061224,0.40012353321534355,1.0,2/7,1.59%,SLC6A6;SLC16A2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.7092896119712162,-1.4643956508133285,0.08196721311475409,0.3999278797655271,1.0,8/34,12.24%,KIAA1217;SLC16A2;ITGB5;CHKA;SMARCA1;KCTD3;ADAMTS1;RORA
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5631789620376437,1.463635197388184,0.0851063829787234,1.0,1.0,8/73,3.16%,PDK4;ABL2;INSIG1;SLC26A3;PRKD1;TAF1;HSP90B1;SLC38A9
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6407411481657208,1.4636299446816563,0.024390243902439025,1.0,1.0,15/48,12.19%,ATRNL1;NOVA1;TAFA1;CADM2;GRIA2;SNAP25;MAPK10;FBXO7;PIK3CA;NRXN1;PARVA;ADGRB3;RBFOX1;CNTN1;GCNT2
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.8278119405621294,-1.4630240852229146,0.07692307692307693,0.4028960062444738,1.0,3/7,14.50%,TNIP1;ALG11;GCNT1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.8153152071357435,1.462266831478062,0.018518518518518517,1.0,1.0,4/12,8.61%,CRY1;MAPK10;UBE2B;ERCC6
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.7016920441008412,-1.4608594746875851,0.04838709677419355,0.409903541122002,1.0,3/41,2.15%,VCAM1;KIAA1217;IRF2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5997036379961975,-1.4605198695825974,0.016129032258064516,0.40872025442957677,1.0,10/135,3.24%,HES1;TBX3;CX3CL1;SLC6A6;TPM1;FN1;CNOT8;CXCL12;GRK5;UFL1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6731748475878994,-1.4602021685385722,0.05263157894736842,0.4075517588208068,1.0,8/47,5.60%,VCAM1;SAT1;TPM1;FN1;ITGB5;CXCL12;IL32;SERPINE1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.7062728208801674,-1.460143943070051,0.0,0.4054139235078583,1.0,6/48,4.94%,HES1;CX3CL1;EML1;SMARCA1;GPM6A;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.7601905747635014,-1.4600128137650175,0.0625,0.4033024812234648,1.0,4/22,8.37%,CX3CL1;PLXND1;SERPINE1;ACER2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7923007792864909,-1.4594605379408279,0.075,0.4025126573195774,1.0,7/14,10.89%,PARP14;PPARG;STAT1;CDC37;NLRC5;PARP9;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.8737300593810133,-1.458848754300147,0.03389830508474576,0.40302027585021105,1.0,1/8,0.24%,HES1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6859118542327991,-1.4585087315113896,0.06779661016949153,0.40217773562879844,1.0,8/39,8.63%,HES1;CYLD;TMSB4X;UFL1;SP100;NLRC5;NFKBIA;BHLHE40
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6088701304750298,1.4581439450893992,0.05405405405405406,1.0,1.0,10/54,8.90%,GRIK2;NOVA1;SLC12A6;GRM5;GRIA2;SNAP25;DNAJC5;DLGAP2;NRXN1;HOMER1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.9432541601931127,1.458071470634861,0.037037037037037035,1.0,1.0,1/5,0.08%,PDK4
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.8302495087624795,-1.454751346602316,0.057692307692307696,0.41667649699449344,1.0,1/13,0.53%,CEMIP
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.7910809147094902,-1.454300183566141,0.05555555555555555,0.41607844232494884,1.0,7/16,9.19%,SAMD9L;IFIH1;DDX60L;IRF1;SP100;NFKB1;HLA-E
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.6986481905926434,-1.4538203565364103,0.02,0.41586465183858995,1.0,5/40,5.74%,CD74;HES1;RIMS1;SPG7;GEMIN5
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8480670327394964,-1.4538184437028066,0.11627906976744186,0.4109721265228418,1.0,2/5,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.8480670327394964,-1.4538184437028066,0.11627906976744186,0.4109721265228418,1.0,2/5,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9696680470730493,-1.4534391212859556,0.0,0.40754408436908246,1.0,1/5,0.50%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9696680470730493,-1.4534391212859556,0.0,0.40754408436908246,1.0,1/5,0.50%,DDX60
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.9631813493074233,-1.4525666442544511,0.0,0.40848453741275814,1.0,1/7,0.27%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8306704916238479,-1.452470670223405,0.023809523809523808,0.40650106463128316,1.0,2/10,9.88%,SERPINE1;CST3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.7429513687529035,-1.4523981575289524,0.03508771929824561,0.4044799169926097,1.0,2/18,4.01%,CYLD;PRKN
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.8740605383613181,-1.449935086960718,0.018518518518518517,0.4116017762989672,1.0,4/8,7.68%,PPARG;ABCA5;NFKBIA;NFKB1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.8944450790884565,-1.4499313295572824,0.04,0.40927634253456624,1.0,1/6,2.66%,CDK14
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.878353258336911,-1.4498211215109207,0.13953488372093023,0.40751097212793475,1.0,2/8,2.23%,CX3CL1;PLCG2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7910182754597985,-1.4498065020976652,0.03571428571428571,0.40529336918628533,1.0,7/12,14.26%,RPS6;RPS28;RPS19;RPS7;RPS14;RPS15;RIOK3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.9133235041542038,1.448572128512494,0.0,1.0,1.0,2/6,4.62%,PRKD1;PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.7262366274162813,-1.4484646928283766,0.05172413793103448,0.40773509294533256,1.0,3/25,4.38%,CX3CL1;PRKN;LGALS3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.7887798607563645,-1.447779784091832,0.07692307692307693,0.4081078385686778,1.0,5/14,9.46%,SP100;LGALS3;TNFSF10;SERPINE1;PMAIP1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.9098032017870226,1.44776246997507,0.05660377358490566,1.0,1.0,4/8,4.94%,ERBB4;CDH2;PHACTR4;SEMA3F
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.8486309296117546,-1.4474916316183202,0.058823529411764705,0.4065617545483676,1.0,3/11,4.30%,PARP14;PARP12;ZC3HAV1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.735702681717193,-1.4474431711007358,0.037037037037037035,0.4045709262846647,1.0,1/28,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.7823902982576003,-1.4468842020416832,0.075,0.40432348401937457,1.0,1/10,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.8112538348289283,-1.4466206357915463,0.1346153846153846,0.4032224968943024,1.0,1/9,0.27%,TBX3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.8067706440186868,-1.445529071938786,0.10204081632653061,0.406107559039865,1.0,3/9,1.81%,CEMIP;OMD;HGSNAT
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.8996794273474729,-1.4452791195950239,0.04,0.40517821916585,1.0,2/6,4.30%,CNOT8;ZC3HAV1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6983551196807305,-1.4450608290245408,0.06382978723404255,0.4046519590724565,1.0,9/21,15.46%,IRF1;CDC37;SAMHD1;ERAP1;HLA-E;PARP9;APPL2;RIOK3;N4BP1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.8773560393898432,-1.4437097263728433,0.02127659574468085,0.40787477608782846,1.0,1/6,0.24%,HES1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.9485178600758535,1.4433279485282895,0.0,1.0,1.0,2/5,4.57%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.8100621908997572,1.4425210317584705,0.018518518518518517,1.0,1.0,2/10,1.51%,HSD17B4;INSIG1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.6565800681295075,-1.441676750807842,0.05172413793103448,0.4137314697003484,1.0,9/51,8.92%,BTG2;SAT1;RPS12;PLK2;NDRG1;TAP1;BLCAP;FOS;JUN
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.8211006335749996,-1.441526313475189,0.14516129032258066,0.4121182183182881,1.0,2/9,4.91%,BTG2;PABPC1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.822660607094223,-1.440883106103877,0.10416666666666667,0.4127767813697915,1.0,1/10,0.48%,NR4A1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7735605519240106,-1.4395998712781968,0.06382978723404255,0.4152341235808575,1.0,10/17,19.07%,PPARG;STAT1;LGALS3;AHI1;JAK2;PGK1;PPP2R3A;MFSD2A;CD34;PKD2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.892584875707231,-1.4390629457733866,0.08771929824561403,0.4154343701584069,1.0,2/8,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.7801218932361512,-1.4387262012462678,0.07692307692307693,0.4143870190881264,1.0,5/15,8.07%,CYLD;IFIH1;ISG15;NLRC5;TRIM25
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8642449246010809,-1.4380187430481455,0.08333333333333333,0.41496668877968823,1.0,2/6,2.23%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.9007163897251341,1.4380141767984997,0.038461538461538464,1.0,1.0,1/6,0.27%,HDAC9
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.923866208415537,-1.4372554765563832,0.0,0.41655895505245755,1.0,1/5,2.28%,SHLD1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.7203097346504456,-1.4367755708513226,0.08695652173913043,0.41616179597808106,1.0,3/27,5.82%,CD74;TIE1;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.7216514192371221,-1.4366319480002652,0.08163265306122448,0.41438892400550836,1.0,2/25,3.45%,CX3CL1;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.670765881140879,-1.4347311647021654,0.07142857142857142,0.42013141310926766,1.0,5/46,6.40%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.7873799844736329,-1.4343711951316962,0.06896551724137931,0.41903942033698777,1.0,5/23,7.01%,CYLD;TMSB4X;NR3C2;EIF2AK2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.6936082105862453,-1.4333764820761423,0.07142857142857142,0.42109488657414185,1.0,10/42,8.74%,CX3CL1;CYLD;PPARG;TMSB4X;UFL1;TNIP1;SNX6;SERPINE1;NFKBIA;CD47
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.6075607147082717,-1.4325500913681428,0.014705882352941176,0.42339020155705503,1.0,6/105,3.00%,CD74;TBX3;CX3CL1;KLHL20;PLK2;GRK5
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8362174783767045,-1.4307873828619833,0.08928571428571429,0.4275265509059037,1.0,3/10,3.08%,XAF1;STAT1;IRF1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.656973769251952,-1.4304987113402114,0.017543859649122806,0.42605920454476376,1.0,2/64,0.32%,VCAM1;CX3CL1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.782892653114035,-1.4298744065132403,0.0784313725490196,0.42696417269365194,1.0,2/19,3.93%,VCAM1;SNX6
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7531143481303029,1.4291352849474162,0.0851063829787234,1.0,1.0,2/13,1.62%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.8345555961572522,-1.4287528289920117,0.08163265306122448,0.4305641769732383,1.0,3/10,7.68%,MAP3K2;IRF1;NFKB1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.8784105731446236,-1.4282973046361827,0.09615384615384616,0.4300172403876965,1.0,1/6,0.27%,TBX3
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.8756206792757242,-1.4270952079487662,0.046511627906976744,0.432305023540152,1.0,1/9,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.6907521665965148,-1.42692896842068,0.07142857142857142,0.43105100309073674,1.0,2/30,2.26%,CYLD;PLK2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.7152335112939571,-1.4268224241176262,0.03773584905660377,0.4294084882162853,1.0,1/18,0.27%,TBX3
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.8897974528413937,1.4267542984427488,0.041666666666666664,1.0,1.0,1/6,0.05%,TRIM5
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8714712821638557,-1.4267065449726597,0.10909090909090909,0.42768184569373735,1.0,2/9,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9604733786870674,-1.426351844554437,0.0,0.4270125470306798,1.0,2/6,0.53%,CX3CL1;CEMIP
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7366355270193589,1.426199137763891,0.0625,1.0,1.0,7/19,15.43%,IL1R1;ITGA2;ITGA1;PGR;ITGA5;ITPR2;RAI14
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.7670945944834665,-1.4260442121447645,0.08888888888888889,0.4261521194659185,1.0,3/18,2.42%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.7272722389193265,-1.4256995362468483,0.03508771929824561,0.4257417442978254,1.0,2/29,2.63%,CD74;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.7014623631618991,-1.4241679913257295,0.10638297872340426,0.4296374096886789,1.0,7/27,7.81%,IFIH1;ISG15;STAT1;IRF1;OAS3;NFKB1;LRRFIP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7490671384735682,-1.4238690893693988,0.08620689655172414,0.428582126076662,1.0,3/18,5.60%,CD74;TMSB4X;SERPINE1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.7087437405496783,-1.423569406086112,0.0392156862745098,0.4258736187121132,1.0,2/17,9.85%,MLLT1;POLR2A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.7087437405496783,-1.423569406086112,0.0392156862745098,0.4258736187121132,1.0,2/17,9.85%,MLLT1;POLR2A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.8586777637077224,-1.4234452097388024,0.0625,0.4244658318147833,1.0,2/12,0.53%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.618457057531289,-1.4232604876351673,0.04838709677419355,0.42307078507037044,1.0,19/63,14.63%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;SMAD3;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7864412593074479,-1.4232014965152855,0.061224489795918366,0.42140289967754635,1.0,4/12,6.19%,IFIH1;ISG15;IRF1;OAS3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.9173459221110045,-1.4206096411379225,0.020833333333333332,0.42867184996617647,1.0,1/8,0.27%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.9173459221110045,-1.4206096411379225,0.020833333333333332,0.42867184996617647,1.0,1/8,0.27%,TBX3
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.9210084301147244,-1.4196115647460503,0.022222222222222223,0.4310845270449358,1.0,1/6,1.41%,ABCA5
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.8518357290681418,1.4190811639232614,0.06779661016949153,1.0,1.0,3/7,11.85%,PEX14;PCM1;CLASP1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.9363180514005938,1.4190056870390564,0.017543859649122806,1.0,1.0,2/5,4.25%,MCPH1;TENT4A
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.850576352991308,1.4189815804537902,0.018867924528301886,1.0,1.0,1/11,0.03%,CREB5
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7765475575696191,1.4187088106344898,0.06976744186046512,1.0,1.0,4/9,18.27%,INPP5A;PPP3CA;PPP3CB;EDN1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6345643130678962,-1.4186810201291102,0.06557377049180328,0.4328216908839822,1.0,15/56,12.70%,VCAM1;TLL1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.860868851146305,-1.4186177511910143,0.058823529411764705,0.43110106749810884,1.0,3/6,7.73%,CX3CL1;CXCL12;STK39
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.7144457120337008,-1.4177962798255106,0.1206896551724138,0.43231344462912535,1.0,2/24,2.23%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.6730506482495956,-1.416802835331325,0.1,0.4337458019942092,1.0,5/27,7.09%,HES1;PSMA1;PSMB9;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8860775300739031,1.4162885048958143,0.0851063829787234,1.0,1.0,1/5,4.04%,ZEB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.9377736483860178,-1.416205761647888,0.02,0.43369648034600566,1.0,1/7,0.13%,CD74
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8830245928143075,-1.4160662910145883,0.07272727272727272,0.4322761512351002,1.0,2/6,3.08%,STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.8706811857738329,1.4157108979869288,0.03773584905660377,1.0,1.0,1/6,0.74%,ABL2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.6746173862823887,1.415037176441813,0.10638297872340426,1.0,1.0,10/24,16.33%,GRM5;CADM2;GRIA2;SNAP25;NRXN1;ADGRB3;RBFOX1;NEGR1;PLPPR4;MRTFB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.576048337185485,-1.41500157441337,0.047619047619047616,0.434372909052292,1.0,15/140,6.40%,CD74;CX3CL1;CEMIP;SOD2;TMSB4X;TPM1;ULK4;CXCL12;CARMIL1;CASS4;CTNNA2;NTNG1;PLXND1;SERPINE1;SRGAP2C
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.6813799870656743,-1.4138295915619588,0.06,0.4369955339563414,1.0,3/29,6.99%,CD74;TIE1;LCP2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.7930769941356253,-1.4132160485456866,0.06382978723404255,0.4377003504678229,1.0,2/11,1.65%,PPARG;RREB1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.848410350543034,-1.4126420660492063,0.13953488372093023,0.43902827763885616,1.0,1/9,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.8512154072032284,-1.4119018433107087,0.1320754716981132,0.4384423984608403,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.8512154072032284,-1.4119018433107087,0.1320754716981132,0.4384423984608403,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.778257574149094,1.4109583523682858,0.07547169811320754,1.0,1.0,4/11,17.42%,NAA50;MORF4L1;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7619466840944136,1.4107134423762908,0.08333333333333333,1.0,1.0,1/14,0.08%,PDK4
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.8155060883852127,1.410520203561611,0.10638297872340426,1.0,1.0,6/11,17.18%,SLC12A6;SLC8A1;SLC24A2;ATP2B4;SLC39A10;ATP1A1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5598933894541389,-1.409471160170492,0.012987012987012988,0.4460066306581023,1.0,22/165,3.61%,VCAM1;RSAD2;CX3CL1;MX1;PSMA1;GBP1;XAF1;PSMB9;SOD2;ISG15;TMSB4X;STAT1;IRF2;FN1;IFI27;HLA-F;CXCL12;HLA-B;IRF1;HLA-C;IL32;SP100
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.9350781857472537,-1.4087483539210381,0.08333333333333333,0.44741013166948546,1.0,1/6,1.41%,ABCA5
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.6179056387171398,1.408090574756669,0.11363636363636363,1.0,1.0,15/36,16.15%,NOVA1;GRM5;CADM2;GRIA2;SNAP25;MAPK10;PRKX;NRXN1;NKAIN2;ADGRB3;RBFOX1;GCNT2;CREBRF;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6774899617856702,1.4080076961044345,0.1568627450980392,1.0,1.0,3/16,10.60%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7745349604197522,1.4079564540882281,0.044444444444444446,1.0,1.0,3/10,8.42%,GRIK2;BCR;PXK
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.9244988886398888,1.4075658089831573,0.07407407407407407,1.0,1.0,2/5,3.03%,CALR;HSP90B1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.9161589020929648,-1.4072482307278917,0.04,0.45108994671318875,1.0,1/6,0.82%,SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.44612933271268684,1.0,1/8,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.44612933271268684,1.0,1/8,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.44612933271268684,1.0,1/8,1.12%,GBP1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.7739977163877058,1.4066769227561435,0.10714285714285714,1.0,1.0,1/9,0.08%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.9230112657389038,-1.4066021647993252,0.057692307692307696,0.4442115496820012,1.0,1/5,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.9230112657389038,-1.4066021647993252,0.057692307692307696,0.4442115496820012,1.0,1/5,1.12%,GBP1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.6208854511954832,1.40637140877438,0.06818181818181818,1.0,1.0,8/45,8.15%,HDAC9;RBM20;ERBB4;HSPG2;FGF12;PIK3CA;UTY;TAB2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.6449600897187993,-1.4062159119895923,0.07017543859649122,0.44399411121251886,1.0,11/54,6.77%,CD74;MX1;KLHL20;XAF1;ISG15;STAT1;SP100;NUB1;EIF2AK2;CALCOCO2;SMAD3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7672434248782843,1.4060378534544666,0.046511627906976744,1.0,1.0,7/13,16.44%,GRM5;CDH2;NRXN1;HOMER1;DGKI;LRRK2;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.7090055785182076,-1.4055323099012411,0.019230769230769232,0.44510378322762023,1.0,5/37,3.72%,CD74;HES1;PARP14;PLCG2;CASS4
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.7661979249511279,-1.4052842062008324,0.1320754716981132,0.4439903031709079,1.0,3/13,11.26%,SHLD1;POLR2A;MSH2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.6282033577000453,-1.4046719862555472,0.06779661016949153,0.44386119262538104,1.0,7/46,2.39%,CX3CL1;CYLD;GBP1;IFIH1;ISG15;TMSB4X;FN1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.888877645767876,-1.403882541313587,0.02127659574468085,0.4450425606152313,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.8162826287677422,1.4038731195320082,0.0625,1.0,1.0,6/8,14.21%,RALA;FBXO7;DNAJC15;HSPD1;PINK1;MFF
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8710835683734441,-1.4035830184898208,0.08695652173913043,0.4442792081575787,1.0,1/8,0.50%,DDX60
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.8029637656278782,-1.4035782365073468,0.17777777777777778,0.44260000531229216,1.0,2/12,6.99%,PPARG;LCP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.8098562725123833,-1.4035720515276877,0.08,0.4408505981766704,1.0,3/13,2.12%,CX3CL1;PPARG;STAT1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.7660488550465587,-1.4027875784504853,0.07547169811320754,0.44169261481970107,1.0,3/14,4.75%,SLC6A6;SLC16A2;SLC38A3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.718198642593041,-1.40272022255671,0.08620689655172414,0.44008472274871424,1.0,6/28,6.56%,SLC22A5;ABCA5;CHKA;SLCO1A2;TAP1;SLCO2B1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.9436597463847854,1.4024606503032686,0.020833333333333332,1.0,1.0,1/5,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.7066259678123269,1.4018690363917126,0.15217391304347827,1.0,1.0,4/15,10.92%,TEAD4;RARB;PBX3;TBC1D23
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.8370575602610054,-1.4016593995333075,0.10909090909090909,0.4426556603143803,1.0,1/9,0.27%,TBX3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.9427427289256108,-1.401299584710431,0.018518518518518517,0.4426590309514946,1.0,1/6,1.01%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.8127902959696832,-1.4008511522230156,0.08163265306122448,0.44079016481195427,1.0,2/8,2.12%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.8127902959696832,-1.4008511522230156,0.08163265306122448,0.44079016481195427,1.0,2/8,2.12%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.827221940343738,-1.4004122972402004,0.08163265306122448,0.4403132848210642,1.0,2/10,4.01%,MX1;PRKN
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8699149386453275,-1.4001275646040454,0.10204081632653061,0.4396782193040862,1.0,1/5,0.48%,NR4A1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.8301406430516185,-1.399849445933658,0.06,0.43904800161548213,1.0,2/14,3.93%,VCAM1;SNX6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7937688867008255,-1.3986236953418083,0.0392156862745098,0.4417150621486931,1.0,2/7,10.07%,SHLD1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.8174036049477924,1.398622889586983,0.05555555555555555,1.0,1.0,1/8,0.74%,ABL2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.8477299260907101,-1.3979165044393622,0.05172413793103448,0.44240190921929806,1.0,1/10,0.24%,HES1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.7584719570583879,-1.3979074066455346,0.10909090909090909,0.4407324680524327,1.0,5/11,11.08%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7685823053699912,-1.3977876336278363,0.15217391304347827,0.43963137094703864,1.0,3/16,2.42%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7817347970332611,-1.3976226463588535,0.09259259259259259,0.438459420295073,1.0,2/12,5.37%,CYLD;CDC37
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.9134395145891192,-1.397463714093497,0.04,0.43586686242944295,1.0,1/5,0.37%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.9134395145891192,-1.397463714093497,0.04,0.43586686242944295,1.0,1/5,0.37%,MX1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.6849479498555511,-1.3968567210066798,0.11475409836065574,0.43675566263026655,1.0,4/33,6.72%,SLC22A5;SLC6A6;SLC38A3;TMEM30A
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.8507810770443514,1.396465245102173,0.02127659574468085,1.0,1.0,2/8,1.51%,HSD17B4;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8757313974513556,-1.395913475735688,0.061224489795918366,0.4389627799863287,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.8613166401634789,-1.395234949585491,0.0851063829787234,0.4397171917508414,1.0,2/9,3.43%,CD74;VAV3
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.9164987839221739,1.3949660675516902,0.06451612903225806,1.0,1.0,1/5,0.27%,HDAC9
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.6229588139937899,1.3945011561786842,0.05,1.0,1.0,5/29,7.17%,NOVA1;PRPF8;MBNL1;PPIG;IVNS1ABP
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.7559673396282859,1.3924152709057391,0.1,1.0,1.0,3/10,9.16%,CRY1;WRNIP1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.7491913275956632,-1.3915321904789777,0.11764705882352941,0.45222524831596644,1.0,1/17,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.8420893702194636,-1.3914897008324318,0.08,0.4506133315176333,1.0,1/6,0.21%,RSAD2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6259358074499816,-1.3912050015672608,0.04,0.4499731418935321,1.0,9/76,8.92%,TBX3;NR4A1;CYLD;GRK5;IRF1;CDC14A;SMAD3;RPL23;JUN
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.8979466613443225,-1.3909457814641795,0.06521739130434782,0.44926106925531073,1.0,1/5,0.08%,VCAM1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.7820754693893781,-1.390724734762862,0.08695652173913043,0.4483254004865491,1.0,1/10,1.04%,KLHL20
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7014196651351441,-1.3906043351786759,0.1111111111111111,0.447092576944248,1.0,1/18,0.37%,MX1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.7968118610263397,1.390536899762622,0.11904761904761904,1.0,1.0,1/11,0.58%,BTBD10
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6497382678810188,1.3904088388224332,0.07142857142857142,1.0,1.0,10/25,11.61%,ITPR3;GRM5;PRKG1;CADM2;GRIA2;SNAP25;NRXN1;CNTNAP2;ADGRB3;RBFOX1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7306759593268214,-1.3902842231100947,0.03571428571428571,0.44685268111511683,1.0,2/29,1.01%,TBX3;PPARG
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.9024906096379044,-1.3902155572702835,0.09803921568627451,0.44548306537340604,1.0,1/5,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8925002902280574,1.3900842561156892,0.02,1.0,1.0,1/6,0.05%,TRIM5
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.8297935571919487,-1.388670494956981,0.047619047619047616,0.4489334676558487,1.0,2/10,1.30%,CYLD;IFIH1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.7352898056872266,-1.3883525852812497,0.05660377358490566,0.44857725501841167,1.0,5/13,18.65%,ATP6V1E1;TFRC;IREB2;LMTK2;FTH1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7913909961252154,-1.3882075826830094,0.12,0.4475518961087716,1.0,1/13,0.32%,CX3CL1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.8130849138655845,1.3874340742124092,0.0425531914893617,1.0,1.0,1/7,1.94%,PRPF8
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.8661512163589085,-1.3871724923290283,0.0851063829787234,0.4502149006833395,1.0,1/5,2.36%,TPM1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.9464183688318207,-1.3869947866311063,0.02,0.44926509673264586,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.8906047818504488,-1.3869935465486614,0.0851063829787234,0.4476942397510632,1.0,3/7,9.46%,CYLD;TNFSF10;PMAIP1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.8645447350214892,-1.386900905543032,0.08695652173913043,0.4465022753467976,1.0,2/7,8.53%,LGALS3;CDA
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.8446042666211091,-1.3868337585614416,0.1509433962264151,0.44524525482330696,1.0,1/10,0.13%,CD74
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.8258502584751855,-1.3849091068597945,0.06,0.45148762316987645,1.0,2/8,4.38%,GBP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7753751317588127,-1.38427943401192,0.08771929824561403,0.45218843421241633,1.0,2/14,5.37%,CYLD;CDC37
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.9134970485204492,-1.3839974698273743,0.13043478260869565,0.45150545366098,1.0,1/5,0.32%,CX3CL1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6366168036685395,1.382996878149725,0.13636363636363635,1.0,1.0,8/25,15.22%,NOVA1;MBNL1;NOVA2;REST;KHDRBS3;CELF2;RBFOX1;KHDRBS1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.6401459757424578,-1.3828913009232982,0.07142857142857142,0.45422661778397944,1.0,6/42,7.04%,CYLD;BTG2;PSMA1;PSMB9;SMAD3;ANAPC16
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.730101432868642,1.3815462731947856,0.14285714285714285,1.0,1.0,3/12,12.46%,KDM4C;UTY;KDM5A
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.5895050597342842,-1.3815301730308747,0.01694915254237288,0.45649671407381087,1.0,11/89,8.42%,HES1;TBX3;BTG2;PPARG;SOD2;SLC16A2;IRF1;EIF2AK2;WARS1;B2M;COL18A1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.675448200035635,-1.380684842367175,0.09615384615384616,0.45770973038341267,1.0,16/32,9.19%,VCAM1;CX3CL1;GBP1;STAT1;IRF2;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;GBP4;B2M;TRIM25;CD47;HLA-E
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.8200691713307824,-1.3804877160817948,0.17307692307692307,0.45673092020978406,1.0,3/8,13.44%,HLA-F;B2M;HLA-A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.7519746272392035,-1.3803476651791278,0.14285714285714285,0.4556160202998598,1.0,2/11,4.38%,VCAM1;LGALS3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8360007011652804,1.3798724278202343,0.04,1.0,1.0,5/6,16.49%,ATP2A2;PACS2;PDZD8;VMP1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.7983534456752854,-1.3782503640331576,0.14583333333333334,0.46126421284323516,1.0,2/8,2.23%,ISG15;PLCG2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.6614141608885076,-1.3769099971916468,0.15217391304347827,0.46428764125274224,1.0,3/22,9.24%,MX1;TFRC;SNX25
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6494753291508836,1.3767619520164338,0.11764705882352941,1.0,1.0,3/22,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8485682151717592,-1.3766459200798902,0.08333333333333333,0.4636884224875575,1.0,2/8,3.93%,PPARG;SNX6
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.8408894128792406,-1.376399180118209,0.07547169811320754,0.46284679745077795,1.0,5/8,14.26%,RPS8;RPS28;RPS19;RPS14;RIOK3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.7896161853563146,-1.376163780473585,0.0,0.4620458478148165,1.0,1/16,0.37%,MX1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.9184702714852298,-1.3755894523874144,0.11904761904761904,0.46243908178396503,1.0,2/6,1.35%,PARP14;PARP12
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.8239096411837554,-1.374482494966255,0.09523809523809523,0.46422378557149335,1.0,3/7,7.14%,SP100;PLXND1;WARS1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.6890939886556479,1.3742316079704553,0.14893617021276595,1.0,1.0,1/16,0.05%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.8901202379244049,-1.3742125565720613,0.08,0.4638430543817799,1.0,2/7,3.43%,CD74;VAV3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.7926801137916901,-1.3732086151105591,0.08333333333333333,0.46609617540814346,1.0,2/10,2.79%,STAT1;CXCL12
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7528022728103124,-1.3731473517581294,0.20408163265306123,0.4649871047266535,1.0,4/20,8.92%,SOD2;TPM1;FOS;JUN
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6918680749605828,-1.37309477682211,0.14285714285714285,0.46364447646325535,1.0,1/24,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.9644660880400846,-1.372272360032421,0.023255813953488372,0.46488200623387727,1.0,1/5,0.21%,RSAD2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.7454997025620926,-1.3722658586727834,0.15384615384615385,0.4634117086265594,1.0,1/15,0.56%,CYLD
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6950083346184148,1.3720778558147533,0.058823529411764705,1.0,1.0,4/15,11.61%,ANO5;CADM2;CKMT2;RBFOX1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8478423349219667,1.3715968218074965,0.09803921568627451,1.0,1.0,2/6,9.16%,ABL2;ABL1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.7850558226838873,1.3712276195545627,0.10344827586206896,1.0,1.0,1/8,0.08%,PDK4
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6519417391986246,1.3709122825582598,0.14285714285714285,1.0,1.0,3/22,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.8071484809209318,1.3701463715764257,0.1346153846153846,1.0,1.0,1/7,0.96%,CRY1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.6283606402971962,-1.369640368817646,0.05357142857142857,0.4705351919209553,1.0,14/52,11.69%,CX3CL1;BTG2;IRF1;TNFSF10;EIF2AK2;LY6E;SERPINE1;LCP2;NFKBIA;NFKB1;SCARF1;BST2;IFNGR2;GPC3
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6955379555287569,1.3693017883059966,0.15789473684210525,1.0,1.0,9/18,18.78%,NRXN1;CNTNAP2;ABL1;PPM1F;NRP1;IL1RAPL1;NLGN1;RAC1;ROCK1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.7313936949182783,-1.3689743438250512,0.125,0.47133116589851676,1.0,1/20,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.868747770622607,-1.3674107220817822,0.06666666666666667,0.47526974337064415,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.841547379713588,-1.3666218460904955,0.04081632653061224,0.4760117667252743,1.0,3/10,6.19%,CD74;EIF2AK2;OAS3
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.607396279207376,-1.3645891360412847,0.08928571428571429,0.4826344395337599,1.0,7/60,9.46%,HES1;SLC22A5;CXCL12;FOS;BHLHE40;PRSS23;PMAIP1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.84029517077457,-1.3645032742513974,0.0425531914893617,0.4812028385724402,1.0,2/13,3.93%,VCAM1;SNX6
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.7052529943269253,-1.3630331688503086,0.06,0.48502690329730447,1.0,4/16,6.19%,IFIH1;ISG15;IRF1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.6405944030416326,-1.3623405049589825,0.0851063829787234,0.4857287838969026,1.0,3/37,4.86%,CD74;RFC3;TIE1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.7103090183287593,-1.36157169267632,0.07936507936507936,0.48722323472463036,1.0,5/25,6.56%,CD74;SOD2;PLA1A;CPM;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.7999727965863626,-1.3611756534190163,0.11764705882352941,0.4874172759003513,1.0,6/12,12.70%,LRPAP1;OPTN;PRKN;NFKB1;MTMR2;ITGAV
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.5304719239044621,1.3611158263543632,0.022727272727272728,1.0,1.0,8/73,3.16%,TRIM5;ABL2;DEPP1;EIF4G3;UBQLN1;MTDH;PRKD1;SLC38A9
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6849481595784533,1.3604021812631852,0.13725490196078433,1.0,1.0,3/17,8.87%,HDAC9;MORF4L1;REST
prerank,PanglaoDB_Augmented_2021__B Cells,-0.7725520913272883,-1.3597216685041458,0.10526315789473684,0.49097611884501724,1.0,1/15,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.8366905693749807,-1.3593771406299073,0.10638297872340426,0.49089408110779953,1.0,3/7,10.73%,DDX60;RPS19;APPL2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7811417615570103,-1.3590096417652184,0.14583333333333334,0.49058298671364287,1.0,2/11,0.40%,HES1;PARP14
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7596537838225992,-1.3584664703404044,0.25,0.4899991516658777,1.0,3/8,14.87%,WARS1;LARS1;PPA2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7596537838225992,-1.3584664703404044,0.25,0.4899991516658777,1.0,3/8,14.87%,WARS1;LARS1;PPA2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7782471625507006,-1.3581551941895742,0.10416666666666667,0.4894662354059228,1.0,6/12,14.63%,RPL23;PMAIP1;RPS7;RPS15;ATM;RPL37
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.7291487028187285,-1.3572807512274383,0.12962962962962962,0.49117169024116786,1.0,7/22,12.54%,SLC6A6;HEBP2;MAP3K5;FOS;ACER2;EFNB2;CLU
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.7065373144776323,1.3562339553736982,0.10204081632653061,1.0,1.0,3/14,10.17%,HDAC9;MORF4L1;HDAC7
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.787970825048766,1.3560134576478737,0.1320754716981132,1.0,1.0,4/8,20.35%,NAA50;CREBBP;EP300;NAA25
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.8872122365918241,1.354918322887002,0.08163265306122448,1.0,1.0,4/5,10.94%,ZBTB1;CBFB;ABL1;ZMIZ1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6616297329196604,-1.3538156430233586,0.0784313725490196,0.5007972831802231,1.0,14/43,12.70%,VCAM1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6616297329196604,-1.3538156430233586,0.0784313725490196,0.5007972831802231,1.0,14/43,12.70%,VCAM1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.7672070494365523,-1.3532734847663321,0.16363636363636364,0.5009441679419234,1.0,3/11,8.55%,CYLD;PRKN;TAOK3
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.7017774832125341,1.3519068736163076,0.04878048780487805,1.0,1.0,5/19,17.42%,NAA50;MORF4L1;ZZZ3;CREBBP;EP300
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.6643156507868738,1.350772634815698,0.11627906976744186,1.0,1.0,6/23,11.29%,ABL2;YES1;CSNK1G3;ABL1;PPP4R2;ST8SIA4
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.9314618657467462,-1.3505463653752738,0.05128205128205128,0.5074564497858779,1.0,1/5,0.56%,CYLD
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.9314618657467462,-1.3505463653752738,0.05128205128205128,0.5074564497858779,1.0,1/5,0.56%,CYLD
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.7639998606386355,-1.3505459995082136,0.10714285714285714,0.5059279665033903,1.0,3/13,2.74%,NR4A1;PPARG;FAM120B
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.6267589665061499,1.3504295443432106,0.0,1.0,1.0,8/31,10.73%,SLC26A3;TAF1;HSP90B1;SLC38A9;DIAPH1;CAPN2;ACTB;CPEB3
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.8249857482369894,-1.3501317512679862,0.0625,0.505867408334742,1.0,2/7,9.30%,VPS36;MVB12B
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5325056719641862,-1.3501077452602652,0.0,0.5043844521588077,1.0,21/180,8.98%,HES1;TBX3;CX3CL1;BTG2;SOD2;STAT1;FN1;CNOT8;GRK5;IRF1;UFL1;EIF2AK2;RPS6;WARS1;RPL23;TFRC;ACER2;COL18A1;CD47;JUN;STAT5B
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.8878649203557106,-1.3499088532370562,0.10638297872340426,0.5034777548863366,1.0,1/6,0.56%,CYLD
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.7056849645339494,1.349389880505044,0.13636363636363635,1.0,1.0,5/19,7.01%,INPP5F;PITPNM2;PI4KA;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.7877040382301458,-1.3493170848292904,0.15517241379310345,0.5043678909239488,1.0,1/10,2.42%,CNOT8
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.731289787971052,-1.3492443300018462,0.08163265306122448,0.5033726174469133,1.0,4/15,8.92%,PPARG;SMAD3;FOS;JUN
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.8703991623942606,1.3492215263074638,0.12962962962962962,1.0,1.0,2/6,4.25%,MCPH1;TENT4A
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.758299061348646,1.3482449612225722,0.07692307692307693,1.0,1.0,5/10,14.21%,FBXO7;HSP90AA1;DNAJC15;HSPD1;MFF
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.8971937355048273,-1.3481668429490063,0.10344827586206896,0.5061636045061172,1.0,2/6,2.07%,CYLD;TMSB4X
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.857033648501732,-1.3477863602618925,0.1320754716981132,0.5058542184508249,1.0,2/6,4.01%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6904205733699701,1.3470556555972117,0.08,1.0,1.0,6/22,11.71%,SMAD9;BMP6;SMAD6;HIVEP1;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6904205733699701,1.3470556555972117,0.08,1.0,1.0,6/22,11.71%,SMAD9;BMP6;SMAD6;HIVEP1;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.7532727358805295,-1.3469600882390167,0.125,0.5079381920461423,1.0,1/8,4.01%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.8296490286401994,-1.346138982113825,0.14285714285714285,0.5097621999177879,1.0,4/7,14.26%,NLRC5;HLA-E;RPS19;RIOK3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.7873137094427556,-1.3452385333602694,0.1346153846153846,0.511081503856959,1.0,1/7,1.30%,IFIH1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.7482458176659292,1.3444921432005303,0.09615384615384616,1.0,1.0,2/8,6.67%,VAPB;CTDSP2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.7123360606831494,-1.3440145744110235,0.16666666666666666,0.5136861818666096,1.0,2/15,2.23%,VCAM1;PLCG2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.8234188867637893,1.3438856053400032,0.08333333333333333,1.0,1.0,2/6,12.48%,BACH2;DENND5B
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.620819613184025,1.343189085148888,0.09523809523809523,1.0,1.0,9/22,17.74%,GRIA2;FGF12;LRRC7;HOMER1;FGF14;ANK2;NLGN1;CALM1;ANK3
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.7738817461358135,-1.342963148941353,0.1590909090909091,0.5162450185925624,1.0,2/10,4.01%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6440523012468561,-1.3428133219735736,0.140625,0.515238397463781,1.0,3/27,9.85%,NR4A1;CEP57;POLR2A
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.7459813376605252,-1.3427825698121119,0.06976744186046512,0.5137797895103385,1.0,2/11,10.94%,SERPINE1;RECK
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.7641144639208416,-1.3420442181279142,0.16666666666666666,0.5150685052383039,1.0,2/9,11.34%,VPS36;STAM2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6952390448952158,-1.3415786159173877,0.10638297872340426,0.5158339502588222,1.0,5/29,3.72%,CX3CL1;RREB1;FN1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.8619743120707414,1.340708751554046,0.12244897959183673,1.0,1.0,1/6,0.96%,CRY1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.7185707158817445,-1.3406581550479248,0.0851063829787234,0.5176842971434541,1.0,4/24,4.91%,BTG2;CNOT8;ZC3HAV1;PABPC1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.882256024856057,-1.3404813372003073,0.16666666666666666,0.5169896596798722,1.0,1/7,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.687951899260334,-1.3404629550699005,0.1111111111111111,0.5155167546665392,1.0,5/20,8.74%,CX3CL1;TPM1;CARMIL1;LIMCH1;CD47
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7592443983659811,-1.3401750077548322,0.19148936170212766,0.5150722228335982,1.0,4/8,6.91%,ISG15;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.8334763071046712,-1.3397897515994988,0.18867924528301888,0.5151088518868578,1.0,1/8,1.01%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.5559265114121934,-1.3395502643749804,0.11475409836065574,0.5143100161544064,1.0,4/106,2.23%,CD74;CX3CL1;CEMIP;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.7168225448166358,-1.339548523675543,0.125,0.5128612555455208,1.0,5/13,9.75%,ISG15;NLRC5;OAS3;SAMHD1;RPS19
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6564280357849634,-1.3380357241909995,0.12962962962962962,0.5163447002351842,1.0,3/34,3.88%,VCAM1;DOK5;MAP2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.716052183589109,1.3379041630709934,0.09090909090909091,1.0,1.0,7/14,17.03%,ABL2;YWHAB;PHACTR4;ABL1;SSBP1;POT1;PSEN1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.8513893578059903,-1.336944503268144,0.11538461538461539,0.5184775316471161,1.0,2/6,5.05%,CD74;EIF2AK2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6590683821704868,1.3357405796969821,0.075,1.0,1.0,9/18,12.75%,BTBD10;GRIA2;SNAP25;KCTD8;FGF12;ADGRB3;TOX2;RBFOX1;DPP10
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.7072614319146585,-1.3356871318846595,0.10526315789473684,0.5213358811498113,1.0,7/24,11.39%,SLC6A6;SLC5A6;SCN3A;SCN2A;TRPM6;TRPM3;NDFIP1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.8326886992064316,1.3350447374821628,0.16363636363636364,1.0,1.0,3/7,8.10%,ANGPT2;SEMA3F;ROBO2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8110993263817089,1.334832300107411,0.16326530612244897,1.0,1.0,1/7,1.57%,ERBB4
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.8738001297424649,-1.3347759393827634,0.12244897959183673,0.5233546819755132,1.0,3/5,10.65%,RPS8;RPS19;RPS14
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.8741134151358458,1.333565365312073,0.07407407407407407,1.0,1.0,1/6,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8500438334255226,1.3327543822705092,0.09090909090909091,1.0,1.0,1/6,0.74%,ABL2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8384897588003251,1.331613880289754,0.07547169811320754,1.0,1.0,3/5,13.86%,NRCAM;RTN4;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.6817933191222497,-1.3314402452134873,0.1568627450980392,0.5338983040789926,1.0,1/16,0.08%,VCAM1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6627311019718929,1.3293948292567495,0.12244897959183673,1.0,1.0,5/20,20.82%,PIK3CA;GAREM1;RPS6KA5;GRB2;ADAM17
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.8089602217736926,1.3276159531177094,0.16666666666666666,1.0,1.0,3/6,18.33%,HSP90B1;URI1;PPP6R3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.640972247777796,1.3275472113378604,0.09433962264150944,1.0,1.0,8/18,17.74%,UGCG;NRXN1;STX2;ANXA2;IL1RAPL1;NLGN1;PTEN;ANK3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.6181534616492739,1.3275213762746865,0.07142857142857142,1.0,1.0,10/29,12.06%,NOVA1;GRIA2;SNAP25;NTM;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1;CNTN1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.6536303799443983,1.3270325788377886,0.13043478260869565,1.0,1.0,6/24,7.01%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PLCB1;PIK3CA
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5929039516301333,1.326812784579313,0.08333333333333333,1.0,1.0,11/40,12.56%,ATRNL1;NOVA1;CADM2;GRIA2;SNAP25;RAB11FIP2;SLC25A46;CNTNAP2;ADGRB3;SMAD1;CHN1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.5394965475837643,1.3266282679985666,0.07142857142857142,1.0,1.0,10/60,12.86%,NOVA1;PRPF8;TENT4A;MBNL1;PPIG;HNRNPR;IVNS1ABP;SETX;CELF2;DICER1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.7023888767582687,-1.326530143091351,0.10909090909090909,0.5499706836898844,1.0,4/33,4.06%,KIAA1217;SLC16A2;ATP9A;SMARCA1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.7910160579741023,1.326427922514751,0.11320754716981132,1.0,1.0,3/8,11.29%,FUT8;MAN1A2;ST8SIA4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7201991240287915,1.32477661510053,0.13333333333333333,1.0,1.0,3/13,2.50%,ANO5;SLC12A6;CLIC1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.8590495104645065,1.32468762007013,0.061224489795918366,1.0,1.0,1/5,4.62%,PHACTR4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7912116647926897,-1.3244289884446578,0.10416666666666667,0.5558609623964371,1.0,1/7,0.24%,HES1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.7306790530329668,-1.3240787825974019,0.16981132075471697,0.5557551256765063,1.0,5/12,20.85%,PABPC1;MAPK14;FUS;ZFP36;LARP1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7805934538228265,1.3224876697003352,0.1320754716981132,1.0,1.0,3/7,18.19%,YWHAZ;CDC42;UVRAG
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.7184946622536945,1.3222045967631566,0.10638297872340426,1.0,1.0,3/9,17.34%,RTN4;RAB7A;CD81
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5890439225059034,1.322157967527899,0.14285714285714285,1.0,1.0,3/49,1.51%,PDK4;HDAC9;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8631320136693527,1.321977191279125,0.05357142857142857,1.0,1.0,1/5,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.8155349516013077,1.3216481763589045,0.08333333333333333,1.0,1.0,2/8,5.66%,PCM1;SYNE2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6272396498192951,1.3210335646373048,0.07142857142857142,1.0,1.0,14/28,18.27%,CALR;STIM1;VAPB;ATP2A2;MT2A;MT1M;MT1E;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;SLC39A10;EDN1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.815672109832662,1.3209748711582976,0.1111111111111111,1.0,1.0,2/5,15.91%,YWHAZ;CDC42
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.6158787454606732,1.3208784515371919,0.1,1.0,1.0,8/27,15.33%,TMTC1;TRAK1;TET2;GXYLT1;TMTC2;TMTC4;GALNT2;GALNT10
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7919492881016621,-1.3205864281684232,0.11538461538461539,0.5663259605065424,1.0,5/7,18.03%,FN1;SMAD3;ITGAV;LRRC32;CD34
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.8446454888830093,-1.320432543878711,0.10526315789473684,0.5652372886398475,1.0,5/9,13.44%,PLCG2;HLA-F;B2M;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.8336313907857537,-1.3200890338985503,0.1320754716981132,0.5650489958892364,1.0,1/8,1.01%,PPARG
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.8497504576145506,1.3195377680673055,0.11764705882352941,1.0,1.0,1/7,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.8361884239948384,1.3194297136204194,0.109375,1.0,1.0,2/5,2.66%,UGP2;FUT8
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.7774267236419223,-1.319164270517386,0.1346153846153846,0.5666457151577199,1.0,1/11,0.27%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8423502665116323,-1.3187529490782997,0.16363636363636364,0.5663398353872517,1.0,2/6,4.01%,RSAD2;PRKN
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.7269788003396775,-1.3180653923679806,0.2222222222222222,0.567495131995504,1.0,2/12,2.23%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.794071943272461,-1.3179121550955901,0.1509433962264151,0.5663894713241386,1.0,4/8,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.7543284406554688,-1.3161454207193,0.15384615384615385,0.5716941113945435,1.0,3/11,7.22%,STAT1;PLXND1;MAML3
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5962323747894203,1.3153115551037329,0.17777777777777778,1.0,1.0,4/33,10.15%,PDK4;PIK3CA;IDE;GRB10
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.7184939326195553,-1.3137838767951175,0.11904761904761904,0.5782192695430596,1.0,2/12,0.32%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5872667219933999,1.3127106087986582,0.06382978723404255,1.0,1.0,10/34,12.08%,GRIK2;GRM5;CDH2;BCR;DLGAP2;PXK;HOMER1;DGKI;USP46;LRRK2
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.7510261192825534,-1.311639490869782,0.08,0.5838601068243434,1.0,2/10,8.31%,ATP6V1E1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.8156545595678892,-1.3115307486941734,0.1320754716981132,0.5826660439516711,1.0,4/7,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.8511640109960379,-1.3102071613109934,0.09302325581395349,0.5855052467927037,1.0,3/6,9.19%,SHLD1;TFRC;HLA-E
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.587877902651796,1.3101025857741415,0.05555555555555555,1.0,1.0,14/34,18.27%,CALR;STIM1;VAPB;ATP2A2;PACS2;PDZD8;MICU3;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;PSEN1;EDN1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5713362291508185,1.3097549485599713,0.14285714285714285,1.0,1.0,12/30,11.61%,GRM5;CADM2;GRIA2;SNAP25;FRMD3;NCAM1;SGIP1;NRXN1;CNTNAP2;ADGRB3;NLK;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8796102871671078,1.3096459000902478,0.09259259259259259,1.0,1.0,1/5,0.05%,TRIM5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7385546680235395,1.3089790454746155,0.1346153846153846,1.0,1.0,6/12,19.34%,HSD17B4;ACAT1;ACOX1;ETFA;SCP2;HADHB
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8631785569254056,-1.3087226944639934,0.1111111111111111,0.5894527565944417,1.0,6/7,13.44%,HLA-F;HLA-B;HLA-C;B2M;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8148057598439469,-1.3084618148679337,0.1346153846153846,0.5889536292076184,1.0,1/7,2.26%,PLK2
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.8006265864887694,-1.3079126514775448,0.17391304347826086,0.5880468649380323,1.0,1/9,2.55%,ITGB5
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.8006265864887694,-1.3079126514775448,0.17391304347826086,0.5880468649380323,1.0,1/9,2.55%,ITGB5
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8573060951024127,-1.30789399185552,0.16,0.5866105315626446,1.0,2/5,7.01%,TMSB4X;NFKBIA
prerank,PanglaoDB_Augmented_2021__Basophils,0.6931754046628964,1.3077861828486284,0.08888888888888889,1.0,1.0,2/18,2.02%,JAZF1;SLC26A3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7617978496003054,-1.306908090689291,0.21739130434782608,0.5867183435462401,1.0,1/9,0.61%,TLL1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7617978496003054,-1.306908090689291,0.21739130434782608,0.5867183435462401,1.0,1/9,0.61%,TLL1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.6924131442937628,1.3065630791427383,0.18867924528301888,1.0,1.0,3/12,7.78%,TRAK1;HSPB1;TRAK2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5855875271477908,1.0,1/7,9.85%,POLR2A
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5855875271477908,1.0,1/7,9.85%,POLR2A
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.80076612627184,1.3062118428424339,0.10526315789473684,1.0,1.0,4/7,17.05%,MT2A;MT1M;MT1E;SLC39A10
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7395285420001138,1.3058874229697846,0.12962962962962962,1.0,1.0,5/9,24.89%,ANO6;WNK1;NEDD4L;AKAP6;YWHAE
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8496384429721232,-1.3055676802810756,0.16666666666666666,0.5872482486004756,1.0,1/5,1.57%,RIMS1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.794671492170913,-1.304983081383367,0.14814814814814814,0.5879428481931881,1.0,2/10,4.44%,UFL1;GPM6A
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.7239377395239395,-1.3048889796701906,0.17647058823529413,0.5866691984824929,1.0,4/13,12.01%,CX3CL1;NTNG1;AFAP1L2;SULF2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.8827529951631229,-1.3047259270043483,0.16326530612244897,0.5858375797733039,1.0,1/5,0.32%,CX3CL1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.714820562810917,-1.3041622028699353,0.1111111111111111,0.5863947157212491,1.0,4/16,14.13%,IL32;LCP2;RORA;IL18R1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.8253081477864255,-1.3036965295743612,0.21428571428571427,0.5869219175218393,1.0,1/6,3.24%,UFL1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5843386150271281,-1.3034172587773347,0.11475409836065574,0.586231072124547,1.0,16/74,8.71%,CD74;CX3CL1;APOL3;STAT1;PLCG2;PLK2;OPTN;UFL1;SHISA5;TNIP1;PRKN;TNFSF10;ZDHHC17;TRIM25;TFRC;TANK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.7910801670834366,-1.3030553490255055,0.14583333333333334,0.5859747737169423,1.0,4/12,10.97%,CD74;SERPINE1;AFAP1L2;RAB1A
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.5340007052990869,-1.3029191734872099,0.04838709677419355,0.5848599285879361,1.0,12/109,12.54%,CD74;PPARG;OPTN;ATP6V1E1;SNX6;ZDHHC17;TFRC;RAB1A;COPA;USO1;STX17;CLU
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.7975059109163218,-1.3022242290463615,0.125,0.585921716407269,1.0,3/8,9.08%,TMEM117;MAP3K5;ERO1A
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7144848871349344,1.3016466968461262,0.14634146341463414,1.0,1.0,11/14,27.25%,NRCAM;RTN1;DPYSL2;NRP1;UNC5C;ADGRG1;OPHN1;CDK6;NF1;MYH9;RASA1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.8480533106168362,1.3010054308409134,0.03333333333333333,1.0,1.0,1/7,0.96%,CRY1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6541250548764426,1.30033636576168,0.13953488372093023,1.0,1.0,7/20,17.69%,GRIA2;SNAP25;MAPK10;NRXN1;CNTN1;PLPPR4;KCNT2
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.6430070774836654,1.2989142208908286,0.08695652173913043,1.0,1.0,1/29,0.08%,PDK4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.8164016900917351,-1.2987497538912358,0.14285714285714285,0.5958539132253176,1.0,1/5,7.52%,JCAD
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7254979661750219,-1.297767486793472,0.1702127659574468,0.5976292457814157,1.0,5/9,17.74%,RFC3;UBC;PRIMPOL;RFC1;POLK
prerank,MSigDB_Hallmark_2020__Glycolysis,0.5797908510402842,1.29700628257502,0.14285714285714285,1.0,1.0,10/34,13.92%,UGP2;FUT8;P4HA1;IGFBP3;PKM;HOMER1;PPP2CB;AK3;GLCE;EXT1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7850676615307559,1.2967302503225364,0.1276595744680851,1.0,1.0,1/7,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.7170224310290901,1.2961889829307551,0.10869565217391304,1.0,1.0,6/15,19.34%,HSD17B4;ACAT1;ACOX1;AIG1;SCP2;HADHB
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6996437069419458,1.2959486985181408,0.20833333333333334,1.0,1.0,4/13,10.36%,ANKH;SMAD6;CHSY1;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.8044970881502241,1.2958289340172806,0.1346153846153846,1.0,1.0,1/7,7.62%,YTHDF2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.7926918647497297,-1.295331669042716,0.1951219512195122,0.6049017540766415,1.0,1/5,3.21%,CHKA
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.7732673512967211,-1.2951393966529834,0.17391304347826086,0.6042574820912695,1.0,3/15,9.46%,CYLD;TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.8595500093047048,-1.294983702824582,0.1875,0.603140046506054,1.0,3/5,10.07%,PARP14;ZC3HAV1;PARP9
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.5232793863143723,-1.2948574358674239,0.07692307692307693,0.6022129988962865,1.0,16/128,8.98%,VCAM1;CX3CL1;GBP1;STAT1;FN1;CXCL12;IRF1;IL32;GBP4;SMAD3;NFKB1;STK39;FOS;TANK;CD47;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.8179212510238424,1.2943600269519075,0.09615384615384616,1.0,1.0,2/5,9.22%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6898861701969266,1.2943142021154603,0.10714285714285714,1.0,1.0,8/15,24.01%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;CYFIP1;HSP90AB1;USP9X
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7961488278489316,-1.294313047379496,0.15384615384615385,0.6023966146512879,1.0,2/8,4.38%,CXCL12;LGALS3
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.658331792654396,1.2938585150027544,0.1320754716981132,1.0,1.0,10/24,21.65%,EIF4G3;EIF5;HSPB1;YTHDF2;EIF3E;KHDRBS1;EIF4A2;EIF5B;AGO2;EIF2AK3
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.7727985605821699,-1.2923732988340542,0.2037037037037037,0.6077542646010876,1.0,1/12,1.54%,SOD2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.7428444747784264,-1.292362228415529,0.17777777777777778,0.6062723930898508,1.0,3/13,11.29%,LRPAP1;AHI1;MTMR2
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7661116412578186,-1.2918642207566535,0.2708333333333333,0.6067844008027392,1.0,2/7,9.54%,RIMS1;ARHGAP17
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6558893705237092,-1.2912194668159995,0.125,0.6074242510154736,1.0,9/22,6.19%,RSAD2;MX1;IFIH1;ISG15;STAT1;TNIP1;ZC3HAV1;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.8214471149937885,1.2905544367081727,0.057692307692307696,1.0,1.0,3/9,11.71%,SMAD9;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.850348501532635,1.2899685615097851,0.18518518518518517,1.0,1.0,1/5,1.62%,SLC12A6
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.850348501532635,1.2899685615097851,0.18518518518518517,1.0,1.0,1/5,1.62%,SLC12A6
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5542318586913179,1.2899667353431428,0.08888888888888889,1.0,1.0,9/46,12.08%,INSIG1;SLC26A3;TAF1;HSP90B1;DIAPH1;URI1;ACTB;NCOA3;LRRK2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7904428800614827,-1.2895846301987415,0.18181818181818182,0.6118844140330335,1.0,4/6,17.74%,RFC3;UBC;RFC1;POLK
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.8355291364167884,-1.2890362025679365,0.1568627450980392,0.6121972365786229,1.0,1/6,2.34%,CENATAC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6371238698122146,1.2889595420893576,0.09259259259259259,1.0,1.0,4/23,9.16%,ABL2;ERBB4;TPST2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6661306643093556,-1.288929064708045,0.1346153846153846,0.6112144024484147,1.0,2/21,5.58%,CX3CL1;PLXND1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8163715753242375,1.2888062334676824,0.1323529411764706,1.0,1.0,3/5,17.74%,SLC8A1;CALM1;ANK3
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7630018177268509,1.288670387036989,0.09302325581395349,1.0,1.0,1/6,1.86%,RARB
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7281113472659608,-1.2881902846396116,0.29545454545454547,0.612353547304076,1.0,3/11,8.55%,CYLD;PRKN;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8185834379729757,1.2875882816886428,0.1875,1.0,1.0,1/6,1.57%,ERBB4
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5551295310103919,1.287438657933868,0.15384615384615385,1.0,1.0,9/42,15.22%,NOVA1;MBNL1;NOVA2;REST;KHDRBS3;CELF2;RBFOX1;SFSWAP;KHDRBS1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.78038063547439,1.2872758372857118,0.14285714285714285,1.0,1.0,4/8,13.39%,PPM1F;PPP2CB;PPP3CA;PPP2R2B
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6637698357241318,-1.2871224201444316,0.25,0.6144143588692624,1.0,1/16,0.24%,HES1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8667553154281774,-1.2865738141970389,0.14814814814814814,0.614615207163491,1.0,4/5,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.7385005612236601,1.2865430278521193,0.12244897959183673,1.0,1.0,3/12,11.55%,HSD17B4;ACAT1;ACOX1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.8392562180883643,-1.286121663580894,0.1956521739130435,0.6145587686802553,1.0,1/5,2.26%,PLK2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5596851593839807,-1.2860678818927183,0.09375,0.613326424096833,1.0,8/104,4.97%,VCAM1;IFI27;CXCL12;CAVIN2;LAMA4;GPM6A;TIE1;MMRN2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.7400117597280025,1.2858873470458758,0.10909090909090909,1.0,1.0,3/10,8.45%,GLO1;PKM;SLC16A1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.7160531356494045,1.2855799536125374,0.17777777777777778,1.0,1.0,1/11,0.74%,ABL2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7873309295566238,1.2854265833353296,0.17307692307692307,1.0,1.0,2/5,18.11%,CHPT1;AGPS
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.663268425682384,1.2851486007444077,0.2222222222222222,1.0,1.0,10/15,16.15%,GRM5;CADM2;GRIA2;SNAP25;NKAIN2;ADGRB3;RBFOX1;HS6ST3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7713377443004616,1.2841722093556422,0.16666666666666666,1.0,1.0,3/7,9.19%,DSE;CHSY1;CHST15
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.768706771470708,-1.283970504665536,0.22448979591836735,0.6191145558942204,1.0,1/10,0.21%,RSAD2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4778980411158214,-1.2839110522136354,0.0136986301369863,0.6178517266273769,1.0,32/334,8.98%,CD74;HES1;TBX3;CX3CL1;NR4A1;ZIC1;PPARG;RREB1;MAP3K2;STAT1;IRF2;HMGN1;IRF1;TNIP1;SP100;PRKN;SMARCA1;SERPINE1;NLRC5;MAP3K5;MEF2A;SMAD3;PAXBP1;NFKBIA;LMO2;MAML3;FOXK1;NFKB1;FOS;CEBPZ;JUN;STAT5B
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5752079385526504,1.2824441201789298,0.15,1.0,1.0,11/32,12.83%,GRM5;CADM2;GRIA2;SNAP25;NTM;SLC25A46;NRXN1;ADGRB3;S1PR1;RBFOX1;BAALC
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8467483799788071,-1.282426884457854,0.12244897959183673,0.6209103718939231,1.0,2/5,6.43%,ACSL4;MYRIP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.8467296965204004,-1.2822154577417302,0.13636363636363635,0.6198772075016314,1.0,2/5,10.17%,PRKN;RPS7
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6887726440218914,-1.282130661753827,0.12,0.6186721436111957,1.0,2/25,2.23%,CD74;PLCG2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5666763399912276,1.2816757657031213,0.15555555555555556,1.0,1.0,7/47,8.15%,HDAC9;RBM20;ERBB4;FGF12;CHD7;UTY;TAB2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.6261824277684502,-1.2811216872311442,0.1,0.6207492182702348,1.0,5/44,2.44%,CD74;CX3CL1;PLCG2;FN1;ULK4
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7318272404866124,1.2807235740175305,0.125,1.0,1.0,2/9,3.85%,ATP2A2;PACS2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.82115063743038,1.279208619595055,0.14035087719298245,1.0,1.0,4/5,17.74%,SLC12A6;TMTC2;SLC8A1;ANK3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8341758009230309,-1.2789222674900433,0.17391304347826086,0.6260095587350188,1.0,2/5,12.86%,RREB1;ENPP2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5946813581805495,-1.2787918840372707,0.08928571428571429,0.625049348279654,1.0,9/46,15.09%,SLC22A5;CXCL12;FOS;PRSS23;HOMER2;JAK2;ELOVL5;COX6C;FLNB
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.8387159805047303,-1.2777329361327132,0.21568627450980393,0.6273718069971147,1.0,1/5,3.72%,CASS4
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.7759247279615812,1.2774861014502006,0.14,1.0,1.0,5/9,13.20%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.7759247279615812,1.2774861014502006,0.14,1.0,1.0,5/9,13.20%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.8354737448396866,1.277380509890463,0.17647058823529413,1.0,1.0,1/6,5.29%,CCDC88A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.7706429206228431,-1.2773651229219918,0.1509433962264151,0.6271618555011569,1.0,3/9,2.36%,PPARG;SOD2;TPM1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.625055309238731,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.625055309238731,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6981581892044479,-1.2770129083654556,0.20833333333333334,0.6242077642389149,1.0,1/11,3.45%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.7658611544203461,-1.2764397215435033,0.21568627450980393,0.6247985745862075,1.0,1/6,2.52%,IFI27
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.7498878541668649,1.2761388716286426,0.23076923076923078,1.0,1.0,1/10,0.08%,PDK4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7520727734879276,1.2759558744235486,0.1836734693877551,1.0,1.0,5/6,24.86%,CBFB;ELF1;SLC39A10;CD81;ELF2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7888183111671073,1.2754353126842504,0.1568627450980392,1.0,1.0,2/7,11.13%,STIM1;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.6713135687649823,-1.2750857206892114,0.22807017543859648,0.6278539245049345,1.0,2/20,3.45%,CX3CL1;CARMIL1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.711536464949893,-1.274853714659662,0.1346153846153846,0.6270550137962109,1.0,4/14,10.94%,NR4A1;RNF213;EFNB2;RECK
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.8401762847629116,1.2746476798027224,0.10909090909090909,1.0,1.0,1/6,0.05%,TRIM5
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7664023028186585,-1.2742032288670473,0.17391304347826086,0.6279297796464639,1.0,2/9,4.01%,MX1;PRKN
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.593197706213949,1.2741750760047963,0.1509433962264151,1.0,1.0,4/27,5.21%,PDK4;CRY1;HECTD4;BACE2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.7992268268863778,1.274013073081285,0.21052631578947367,1.0,1.0,2/6,12.08%,SLC26A3;LRRK2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.8047291961192365,-1.2734982158676318,0.2765957446808511,0.6290209976509018,1.0,1/5,6.99%,LCP2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6861536603850181,-1.2734879957866034,0.2222222222222222,0.6275649305267099,1.0,10/20,13.44%,ISG15;OPTN;SERPINE1;OAS3;GBP4;RPL30;HLA-E;RPS19;RAB1A;HLA-A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6414790336936509,-1.2725906033251553,0.19607843137254902,0.6294811461352638,1.0,13/26,9.19%,VCAM1;GBP1;STAT1;IRF2;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;B2M;TRIM25;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6485436501555378,-1.272324031799186,0.14035087719298245,0.6289066772285389,1.0,3/35,4.01%,HES1;PPARG;PRKN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4853900243917701,-1.2718460733944743,0.04477611940298507,0.628917472762177,1.0,26/264,8.98%,HES1;TBX3;CX3CL1;NR4A1;PPARG;RREB1;STAT1;IRF2;IRF1;TNIP1;PRKN;SMARCA1;PLXND1;SERPINE1;NLRC5;MEF2A;SMAD3;PAXBP1;NFKBIA;LMO2;MAML3;NFKB1;FOS;CEBPZ;JUN;STAT5B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.8156968619805323,-1.2717487710672464,0.18867924528301888,0.6276929840864706,1.0,4/6,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7270323108391821,1.2717273634456971,0.17307692307692307,1.0,1.0,7/12,22.55%,TRAK1;TRAK2;ERCC6;ANXA1;RYK;CDK5RAP2;CDK6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.7070828052727656,-1.271494709238219,0.22,0.6257670841073878,1.0,6/17,13.23%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.7070828052727656,-1.271494709238219,0.22,0.6257670841073878,1.0,6/17,13.23%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7326751464964963,1.2711548001837563,0.1875,1.0,1.0,5/8,16.63%,KPNA3;RANBP2;KPNA1;CBLB;KPNA5
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6745974528606579,1.2711326150155873,0.16666666666666666,1.0,1.0,5/17,13.44%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.45834118792051337,1.270708971849584,0.06060606060606061,1.0,1.0,41/179,20.74%,PDK4;ABL2;CRY1;ERBB4;PRKG1;PRKD1;TAF1;BCR;PRAG1;MORC3;MAPK10;IGFBP3;CSNK1G3;STK38L;PRKX;PXK;YWHAZ;ABL1;NLK;LRRK2;PPP3CB;EPHA4;FNIP2;PINK1;ADAM10;RPS6KA5;STK24;NEK7;OXSR1;BAZ1B;WNK1;ACVR2A;PRKCA;ROCK1;RYK;LIMK2;TOP1;FES;TAOK1;DYRK1A;CDK12
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.7898273219560219,-1.2705479359365344,0.16,0.6277333696236548,1.0,4/7,18.91%,NFKBIA;NFKB1;ITGAV;PTPN2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.7996520760568091,1.2705471522325846,0.23404255319148937,1.0,1.0,2/7,9.19%,CRY1;CHST15
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.8125087152762409,1.2703070818861688,0.20833333333333334,1.0,1.0,1/5,7.92%,CA5B
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.7608854985102846,-1.2698582977913406,0.24,0.6287067132319385,1.0,2/7,16.02%,NTNG1;MFSD2A
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.750999580707008,-1.2697339179568206,0.19230769230769232,0.6277839337394089,1.0,1/12,1.01%,PPARG
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.6482966906550435,-1.2694047577462224,0.22916666666666666,0.6272953768244661,1.0,3/15,11.26%,GMPS;RFC3;MSH2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.788401322455116,-1.2693659087543399,0.17647058823529413,0.6260223856204291,1.0,3/5,18.03%,RAPGEF2;RIN2;CD34
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.852557630648499,-1.2692572272092204,0.15217391304347827,0.6249453997024047,1.0,2/5,12.54%,ABCA5;CLU
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.7529408991126363,1.268807547774071,0.17777777777777778,1.0,1.0,4/9,17.69%,SLC12A6;SLC24A2;ATP1A1;KCNT2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.595145879729162,-1.2685077538056122,0.21818181818181817,0.6261276459220008,1.0,5/36,8.55%,CYLD;ULK4;PRKN;MAP3K5;TAOK3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.7494573377487243,-1.2682898544926644,0.19298245614035087,0.6254814437076598,1.0,4/14,6.80%,SLC6A6;SLC5A6;SCN3A;SCN2A
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5608607973571764,-1.2674556702163076,0.17647058823529413,0.6263500856120671,1.0,3/24,11.10%,ATP9A;RAB1A;COPA
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.6418444583006322,-1.2669102984491474,0.16666666666666666,0.6269555628175719,1.0,3/26,4.86%,NR4A1;STAT1;TIE1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5792080441525228,-1.2663774209962186,0.17647058823529413,0.6270409243059051,1.0,14/39,13.44%,CD74;STAT1;TAP1;LCP2;WARS1;B2M;CD47;HLA-E;RPS19;IFNGR2;SRGN;RPL9;JAK2;HLA-A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.8174408771176433,-1.2663506066396837,0.22,0.6257883006373055,1.0,1/8,1.01%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7351649478600001,-1.2661264492849595,0.24,0.6251968444262944,1.0,2/6,4.38%,CXCL12;LGALS3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.7770282857361995,-1.264884981564609,0.22,0.6276451865269449,1.0,1/8,0.56%,CYLD
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6755966418809867,1.264841526929565,0.21568627450980393,1.0,1.0,1/13,0.16%,AFF3
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.7564457323806413,-1.2648037638749974,0.23529411764705882,0.6251128298808502,1.0,3/12,6.75%,CEMIP;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.7564457323806413,-1.2648037638749974,0.23529411764705882,0.6251128298808502,1.0,3/12,6.75%,CEMIP;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7879251201670444,-1.2644119581519848,0.22,0.6252707423597871,1.0,1/6,1.12%,GBP1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.6953261753191151,-1.264091026635298,0.13636363636363635,0.6249648023465935,1.0,1/11,0.50%,DDX60
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.7509733111025447,-1.2635995658533754,0.1509433962264151,0.6249374890881014,1.0,1/9,0.56%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5818719317112053,-1.263019587056226,0.18333333333333332,0.6255097736711088,1.0,4/50,10.09%,CX3CL1;RGS6;LARS1;NET1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.49483267484015997,-1.262929348442419,0.0945945945945946,0.6244460935377185,1.0,31/123,14.63%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;YTHDC1;RPS6;RPL7A;RPL38;MEF2A;WARS1;RPL23;RPL30;RPS28;RPS19;POLR2A;PTMA;RPS7;RPS14;RPS15;RPL28;RPL10;SRSF5;RPL9;SRRM1;EEF1A1;NUP54;RPL24;RPL37
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.8172969398346408,1.2628334404499748,0.1702127659574468,1.0,1.0,2/6,7.38%,TET2;WDR82
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.7345203473519448,-1.2621151942963267,0.1794871794871795,0.6256597435607685,1.0,5/13,6.91%,ISG15;CDC37;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6995548543781275,-1.2617771111835763,0.2916666666666667,0.6252646506551113,1.0,2/13,4.75%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5748937423430218,-1.2615320559997991,0.125,0.6246426956933597,1.0,5/58,6.40%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7281382027626347,-1.2614496682851333,0.2127659574468085,0.6236813092550062,1.0,1/9,0.24%,HES1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.7709764903300181,1.2613372629688555,0.1276595744680851,1.0,1.0,1/6,2.44%,NDUFAF2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.7709764903300181,1.2613372629688555,0.1276595744680851,1.0,1.0,1/6,2.44%,NDUFAF2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.8402905929830156,-1.2613269208105993,0.2391304347826087,0.6226557905669945,1.0,1/5,1.35%,PARP12
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7876610669939212,-1.2612518710227696,0.25925925925925924,0.6217482315891751,1.0,1/6,1.01%,PPARG
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.8040372111283007,-1.2611283900092107,0.23529411764705882,0.6209352118822709,1.0,1/6,1.62%,ATP9A
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7844951755007195,1.2610939038023812,0.23404255319148937,1.0,1.0,1/6,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.702913374218276,1.2606267145612071,0.14285714285714285,1.0,1.0,8/13,24.01%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;CYFIP1;HSP90AB1;USP9X
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.8186875177339943,-1.2605035971173508,0.14545454545454545,0.621369362509224,1.0,3/8,12.70%,PPARG;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.7271348385298281,-1.2589909887599064,0.2459016393442623,0.6248703889836797,1.0,3/12,6.80%,SLC6A6;SCN3A;SCN2A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8195187195065364,-1.25836577143859,0.2,0.6255419746275717,1.0,2/5,13.71%,JCAD;PPP1R16B
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5978818628727438,1.2579393856681318,0.14634146341463414,1.0,1.0,11/23,18.27%,CALR;STIM1;VAPB;ATP2A2;NPTN;TMTC2;SLC8A1;SLC24A2;ANK2;ATP2B4;EDN1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.8331161920316352,-1.257352609810358,0.2708333333333333,0.6272667070174814,1.0,3/5,12.86%,PDXDC1;ACER2;ENPP2
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.7144981866487892,-1.2572510591334178,0.25925925925925924,0.626203976316536,1.0,3/12,12.54%,ABCA5;LIMA1;CLU
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.596833816533682,1.2568562545971382,0.20454545454545456,1.0,1.0,5/22,15.64%,CRY1;UBQLN1;LRRK2;PINK1;UBE3A
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6374563165441669,1.2566057828945492,0.16981132075471697,1.0,1.0,8/20,18.27%,ABL2;ITPR3;ABL1;CACNA1C;NPTN;SLC8A1;ATP2B4;EDN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7228553307919092,1.256502898377424,0.1702127659574468,1.0,1.0,5/10,21.25%,ATP2A2;SLC8A1;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6935037987750104,1.2564016326348462,0.2,1.0,1.0,6/17,14.48%,ABL2;ITPR3;ABL1;CACNA1C;NPTN;SLC8A1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.8112461177360201,-1.2561752293551407,0.2,0.6281884737073005,1.0,2/5,5.60%,CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.7147343717393309,-1.255508290885868,0.19148936170212766,0.6290036447459273,1.0,2/13,0.40%,HES1;PARP14
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8725632328894453,-1.2540480327047399,0.1956521739130435,0.6323105768859536,1.0,1/5,2.82%,OPTN
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.8247158909402584,1.2536074795315142,0.1590909090909091,1.0,1.0,1/5,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7793025746410343,1.2534966062693635,0.18181818181818182,1.0,1.0,2/6,3.93%,PNP;HSPH1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6403016959568473,-1.253019250575693,0.16,0.6337583560853214,1.0,3/30,8.50%,CX3CL1;ACER2;LIMCH1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5415851587501264,-1.2527410005294775,0.11290322580645161,0.6335583644217113,1.0,5/86,5.74%,CD74;HES1;RIMS1;SPG7;GEMIN5
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.5335709289281425,-1.252388245826172,0.109375,0.6331599651546904,1.0,8/90,3.72%,CEMIP;SOD2;RREB1;PLCG2;FN1;CXCL12;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.6529874719798093,-1.2517258337090182,0.20754716981132076,0.6339120243987861,1.0,2/12,6.72%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6506235887014806,1.2507351972356473,0.15384615384615385,1.0,1.0,8/25,22.50%,TRAM2;VAPB;RTN4;LRRK2;TOR1AIP2;ATL2;EIF2AK3;RTN3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5779700845641118,1.250696862761656,0.15555555555555556,1.0,1.0,10/38,10.12%,ABL2;ERBB4;INPP5F;PRAG1;NRG2;PRKX;DIAPH1;FRMD5;ABL1;HACE1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7901593704811035,-1.2506073045875046,0.24489795918367346,0.6360057509945426,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.7973626397499376,-1.2505859455206243,0.2916666666666667,0.6347687393930762,1.0,3/6,18.35%,RAB1A;SEC23A;SEC24D
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.5143422138978809,-1.2504599674456178,0.08064516129032258,0.6337783692146921,1.0,19/149,8.39%,CD74;CX3CL1;DDX60;APOL3;PLCG2;PLK2;FN1;SHISA5;CASS4;PRKN;TNFSF10;NR3C2;EIF2AK2;ZDHHC17;JCAD;RPL23;TRIM25;TFRC;LARS1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.8579748914006863,-1.2497086904742456,0.2926829268292683,0.6344571778825336,1.0,2/5,4.01%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5349362145585375,-1.2497020408695405,0.09230769230769231,0.6331654653932793,1.0,10/129,4.01%,CD74;TBX3;CX3CL1;KLHL20;SOD2;PLK2;GRK5;RNF213;SNX6;PRKN
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.8577123033796911,-1.2496943888439103,0.2127659574468085,0.6305762470732507,1.0,1/6,0.53%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.8577123033796911,-1.2496943888439103,0.2127659574468085,0.6305762470732507,1.0,1/6,0.53%,CEMIP
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.7685530803646672,1.249605474912595,0.23076923076923078,1.0,1.0,4/7,14.50%,FUT8;MBNL1;CHD7;ADAM10
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.7048523818250592,-1.2486016199638124,0.24242424242424243,0.6325380384082907,1.0,2/10,11.34%,VPS36;STAM2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7337511893920464,1.2484057584933943,0.17073170731707318,1.0,1.0,1/9,0.27%,HDAC9
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.8682051414088758,1.2483607931290677,0.1111111111111111,1.0,1.0,3/5,12.78%,TMTC1;TMTC2;TMTC4
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7656411998364826,1.247707727375224,0.19230769230769232,1.0,1.0,2/6,6.06%,SOX5;TRPS1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.5486320680072091,-1.2475525616352845,0.12307692307692308,0.6342966182590921,1.0,8/65,11.39%,PARP14;LRPAP1;OPTN;PRKN;NFKB1;PARP9;MTMR2;NDFIP1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.5805361110685454,1.2474665361169386,0.18,1.0,1.0,11/29,24.36%,BCR;EVI5;RALGAPB;TIAM2;TBC1D5;TIAM1;RALGAPA2;RABGAP1L;RALGAPA1;TBC1D9;TBC1D22A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.6997258182909104,-1.2473579576544824,0.2553191489361702,0.6335594554857945,1.0,4/14,11.18%,NDRG1;ACER2;PMAIP1;FHIT
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.6282632633368767,1.2469723472393484,0.17391304347826086,1.0,1.0,6/23,13.65%,MCPH1;TENT4A;NAA50;DIS3L2;INO80;SMC1A
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6243660686712671,1.2467640993749656,0.23529411764705882,1.0,1.0,7/14,25.18%,IFNAR1;SMAD6;TAB2;GCH1;ADAM17;CYRIB;NOS3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.7698367726307771,1.2463655932108153,0.19230769230769232,1.0,1.0,5/7,21.25%,ITPR3;CACNA1C;SLC8A1;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7242203891211599,1.2455156628542559,0.20408163265306123,1.0,1.0,4/10,14.26%,SMAD6;ROBO2;PARVA;NRP1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.7396496256692481,-1.2453915587583873,0.2708333333333333,0.63839686547998,1.0,4/11,13.23%,SP100;NFKBIA;JUN;JAK2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.7851840277899336,1.2450794006453219,0.20754716981132076,1.0,1.0,2/6,10.60%,ABL2;SETX
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.5665218646564727,1.2448504252477788,0.1951219512195122,1.0,1.0,9/32,15.33%,FUT8;MGAT5;TRAK1;TET2;STT3B;ST8SIA4;GCNT2;GALNT2;GALNT10
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.751269226891421,1.2438934485768558,0.18181818181818182,1.0,1.0,1/7,1.99%,TRAM2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7704953133670152,-1.2436649080099074,0.2765957446808511,0.6426326508814085,1.0,2/7,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.7222787146262204,-1.2405435071026165,0.2,0.6505074101658385,1.0,4/11,12.32%,ISG15;PLCG2;CD47;VSIR
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.6609496813000111,-1.2402523641915517,0.19230769230769232,0.6500008539089202,1.0,5/14,11.08%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7609780251466083,-1.2397750865962671,0.1875,0.6499890119738791,1.0,3/8,20.27%,MMRN2;RHOA;MAP2K5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6060601062105779,1.2396443937236692,0.18181818181818182,1.0,1.0,2/24,1.57%,ABL2;ERBB4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.4952796871866977,1.2396408354470552,0.15789473684210525,1.0,1.0,8/54,15.78%,NOVA1;FASTKD1;HNRNPR;SETX;CELF2;DICER1;SND1;RBPMS
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5364559242132418,1.2387734351743107,0.1875,1.0,1.0,6/41,10.60%,RBM20;PTBP3;MBNL1;HNRNPLL;KHDRBS3;SETX
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5747208728424247,-1.2379605932870241,0.2,0.6545518126226938,1.0,3/38,2.79%,TBX3;ITGB5;CXCL12
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6663915705397526,-1.2368184962282058,0.2549019607843137,0.6554466995981381,1.0,4/11,13.49%,TANK;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6663915705397526,-1.2368184962282058,0.2549019607843137,0.6554466995981381,1.0,4/11,13.49%,TANK;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4927389231644831,-1.2366715890836033,0.0821917808219178,0.6545528448936221,1.0,33/209,13.23%,CD74;TBX3;CX3CL1;KLHL20;STAT1;PLK2;GRK5;NDRG1;VAV3;PRKN;TNFSF10;RASGRF2;RPS6;MAP3K5;NFKBIA;BCL2L14;NFKB1;TFRC;ACER2;JUN;BABAM2;PMAIP1;PTMA;NET1;AHI1;ACTN1;ARHGEF11;UBC;RPL10;MCF2L;CLU;ATM;JAK2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7630440509769287,1.2366656618065228,0.2,1.0,1.0,2/6,6.06%,SOX5;TRPS1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.7392651791108231,1.2366608875329312,0.15384615384615385,1.0,1.0,2/8,3.13%,BCL6;IL6R
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7607236615077715,1.236541761002811,0.21818181818181817,1.0,1.0,3/6,14.61%,PRKD1;CRTC3;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6343967385709238,1.2363985765981733,0.2,1.0,1.0,3/14,8.21%,GRIA2;LRRC7;DLGAP2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.698346450462061,1.2359971452414125,0.2826086956521739,1.0,1.0,1/8,1.57%,ERBB4
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7001225622272785,-1.233797951793856,0.20833333333333334,0.6620597246392913,1.0,2/10,11.61%,PLCG2;VIM
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7056616110781738,-1.2335607961537691,0.17777777777777778,0.6613466617073646,1.0,4/8,17.69%,RFC3;UBC;NPLOC4;RFC1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7177507993871411,1.2331173626402219,0.19607843137254902,1.0,1.0,5/11,14.48%,ITPR3;ATP2A2;MICU3;CACNA1C;SLC8A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.7474439454812389,-1.2327659058491447,0.18,0.662600619503685,1.0,2/10,7.28%,TPM1;DSP
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.731237033922836,-1.2326791372548764,0.2037037037037037,0.6614888427296793,1.0,3/10,14.08%,PRKN;B2M;IREB2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7664048175549073,1.2322821024035768,0.2037037037037037,1.0,1.0,4/7,17.18%,FGF12;PIK3CA;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8142951344523288,-1.2322750764323809,0.12244897959183673,0.6613912208182969,1.0,1/5,3.88%,MAP2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6425041106097162,-1.2310392882449004,0.23076923076923078,0.6638972587376019,1.0,4/20,8.92%,PPARG;SMAD3;FOS;JUN
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.6334440383660658,-1.2307687665125928,0.23076923076923078,0.663271433827207,1.0,3/35,2.79%,EPSTI1;PPARG;CXCL12
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.631458559568093,1.2303572681034374,0.14893617021276595,1.0,1.0,4/19,5.21%,PDK4;CRY1;HECTD4;BACE2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.6727360962628095,-1.2300507966654854,0.19230769230769232,0.6641327671058842,1.0,1/16,1.01%,PPARG
prerank,MSigDB_Hallmark_2020__Complement,-0.5514595207203206,-1.2288917785977111,0.18181818181818182,0.6665559200513481,1.0,13/60,8.53%,LAP3;PSMB9;IRF2;FN1;IRF1;LGALS3;CPM;CPQ;SERPINE1;GPD2;LCP2;DGKG;CDA
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.8276479472188929,1.2278128367904753,0.18,1.0,1.0,1/5,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.682925327203853,-1.227566763582503,0.3191489361702128,0.669573540483433,1.0,5/20,6.56%,SLC6A6;SLCO1A2;SLC5A6;SLC38A3;SLCO2B1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.7785165116568419,1.22728303768063,0.18518518518518517,1.0,1.0,1/5,5.05%,PEX14
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7369580882994037,-1.227248816649465,0.28846153846153844,0.6690038320191284,1.0,3/9,10.20%,MAP3K2;LCP2;BST2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8106261695352597,-1.2268577563429222,0.3,0.669162494894652,1.0,1/5,2.12%,STAT1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.7396380123937718,1.2263786834127934,0.1836734693877551,1.0,1.0,6/11,17.74%,FGF12;NKAIN2;ATP2B4;ATP1A1;WNK1;ANK3
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8173760684206979,-1.2263532419640866,0.25,0.6695690072233543,1.0,3/5,13.84%,B2M;UBC;PGK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.758760025980099,-1.2262507678205687,0.2558139534883721,0.6672835047130345,1.0,5/7,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.758760025980099,-1.2262507678205687,0.2558139534883721,0.6672835047130345,1.0,5/7,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.4895364442099799,-1.2261631932165777,0.1044776119402985,0.6661886059820673,1.0,15/152,8.15%,CD74;HES1;ZIC1;PPARG;RREB1;MAP3K2;STAT1;IRF1;SP100;SMARCA1;MAP3K5;SMAD3;FOXK1;NFKB1;FOS
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7841421786012615,-1.2261502351861988,0.20930232558139536,0.6649336088714901,1.0,2/5,8.23%,RPL7A;ZNHIT6
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.6308595857007928,1.2247950434573298,0.11538461538461539,1.0,1.0,6/20,22.10%,CCDC88A;CNOT2;RALB;G3BP1;FSCN1;RAB3GAP2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.759340795457532,-1.2245022227124926,0.25,0.6686866915938376,1.0,1/6,1.30%,IFIH1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.794735647142963,1.2244517479629704,0.1568627450980392,1.0,1.0,2/6,7.89%,PNP;ACAT1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.5481850859376511,-1.2231569440051866,0.14516129032258066,0.6712791760264274,1.0,17/58,14.82%,OMD;PPARG;RREB1;ITIH5;CAVIN2;LAMA4;SLC5A6;AGPAT3;GPD2;TANK;CMPK1;UBC;HIBCH;ENPP2;ARL4A;RIOK3;STOM
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.5702136359330731,-1.2230653142186318,0.21666666666666667,0.6702667223745727,1.0,10/54,8.31%,CD74;CX3CL1;APOL3;PLK2;SHISA5;PRKN;TNFSF10;ZDHHC17;TRIM25;TFRC
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.7782928386959485,-1.2226082228499575,0.3137254901960784,0.6703794181702111,1.0,1/5,3.37%,RNF213
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7080284987104846,-1.2221457178051742,0.3103448275862069,0.6703492513250016,1.0,1/10,0.21%,RSAD2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7241434319879491,-1.2218774469108828,0.13953488372093023,0.6698521215673279,1.0,6/10,22.60%,PABPC1;PARN;DHX36;FUS;LARP1;TENT2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.799549378231132,1.2216152908866726,0.25,1.0,1.0,1/5,4.33%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.799549378231132,1.2216152908866726,0.25,1.0,1.0,1/5,4.33%,TUBB4B
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.7180783814104271,-1.2211498552123672,0.24489795918367346,0.6708162538840279,1.0,1/10,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.6374340276526531,-1.220716739026486,0.20408163265306123,0.671068643174526,1.0,1/12,0.69%,ZIC1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6966161224027898,1.2195141891419237,0.19607843137254902,1.0,1.0,5/10,23.67%,PARVA;CDC42;CYFIP1;RAC1;GSN
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.6602893289669215,1.219199502112501,0.24444444444444444,1.0,1.0,2/17,3.03%,YWHAB;HSP90B1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5644597030007258,-1.2181379370241765,0.14285714285714285,0.6775995590319915,1.0,7/56,9.46%,MX1;IFI27;IRF1;SCN2A;NFKBIA;BCL2L14;PMAIP1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7316579584472173,1.2178404565302028,0.23404255319148937,1.0,1.0,1/7,0.24%,HSD17B4
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5849229592635854,-1.217834013284606,0.14754098360655737,0.6771931514865072,1.0,5/46,6.00%,HES1;CXCL12;DOK5;SLC38A3;SPC25
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.7943338280272306,-1.2169990013244063,0.3191489361702128,0.6789405300198194,1.0,3/5,18.25%,DSP;VIM;KLHL24
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.558322896201025,1.216622074176586,0.2765957446808511,1.0,1.0,10/25,17.18%,ITPR3;STIM1;ATP2A2;CELF2;ITPR2;SLC8A1;ANK2;CALM1;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.6300188414665009,-1.2165362001163078,0.21568627450980393,0.6791153262114281,1.0,1/21,0.56%,CYLD
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.7032163358597171,1.216177376979889,0.25,1.0,1.0,6/10,19.73%,ABL2;ABL1;NRP1;CDC42;ESAM;FES
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.7419861900568627,1.2153310874701875,0.2608695652173913,1.0,1.0,2/7,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.6730600778823648,-1.215094004935431,0.28,0.6823552787222732,1.0,1/17,0.56%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.81892781942834,-1.2149703501729967,0.3181818181818182,0.6813829405602291,1.0,1/5,9.85%,POLR2A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7869183724259419,1.2149198253075493,0.2708333333333333,1.0,1.0,3/5,10.31%,TET2;UPP1;DPYSL2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.8104505328319466,1.2146554861235428,0.23076923076923078,1.0,1.0,2/5,13.86%,ANXA2;EPHA4
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.6438110012570459,-1.214333758931896,0.2830188679245283,0.6823306573155796,1.0,3/18,8.55%,ULK4;EIF2AK2;TAOK3
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.7785547447799406,1.2139162019491512,0.2222222222222222,1.0,1.0,2/5,17.32%,PXK;WNK1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7599459406372433,-1.2132935268220337,0.24074074074074073,0.683892460824218,1.0,1/6,0.24%,HES1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5955960483991752,1.2132158871972705,0.19230769230769232,1.0,1.0,4/19,11.77%,PSMD14;UIMC1;ERCC6;HERC2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5748894812456996,-1.2130551943365424,0.25,0.6835392210522631,1.0,8/44,8.74%,CX3CL1;PSMA1;GBP1;PSMB9;NFKBIA;NFKB1;TANK;CD47
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8186148325543612,1.2123294145025805,0.18518518518518517,1.0,1.0,2/5,6.51%,CALR;CTBP2
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.7048767529148857,1.2112872387661768,0.22916666666666666,1.0,1.0,2/6,8.07%,YWHAB;URI1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7723813083244577,1.2105432139901657,0.21739130434782608,1.0,1.0,2/5,17.34%,SLC39A10;CD81
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.6634290790658922,-1.2099368272367286,0.27906976744186046,0.6918417826886438,1.0,4/24,8.37%,PPARG;TNFSF10;SMAD3;ACER2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6249566223697032,1.2093430682273292,0.2,1.0,1.0,6/17,17.42%,TAF1;ZBTB1;YY1;INO80;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.6409716705395052,1.2090063057185307,0.18,1.0,1.0,2/16,0.72%,PDK4;PSMD14
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.7513725795050004,-1.2079558261252101,0.24444444444444444,0.6964676960911657,1.0,1/11,2.36%,TPM1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6715261771827821,-1.2074147210071586,0.37209302325581395,0.6968048048672736,1.0,2/11,14.37%,SAMHD1;PRIMPOL
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7327966799645518,-1.2064717548073631,0.28888888888888886,0.6983841728088526,1.0,2/6,19.81%,IGF2R;CFL1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.7081200312443499,1.2055544968895449,0.32,1.0,1.0,7/9,26.72%,ZMYND11;RNF168;WDR43;CDK12;CDC73;TCERG1;BRD4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.7194224093253467,-1.2051827438924956,0.29411764705882354,0.7008639201542755,1.0,3/8,20.85%,PABPC1;FUS;LARP1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.568764415768738,-1.2042637308136621,0.2857142857142857,0.7021938683602075,1.0,3/36,1.51%,PPARG;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.5253700741654198,-1.2037162711932499,0.24528301886792453,0.7027141106834408,1.0,1/65,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.7196252966057342,-1.2033124434366171,0.23076923076923078,0.7026838488124595,1.0,3/7,13.89%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.8230121424503463,1.203181153461334,0.18604651162790697,1.0,1.0,2/6,10.94%,ZBTB1;ZMIZ1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5245797171209925,1.2024389249608913,0.1951219512195122,1.0,1.0,18/53,21.35%,DUSP6;BTRC;CTDSP2;PPM1F;CDC14B;PPP4R2;PPP1CB;PPP2CB;PPP3CA;PTPN21;PPP3CB;PLPPR4;PTEN;PPP6C;MTMR3;PTPN1;PPP4R1;PPP2R5E
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.7379264629085843,-1.201880068873738,0.3125,0.7055479337349955,1.0,2/7,4.01%,SOD2;PRKN
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.5834708249788154,1.2017881816985658,0.22033898305084745,1.0,1.0,7/27,9.16%,ABL2;ERBB4;INPP5F;PRAG1;NRG2;DIAPH1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5235824508407354,-1.2017022619833437,0.23529411764705882,0.7045365709805689,1.0,17/70,14.13%,CD74;IFIH1;ISG15;PLCG2;IRF1;EIF2AK2;SERPINE1;NFKB1;LRRFIP1;HLA-E;AFAP1L2;RAB1A;SULF2;RORA;HLA-A;TBK1;IL18R1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7828396728195354,-1.201472335616686,0.18,0.7040549941227686,1.0,1/5,4.38%,LGALS3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7700067635740433,-1.2009847663534625,0.3076923076923077,0.7041780665586491,1.0,2/5,8.71%,TNIP1;TANK
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6220880634571277,-1.2008758252693739,0.2777777777777778,0.7032524467044623,1.0,6/16,17.74%,HMGN1;RFC3;POLR2A;UBC;RFC1;POLK
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7489245502577125,1.2008230449772213,0.22916666666666666,1.0,1.0,4/6,21.25%,CACNA1C;SLC8A1;ATP1A1;RYR2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7754734162292172,1.1992108387815468,0.19230769230769232,1.0,1.0,2/6,8.10%,SMAD6;ROBO2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5383276949911991,-1.1989374678466413,0.2,0.7071742812225318,1.0,8/51,10.92%,RHOBTB1;TPM1;CARMIL1;CASS4;PPP1R9A;ARHGAP17;ACTN1;CD2AP
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.6759449744672352,-1.1978747926412756,0.2631578947368421,0.7088962461091916,1.0,3/14,4.01%,SOD2;SNX6;PRKN
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7147490676547876,-1.1976760082879552,0.3125,0.7084883226178467,1.0,1/7,2.36%,TPM1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7919042763758116,-1.1973511483309685,0.3125,0.7081396983668314,1.0,4/7,11.58%,RPS28;RPS19;RPS14;RPS15
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.852018010139237,-1.1972682365023557,0.2711864406779661,0.7071191172004395,1.0,1/5,4.28%,SPG7
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.7274592366665709,1.1967125233858864,0.3018867924528302,1.0,1.0,1/7,2.79%,PRKD1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6738693332077241,1.196380824851219,0.19607843137254902,1.0,1.0,7/13,25.63%,ABL1;PPM1F;NRP1;RAC1;ROCK1;TEK;MAP4K4
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.660659974671639,1.1960972287657314,0.24528301886792453,1.0,1.0,1/10,2.02%,SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6361699803861075,1.1959898995194327,0.25925925925925924,1.0,1.0,5/10,20.82%,TAF1;NCOA3;NRP1;EDN1;ADAM17
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5933246838435922,1.19570509746377,0.2558139534883721,1.0,1.0,9/29,20.82%,ERBB4;NRG2;PIK3CA;HSP90AA1;GAREM1;RPS6KA5;GRB2;PRKCA;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.7804318097745657,-1.1956846772654122,0.25925925925925924,0.7106526668759731,1.0,1/6,10.07%,PARP9
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6796862282273934,-1.1954160987967521,0.2222222222222222,0.7099953689395351,1.0,1/8,1.30%,IFIH1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.7543826616535569,1.1949768253643935,0.2909090909090909,1.0,1.0,2/8,4.57%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7305464501258911,1.194861424447174,0.21568627450980393,1.0,1.0,4/7,23.45%,HECTD4;CHST15;HK1;GALK2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.7536352872614444,1.1948344151879258,0.32786885245901637,1.0,1.0,1/5,7.57%,SMAD6
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.6948669814687028,-1.1942176626754233,0.26785714285714285,0.7120761164972397,1.0,2/11,5.60%,TNFSF10;SERPINE1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.6375083598410135,1.19391523952433,0.2807017543859649,1.0,1.0,2/13,2.55%,HDAC9;CDH2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5991863760305738,1.1936396124991133,0.27906976744186046,1.0,1.0,7/15,27.22%,OTUD7B;ROCK2;PICALM;NEDD4L;MFHAS1;CTNNA1;LATS2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7701870468101568,-1.1936001908817102,0.19148936170212766,0.7123161301126422,1.0,2/9,2.12%,CX3CL1;STAT1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7981855037041051,1.1929721288097925,0.2857142857142857,1.0,1.0,1/5,2.55%,CDH2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.6726903110576729,-1.19261678475883,0.2708333333333333,0.7144614226631306,1.0,3/14,7.60%,PIGC;PLA1A;GPCPD1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7117149606103915,1.1922461573681595,0.28,1.0,1.0,7/10,25.63%,ABL1;PPM1F;NRP1;RAC1;ROCK1;TEK;MAP4K4
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6487180571422805,-1.1919273918566484,0.25925925925925924,0.7148104361704959,1.0,4/22,3.88%,ZIC1;PARP12;ISG15;MAP2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.5915981154584102,-1.1914245327108794,0.2786885245901639,0.7151771871213108,1.0,4/26,2.12%,PSMA1;PSMB9;TMSB4X;STAT1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.7365447779393148,1.191089802152706,0.2553191489361702,1.0,1.0,6/10,21.33%,NAV3;CLASP1;RAC1;FES;CDK5RAP2;CLIP1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.7116990912950018,-1.1908518381294384,0.2765957446808511,0.7157322090843793,1.0,3/7,9.75%,LGALS3;CD47;RPS19
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6752760565375285,1.1907530979411516,0.21739130434782608,1.0,1.0,4/9,23.11%,PITPNC1;SCP2;PITPNB;PRELID2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.48429492622255604,-1.190066937955449,0.22807017543859648,0.7165501891013751,1.0,12/88,9.03%,CYLD;PSMA1;IFIH1;PSMB9;TNIP1;PRKN;SMAD3;NFKBIA;FOXK1;ATXN7;SENP7;BABAM2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5767771519668797,1.1895438919379167,0.30612244897959184,1.0,1.0,6/20,17.42%,TAF1;ZBTB1;YY1;INO80;CREBBP;EP300
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7235967012503327,1.1891554731053795,0.17647058823529413,1.0,1.0,6/6,27.76%,ABL1;NRP1;CDC42;FES;TEK;BCAS3
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5087044773750642,1.1891100968000063,0.23684210526315788,1.0,1.0,19/60,21.35%,DUSP6;BTRC;CTDSP2;PPM1F;CDC14B;PPP4R2;PPP1CB;PPP2CB;PPP3CA;PTPN21;PPP3CB;PPP2R2B;PTEN;PPP6C;MTMR3;RPAP2;PTPN1;PPP4R1;PPP2R5E
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7467421508439246,1.1890634258166364,0.22448979591836735,1.0,1.0,6/9,23.61%,FGF12;CACNA1C;ANK2;ATP1A1;RYR2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.6793996048632919,-1.1888622006640734,0.3137254901960784,0.7182531175653872,1.0,2/14,3.61%,PPARG;SP100
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6990101405347494,1.1887502177598241,0.2909090909090909,1.0,1.0,1/7,1.99%,TRAM2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7534886299772213,-1.1887379298304754,0.2727272727272727,0.7159936781608102,1.0,1/5,0.40%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7534886299772213,-1.1887379298304754,0.2727272727272727,0.7159936781608102,1.0,1/5,0.40%,PARP14
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7118850746864983,1.186387963109705,0.27450980392156865,1.0,1.0,2/7,15.83%,DIAPH1;ANK2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.42614967021278566,1.1860086714811875,0.12195121951219512,1.0,1.0,34/142,19.12%,PDK4;ERBB4;COL4A2;PRKD1;ACTG1;YES1;ANGPT2;PLCB1;PIK3CA;HSP90AA1;ELMO1;ACTB;IDE;GRB10;SETX;FRS2;CHN1;AP2B1;EPHA4;NRP1;GRB2;CDC42;APPL1;PSEN1;ROR1;CYFIP1;TIAM1;RAC1;WASF2;FOXC1;ROCK1;PXN;CRK;RYK
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.5768642812743162,-1.1858626314836616,0.25925925925925924,0.7233443316122363,1.0,6/29,9.99%,BTG2;CNOT8;EIF2AK2;NFKB1;CST3;CAPRIN1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6958452295388966,1.1856411052126297,0.2909090909090909,1.0,1.0,7/11,22.90%,GRM5;SOBP;CHD7;SHROOM4;CYFIP1;NIPBL;NF1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5791366108246967,-1.1849673029588284,0.26785714285714285,0.7244979046012894,1.0,3/38,0.93%,TBX3;TLL1;KIAA1217
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.5563497820146925,-1.1843599016222524,0.2698412698412698,0.72486100053355,1.0,3/42,4.06%,TBX3;FN1;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.8083992587924345,-1.183698441331319,0.32608695652173914,0.7258022119010118,1.0,1/5,2.23%,PLCG2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6114879147193334,-1.183664807492024,0.22641509433962265,0.7246131624592493,1.0,3/19,10.23%,SLC5A6;CPM;BTD
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7845915081876498,1.1833250091877279,0.2978723404255319,1.0,1.0,1/5,0.53%,PNP
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.6592385719781501,-1.1832006584062826,0.27586206896551724,0.7247506409443724,1.0,2/16,5.05%,NR3C2;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.7095104938227537,-1.182022549376761,0.2830188679245283,0.726653840155613,1.0,3/10,2.36%,PPARG;SOD2;TPM1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7059363886500671,1.1818103805763829,0.2459016393442623,1.0,1.0,2/6,21.57%,DICER1;AGO2
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.5038994489245107,1.1816954755791316,0.20512820512820512,1.0,1.0,11/47,17.77%,CALR;YWHAB;HSP90B1;MAPK10;PLCB1;RALB;ITPR2;GRB2;PTEN;TIAM1;RAC1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.8103624632363406,1.1811083464764955,0.24528301886792453,1.0,1.0,2/5,9.16%,NRCAM;ABL1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7301922575044014,1.1810087379165912,0.2962962962962963,1.0,1.0,1/5,2.05%,STIM1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.7150127573538906,-1.1806601623418933,0.3111111111111111,0.7289957646661894,1.0,1/7,0.40%,PARP14
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.5760492324813724,1.1804755017299706,0.2653061224489796,1.0,1.0,4/25,9.22%,TRIM5;WDPCP;HSP90AA1;PPM1F
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.7163071840510664,1.1802022203482514,0.27450980392156865,1.0,1.0,5/8,23.67%,PARVA;CDC42;CYFIP1;RAC1;GSN
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.7695770757177405,-1.1794141982705246,0.23404255319148937,0.7310145231701748,1.0,2/6,14.02%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8037145963936014,-1.1793807206755684,0.32,0.729974708930726,1.0,1/5,0.27%,TBX3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6316640855618529,1.1793023397941693,0.25,1.0,1.0,1/10,1.70%,SOX5
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5694970986417933,-1.1792706621041673,0.25862068965517243,0.7289385304054012,1.0,8/27,17.74%,HMGN1;RFC3;POLR2A;UBC;RNF111;XPC;RFC1;POLK
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.7852454356218954,1.1789863989878466,0.28888888888888886,1.0,1.0,4/5,20.82%,ADAM10;PSEN1;DYRK1A;ADAM17
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6830351516402267,1.178756872938799,0.25925925925925924,1.0,1.0,3/6,16.49%,HSP90AA1;GCH1;CALM1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6507743786506849,1.1783829169828464,0.3269230769230769,1.0,1.0,3/13,11.26%,AEBP2;DNMT3A;PPHLN1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.6258451288098905,1.1779485092287183,0.24444444444444444,1.0,1.0,7/17,21.46%,PIK3CA;CDC42;CAPZB;CYFIP1;RAC1;WASF2;FSCN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6272063600296494,-1.1776793868084927,0.22413793103448276,0.7322000185039615,1.0,2/27,2.66%,PLK2;CDK14
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5728484605700612,-1.1776300327077147,0.21818181818181817,0.7310163951753196,1.0,1/25,0.56%,CYLD
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5356507522367933,-1.1773524685049204,0.2,0.7307918842230895,1.0,8/42,9.61%,BTG2;TPM1;CARMIL1;MAP2;GPM6A;PPP1R9A;FRYL;LIMA1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6392435752575695,1.1766295986483124,0.2682926829268293,1.0,1.0,3/9,11.93%,DUSP6;PPM1F;PPP2CB
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.6275639968378073,1.1764538945937157,0.18181818181818182,1.0,1.0,1/12,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.6769642924577822,-1.1760062387953036,0.37037037037037035,0.7326031616050129,1.0,6/15,20.56%,RAB1A;PPP1R16B;RAPGEF2;AFDN;TJP1;MSN
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.6315339194997859,1.1759663141630319,0.21428571428571427,1.0,1.0,5/19,13.44%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6072223429915937,1.175610931166571,0.25,1.0,1.0,5/20,17.29%,CDH2;CADM2;ACTB;CDH12;NECTIN3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7436258880647264,1.1755206750775953,0.21818181818181817,1.0,1.0,4/6,23.67%,PIK3CA;SLC8A1;ATP1A1;GSN
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7436258880647264,1.1755206750775953,0.21818181818181817,1.0,1.0,4/6,23.67%,PIK3CA;SLC8A1;ATP1A1;GSN
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5836595694252777,1.175148603480191,0.21212121212121213,1.0,1.0,11/26,18.27%,CALR;STIM1;VAPB;ATP2A2;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;ATP1A1;EDN1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.7567741303631668,1.1749258808525957,0.19607843137254902,1.0,1.0,1/5,1.04%,TEAD4
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.764994975863683,1.1747552635108363,0.2222222222222222,1.0,1.0,1/5,1.86%,RARB
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6247953092213666,1.1746348036558807,0.2826086956521739,1.0,1.0,3/17,7.30%,PI4KA;PIK3CA;TTC7A
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7636868680276732,1.1744643419378527,0.2807017543859649,1.0,1.0,4/5,16.49%,HSP90AA1;GCH1;MTHFD1L;CALM1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6990235799418149,-1.1742790067037625,0.2916666666666667,0.7364762459105926,1.0,2/11,6.99%,NR4A1;LCP2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.735065169129504,1.17396473844409,0.3148148148148148,1.0,1.0,2/6,11.29%,FUT8;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7641369720974157,-1.173778041759909,0.2982456140350877,0.7366453935824465,1.0,1/7,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7008680306998675,-1.1736524388012781,0.3559322033898305,0.7357743670004372,1.0,2/10,4.91%,BTG2;PABPC1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5577553522473438,-1.1734516915988817,0.23333333333333334,0.7350519997593684,1.0,3/46,4.97%,CX3CL1;CXCL12;MMRN2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.686590906645413,1.1733182351154858,0.2826086956521739,1.0,1.0,4/13,20.11%,BMP6;PPM1F;WNK1;RGCC
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.6907058671126722,1.1730773291642895,0.21951219512195122,1.0,1.0,4/9,23.56%,PTBP3;SFSWAP;SRSF7;PTBP2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7054430640479044,1.1726095535838263,0.26666666666666666,1.0,1.0,3/6,22.26%,FRS2;GRB2;SORT1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7204226559898232,1.1724206566982733,0.3111111111111111,1.0,1.0,2/6,13.33%,TPST2;PAPSS2
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7284044411968521,-1.1723637481397646,0.30434782608695654,0.7367494789824118,1.0,2/6,13.23%,STAT1;JAK2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6874799571548507,-1.171971688691353,0.2619047619047619,0.7364815288578676,1.0,1/8,2.23%,PLCG2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6876232493690728,1.1715558157513453,0.30434782608695654,1.0,1.0,2/10,7.68%,PRKD1;AMBRA1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7093724011562597,1.1697050481135653,0.22916666666666666,1.0,1.0,1/7,0.08%,PDK4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.7248767362922814,-1.1695983417032674,0.3023255813953488,0.7418296165168249,1.0,3/8,14.02%,ACSL4;CBR4;ELOVL5
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.5135633645884596,1.1695586867051093,0.20454545454545456,1.0,1.0,9/42,13.44%,PSMD14;UIMC1;TENT4A;YY1;MORF4L1;SEM1;SETX;HERC2;INO80
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7058972262343278,1.1694141308536994,0.2553191489361702,1.0,1.0,7/9,27.12%,TRIOBP;CAPZB;ADD3;GSN;ADD1;CAPZA1;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7058972262343278,1.1694141308536994,0.2553191489361702,1.0,1.0,7/9,27.12%,TRIOBP;CAPZB;ADD3;GSN;ADD1;CAPZA1;SVIL
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6811066170454041,1.1688201766593462,0.33962264150943394,1.0,1.0,4/13,18.33%,HSP90B1;ITGA1;CALM1;PPP6R3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.7153390002899793,1.1687151686600885,0.21428571428571427,1.0,1.0,3/7,14.08%,MORC3;TAF3;PINK1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.6531938285159928,-1.168189821278691,0.2553191489361702,0.7448448582706083,1.0,3/18,5.58%,NR4A1;STAT1;PLXND1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6662338472555301,1.1681748461770025,0.32,1.0,1.0,6/12,21.33%,NAV3;CLASP1;RAC1;FES;CDK5RAP2;CLIP1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.7101407662262658,1.16774351705106,0.3333333333333333,1.0,1.0,1/7,4.75%,KDM4C
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.7901920472424504,-1.1677192097490783,0.23255813953488372,0.744835214393373,1.0,3/7,15.43%,SERPINE1;ACER2;PDE3B
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7670638988182442,1.1677025702394164,0.3404255319148936,1.0,1.0,1/5,1.70%,SOX5
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5996765724447101,1.167174778873982,0.3469387755102041,1.0,1.0,3/15,8.61%,UIMC1;WRNIP1;ERCC6
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.5351825809590914,1.1663170470595592,0.2558139534883721,1.0,1.0,10/31,14.08%,PDK4;IL1R1;ATP2A2;MT2A;UPP1;ACOX1;GCNT2;PAPSS2;GCH1;PINK1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.731853587388215,1.1657185959987695,0.36363636363636365,1.0,1.0,4/7,14.48%,ATP2A2;MICU3;CACNA1C;SLC8A1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.8400011096938261,-1.1655940316939506,0.22727272727272727,0.7499975028832281,1.0,1/5,0.93%,KIAA1217
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.6747487047889373,-1.1654293214136549,0.35,0.7492415298316517,1.0,1/7,1.65%,RREB1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5901111515032107,1.1650631972478682,0.24444444444444444,1.0,1.0,4/17,7.28%,FUT8;MCFD2;MGAT5;STT3B
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5143840668755463,1.1647135489591884,0.20930232558139536,1.0,1.0,4/37,5.63%,TRIM5;MTDH;PRKD1;FBXO7
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.7366600660555837,-1.1645996772142366,0.3409090909090909,0.7503558912795011,1.0,3/6,20.00%,PMAIP1;ATM;DDX5
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.5937900742836112,-1.164517747706294,0.22641509433962265,0.7492433013285243,1.0,3/20,4.38%,PPARG;CHKA;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.7662747343746779,-1.164084692746381,0.37777777777777777,0.7491367922791955,1.0,1/5,3.93%,SNX6
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7567261830769375,-1.1639484452412439,0.3508771929824561,0.7481729749906277,1.0,1/5,4.86%,TIE1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7103902528721322,-1.1637035828693567,0.3,0.7475334963082853,1.0,2/5,11.69%,RNF213;GPC3
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6632389098445273,-1.1628499689496203,0.26785714285714285,0.749015306631869,1.0,1/11,1.57%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.6053881136293439,-1.1627286492987177,0.32,0.7480921173376757,1.0,10/32,18.91%,PPARG;PLCG2;PLK2;RPS19;RORA;PRKAR1A;RAMP3;OTULIN;MAPK14;PTPN2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6288635795301175,-1.1627193956384478,0.2857142857142857,0.7468348196614779,1.0,6/16,11.58%,RPS6;RPL38;RPS28;RPS19;RPS7;RPS15
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.674654159424839,1.1624761548229356,0.2708333333333333,1.0,1.0,5/9,15.19%,AHCTF1;RTN4;PLEKHA7;ADAM10;ANO6
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4750116051054551,-1.1624520396546698,0.21428571428571427,0.7463081871930528,1.0,11/88,9.03%,CYLD;PSMA1;IFIH1;PSMB9;TNIP1;PRKN;SMAD3;NFKBIA;FOXK1;ATXN7;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.7661911727598982,1.1622670903905907,0.27586206896551724,1.0,1.0,3/6,11.34%,PKM;ITGA5;SMAD1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5782515978233906,-1.1621225556693167,0.22950819672131148,0.7458540730616924,1.0,5/38,4.06%,ZIC1;EML1;CXCL12;LAMA4;SMARCA1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.5180347071573023,1.162070599476604,0.24489795918367346,1.0,1.0,8/29,17.42%,TAF1;ZBTB1;YY1;UBE2B;ERCC6;INO80;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.661525598393149,1.1619573291781453,0.2926829268292683,1.0,1.0,3/9,16.44%,GRIA2;LRRC7;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4909830380959256,-1.1613976221554632,0.2033898305084746,0.746637603442624,1.0,11/112,10.33%,CD74;RIMS1;PLCG2;FN1;PRKN;SMAD3;WARS1;RPL23;TFRC;RPS7;AHI1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7594155113019376,1.1609924998922079,0.2653061224489796,1.0,1.0,1/6,0.66%,ARHGEF4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.7826241618548704,-1.1607897121416093,0.36538461538461536,0.7470306696109329,1.0,1/6,1.51%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.60080701456355,1.1607287482017847,0.28888888888888886,1.0,1.0,5/19,14.08%,EIF4G3;PIK3CA;TAB2;LRRK2;PINK1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7460264294147193,1.1604498108809973,0.32653061224489793,1.0,1.0,1/5,12.93%,STARD4
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5905712218005914,-1.159940847173339,0.2545454545454545,0.747651226546089,1.0,8/15,17.74%,ISG15;RFC3;TRIM25;UBC;NPLOC4;PRIMPOL;RFC1;POLK
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5203927772869883,1.159453262758258,0.2631578947368421,1.0,1.0,12/37,16.15%,GRIA2;TTLL7;SNAP25;MAPK10;NOVA2;NRXN1;ADGRB3;RBFOX1;DST;CNTN1;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5561618559531304,1.1593786826728587,0.2978723404255319,1.0,1.0,5/21,12.08%,ABL2;DEPP1;HSPB1;ABL1;LRRK2
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.698548829008888,1.158881932301817,0.2857142857142857,1.0,1.0,2/8,2.50%,ANO5;CLIC1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5815657475931381,1.158592583267266,0.28,1.0,1.0,4/21,9.03%,COL4A2;HSPG2;SEMA3F;PARVA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6618569075749331,-1.1584484003532471,0.28,0.7506417752257412,1.0,1/12,1.57%,RIMS1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5597165903175505,-1.1578672300861916,0.28125,0.751324438411405,1.0,8/30,13.47%,SOD2;RNF213;SAMHD1;B2M;APPL2;CBR4;CLYBL;SPAST
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.6808890206640722,1.1576843614300343,0.3389830508474576,1.0,1.0,2/6,10.86%,CRY1;PPP1CB
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6371656933936556,-1.1575299858360446,0.3023255813953488,0.7508840365174284,1.0,5/11,13.23%,STAT1;CDC37;PARP9;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6570219200411828,1.157455434511931,0.2978723404255319,1.0,1.0,6/8,31.77%,OTUD7B;MFHAS1;CTNNA1;LATS2;UFM1;LATS1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.6500205640382765,-1.1570654982772342,0.37037037037037035,0.7508996644060307,1.0,2/10,9.80%,SHLD1;CYREN
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5553359209303176,1.1569167862883099,0.2857142857142857,1.0,1.0,8/32,17.42%,BAG3;HSPH1;NUP58;RANBP2;HSP90AA1;HSPA8;CREBBP;EP300
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.7878394768967671,-1.1567184132571422,0.36363636363636365,0.7503916020087525,1.0,2/5,15.62%,SPG7;IMMP2L
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.4731372358059638,1.1566338599621009,0.22727272727272727,1.0,1.0,8/62,8.66%,HDAC9;NOVA1;CALR;MCC;SMAD6;NOVA2;CHSY1;KLF7
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5508124554521567,1.1565080137831352,0.3488372093023256,1.0,1.0,8/23,18.57%,VAPB;MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.627800951950585,-1.1564756225167825,0.37254901960784315,0.7499200680206162,1.0,2/11,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7176236951786706,1.1564485216558493,0.27906976744186046,1.0,1.0,4/7,19.71%,PEX14;DNAJC15;HSPD1;SEC63
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6036124836744884,-1.1561059886786806,0.3333333333333333,0.7495022790155019,1.0,4/21,12.54%,LRPAP1;SERPINE1;B2M;CLU
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.49207471925355106,1.1557065033774625,0.22727272727272727,1.0,1.0,3/55,3.16%,PDK4;PRKD1;SLC38A9
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7310411404015892,1.1555750836669607,0.3333333333333333,1.0,1.0,1/6,19.73%,FES
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7411262352660095,-1.1550699442034424,0.3409090909090909,0.7508227139170959,1.0,1/5,3.37%,RNF213
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.7117012203847418,-1.1548541544223703,0.3469387755102041,0.7500059953289635,1.0,3/6,23.80%,KANSL1;MSL2;KMT2A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6821386776092934,-1.154509263981351,0.26,0.749763235660626,1.0,3/13,2.36%,PPARG;SOD2;TPM1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5847607043630386,1.1543411717022896,0.25,1.0,1.0,1/12,5.31%,PCM1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6948722206493351,1.1543121857537098,0.32,1.0,1.0,3/7,27.84%,ACTB;NEDD4L;CTTNBP2NL
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6549825865085561,-1.1542226985926132,0.32653061224489793,0.749434854538071,1.0,4/11,6.56%,SAT1;IFI27;TNFSF10;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5375683685883188,1.1538181891568835,0.3333333333333333,1.0,1.0,7/35,11.34%,STIM1;MTDH;PRKD1;PKM;HSPB1;ITGA5;SMAD1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7804796706629221,1.1536225716521753,0.3404255319148936,1.0,1.0,3/5,16.10%,SEMA3F;NRP1;UNC5C
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.6338630640302466,1.153341649708788,0.3148148148148148,1.0,1.0,4/15,7.54%,ERBB4;NRG2;PIK3CA;HSP90AA1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6527571029490687,-1.1530234838061724,0.22916666666666666,0.7513679484682397,1.0,4/11,12.86%,PDXDC1;CPQ;ERAP1;ENPP2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6446138567496296,1.152070978400272,0.26229508196721313,1.0,1.0,6/14,16.68%,PRAG1;CBFA2T2;RTN4;EPHA4;NLGN1;PTEN
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.7611971176406807,1.1515746042376107,0.2708333333333333,1.0,1.0,3/5,22.55%,CDH2;ANXA1;CDK6
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6697891780553036,-1.151358703551814,0.32,0.7543972523964371,1.0,3/16,11.08%,PPARG;ACSL4;CBR4
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.6864388202547254,-1.1511247800203295,0.3333333333333333,0.7539769346269253,1.0,1/13,1.01%,PPARG
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7319501527331781,1.1510107919317303,0.3018867924528302,1.0,1.0,2/5,13.97%,CDH2;PLEKHA7
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.7927797134888493,-1.1505212645487461,0.375,0.7545195488697864,1.0,2/5,11.29%,PRKN;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5542946161267344,-1.1495657311884737,0.32653061224489793,0.755728975691948,1.0,6/29,13.09%,ISG15;LGALS3;WARS1;TFRC;CLU;ATM
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7026640769513368,1.1494170970267428,0.3170731707317073,1.0,1.0,2/6,13.31%,PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7026640769513368,1.1494170970267428,0.3170731707317073,1.0,1.0,2/6,13.31%,PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.7092331558006313,1.148453912901908,0.3442622950819672,1.0,1.0,2/7,11.85%,RANBP9;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5738064631958539,1.1482774792563097,0.2857142857142857,1.0,1.0,8/19,26.06%,PLCB1;PPM1F;INO80;ADAM10;CDC42;ADAM17;AKAP6;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6488686833160647,-1.1481094319877017,0.32727272727272727,0.7587144574345549,1.0,3/11,15.51%,UBR2;ATM;SPAAR
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.4943163021313032,-1.1480791838040445,0.21311475409836064,0.7575722013996502,1.0,9/63,12.24%,CYLD;TMSB4X;STAT1;TNIP1;UBR2;DGKG;TANK;CD2AP;RORA
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7472842175968981,1.1475827581154407,0.2641509433962264,1.0,1.0,2/7,14.21%,PEX14;MFF
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7468609132720019,1.1474589812561546,0.3333333333333333,1.0,1.0,3/5,16.44%,NRXN1;IL1RAPL1;NLGN1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.4895682930679822,-1.1474172171307442,0.21875,0.7577984238104395,1.0,34/125,14.63%,RPS12;FN1;DENND3;RPL31;SHISA5;TNIP1;PRKN;SPG7;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;RPL23;RPL30;PRSS23;ERO1A;RPS28;RPS19;CST3;RPS7;RPS14;RPS15;GPC3;UBE2D2;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37
prerank,MSigDB_Hallmark_2020__DNA Repair,0.524592644540458,1.1471211680425801,0.2926829268292683,1.0,1.0,2/23,2.84%,PNP;RALA
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.7266531845165716,-1.1470078741415985,0.3404255319148936,0.7576832698401396,1.0,3/9,12.70%,LRPAP1;MTMR2;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.5357019515696773,-1.146225209128655,0.27692307692307694,0.7586397957072306,1.0,4/42,4.01%,CYLD;PSMA1;PSMB9;PRKN
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.7632052071466393,1.14577692014512,0.2857142857142857,1.0,1.0,1/5,8.34%,MORF4L1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5334751291297597,-1.1454973546188227,0.32,0.7595932459284467,1.0,3/52,2.23%,CD74;CX3CL1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7341231284716698,-1.1454320443704094,0.3181818181818182,0.7585265479577016,1.0,2/6,4.01%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7383723144467826,1.14498906744377,0.3275862068965517,1.0,1.0,2/5,10.49%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7230903352870872,-1.1445073280415337,0.3125,0.7598663561844927,1.0,2/6,14.42%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6408066341709069,-1.1442470827776543,0.2916666666666667,0.7594615815145798,1.0,3/8,9.61%,TPM1;CARMIL1;LIMA1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.7024590023270982,-1.1440508445965907,0.34782608695652173,0.7574601109823436,1.0,2/7,8.39%,UBR2;LARS1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.7024590023270982,-1.1440508445965907,0.34782608695652173,0.7574601109823436,1.0,2/7,8.39%,UBR2;LARS1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.7043427938304812,-1.1439065244595152,0.3958333333333333,0.756556640774264,1.0,1/5,15.43%,PDE3B
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.7350100960851583,1.143842129943544,0.32653061224489793,1.0,1.0,5/7,18.83%,CNOT2;REST;NCOA3;ZNF706;WDR43
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5420622178496997,1.143401035837612,0.24444444444444444,1.0,1.0,5/32,8.63%,CALR;BAG3;HSP90B1;CNOT2;YWHAZ
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5060805658123554,1.1431434333640402,0.25,1.0,1.0,17/39,16.15%,NOVA1;ERBB4;GRIA2;SNAP25;MAPK10;FGF12;NRXN1;PXK;RNF180;FGF14;CNTN1;ADGRL2;GAREM1;ANK2;THSD7A;UNC5C;PLPPR4
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6062506277096418,-1.142374677208272,0.35294117647058826,0.7596181589534177,1.0,4/24,3.72%,GBP1;RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6648777062226667,-1.1423635001142967,0.37254901960784315,0.7584459397981668,1.0,2/11,13.09%,SP100;ATM
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.669846606458665,-1.1423214643141182,0.2857142857142857,0.7573443777278623,1.0,1/8,3.93%,SNX6
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7511507472306092,1.1420841145486238,0.3090909090909091,1.0,1.0,3/5,21.25%,STIM1;CALM1;RYR2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.6464646231901552,1.1413427717900126,0.2962962962962963,1.0,1.0,6/10,26.40%,ROBO2;NRXN1;IL1RAPL1;NLGN1;SETD5;MEF2C
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.47575096419180124,1.1411044705268225,0.2222222222222222,1.0,1.0,17/65,18.22%,CALR;BAG3;TAF1;MORC3;UBE2B;HSP90AA1;PARVA;RTN4;NLK;HSPD1;EPHA4;ATF7IP;PINK1;ANK2;PTEN;EP300;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.61484148344837,-1.140932987782676,0.29310344827586204,0.7595546703213748,1.0,2/16,4.97%,PPARG;MMRN2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.7176480017626707,1.1407806185914626,0.32608695652173914,1.0,1.0,2/6,14.08%,ABL1;PINK1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7785434110908266,-1.1407443732007456,0.34615384615384615,0.7588218529528342,1.0,6/7,13.44%,HLA-F;TAP1;B2M;ERAP1;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.6070719518581905,-1.1407330756557252,0.26229508196721313,0.7576582855051884,1.0,2/17,4.01%,PSTPIP2;PRKN
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.6591498695737327,1.140619341685782,0.3392857142857143,1.0,1.0,1/9,1.70%,SOX5
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6979288737077692,-1.1401431519518392,0.30357142857142855,0.7582112721187738,1.0,3/6,13.44%,GBP4;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5550535381928643,-1.139728149205172,0.2711864406779661,0.7579489313639807,1.0,3/27,4.54%,CX3CL1;GBP1;NUB1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6294057650396433,1.1394700930858415,0.2037037037037037,1.0,1.0,5/12,16.31%,HOMER1;LRRK2;EPHA4;IL1RAPL1;TANC2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6998861641071586,1.1385821581260542,0.3333333333333333,1.0,1.0,5/10,17.32%,FGF12;HOMER1;DPP10;ATP2B4;WNK1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6012748814984947,1.1381115748356476,0.29545454545454547,1.0,1.0,1/17,0.27%,HDAC9
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.662583624411846,1.1376378292935478,0.40425531914893614,1.0,1.0,3/9,20.98%,MAP4;CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.7257477485765114,1.1373815578325372,0.34146341463414637,1.0,1.0,2/7,20.03%,DIP2A;TAOK1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.677186228611622,-1.1370268055453512,0.375,0.7634896371271613,1.0,2/7,17.77%,MSH2;RAD21
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.7940901628106987,-1.136993287851788,0.28888888888888886,0.7623426002926643,1.0,2/5,4.01%,HEBP2;PRKN
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.6573844202929793,-1.136335860602134,0.2549019607843137,0.7628021651705608,1.0,3/15,4.38%,PPARG;TDRD7;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.7040649507830443,1.1357065792159957,0.3829787234042553,1.0,1.0,4/8,23.56%,PTBP3;SHQ1;NCOR2;PTBP2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.6124149543972667,1.134626268969776,0.32608695652173914,1.0,1.0,6/15,21.46%,PIK3CA;CDC42;CYFIP1;RAC1;WASF2;FSCN1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.6450668975175871,1.1340217598729294,0.36507936507936506,1.0,1.0,3/9,18.22%,RANBP9;CLASP1;ZNF207
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7854316558124614,-1.133938108448979,0.37209302325581395,0.7674678120660805,1.0,1/5,2.42%,CNOT8
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.542793530153916,1.1332576838672201,0.21428571428571427,1.0,1.0,4/24,7.84%,RBM20;PRKG1;ATP2A2;CKMT2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.4687655613157739,-1.132881707899053,0.2631578947368421,0.7694171114300691,1.0,9/101,12.40%,CD74;SNX6;SEPTIN11;DMD;AHI1;RAB1A;COPA;USO1;STX17
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6895881790503491,1.1322930745453672,0.32653061224489793,1.0,1.0,3/8,17.80%,BMP6;RBPMS;ACVR2A
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.7620459640403973,1.1320970518414748,0.34615384615384615,1.0,1.0,1/5,1.25%,CALR
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7546651676668316,1.131064435468167,0.3389830508474576,1.0,1.0,2/5,8.87%,HDAC9;REST
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6526359433181111,1.1309420406893627,0.4,1.0,1.0,1/7,4.44%,INVS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6301391652142648,-1.1307516048011315,0.32727272727272727,0.7739098819234006,1.0,4/17,10.07%,ZIC1;SMAD3;TFRC;PARP9
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7357677745974964,-1.130586907902664,0.34,0.7731497129475672,1.0,1/5,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.6991239963854541,-1.1302872880042985,0.3076923076923077,0.7727690492296894,1.0,3/10,13.89%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6744287437279525,1.1302196187834066,0.3389830508474576,1.0,1.0,3/8,24.99%,PIGU;ANK2;SMURF1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5840474873667122,1.1290380622480707,0.2857142857142857,1.0,1.0,6/18,17.32%,SLC12A6;SLC26A3;SLC8A1;ANO6;SLC24A2;WNK1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.5153989854640635,-1.1287794731995218,0.2857142857142857,0.7756967429274986,1.0,5/65,3.72%,CEMIP;SOD2;CXCL12;CARMIL1;CASS4
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5775741481472428,-1.1286479102305917,0.3103448275862069,0.7748392571908095,1.0,3/33,2.39%,TBX3;TPM1;FN1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6302127138098497,-1.1284785098729158,0.3673469387755102,0.7742782100812947,1.0,1/13,1.57%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5803468852847664,-1.127311334583165,0.32075471698113206,0.776065571392591,1.0,2/19,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6462009759154469,-1.127130911879822,0.36,0.7752602948476786,1.0,4/12,18.65%,TFRC;ATP7B;IREB2;FTH1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.7213869883924051,-1.127106333608836,0.36363636363636365,0.7741163253736331,1.0,1/5,1.75%,PIGC
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.5116805003382322,-1.126922647068315,0.24561403508771928,0.7733976233709207,1.0,7/71,10.46%,CX3CL1;VAV3;PLXND1;RGS6;LARS1;NET1;ARHGAP15
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.527228718525834,-1.1266256445932668,0.2916666666666667,0.773134624865203,1.0,6/28,12.54%,LGALS3;TMEM30A;WARS1;TFRC;GPC3;CLU
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.7048962683067662,-1.1264458545992722,0.3333333333333333,0.7724357990494533,1.0,1/7,6.03%,AGPAT3
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6874860699159688,1.126013038381266,0.3829787234042553,1.0,1.0,2/6,11.13%,STIM1;CACNA1C
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7063893908719525,1.1257671121973645,0.2807017543859649,1.0,1.0,2/5,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.526332170814933,1.1242274865421895,0.2857142857142857,1.0,1.0,8/22,18.46%,ITPR3;MT2A;HOMER1;PPP2CB;PPP3CA;CALM1;PAM;ANXA11
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.7437074413295403,-1.1237379626484147,0.4230769230769231,0.7784239098066744,1.0,1/6,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6909995122805088,1.123386571896565,0.3617021276595745,1.0,1.0,2/7,7.68%,PRKD1;AMBRA1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.7142769443916921,1.122977475920495,0.38095238095238093,1.0,1.0,5/7,22.79%,ACTG1;CDC42;RAC1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.5252990747846672,-1.122546210021363,0.2786885245901639,0.7803631845109402,1.0,5/50,4.01%,CYLD;PSMA1;PSMB9;RNF213;PRKN
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.7183460697494527,1.1223864555007586,0.36363636363636365,1.0,1.0,4/7,25.07%,ST8SIA4;SPTLC1;SAMD8;ST6GALNAC3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5590415601995476,1.1222596532069213,0.28,1.0,1.0,3/26,6.14%,HDAC9;INSIG1;PKM
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5985521508493173,-1.1221738033785598,0.38,0.7801555619429872,1.0,3/18,7.28%,TPM1;SMAD3;DSP
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5171704791681491,1.122070040252636,0.358974358974359,1.0,1.0,4/24,10.17%,HDAC9;PRKD1;HSPB1;HDAC7
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5689975168725379,-1.1218509173951952,0.3114754098360656,0.7797235476050468,1.0,3/23,4.01%,SOD2;CXCL12;PRKN
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.6669094057662415,1.1212040571176054,0.40384615384615385,1.0,1.0,4/7,28.23%,ETFA;NDUFS4;MTFR1;UQCRC2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.7003988426703521,1.1211746214434946,0.34,1.0,1.0,3/7,17.18%,URI1;UBE3A;ATP1A1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6161216841053128,-1.121049936684455,0.35294117647058826,0.7806088399018118,1.0,3/11,10.07%,SHLD1;CYREN;PARP9
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.6808420201251715,1.1202209592908983,0.36666666666666664,1.0,1.0,2/7,10.86%,CRY1;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.7307850471088374,1.1200246416106459,0.3333333333333333,1.0,1.0,4/5,26.72%,CDK12;CDC73;TCERG1;BRD4
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6035663523293002,1.1193019906473436,0.30612244897959184,1.0,1.0,4/16,15.91%,PEX14;TRAK1;TRAK2;CDC42
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6846759157819262,-1.1187801629969003,0.4,0.785209094244509,1.0,1/11,2.82%,OPTN
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.737936557490374,1.1185936426640093,0.4339622641509434,1.0,1.0,2/5,14.26%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7539329809558895,1.118229202774358,0.39622641509433965,1.0,1.0,2/5,10.15%,ITGA5;GRB10
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5682236992311829,-1.1182053284011118,0.37037037037037035,0.7855873902625068,1.0,1/28,0.53%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5852437036797673,-1.1178595912990659,0.3191489361702128,0.7851178209138054,1.0,5/15,14.26%,STAT1;TNIP1;TANK;RORA;RIOK3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.5492835470769282,1.1177625175149568,0.32608695652173914,1.0,1.0,7/29,17.77%,ABL2;BCR;PRAG1;ABL1;NRP1;HEG1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6664091510188819,1.117642361707651,0.3559322033898305,1.0,1.0,1/6,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.7456512654283453,-1.1172003497505032,0.3541666666666667,0.7854951119186533,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.738216556192577,-1.1168770839324282,0.375,0.7849156045579344,1.0,1/5,4.97%,MMRN2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6856300422560461,1.116863344497943,0.3333333333333333,1.0,1.0,2/7,15.91%,BAG3;CDC42
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.674427983967153,-1.1168589578934496,0.2619047619047619,0.7837812137931153,1.0,2/6,10.07%,STAT1;PARP9
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.589930140052409,1.1156308207782535,0.2978723404255319,1.0,1.0,9/16,11.61%,GRM5;CADM2;GRIA2;SNAP25;NRXN1;YWHAZ;ADGRB3;RTN4;RBFOX1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.6236383124162448,1.1149537339478435,0.39215686274509803,1.0,1.0,1/10,2.44%,NDUFAF2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7705030888616128,1.11442256374867,0.4230769230769231,1.0,1.0,1/5,2.55%,CDH2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6374378523866195,-1.1142102024653837,0.3673469387755102,0.789907288604607,1.0,11/15,24.09%,RPS28;RPS19;RPS14;RPS15;RPL10;RPL24;RPL11;DHX29;RPS27;RPL3;NPM1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6585865032415494,1.1141839247570295,0.32653061224489793,1.0,1.0,2/8,15.48%,WAPL;YLPM1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6899600656399979,-1.1141621696676614,0.38,0.7889115127161198,1.0,1/6,5.44%,YTHDC1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.554264576022647,1.1140653583212705,0.32075471698113206,1.0,1.0,6/14,15.35%,GRIA2;ST18;DLGAP2;NRXN1;RPS6KA5;SLC24A2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.68643726038049,-1.1127708308270101,0.4230769230769231,0.7911801460326553,1.0,2/6,14.10%,STK39;HECW2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7304103431724318,1.1127201510154456,0.4528301886792453,1.0,1.0,3/5,18.75%,PIK3CA;NRP1;FOXC1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.6982506409996317,-1.1115718852925718,0.4888888888888889,0.7929044996843639,1.0,1/8,2.79%,CXCL12
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7182100237663618,1.1099982127301202,0.38333333333333336,1.0,1.0,2/6,13.07%,ANKRD11;SKI
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.69787448817038,1.109740792109759,0.3448275862068966,1.0,1.0,2/5,25.76%,DIP2A;SETD5
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.614695201184714,-1.1092424441355662,0.38,0.7969209317105859,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.614695201184714,-1.1092424441355662,0.38,0.7969209317105859,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5158745676989739,1.1088171654530141,0.275,1.0,1.0,6/34,15.43%,TEAD4;COL4A2;PARVA;MPDZ;PTPN21;RAI14
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5246793537313776,1.1082054183185803,0.30434782608695654,1.0,1.0,4/29,7.41%,STIM1;MTDH;PRKD1;HSPB1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.46856367326479925,-1.10810342696599,0.2833333333333333,0.7986919714064936,1.0,19/68,20.08%,BTG2;SP100;RFC3;SAMHD1;TOPBP1;MSH2;UBC;SMARCAD1;PWWP3A;ATM;PDS5B;PRIMPOL;XPC;RFC1;POLK;RAD21;ORC2;PSME4;FANCL
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.4772591464004673,-1.1079353673138963,0.3,0.7978334431112851,1.0,10/106,6.80%,HES1;TBX3;ZIC1;FN1;PRKN;SPG7;GPM6A;PLXND1;RAPGEF5;SCN2A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6861938068364781,-1.1077078901723039,0.391304347826087,0.7972599042319738,1.0,2/6,12.54%,CXCL12;CLU
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.6252591609519957,1.1072482511050372,0.32558139534883723,1.0,1.0,5/11,8.39%,ATRNL1;GRIA2;SNAP25;NOVA2;NRXN1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.65838948646278,1.1072393693283784,0.3125,1.0,1.0,5/6,31.77%,DUSP6;PTEN;LATS2;WWC3;LATS1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6767843648969368,-1.1068058085979617,0.43137254901960786,0.7968375721468611,1.0,2/9,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.6767843648969368,-1.1068058085979617,0.43137254901960786,0.7968375721468611,1.0,2/9,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.44290605096198105,1.1063861235127097,0.3,1.0,1.0,11/65,18.78%,PACS2;MAP7;TTC7A;LRRC7;NRXN1;DPP10;ANK2;NLGN1;CD81;ANK3;ROCK1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6418322165198777,1.105819041830554,0.42857142857142855,1.0,1.0,2/8,13.86%,ABL1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.7299262604178836,-1.105522727778895,0.4222222222222222,0.7987206067032212,1.0,1/5,3.24%,UFL1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.551882328381532,1.1054738341337202,0.3333333333333333,1.0,1.0,7/16,15.41%,UBQLN1;ATP2A2;PACS2;AMBRA1;RAB7A;VMP1;ATG2B
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.712329981364647,1.1047226678831639,0.3620689655172414,1.0,1.0,1/5,20.21%,NCOR2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5981626595238196,1.1046546686871521,0.3584905660377358,1.0,1.0,4/12,20.21%,KDM4C;NCOA2;EP300;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6278948114935412,1.1042735039035767,0.3673469387755102,1.0,1.0,1/8,2.12%,YWHAB
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.7377981193309181,1.1036415866797695,0.3508771929824561,1.0,1.0,3/5,24.89%,NEDD4L;AKAP6;YWHAE
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4710589667954127,-1.1036380800797088,0.3283582089552239,0.8024074805761524,1.0,8/64,8.31%,BTG2;KLF3;OPTN;GMPS;RNF19A;CDR2;LMO2;TFRC
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7184707986536161,-1.1035212245384909,0.43478260869565216,0.8015043439090909,1.0,1/7,5.05%,EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5609905268513802,1.1031329837773682,0.4117647058823529,1.0,1.0,3/18,10.60%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6554283651560978,1.1031196093264415,0.35555555555555557,1.0,1.0,1/9,1.70%,SOX5
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.5213806998916938,1.1028846468659175,0.375,1.0,1.0,10/36,17.42%,HDAC9;NAA50;UBE2B;MORF4L1;RPS6KA5;BAZ1B;BAZ2A;USP22;CREBBP;EP300
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6527552778633651,-1.1028168739563464,0.3617021276595745,0.8022524165263277,1.0,7/12,18.91%,UFL1;RPS19;RPS14;JAK2;ACIN1;CDIN1;PTPN2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.655095154913634,-1.1025025868916922,0.43137254901960786,0.8018956959363657,1.0,4/13,20.56%,COL18A1;PPP1R16B;RAPGEF2;MSN
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.44469500202845846,-1.1018696182746577,0.2711864406779661,0.8024859301498014,1.0,25/147,14.42%,NR4A1;BTG2;LRPAP1;SOD2;IRF1;SP100;PRKN;EIF2AK2;PLXND1;UBR2;SMAD3;WARS1;COL18A1;CDA;BST2;ACTN1;APPL2;GNG4;ADAMTS1;CLU;SMARCA2;JAK2;PDS5B;BRD7;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7403571323678457,1.101739475695566,0.45161290322580644,1.0,1.0,2/5,22.79%,ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4827815761538862,-1.101474701704455,0.26153846153846155,0.8023002365816226,1.0,2/82,1.57%,CD74;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6173257289848219,-1.101052393676714,0.4,0.8022542381778516,1.0,3/13,6.77%,BTG2;PLK2;SMAD3
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.555934192969617,1.100989901319204,0.3448275862068966,1.0,1.0,4/17,8.92%,PNP;SLC25A37;FBXO7;ELF1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.7262114427894129,-1.1003134448349483,0.34,0.8029803074282351,1.0,2/5,14.42%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6671327662337009,-1.099940258509271,0.38461538461538464,0.8027484570231338,1.0,2/10,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6804115533535953,-1.09975163526775,0.38636363636363635,0.8019015364692027,1.0,1/5,22.07%,LPGAT1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.6404583239200295,1.0988997941668552,0.45614035087719296,1.0,1.0,2/8,10.60%,ABL2;SETX
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.7076694629452465,-1.0987732617059258,0.4230769230769231,0.8031936845844289,1.0,2/6,6.43%,ACSL4;MYRIP
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.551454191256723,-1.0987664051746435,0.36363636363636365,0.8020262519033469,1.0,3/29,4.38%,PLCG2;PLK2;LGALS3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5744374574144633,1.0986205312806554,0.4,1.0,1.0,4/15,20.80%,WRNIP1;KPNA1;YLPM1;PARG
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6607069703808988,-1.0981237053255284,0.42857142857142855,0.8027473830405557,1.0,2/7,14.10%,STK39;HECW2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5586389291469284,1.0980723293447359,0.358974358974359,1.0,1.0,8/24,17.69%,DEPP1;SNAP25;MAPK10;PGR;FGF14;PDZRN3;PLPPR4;KCNT2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.6614004060669659,1.0980099884094563,0.36538461538461536,1.0,1.0,3/8,13.92%,HSPG2;GCNT2;EXT1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6820396919265219,-1.0978402345790432,0.3888888888888889,0.8023032884882015,1.0,2/8,18.49%,TOPBP1;ORC2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6682874022751851,1.0975681874130487,0.3283582089552239,1.0,1.0,5/7,30.60%,DLGAP2;DLGAP4;ROCK2;NOS3;DLGAP1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6481523865770742,1.0973442592962153,0.391304347826087,1.0,1.0,3/11,17.42%,NAA50;CREBBP;EP300
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.6627337975442523,-1.0972669715582708,0.3076923076923077,0.802594028055375,1.0,3/10,15.30%,STAT1;STAT5B;RAMP3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5977700504259835,-1.0966700008645665,0.37254901960784315,0.8027618458830746,1.0,1/8,3.24%,UFL1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6861905788568785,-1.096584374182604,0.4528301886792453,0.801801555474073,1.0,1/6,3.51%,ATP6V1E1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5294078915080263,-1.0961380237678544,0.34375,0.8020004639762269,1.0,7/33,12.62%,STAT1;FN1;CXCL12;LAMA4;HMCN1;NID1;LAMA2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.5916652725567711,1.095592522658382,0.34,1.0,1.0,3/17,12.70%,INPP5F;SGIP1;AP2B1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7002512057295512,-1.0955042002051971,0.3888888888888889,0.8025026862833442,1.0,2/7,10.92%,MAPKAP1;CD2AP
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.5382316292265532,-1.0954712726628641,0.3333333333333333,0.80145587253726,1.0,3/21,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.7143221101507651,1.0953631091640024,0.4,1.0,1.0,2/5,19.47%,MAP4;LIMK2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5440590534354606,-1.0948740898151272,0.3023255813953488,0.8020028872167485,1.0,6/36,9.46%,PPARG;TNFSF10;MAP3K5;SMAD3;ACER2;PMAIP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6800715800503643,1.0947313189790435,0.4166666666666667,1.0,1.0,2/6,6.85%,IGFBP3;PLCB1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6319111387924045,1.0938117124689526,0.2857142857142857,1.0,1.0,5/9,22.79%,CBFB;NCOA3;FOXC1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5728891991931873,-1.092345835210181,0.37735849056603776,0.8072534551107728,1.0,1/16,0.48%,NR4A1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5204606701185495,1.0921569172272605,0.30434782608695654,1.0,1.0,9/28,21.73%,AEBP2;ERCC6;ACTB;DNMT3A;PPHLN1;BAZ1B;EP300;JARID2;HDAC4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.6669516485111592,1.0917503673797073,0.4222222222222222,1.0,1.0,1/5,6.11%,CHD7
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5721456832384281,-1.091637938222486,0.3333333333333333,0.8078208252683913,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.560695470531581,-1.091308163993081,0.34545454545454546,0.8075719422813809,1.0,2/25,1.65%,NR4A1;RREB1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.6805462347780464,-1.0908931272198479,0.44642857142857145,0.8074141549283363,1.0,4/8,13.68%,SCN3A;SCN2A;DMD;GNA14
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4655734332143385,1.0908267918678687,0.2916666666666667,1.0,1.0,6/48,7.46%,BTBD10;GRM5;CCDC88A;NUP58;HSPB1;RANBP2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.6662675150603407,-1.0897746986119594,0.37254901960784315,0.8091371671070464,1.0,2/8,14.02%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.6409496996389463,1.0895076910412202,0.36538461538461536,1.0,1.0,2/8,20.53%,PCM1;CEP290
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5791263376986491,1.0891471586251689,0.4230769230769231,1.0,1.0,6/13,22.66%,PBX3;CACNA1C;SKI;FOXC1;CEP290;NIPBL
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.49789392576901254,1.0888698979355447,0.3333333333333333,1.0,1.0,8/26,21.81%,GRM5;ACTG1;ACTB;VMP1;CDC42;PSEN1;CTNND2;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6437170582837167,-1.0885600687850912,0.42857142857142855,0.8107050633823649,1.0,1/10,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.6787739333257621,-1.0871303330389133,0.34,0.8130785089025334,1.0,1/8,6.03%,AGPAT3
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6984190318666683,1.0864240012574813,0.4489795918367347,1.0,1.0,3/6,16.44%,LRRC7;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6430245485403087,-1.0858703488251042,0.3409090909090909,0.8149059848742521,1.0,2/10,2.23%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.48939993120678094,-1.0858375195350876,0.3114754098360656,0.8137517271053084,1.0,5/52,6.77%,CEMIP;ZIC1;ARIH2;TMEM30A;SMAD3
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.6288604337570494,1.0856945744499502,0.4107142857142857,1.0,1.0,2/9,12.14%,STX8;RAB7A
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.6322855759962347,-1.0854765263689783,0.40816326530612246,0.8135118558929018,1.0,3/10,8.74%,PLCG2;HLA-B;CD47
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6614605462679013,1.0854530977854417,0.41509433962264153,1.0,1.0,2/8,14.40%,BAG3;XPO4
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.7096628524534919,1.085328089572617,0.4489795918367347,1.0,1.0,2/5,17.18%,URI1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5623531678340067,-1.085303394813619,0.32,0.812840118043231,1.0,2/24,3.53%,GBP1;TNIP1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6668204168139715,-1.0849109034295645,0.39215686274509803,0.8126766806521928,1.0,3/9,10.20%,KLHL20;EIF2AK2;BST2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7002806165467746,-1.0821884337299568,0.5087719298245614,0.8180316992924901,1.0,2/5,15.64%,ATM;TNKS2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.6268727546380306,1.081646783654904,0.40625,1.0,1.0,2/9,7.54%,BAG3;HSP90AA1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4984864976462701,-1.0815458635543556,0.36666666666666664,0.8186188914622673,1.0,4/38,5.58%,CX3CL1;GPM6A;NTNG1;PLXND1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7247251828864709,1.0813880821280881,0.44642857142857145,1.0,1.0,3/5,12.27%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.7179355063905122,-1.081376222232549,0.4782608695652174,0.8179140915686133,1.0,3/6,19.02%,MTERF4;ZC3H13;WTAP
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5643316237151321,1.0813384865939086,0.3392857142857143,1.0,1.0,4/14,16.68%,PRAG1;CBFA2T2;EPHA4;PTEN
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.6360764965123687,-1.0813194134562172,0.37037037037037035,0.8169150542111915,1.0,5/13,17.88%,ATXN7;COL18A1;EYS;ZIC2;OPA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.64658651729756,-1.0812563639611057,0.43636363636363634,0.815874445338359,1.0,2/7,8.55%,EIF2AK2;TAOK3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.5940454391602032,1.0811700133791438,0.42105263157894735,1.0,1.0,4/11,16.97%,CALR;XPO1;XPO4;XPO7
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6657957547089166,1.081025851244356,0.38461538461538464,1.0,1.0,2/8,8.87%,MBNL1;REST
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.5936469735783165,-1.0809395167663023,0.42592592592592593,0.8155752119849389,1.0,3/17,5.50%,DENND3;PRKN;NGLY1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.40753218747909176,1.0808579720617297,0.21212121212121213,1.0,1.0,42/152,22.82%,PDK4;PRKG1;PRKD1;TAF1;BCR;PRAG1;MORC3;MAPK10;IGFBP3;PI4KA;STK38L;PIK3CA;PXK;YWHAZ;ABL1;DGKI;NLK;LRRK2;PPP3CB;FNIP2;PINK1;ADAM10;RPS6KA5;STK24;NEK7;OXSR1;WNK1;ACVR2A;PRKCA;ROCK1;RYK;LIMK2;TOP1;TAOK1;DYRK1A;CDK12;PPP4R1;EIF2AK3;HK1;CDK6;ROCK2;AKT3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.6645284786039809,1.0807358009620402,0.41818181818181815,1.0,1.0,3/6,16.49%,UGP2;GBE1;CALM1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6436313371388835,-1.080719310909893,0.3695652173913043,0.8148491031358471,1.0,2/7,14.02%,CBR4;ELOVL5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.6810152133160403,1.0785546077913826,0.43478260869565216,1.0,1.0,3/10,9.93%,ACTG1;PRKX;ACTB
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6311066643591898,-1.078087688294317,0.41509433962264153,0.8205464700013838,1.0,2/7,13.09%,NLRC5;ATM
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.4593135258382336,-1.0779636963476802,0.28,0.819741922060117,1.0,7/86,8.66%,CD74;FN1;PRKN;WARS1;TFRC;LIMCH1;CCDC88C
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.683884749305484,1.0779500399543862,0.375,1.0,1.0,5/8,25.76%,TET2;WDR82;SETD3;KMT5B;SETD5
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.606945601495194,-1.0777640191304316,0.40816326530612246,0.8190130477262854,1.0,4/9,12.54%,PRKN;TNFSF10;PMAIP1;CLU
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.517968005072853,1.0762236602616007,0.37037037037037035,1.0,1.0,4/25,7.46%,HDAC9;NUP58;PIAS1;RANBP2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6325958513578936,1.076171773515824,0.34545454545454546,1.0,1.0,2/7,18.75%,PBX3;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.6834394470182862,1.0760042428156664,0.43859649122807015,1.0,1.0,4/6,22.90%,MORC3;SKI;CDC73;NF1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.6955078164204359,1.0745905998192595,0.40384615384615385,1.0,1.0,1/6,5.66%,SYNE2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7056579506389886,1.0744645699536088,0.41818181818181815,1.0,1.0,3/6,22.50%,RTN4;ATL2;RTN3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.7161787383630059,-1.0744155273920533,0.43636363636363634,0.8267049010416049,1.0,2/8,3.43%,PLCG2;VAV3
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5541921672806936,-1.0743924294440392,0.4074074074074074,0.8256315242410803,1.0,2/16,6.72%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6925162161448613,-1.0740983798794197,0.42857142857142855,0.825043782146234,1.0,3/5,14.71%,SULF2;CHST12;CSGALNACT1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6785978009122983,-1.0739337981052037,0.425531914893617,0.8244284541496508,1.0,1/5,1.54%,SOD2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7073068603488816,1.073802570635889,0.45098039215686275,1.0,1.0,3/5,22.90%,SEMA3F;NRP1;NF1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5730339602483603,-1.0731668478170857,0.4074074074074074,0.825171295896511,1.0,4/19,12.72%,SPG7;CPM;VSIR;SRGN
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.594986075312519,1.0730706846564786,0.38636363636363635,1.0,1.0,3/11,8.87%,ZEB1;NRCAM;REST
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6209256472725465,1.072810158864954,0.39215686274509803,1.0,1.0,4/8,31.47%,DICER1;AGO2;TUT7;TUT4
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6579019216363342,1.0727800962671126,0.3508771929824561,1.0,1.0,4/7,26.40%,ITGA1;CALM1;HSP90AB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.6606724718371219,-1.072555989640128,0.41304347826086957,0.8255188177620523,1.0,3/5,28.58%,DHX36;RPTOR;MTOR
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.5381293526805628,-1.0721207295745843,0.42592592592592593,0.8255744719207272,1.0,3/24,5.60%,LGALS3;TNFSF10;SERPINE1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.6253052349744853,1.0714983767534279,0.39344262295081966,1.0,1.0,1/8,1.41%,BCL6
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.6389868748740823,1.0714159865170694,0.37735849056603776,1.0,1.0,1/8,3.72%,MT2A
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.45470043772231855,1.0710279567462746,0.30303030303030304,1.0,1.0,9/34,18.46%,ITPR3;STIM1;CPNE8;HOMER1;CLIC4;PPP3CA;NLGN1;CALM1;ANXA11
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5349443291226871,-1.0709018018734409,0.38461538461538464,0.8272858810821104,1.0,7/25,10.73%,CYLD;TMSB4X;IRF1;UFL1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4560986336218146,1.0706832306818332,0.35714285714285715,1.0,1.0,10/52,18.78%,PACS2;CCDC88A;MAP7;TTC7A;DPP10;ANK2;NECTIN3;CD81;ANK3;ROCK1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.6386697261336078,1.0700681604243807,0.4583333333333333,1.0,1.0,3/8,9.93%,ACTG1;HSPB1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6933505827019012,-1.069617296368124,0.55,0.8291666552552371,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7333901740630973,1.0690163950203655,0.45454545454545453,1.0,1.0,3/5,21.73%,PIAS1;ZMIZ1;HDAC4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.6841422755011989,-1.0689968242262902,0.44680851063829785,0.8293619330843618,1.0,2/10,11.87%,PLCG2;HOMER2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.6141689538105122,1.0688800387828783,0.3673469387755102,1.0,1.0,2/13,1.51%,HDAC9;INSIG1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.6141689538105122,1.0688800387828783,0.3673469387755102,1.0,1.0,2/13,1.51%,HDAC9;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5584825617692373,1.0685684487553617,0.43902439024390244,1.0,1.0,4/13,10.89%,GRIK2;INPP5F;HOMER1;ANXA2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6630596547600403,1.068071963484924,0.4727272727272727,1.0,1.0,1/8,2.90%,BAG3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6019106917780807,-1.06799470064966,0.375,0.8304680223044737,1.0,1/12,0.90%,PSTPIP2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.5437280489779942,-1.0673414217777675,0.425531914893617,0.8307043236821763,1.0,4/25,5.60%,PPARG;CD109;CTNNA2;SERPINE1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6548604392086863,-1.0671382417871054,0.38636363636363635,0.8301609596723373,1.0,2/9,14.71%,SLC2A3;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6372437777660204,-1.0666833053979132,0.423728813559322,0.8300368699457557,1.0,6/8,33.25%,UNC13B;RACK1;ZBTB20;GAS6;PCK1;IGF1R
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.713380303277376,-1.0665088525242068,0.44680851063829785,0.8295390567785246,1.0,1/5,2.36%,TPM1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.5783791413354009,-1.0655822132857,0.36363636363636365,0.8306804828243827,1.0,1/14,1.20%,RHOBTB1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.6568577088459062,-1.0650911535834964,0.49019607843137253,0.8308001071205772,1.0,1/7,1.01%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6211229076088635,-1.0643410950622803,0.4222222222222222,0.8314495583334569,1.0,2/15,3.53%,GBP1;TNIP1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.5057152982971436,-1.0642055616342718,0.30357142857142855,0.8306949670415279,1.0,11/36,18.49%,RFC3;SPC25;TFRC;CBX5;LBR;MSH2;PDS5B;GSPT1;RFC1;RAD21;ORC2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6085719224218962,-1.063653590573448,0.42,0.8308998239714578,1.0,3/9,15.19%,CXCL12;STK39;RHOA
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.46318564541080054,-1.0634103026843162,0.36923076923076925,0.8302336369908557,1.0,17/87,11.71%,TLL1;RHOBTB1;TPM1;CARMIL1;PRKN;COL8A1;PPP1R9A;DSP;B2M;COL18A1;CCDC88C;ARHGAP17;CST3;ACTN1;CD2AP;VIM;UBC
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.6496456684983315,1.0632833045321515,0.36363636363636365,1.0,1.0,4/10,23.88%,ANO6;ANK2;WNK1;AKAP6
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.687416866187816,-1.0627915119115545,0.5111111111111111,0.8306380786093259,1.0,6/6,31.39%,BCOR;KMT2A;KDM1A;AUTS2;CTNNB1;MACROH2A1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.45726934106506245,-1.0625576591488253,0.36666666666666664,0.8302017499150934,1.0,5/71,4.06%,TBX3;ZIC1;EML1;PRKN;SMARCA1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5419096284393963,1.062454995511542,0.3793103448275862,1.0,1.0,8/19,17.66%,CDH2;ROBO2;TIAM2;RTN4;CHN1;EPHA4;PTEN;TIAM1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4750496750708428,-1.0623502098151545,0.38461538461538464,0.8295391923221067,1.0,3/44,2.36%,KLHL20;RHOBTB1;TPM1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.6195337184550874,1.0618995396376758,0.4444444444444444,1.0,1.0,5/9,33.04%,LRRK2;WNK1;BCAS3;ARFGEF1;CPEB2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6227563768556093,1.0610984298861268,0.46808510638297873,1.0,1.0,1/7,12.93%,STARD4
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.49270452568899786,1.060920805818542,0.3695652173913043,1.0,1.0,4/28,8.55%,CALR;MORC3;PPP1R10;TAF3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.5448142904338658,1.060498312468985,0.44642857142857145,1.0,1.0,2/17,9.08%,CCDC88A;WAPL
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6990851302802006,-1.059546862675613,0.5370370370370371,0.8347261829698889,1.0,3/5,20.48%,VIM;NOD1;NLRP1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.43455310474438735,-1.0590284483914547,0.31746031746031744,0.8348956299016265,1.0,26/146,14.00%,CYLD;GBP1;TMSB4X;PLCG2;ULK4;OPTN;UFL1;VAV3;RFC3;RASGRF2;ARAP2;NFKBIA;TAOK3;TOPBP1;ARHGAP17;NET1;ARHGAP15;MAPKAP1;ARHGEF11;MCF2L;ITGAV;GNA12;ATM;PPP1R16B;BRD7;PRKAR1A
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6761638799999475,1.0588680342889334,0.4423076923076923,1.0,1.0,1/5,1.51%,INSIG1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6761638799999475,1.0588680342889334,0.4423076923076923,1.0,1.0,1/5,1.51%,INSIG1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4325783257415017,1.0576530291112825,0.3333333333333333,1.0,1.0,11/52,16.20%,SMAD9;SOX5;SMAD6;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;APPL1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5209583637181615,1.0574367473263842,0.40476190476190477,1.0,1.0,3/23,1.14%,BTBD10;INPP5A;RRAS2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7423545841985255,1.0570446673345,0.5,1.0,1.0,2/5,13.94%,PPHLN1;ATF7IP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7423545841985255,1.0570446673345,0.5,1.0,1.0,2/5,13.94%,PPHLN1;ATF7IP
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.5965482794239338,-1.056785840726371,0.40425531914893614,0.8374808832891529,1.0,4/10,19.87%,AGPAT3;DGKG;DGKE;LCLAT1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.5965482794239338,-1.056785840726371,0.40425531914893614,0.8374808832891529,1.0,4/10,19.87%,AGPAT3;DGKG;DGKE;LCLAT1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.6649755142024648,1.0561039186007442,0.43478260869565216,1.0,1.0,3/6,23.67%,ANO6;RGCC;GSN
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6102610637604741,-1.0558592493470815,0.38461538461538464,0.8385353834695062,1.0,2/8,12.01%,STAT1;SULF2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.5721034071161102,-1.05558647482641,0.44680851063829785,0.8382476762669946,1.0,5/16,22.52%,FOXK1;FOXO1;UNC13B;RACK1;ZBTB20
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.5821569775313408,1.0551980440295334,0.4230769230769231,1.0,1.0,4/8,26.77%,ANXA2;MTMR3;RAB5A;PIKFYVE
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6481423389840072,-1.0547297232723742,0.41818181818181815,0.8391293813270672,1.0,3/5,22.23%,PMAIP1;RIOK3;SLC3A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7147420989985781,-1.0544134964946021,0.4782608695652174,0.8387854041302236,1.0,4/5,13.44%,TAP1;B2M;ERAP1;HLA-A
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.478359051622807,1.0542671680168103,0.36,1.0,1.0,8/25,18.49%,KPNA3;PPP1R10;RANBP2;KPNA1;CBLB;APPL1;KPNA5;IPO8
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.5171233002349601,1.0540914603050824,0.44,1.0,1.0,4/22,13.20%,UBQLN1;HSP90B1;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6285212146916527,1.0540174621072433,0.42,1.0,1.0,5/8,23.88%,VMP1;ANK2;CALM1;RYR2;AKAP6
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.6471673230661411,-1.0539731879634717,0.4222222222222222,0.8386951088146329,1.0,3/6,25.29%,SENP6;ATG10;ATG7
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6655395834604316,1.0538194646534278,0.5098039215686274,1.0,1.0,2/5,14.34%,UGP2;GBE1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6404766073027973,1.053631282063689,0.5192307692307693,1.0,1.0,3/8,17.56%,PKM;CPEB3;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5336120289690339,-1.0527190780563194,0.4,0.8401897613613856,1.0,2/17,10.07%,SHLD1;PARP9
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6121852837965277,1.0526795817870311,0.5094339622641509,1.0,1.0,2/9,9.22%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.647978210436484,1.052489630105435,0.49019607843137253,1.0,1.0,5/7,26.80%,AGTPBP1;SKI;NIPBL;NF1;STAT3
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6203704850856272,1.0523601513906862,0.40816326530612246,1.0,1.0,2/8,11.71%,SMAD1;SMAD5
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4356153122162123,1.0523527563458996,0.32,1.0,1.0,13/54,16.20%,SMAD9;BMP6;SMAD6;HIVEP1;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;SMURF2;APPL1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5156463543581524,-1.0515592975119117,0.37037037037037035,0.8414563634648273,1.0,2/31,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6573097545337804,1.051515803206946,0.4745762711864407,1.0,1.0,2/6,16.49%,PARD3;CALM1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6746037463492482,1.0514973137327808,0.4318181818181818,1.0,1.0,2/6,26.51%,APPL1;C2CD5
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4332262410877958,-1.0510610838444057,0.39655172413793105,0.8414607969513835,1.0,18/136,13.09%,CD74;RIMS1;PLCG2;FN1;PRKN;EIF2AK2;SMAD3;TAF1D;WARS1;RPL23;TFRC;POLR2A;RPS7;VIM;UPF3A;VSIR;CLU;ATM
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.6389323302116423,-1.0509510906794335,0.4791666666666667,0.8405991832256653,1.0,1/5,7.92%,CEP57
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6277505761028269,-1.0508914506119058,0.48,0.8396561467179328,1.0,2/14,13.09%,SP100;ATM
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.47419171095941165,-1.0508187100739446,0.36666666666666664,0.8387434613502543,1.0,7/49,12.72%,LAP3;SPG7;CPM;CPQ;ERAP1;SPPL2A;SRGN
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6215093291335558,1.0507998343783116,0.5833333333333334,1.0,1.0,4/8,16.68%,BTRC;CDC14B;PINK1;PTEN
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5665088311301418,1.0505510203723403,0.36585365853658536,1.0,1.0,6/18,21.57%,PLCB1;NLK;PPP3CA;PPP3CB;CALM1;AGO2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6757744051499853,1.0499677092235289,0.4166666666666667,1.0,1.0,2/5,25.07%,ST8SIA4;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.5220474870137548,-1.0496616470713922,0.35294117647058826,0.8402262347562741,1.0,1/36,0.21%,RSAD2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.6657056777274483,1.0494884845050365,0.5333333333333333,1.0,1.0,2/6,26.06%,ANXA2;RFTN1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.6475128567281472,1.048784145853454,0.509090909090909,1.0,1.0,1/8,5.31%,PCM1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5032174211497751,1.048661486734416,0.46153846153846156,1.0,1.0,16/33,28.45%,ACTG1;ABL1;PPM1F;CLASP1;NRP1;PTEN;RAC1;PHLDB2;ROCK1;ROCK2;TEK;MAP4K4;EFNA5;BCAS3;PTK2;CORO1C
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6316655373383432,-1.0485448373661475,0.4727272727272727,0.8414966841749227,1.0,1/9,1.06%,LRPAP1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.580518845977796,1.0483041049187605,0.47058823529411764,1.0,1.0,1/11,3.27%,BCR
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.6490741815139277,-1.0482409719237011,0.4339622641509434,0.84136226434038,1.0,1/5,5.39%,CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6720389493363063,1.0464368729214477,0.45614035087719296,1.0,1.0,3/6,23.64%,ITGA1;CALM1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.45821443400632095,-1.04458252065134,0.38181818181818183,0.8487394108313809,1.0,4/68,10.09%,CX3CL1;RGS6;LARS1;NET1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6498983344847371,1.0438923998662228,0.5,1.0,1.0,1/5,2.47%,BACH2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6419984690549243,-1.0434610942691245,0.42,0.8491023031094297,1.0,3/7,11.61%,TPM1;DMD;VIM
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6419984690549243,-1.0434610942691245,0.42,0.8491023031094297,1.0,3/7,11.61%,TPM1;DMD;VIM
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5138030132837182,-1.0417736574707768,0.46153846153846156,0.8522439916496618,1.0,7/35,15.75%,PLK2;CENATAC;PRKN;GPC3;EEF1A1;HECW2;FOXO1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.6844593262909164,1.039910902322368,0.4915254237288136,1.0,1.0,3/5,21.65%,DICER1;PARD3;EIF2AK3
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4710750249990959,1.0396400356139757,0.3888888888888889,1.0,1.0,10/30,17.03%,STIM1;ATP2A2;CACNA1C;CALCRL;SLC8A1;ANO6;SLC24A2;ANK2;ATP2B4;PSEN1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5501493223073176,1.039434437927421,0.4782608695652174,1.0,1.0,2/15,14.95%,YTHDF2;G3BP1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5912549449882927,1.0385561068447735,0.39215686274509803,1.0,1.0,3/14,4.94%,ERBB4;PHACTR4;SEMA3F
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5780881835779254,1.0382474109244302,0.4418604651162791,1.0,1.0,1/9,5.92%,OTUD7B
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6582592413039594,1.0376988971333991,0.515625,1.0,1.0,1/7,7.57%,SMAD6
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.5431638953965313,1.0376691530746736,0.43137254901960786,1.0,1.0,4/15,17.42%,NUP58;RANBP2;PINK1;EP300
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4906004695355657,1.0374712399098416,0.4117647058823529,1.0,1.0,2/27,5.31%,BMP6;PCM1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6531374400350909,1.03740678945641,0.4745762711864407,1.0,1.0,4/6,23.29%,RANBP9;ROCK1;ROCK2;PICALM
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4514804751708219,-1.037067225113746,0.3559322033898305,0.8613743700685328,1.0,5/69,4.01%,KLHL20;PSMA1;PSMB9;IFI27;PRKN
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.4929223408236043,1.0368582991053725,0.37037037037037035,1.0,1.0,7/28,15.22%,PKM;YTHDF2;LARP4;SAMD4A;CPEB3;EIF3E;KHDRBS1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5889244469967735,-1.0364171836376397,0.42857142857142855,0.8617245011066147,1.0,5/13,13.44%,HLA-F;HLA-B;B2M;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5617106222167894,1.0360762456125063,0.4166666666666667,1.0,1.0,6/16,17.42%,ERCC6;ACTB;ZMIZ1;ARID1A;BAZ1B;EP300
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6481650067109797,1.036020938465716,0.5,1.0,1.0,1/8,7.54%,HSP90AA1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.6925672438602606,-1.0359665265379017,0.5319148936170213,0.8617987191583294,1.0,4/6,17.64%,LMO2;FOXO1;SRP14;STXBP1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.4018762561488768,-1.0358559421349691,0.39655172413793105,0.860980152556822,1.0,15/168,9.99%,HES1;TBX3;BTG2;PPARG;CNOT8;IRF1;SNX6;EIF2AK2;FOXK1;SCML1;BHLHE40;JUN;CBX5;RCOR1;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5216483613165556,-1.0357547590035237,0.43137254901960786,0.8601362834125322,1.0,2/24,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5457373480283068,1.0356174415807835,0.4444444444444444,1.0,1.0,5/15,20.37%,INPP5F;PLPPR4;PTEN;MTMR3;MTMR10
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.6689755736496236,1.0352530244522247,0.45098039215686275,1.0,1.0,1/6,3.72%,MT2A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4860744926816155,1.0352506614148689,0.37777777777777777,1.0,1.0,7/26,16.68%,MED4;CBFB;CCNC;MED15;ATF7IP;MED27;PTEN
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6175856401387622,1.0350035558156456,0.44,1.0,1.0,4/9,17.82%,NRXN1;IL1RAPL1;NLGN1;SPEN
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6119008090493198,1.0346107403300733,0.423728813559322,1.0,1.0,4/10,22.97%,PLEKHA1;PHLPP1;PTEN;PPP2R5C
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.5276297183181899,-1.0345250954267802,0.46,0.8617325904682769,1.0,2/26,2.55%,TPM1;ITGB5
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5315475760776325,-1.0343428765580696,0.3888888888888889,0.8610130421925508,1.0,8/16,17.74%,ISG15;RFC3;TRIM25;MSH2;UBC;PRIMPOL;RFC1;POLK
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.6142948665335531,-1.034084078332563,0.4423076923076923,0.860472950176846,1.0,4/12,17.88%,ATXN7;COL18A1;ZIC2;OPA1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5601393694136797,-1.0335006067162904,0.4117647058823529,0.8608347227500672,1.0,2/20,2.26%,PLCG2;PLK2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5736006489693175,-1.0332567522372218,0.42857142857142855,0.8602281252835371,1.0,5/13,20.00%,PMAIP1;FHIT;MSH2;ZNF385B;DDX5
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.4845496866634201,-1.0331887458319118,0.45901639344262296,0.8592284503341789,1.0,7/44,10.12%,PSMA1;PSMB9;PLCG2;LCP2;NFKB1;BTNL9;INPP5D
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.4560251223183752,1.0330579422589568,0.325,1.0,1.0,10/45,12.83%,GRM5;CADM2;GRIA2;MAPK10;NRXN1;ZEB2;ADGRB3;RBFOX1;NRXN3;BAALC
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6408283300361035,1.033015334541593,0.48214285714285715,1.0,1.0,2/6,9.93%,ACTG1;ACTB
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5885431451974402,-1.0328477851985056,0.5185185185185185,0.8589788421240695,1.0,4/14,6.56%,SLC16A2;SLCO1A2;SLC5A6;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.59215816359331,1.0325075225116462,0.42105263157894735,1.0,1.0,8/14,23.29%,SLC2A13;RTN1;RTN4;EPHA4;ROCK1;RTN3;ROCK2;PICALM
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.5235210450897699,-1.0323856750126792,0.4262295081967213,0.8588384621671756,1.0,4/30,4.04%,PPARG;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.666629965830414,-1.0323775242200952,0.4666666666666667,0.8577359737690148,1.0,3/8,4.17%,SLC6A6;SLC16A2;SLC5A6
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5015958185453997,1.0323660206632355,0.375,1.0,1.0,10/32,20.48%,PRKD1;TAF1;NLK;LRRK2;GALNT2;OXSR1;WNK1;PRKCA;ROCK1;DYRK1A
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5852679427123177,1.0322058836061985,0.45652173913043476,1.0,1.0,3/10,9.96%,BCR;UGCG;CLIC4
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6784141109287004,1.0298499965515904,0.47368421052631576,1.0,1.0,3/6,17.80%,SKI;LEMD3;ACVR2A
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5904491641902406,-1.0298213759385448,0.4807692307692308,0.8622006439697899,1.0,2/12,8.39%,VAV3;LARS1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4693576752415805,1.029416915123743,0.4418604651162791,1.0,1.0,3/38,2.84%,ABL2;INPP5F;RALA
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5506285567720769,-1.0292051145573846,0.42857142857142855,0.8626110466076528,1.0,1/20,0.90%,PSTPIP2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.6386184215291937,-1.0288452973511644,0.4423076923076923,0.8624127243656607,1.0,3/8,17.08%,ISG15;UBC;CHFR
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5808580449301978,1.0287834953336066,0.41509433962264153,1.0,1.0,3/11,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5808580449301978,1.0287834953336066,0.41509433962264153,1.0,1.0,3/11,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5435063723490154,-1.0282828802255135,0.40384615384615385,0.8626599680858431,1.0,2/20,3.45%,RREB1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5562765115311682,-1.0276103378290218,0.46808510638297873,0.863068214432852,1.0,1/15,0.56%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6778630080713453,1.0275441367912324,0.49230769230769234,1.0,1.0,1/5,6.14%,PKM
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5657971036142677,-1.0271516858130831,0.42857142857142855,0.8630853043285206,1.0,5/20,11.63%,TPM1;CXCL12;LAMA4;NID1;ADAMTS1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4617167846810976,1.0271208806695726,0.34782608695652173,1.0,1.0,13/38,22.23%,ZBTB1;KDM4C;ERCC6;ACTB;KDM5A;INO80;ARID1A;BAZ1B;BAZ2A;JARID2;TOP1;HDAC4;BPTF
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.43358337467172053,-1.0270129782757584,0.3157894736842105,0.8622828052169055,1.0,1/69,0.13%,CD74
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.6661922350201708,1.026896664668751,0.5581395348837209,1.0,1.0,2/5,26.06%,ANXA2;RFTN1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4470614098871369,1.0268934253727968,0.42857142857142855,1.0,1.0,8/32,17.24%,RALA;MICALL2;PARVA;S1PR1;NRP1;GRB2;THSD7A;ANXA1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.44983856571782416,1.0262153377674714,0.46153846153846156,1.0,1.0,9/42,16.15%,IL1R1;COL4A2;NTM;MPDZ;PTPN21;ADGRL2;PDZRN3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6450944439670019,-1.0257152176314699,0.5217391304347826,0.8641257114115701,1.0,2/7,10.73%,IRF1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.5970724177447222,1.0255331009337891,0.45714285714285713,1.0,1.0,1/9,0.53%,PNP
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5960153135620878,1.0253570531066603,0.5,1.0,1.0,7/13,28.45%,ROBO2;PTEN;PHLDB2;ROCK1;ROCK2;BCAS3;CORO1C
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6261867537603191,1.0244016467788142,0.5111111111111111,1.0,1.0,5/7,36.71%,IHO1;ZNF207;SMC6;SMC5;PUM2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.49407211223518255,-1.0240045925362051,0.34,0.8670628281704109,1.0,1/28,1.01%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.6749346759696618,1.0237670575247706,0.5,1.0,1.0,2/5,20.11%,ANO6;RGCC
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5354914000474511,1.02335637679679,0.45454545454545453,1.0,1.0,4/20,17.24%,RALA;CLASP1;IL1RAPL1;ANXA1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.48578080970079907,1.0232337547899322,0.4489795918367347,1.0,1.0,6/18,16.15%,GRIA2;SNAP25;NTM;ADGRB3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.594403832751369,1.0222819841032071,0.425531914893617,1.0,1.0,8/11,22.90%,PRKX;ROBO2;FOXC1;ZBTB16;CEP290;C1GALT1;NIPBL;NF1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.570619508609975,-1.0221145150091464,0.45454545454545453,0.8701129565599699,1.0,1/11,4.75%,SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4603513367330599,1.0215872325685114,0.4523809523809524,1.0,1.0,3/49,2.79%,TRIM5;MTDH;PRKD1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5848554139356056,1.0215124595951337,0.4782608695652174,1.0,1.0,4/10,15.64%,PSMD14;EPHA4;PINK1;UBE3A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.6379942085898918,1.0212113907426323,0.5,1.0,1.0,2/7,17.34%,HSP90AA1;CD81
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6617690522389715,-1.0210673367610095,0.5,0.8712705954779745,1.0,2/5,26.27%,KPNB1;SREBF2
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4587854717965953,-1.0201661208900494,0.4,0.8721983531664325,1.0,8/72,6.56%,VCAM1;LRATD1;CXCL12;OPTN;SMARCA1;GPM6A;TRANK1;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5500228589971089,1.018125203102529,0.5106382978723404,1.0,1.0,2/10,15.48%,PPP1R10;YLPM1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.6176396531777048,-1.0181243931726007,0.4222222222222222,0.8759637802887349,1.0,6/16,19.76%,SERPINE1;NFKB1;VIM;RHOA;MAPK14;ZFP36
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5506277577625502,-1.0179803774637877,0.45,0.8752053911394299,1.0,3/14,8.42%,TLL1;COL8A1;COL18A1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4616398126081768,1.0179018140514469,0.3902439024390244,1.0,1.0,13/35,18.99%,PRKD1;PIK3CA;HSPB1;HSP90AA1;ELMO1;NRP1;CDC42;CYFIP1;RAC1;WASF2;ROCK1;PXN;CRK
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4150700597464479,1.017845777677483,0.3695652173913043,1.0,1.0,14/62,13.49%,SRGAP1;GRM5;CADM2;GRIA2;SNAP25;FGF12;NRXN1;SLC16A1;TRIM9;ELMO1;ADGRB3;RBFOX1;CHN1;ADGRL2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.60572925207937,-1.0168797241483318,0.4807692307692308,0.8765768811713944,1.0,2/6,13.71%,MTMR2;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.623307730801776,1.016640778627204,0.45,1.0,1.0,2/8,7.68%,PRKD1;AMBRA1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.5883903075775039,1.0163119673657137,0.5581395348837209,1.0,1.0,6/12,28.76%,YTHDF2;DIS3L2;SND1;XRN2;MTREX;HSPA1A
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.48731286111325406,-1.0154685764784386,0.5,0.87871533933311,1.0,8/48,10.12%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;BTNL9;INPP5D
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5040973565674247,-1.0153030866902506,0.48148148148148145,0.8779828844797205,1.0,5/26,11.71%,ISG15;PRKN;NGLY1;PMAIP1;UBC
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.6700981209979704,1.0150982075465902,0.4897959183673469,1.0,1.0,1/5,4.78%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5543600109758828,-1.0147677246997837,0.4339622641509434,0.877954504061788,1.0,1/23,0.48%,NR4A1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5737837050574285,-1.0145149369701294,0.40816326530612246,0.8773042372013988,1.0,2/11,3.61%,IFI27;SP100
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.4605735861662196,-1.014012195050593,0.4166666666666667,0.8774750258594418,1.0,6/41,9.99%,CX3CL1;CARMIL1;PLXND1;KIDINS220;SCARF1;CAPRIN1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5179223067629128,-1.013262214452314,0.46153846153846156,0.8782789902802008,1.0,7/22,17.24%,CLIC5;PPP1R9A;APCDD1;MCF2L;PDE9A;NEBL;ZNF423
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5545266072447091,1.0129539669588608,0.5192307692307693,1.0,1.0,1/17,1.25%,CALR
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6307224956956639,-1.0128835853391926,0.48936170212765956,0.878026261099641,1.0,1/6,1.57%,RIMS1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5247068301482573,1.0123694412962043,0.4583333333333333,1.0,1.0,3/17,6.75%,ERBB4;GRM5;NCAM1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.4439714166362162,-1.0121095557389759,0.4918032786885246,0.878774864739387,1.0,6/88,4.06%,KIAA1217;TPM1;ITGB5;OPTN;CLIC5;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6183202887129684,-1.0120935064428465,0.40384615384615385,0.8777462537345601,1.0,1/11,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.6140875928953232,1.0120591049410945,0.425531914893617,1.0,1.0,5/10,17.77%,ELMO1;HACE1;CYFIP1;TIAM1;RAC1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.4787581498873168,-1.0116484660508078,0.4838709677419355,0.877784086651869,1.0,10/42,17.64%,TMSB4X;FN1;CD109;SERPINE1;ACTN1;CLU;SRGN;PDGFB;FAM3C;STXBP1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.49730129203698514,-1.011004777850168,0.43478260869565216,0.8782547218524872,1.0,5/25,11.71%,SNX6;CD109;SMAD3;SNX25;UBC
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6822604288686334,1.010507596093152,0.5813953488372093,1.0,1.0,2/5,21.65%,PLCB1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.547332238589843,1.0103417840754534,0.5,1.0,1.0,4/15,16.52%,PKM;ITGA5;SMAD1;KLF2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.4976712161424682,1.0102110113455103,0.43137254901960786,1.0,1.0,7/19,15.41%,UBQLN1;ATP2A2;PACS2;AMBRA1;RAB7A;VMP1;ATG2B
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6437373684899033,1.0099300002231226,0.5,1.0,1.0,5/8,25.18%,ANKH;S1PR1;ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.49072962132795955,-1.0098922233387337,0.3333333333333333,0.8795233986282078,1.0,3/28,5.05%,BTG2;CNOT8;EIF2AK2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5609373630601107,-1.009219182807027,0.4716981132075472,0.8798467710237737,1.0,5/10,12.70%,FN1;ITGB5;COL8A1;DUSP5;ITGAV
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5192030294982424,1.008493823849763,0.4,1.0,1.0,6/15,26.93%,ATN1;PDZRN3;ANK2;CTNND2;FGFR1;GALNT18
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5875746097327248,-1.0081223727115158,0.4883720930232558,0.881371724419211,1.0,3/8,19.23%,PRKN;CLU;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.5731389762570198,1.0079635670870581,0.42857142857142855,1.0,1.0,2/11,7.01%,SLC38A9;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4993588223978117,1.0077707519165207,0.5192307692307693,1.0,1.0,8/22,23.64%,BMP6;ZEB2;RBPMS;CREBBP;EP300;ACVR2A;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5073705299862715,1.0076236408810817,0.45652173913043476,1.0,1.0,10/29,22.79%,PRKD1;TAF1;NLK;LRRK2;OXSR1;WNK1;PRKCA;ROCK1;DYRK1A;ROCK2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6417546421332763,1.007526026848501,0.52,1.0,1.0,4/6,20.16%,CDC42;DIP2A;PTEN;CTNND2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.6113507414824408,-1.0073824025020455,0.4489795918367347,0.8820575025075494,1.0,6/9,31.29%,ELOVL5;MFSD2A;LPGAT1;ZBTB20;MTOR;SORBS1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.4443770227475944,-1.007176313755122,0.41935483870967744,0.881490026359895,1.0,6/46,11.55%,KLHL20;SNX6;SNX2;GOSR1;ANKFY1;CCDC91
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5003010193560484,-1.0068398112992638,0.509090909090909,0.8811062439117631,1.0,2/27,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5671256751575764,1.0059880246900694,0.5084745762711864,1.0,1.0,6/11,28.69%,ROCK1;ROCK2;TEK;CYRIB;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5935599404566685,1.0059109513242324,0.5660377358490566,1.0,1.0,3/7,26.08%,ZMIZ1;ARID1A;KDM3A
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6588461226996348,1.0058170640502198,0.5686274509803921,1.0,1.0,4/6,31.29%,ANK2;ANK3;AKAP6;KCNMB4
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.46292496715302506,1.0048550959559122,0.425531914893617,1.0,1.0,7/25,16.68%,MED4;CBFB;SETX;CCNC;MED15;MED27;PTEN
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6506717419143586,1.0046275668934117,0.5116279069767442,1.0,1.0,3/5,13.52%,AGTPBP1;NRXN1;GCH1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6396579770982008,1.0043934771103398,0.5178571428571429,1.0,1.0,2/5,21.65%,WDR43;EIF2AK3
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.4383941406013985,1.004082987913656,0.4,1.0,1.0,4/35,3.53%,PDIA3;UBQLN1;HSP90B1;ATP2A2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5632235243180254,-1.0036243604105055,0.4583333333333333,0.8871478679633882,1.0,3/16,4.04%,FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5717187637521138,1.0030666413037852,0.42857142857142855,1.0,1.0,5/10,25.92%,GULP1;ELMO1;CDC42;GSN;MYH9
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5007484935619341,-1.002290202371829,0.4807692307692308,0.8891350548425554,1.0,9/26,9.19%,PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C;TAP1;B2M;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4366214192708732,-1.002039653184097,0.5254237288135594,0.8886654567254132,1.0,9/72,10.73%,LRPAP1;RREB1;SHLD1;EIF2AK2;SERPINE1;SMAD3;TFRC;RPS19;APPL2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6568350837722516,1.0018861794593572,0.509090909090909,1.0,1.0,3/6,22.10%,ANXA2;RALB;RAB3GAP2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.4780635261186485,-1.0008812499145812,0.39285714285714285,0.8900110065547868,1.0,4/28,6.69%,SLC22A5;GABARAPL1;ACSL4;GPD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5001091732328835,-1.000355995411326,0.46153846153846156,0.8899167816804509,1.0,9/27,9.19%,PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C;TAP1;B2M;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.6555735684109636,0.9997090545401027,0.52,1.0,1.0,1/5,13.52%,GCH1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6555735684109636,0.9997090545401027,0.52,1.0,1.0,1/5,13.52%,GCH1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.6488794944711717,-0.9994745208204173,0.4583333333333333,0.8907146395408322,1.0,4/5,9.75%,OPTN;SERPINE1;RPL30;RPS19
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4668643550421928,0.9994695722086648,0.39215686274509803,1.0,1.0,2/19,7.70%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5318635043046323,0.9992747811079519,0.5,1.0,1.0,3/15,10.36%,ARHGEF4;CCDC88A;S1PR1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5664839758928241,0.9991693204461989,0.45161290322580644,1.0,1.0,6/11,28.69%,ROCK1;ROCK2;GSN;CYRIB;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.575509157332253,0.9987917907183403,0.5178571428571429,1.0,1.0,5/10,30.70%,LRRK2;ANK2;RYR2;UBAC2;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5479433651877269,-0.9983331136713055,0.47058823529411764,0.8920656590685786,1.0,1/9,3.88%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5998672840391244,0.9976636850585533,0.5961538461538461,1.0,1.0,1/6,8.61%,ERCC6
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.5614329772775022,0.9975680338472033,0.4339622641509434,1.0,1.0,5/10,17.56%,SLC38A9;CAPN2;CPEB3;KLF2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6024952192309599,-0.997553046981833,0.48936170212765956,0.8925623867198261,1.0,1/8,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5791653311556759,0.997436839536391,0.4716981132075472,1.0,1.0,5/9,33.57%,CCDC186;LIMK2;KIF5B;RAB27A;SPG11
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6369020141649557,0.9972581845474314,0.5714285714285714,1.0,1.0,2/6,14.34%,UGP2;GBE1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.5624371413842073,0.9972147147355739,0.5111111111111111,1.0,1.0,3/11,14.08%,PIK3CA;LRRK2;PINK1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5724377884293363,-0.9968010223153744,0.46,0.8929548780053613,1.0,4/12,21.99%,FHIT;N4BP1;RPL11;USP14
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5170364880754991,-0.9967380402952449,0.5535714285714286,0.8919701343836515,1.0,1/22,0.24%,HES1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6339771577837915,-0.9966964758708328,0.5172413793103449,0.8909749399610544,1.0,1/5,7.73%,STK39
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.5392959776744712,-0.9965742653948038,0.44,0.8902644495377818,1.0,2/21,2.26%,PLCG2;PLK2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.6070142164312053,-0.9956573460493053,0.5714285714285714,0.8912986037488926,1.0,2/8,10.07%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5148071314919482,-0.9955690249001303,0.48,0.8903846425230695,1.0,1/14,1.01%,PPARG
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.5198183362381663,-0.994667793570065,0.4603174603174603,0.891147671481839,1.0,8/34,14.45%,SLC6A6;SCN3A;SCN2A;TRPM6;NNT;TRPM3;ITGAV;TRPC4AP
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.6025361713148941,0.9946407608930528,0.5348837209302325,1.0,1.0,3/9,9.96%,BCR;UGCG;CLIC4
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.663133837582618,0.994618843951981,0.54,1.0,1.0,2/5,16.28%,EIF5;EIF4A2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.6171102931537178,-0.9944393135368604,0.62,0.8905808687628856,1.0,1/8,3.51%,ATP6V1E1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.67424984001588,-0.9943634094759282,0.5833333333333334,0.8896838394987006,1.0,3/6,6.56%,SLC16A2;SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4642128821696423,0.9942533697718605,0.5128205128205128,1.0,1.0,9/31,18.59%,RALA;CCDC88A;PIK3CA;NRP1;CDC42;NLGN1;CYFIP1;RAC1;WASF2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.5176948640631178,-0.9941812553492625,0.3958333333333333,0.8888781424148978,1.0,1/14,0.27%,TBX3
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6013851568090361,-0.9934126900785952,0.5094339622641509,0.8894993567748404,1.0,3/9,9.96%,MEF2A;POLR2A;PTMA
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.42984446610377036,0.9933540259453085,0.5,1.0,1.0,15/49,29.93%,PACS2;MAP7;TTC7A;DPP10;ANK2;CD81;ANK3;ROCK1;ROCK2;SMURF1;C2CD5;DPP6;TTC7B;TSPAN14;PACS1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5056808203511439,-0.9930281687989996,0.46551724137931033,0.8892168338731936,1.0,6/18,12.54%,SERPINE1;B2M;APPL2;ANKFY1;GPC3;CLU
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.39602505710011343,0.9920386527542632,0.5,1.0,1.0,20/71,23.48%,PRKD1;TAF1;MORC3;CSNK1G3;STK38L;PRKX;NLK;LRRK2;PINK1;RPS6KA5;WNK1;PRKCA;ROCK1;TOP1;DYRK1A;EIF2AK3;CAMK1D;ROCK2;AKT3;MAST2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7001285284189378,0.9919936712050702,0.6428571428571429,1.0,1.0,3/5,21.57%,PLCB1;SMURF2;AGO2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6645242600734906,0.9912711384092859,0.6037735849056604,1.0,1.0,3/5,25.82%,ADAM17;AKT3;FGFR1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5241925508750918,0.9906419405627971,0.5217391304347826,1.0,1.0,3/19,7.78%,CCDC186;TRAK1;TRAK2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.45149514544195024,0.990093384608539,0.48,1.0,1.0,6/35,12.27%,BCL6;MT2A;CCDC85B;MT1M;RTN4;MT1E
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.5900752517564775,-0.9899082458452866,0.5238095238095238,0.8942403976244143,1.0,6/13,20.72%,SUN1;ATXN7;RPS19;NUP54;NUP98;SUN2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.43089391750928513,-0.9898696154212728,0.45614035087719296,0.8932556196188733,1.0,9/62,12.01%,CX3CL1;LRPAP1;MMRN2;GRB14;CD47;APCDD1;MTMR2;GPC3;SULF2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4756192652655525,-0.989102065352406,0.4642857142857143,0.8940711965621722,1.0,2/38,3.72%,CX3CL1;CASS4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.4535856364852253,-0.9890545223735914,0.5185185185185185,0.8931395669870074,1.0,1/44,1.04%,KLHL20
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5481263754369298,0.9889970106000394,0.5652173913043478,1.0,1.0,4/12,20.37%,INPP5F;PTEN;MTMR3;MTMR10
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.46692753817166016,0.9877242481537915,0.46,1.0,1.0,2/18,7.70%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5207283606332757,0.9873253382846435,0.5636363636363636,1.0,1.0,3/16,10.65%,UIMC1;ERCC6;FAM168A
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5460394259413511,0.9868423525511197,0.49056603773584906,1.0,1.0,5/11,22.90%,PLEKHA1;PIK3CA;PTEN;EDN1;NF1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5793904612924013,-0.9865561880827485,0.4883720930232558,0.8973133461086306,1.0,2/12,5.60%,RREB1;SERPINE1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.616039588900945,-0.9864888677888656,0.5454545454545454,0.8963926856555405,1.0,3/7,17.24%,CXCL12;GPC3;ZNF423
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.499608590887319,-0.9859309227434888,0.4838709677419355,0.8966083562554907,1.0,3/36,4.38%,CEMIP;PRKN;LGALS3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6285252295284787,0.9856792936968654,0.49019607843137253,1.0,1.0,1/5,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5555258686542481,0.9856669773759714,0.574468085106383,1.0,1.0,3/16,19.39%,MICALL2;RAB7A;DENND1A
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6564216260952314,0.9856196619404346,0.5833333333333334,1.0,1.0,2/5,16.68%,SETX;PTEN
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.511438334695355,0.9854907039646891,0.4807692307692308,1.0,1.0,2/15,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.597012425643711,-0.9853832691995029,0.56,0.8966095428078422,1.0,1/8,3.93%,SNX6
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5888566784706524,0.9853699420584999,0.5737704918032787,1.0,1.0,1/7,5.44%,RAB11FIP2
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5873973276990986,-0.985035039952221,0.5434782608695652,0.8961958676018561,1.0,3/8,15.51%,LARS1;ATM;SPAAR
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4757087620894449,-0.984941590390211,0.5517241379310345,0.8953688105248991,1.0,2/28,1.89%,CX3CL1;APOL3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.5264519676501758,-0.9846170255234797,0.43636363636363634,0.8949575914741327,1.0,3/15,6.67%,MAP2;CTNNA2;MEF2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5281418940372485,0.984526492991383,0.48214285714285715,1.0,1.0,6/12,14.21%,RALA;LRRK2;DDHD1;PINK1;MARCHF5;MFF
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6531235722888277,0.9845148881081893,0.56,1.0,1.0,4/5,28.50%,SKI;SORT1;MEF2C;AKAP13
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.5900782870421224,0.9843099033722577,0.5208333333333334,1.0,1.0,3/8,16.92%,ABL1;EIF4A2;POT1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6234244773048494,0.9839694807189755,0.6304347826086957,1.0,1.0,2/7,4.78%,ATP2A2;UGCG
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.4964108059610257,-0.9837714992911583,0.5192307692307693,0.895562014332606,1.0,4/27,8.92%,LRPAP1;SP100;NFKBIA;JUN
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4760275276912032,-0.9837469301521781,0.4318181818181818,0.8945384576055745,1.0,3/34,5.05%,BTG2;CNOT8;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.6434932042093634,-0.9831230342389166,0.5365853658536586,0.8946795533657783,1.0,2/6,17.32%,MVB12B;CDH13
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5705599619607864,0.9830014582736154,0.5192307692307693,1.0,1.0,3/9,23.61%,FGF12;ATP2B4;NEDD4L
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.4461555052826575,0.9829516824030312,0.5087719298245614,1.0,1.0,10/44,17.42%,BAG3;HSPH1;NUP58;RANBP2;HSP90AA1;ABL1;HSPA8;PINK1;CREBBP;EP300
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5869189622025722,0.98239318705378,0.5357142857142857,1.0,1.0,4/7,28.47%,YTHDF2;KHDRBS1;YTHDF3;HABP4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.47258223107204395,-0.9821425624435454,0.5081967213114754,0.8957065605256751,1.0,1/30,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6028732540458557,0.9819590033349728,0.4883720930232558,1.0,1.0,1/7,1.51%,INSIG1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6014066455621614,-0.9818860761959017,0.5,0.895210097113922,1.0,2/7,8.87%,CPQ;ERAP1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.47347539685393275,-0.9817534678034562,0.47368421052631576,0.8944906526957009,1.0,8/34,14.24%,ATP9A;PATJ;RAPGEF5;MYRIP;PPP1R9A;PIK3C2B;MCF2L;PDE9A
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.41586226774014556,0.9815961851600746,0.3829787234042553,1.0,1.0,24/52,26.40%,BCL6;CDH2;PDZD8;LARP4;ADGRB3;CLASP1;LRRK2;CHN1;EPHA4;MARCHF5;ZRANB1;CAPZB;TANC2;PHLDB2;PHIP;RC3H1;NF1;NEDD4L;FMNL2;CYRIB;ETS1;MARK2;EFNA5;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6116619054025634,0.9815901419328114,0.5681818181818182,1.0,1.0,2/6,22.92%,SFSWAP;SRSF7
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6116619054025634,0.9815901419328114,0.5681818181818182,1.0,1.0,2/6,22.92%,SFSWAP;SRSF7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6002944723227918,-0.9803252870432035,0.5660377358490566,0.8965963781642123,1.0,1/7,1.12%,GBP1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4771212644148083,0.9801689879275435,0.475,1.0,1.0,4/30,12.96%,PRPF8;HNRNPR;YTHDF2;DIS3L2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6449248052086556,0.979695559147636,0.5769230769230769,1.0,1.0,2/5,23.61%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5506589586390409,0.9796331929262484,0.5,1.0,1.0,3/13,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5729320079820666,-0.9796268677858958,0.5576923076923077,0.8967093757002926,1.0,2/11,8.98%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.487239017684133,-0.9796217394366438,0.46551724137931033,0.8946044241141418,1.0,8/45,8.92%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.487239017684133,-0.9796217394366438,0.46551724137931033,0.8946044241141418,1.0,8/45,8.92%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5194652017808773,-0.9795725495560308,0.48333333333333334,0.8937165884380932,1.0,2/21,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6588043665212919,0.9795675264363386,0.6,1.0,1.0,2/5,7.78%,TRAK1;TRAK2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5794473685174956,0.9792178755950085,0.49019607843137253,1.0,1.0,3/9,20.96%,ABL1;NRP1;PTPN1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.48327772114328094,-0.9785428258550027,0.4807692307692308,0.8950566027321099,1.0,4/25,7.09%,PSMA1;PSMB9;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5765311643035238,0.9784610743073419,0.5217391304347826,1.0,1.0,2/8,8.90%,GRM5;HOMER1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5911385257294569,0.9774035543120468,0.5510204081632653,1.0,1.0,1/6,20.03%,TAOK1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6963590069779146,0.9767161067342224,0.6440677966101694,1.0,1.0,2/6,13.94%,PPHLN1;ATF7IP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4671395592336323,0.9763358534268772,0.5,1.0,1.0,5/25,16.57%,PRKD1;HSP90AA1;FNIP2;PINK1;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4847805427718563,-0.9761036988115381,0.5686274509803921,0.8990365816155608,1.0,8/24,16.31%,TPM1;CXCL12;CD47;ITGAV;ATM;JAK2;AFDN;PDGFB
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5352445718930565,-0.9751540988239777,0.46938775510204084,0.8998984630199425,1.0,2/12,4.01%,ARIH2;PRKN
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5936770692233357,0.9741056826905893,0.5227272727272727,1.0,1.0,3/9,9.96%,BCR;UGCG;CLIC4
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.45758442941415534,-0.9733738241869662,0.52,0.9028407690905724,1.0,5/40,8.95%,BTG2;MAP2;GPM6A;PPP1R9A;FRYL
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5017726919440689,0.9733102896828447,0.55,1.0,1.0,10/18,31.47%,YTHDF2;CPEB3;DIS3L2;ROCK1;RC3H1;ROCK2;TUT7;YTHDF3;GIGYF2;TUT4
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.550518201398259,0.9730977814874759,0.5416666666666666,1.0,1.0,4/13,8.39%,GRIA2;SNAP25;ALCAM;NRXN1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.43012172197277215,0.9724010672713282,0.5238095238095238,1.0,1.0,6/39,7.01%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5928797922013436,-0.9723019289769975,0.5102040816326531,0.9038808238437961,1.0,2/7,13.55%,CDA;PRKRIP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5073524248603897,-0.9721143730827815,0.4727272727272727,0.9031604983567398,1.0,1/16,2.28%,SHLD1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.39390757504885665,0.9721100641027006,0.4864864864864865,1.0,1.0,3/45,2.79%,TRIM5;MTDH;PRKD1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.43415229958091484,-0.9721040806515522,0.5689655172413793,0.9021471490990204,1.0,6/58,8.95%,BTG2;MAP2;GPM6A;PPP1R9A;TAOK3;FRYL
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6600613115569101,0.9717394781439466,0.5869565217391305,1.0,1.0,2/5,23.61%,LRRK2;NEDD4L
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.48239655706127255,0.9716793409787363,0.5,1.0,1.0,7/27,16.15%,BAG3;GRIA2;NTM;RBFOX1;PDZRN3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.49409502736764577,-0.9715273395407628,0.5370370370370371,0.9022522561080023,1.0,2/22,0.85%,CEMIP;OMD
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6244000380049565,0.971118271847047,0.5370370370370371,1.0,1.0,4/6,26.40%,ADGRB3;SKI;SORT1;MEF2C
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.5915748903097441,0.9710738645180111,0.5384615384615384,1.0,1.0,2/8,16.52%,SMAD6;KLF2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.5156430432126174,-0.9707578136856408,0.5490196078431373,0.9025653800087678,1.0,5/23,10.09%,TPM1;MAP3K5;FOS;JUN;NET1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4465315253295539,0.9705650318105781,0.5,1.0,1.0,14/47,23.29%,ABL2;STK38L;HSP90AA1;URI1;ABL1;HSPA8;CHPT1;PINK1;ROCK1;PTPN1;ITCH;OPHN1;ROCK2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.45914276156891426,0.9704672069015989,0.5,1.0,1.0,6/25,15.64%,CRY1;UBQLN1;PIAS1;LRRK2;PINK1;UBE3A
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5360188951066309,0.9695553815138859,0.48148148148148145,1.0,1.0,3/11,15.83%,STIM1;HOMER1;ANK2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5855018744731186,-0.9685800665535138,0.5192307692307693,0.9060225426863336,1.0,2/11,7.73%,SCN2A;STK39
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.616193547937413,-0.968019550648879,0.5178571428571429,0.9061472438811153,1.0,1/8,4.28%,SPG7
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5247046658021504,0.9678416537621357,0.5178571428571429,1.0,1.0,2/11,7.78%,TRAK1;TRAK2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.566021724682101,-0.967565929217946,0.52,0.9060274938460205,1.0,2/12,4.01%,GBP1;PRKN
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5460795173769083,-0.9656884850253002,0.5306122448979592,0.9088345918911965,1.0,4/14,8.87%,CPM;CPQ;DMD;ERAP1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.585885033996086,0.9650700011414811,0.509090909090909,1.0,1.0,5/7,25.18%,KLF2;EDN1;ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.6553185107451392,-0.9650155794712444,0.5918367346938775,0.909187037853097,1.0,4/5,30.62%,ARHGAP17;ALS2;AUTS2;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4142276232081678,-0.9640853953873484,0.5833333333333334,0.9099766459678691,1.0,9/69,8.31%,CX3CL1;PPARG;PLCG2;EIF2AK2;SMAD3;NFKBIA;NFKB1;TRIM25;TFRC
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.31227763245410217,0.9636923984109793,0.6521739130434783,1.0,1.0,77/490,12.46%,CREB5;HDAC9;SMAD9;IRF2BP2;CRY1;TEAD4;TSHZ2;CALR;BCL6;ZBTB10;ERBB4;SOX5;FOXN2;UIMC1;MTDH;BACH2;AEBP2;ZBTB1;ZEB1;ZNF160;MED4;BICRAL;YAF2;KDM4C;PEX14;BRWD1;BTRC;PIAS1;GPBP1L1;PBX3;CNOT2;TRAK1;ST18;TRPS1;CCDC85B;CHD7;ZNF608;CTBP2;PLCB1;YY1;CBFA2T2;SMAD6;NFYC;URI1;SLTM;ZNF708;CBFB;ERCC6;KLF7;REST;ELF1;ZEB2;ABL1;PPM1F;PGR;ZNF704;ZMYND11;EPC2;TOX2;HIVEP1;ATP8B1;ZNF644;ZMIZ1;PSIP1;ID3;TFCP2;NLK;SMAD1;NCOA2;YWHAQ;ZNF706;SMAD5;CCNC;FOXO3;HSPD1;PHC2;KDM5A
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.5905141582338845,0.9635017935646123,0.6382978723404256,1.0,1.0,5/7,31.77%,INO80;SMC1A;ZNF207;TOP2B;LATS1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.604510838573979,0.962969836963122,0.5818181818181818,1.0,1.0,2/6,10.49%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.6515879281118705,0.9629344394254206,0.5909090909090909,1.0,1.0,4/6,29.69%,SKI;MEF2C;SVIL;MYL6
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.5737461575435147,-0.962861478614615,0.5357142857142857,0.9114570980198261,1.0,2/8,20.56%,MTMR2;MSN
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.36116282271857403,0.9628265418693815,0.5135135135135135,1.0,1.0,22/118,18.75%,CALR;FOXN2;GRM5;YAF2;CCDC88A;GPBP1L1;CHD7;NFYC;ZNF708;REST;ABL1;NLK;NCOA2;FOXO3;TRIM22;RPS6KA5;BAZ2A;CREBBP;EP300;CYFIP1;ZNF280D;FOXC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5629336989512262,0.9627486813253152,0.5833333333333334,1.0,1.0,6/10,21.25%,ATP2A2;CACNA1C;SLC8A1;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5832603445393234,-0.9623696203956508,0.5116279069767442,0.9114654507402902,1.0,3/8,18.03%,SERPINE1;PDGFB;CD34
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.42783972026015327,-0.9622896414488188,0.5076923076923077,0.9105523566536762,1.0,5/78,4.01%,CYLD;PSMA1;PSMB9;CDK14;PRKN
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6329431982557685,-0.9618067070489498,0.5740740740740741,0.9105859480519736,1.0,1/9,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5481563063644386,-0.9617842412301432,0.5227272727272727,0.9095912793626707,1.0,2/11,3.88%,ATP9A;MAP2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5517686014767414,0.9617663299290949,0.5102040816326531,1.0,1.0,4/12,17.80%,BMP6;SMAD6;RBPMS;ACVR2A
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4718299320732979,-0.9613970693091499,0.5636363636363636,0.9093842448834405,1.0,2/24,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.44379066375505466,0.9607878853842895,0.46511627906976744,1.0,1.0,4/31,4.78%,VAPB;PRKD1;KDSR;UGCG
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.6365625129725387,-0.9606887188539137,0.574468085106383,0.9098776637895517,1.0,1/5,2.79%,CXCL12
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.5115282863544053,0.9603203242031315,0.5294117647058824,1.0,1.0,2/14,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.43771051628165547,-0.9598590289896825,0.5,0.910707491871717,1.0,8/39,13.84%,PSMA1;PSMB9;NDRG1;SCN2A;PMAIP1;UBC;RORA;PGK1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4275897227937205,-0.9597534827565467,0.578125,0.9098617144912051,1.0,5/72,7.28%,HES1;ZIC1;SMARCA1;SMAD3;DSP
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.5834532039389746,-0.9596141775950425,0.5319148936170213,0.9091020554179484,1.0,1/16,2.42%,CNOT8
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.5664972190400419,0.9595394763393539,0.5769230769230769,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.6512379077633592,0.9590327602370791,0.5454545454545454,1.0,1.0,1/5,6.85%,PLCB1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.5382464802128377,-0.9583784138180811,0.5283018867924528,0.9106867970327691,1.0,4/16,11.71%,MAP3K5;NFKB1;CCDC88C;UBC
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.6246197467633852,0.9582678252667062,0.5892857142857143,1.0,1.0,2/5,18.83%,HSPD1;WDR43
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4012914580510678,0.9578181008784271,0.4230769230769231,1.0,1.0,10/45,16.20%,SMAD9;SMAD6;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;APPL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30655256318684726,0.9574268313177546,0.7307692307692307,1.0,1.0,75/514,12.67%,CREB5;HDAC9;SMAD9;IRF2BP2;JAZF1;CRY1;TEAD4;TSHZ2;MCPH1;CALR;BCL6;ZBTB10;SOX5;RARB;BMP6;MTDH;BACH2;AEBP2;ATN1;PRKD1;TAF1;ZBTB1;ZEB1;ZNF160;GABPB1;MED4;KDM4C;BRWD1;PIAS1;PBX3;OTUD7B;CNOT2;TRAK1;ST18;TRPS1;MRTFA;ZNF608;TET2;CTBP2;YY1;SMAD6;NFYC;URI1;SLTM;TAF3;CBFB;KLF7;REST;ELF1;ZEB2;ABL1;PGR;ZNF704;EPC2;TOX2;HIVEP1;NCOA3;SETX;CPEB3;ZNF644;ZMIZ1;PSIP1;ID3;TFCP2;DNMT3A;SMAD1;NCOA2;SMAD5;CCNC;MED15;PPP3CA;FOXO3;HSPD1;SS18;CRTC3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5593404080347462,0.9566526866232359,0.6097560975609756,1.0,1.0,1/9,5.44%,RAB11FIP2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5582740288156726,0.9563172615149403,0.5918367346938775,1.0,1.0,5/9,17.18%,FGF12;CACNA1C;SLC8A1;ANK2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5493779808767991,-0.956147306387258,0.4807692307692308,0.9142119453516185,1.0,2/9,11.29%,PLK2;MTMR2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.32051427543041977,0.9561461988243881,0.7037037037037037,1.0,1.0,28/279,9.43%,TRIM5;AFF3;RBM20;NOVA1;CALR;BCL6;FOXN2;BMP6;TAF1;ACTG1;PTBP3;YAF2;KRAS;MBNL1;GPBP1L1;CHD7;YY1;UTY;YTHDF2;NOVA2;NFYC;ZNF708;HNRNPLL;LARP4;REST;ABL1;PPM1F;PGR
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.418174888967267,-0.9558552639610375,0.5172413793103449,0.9137855553162669,1.0,12/90,13.60%,MX1;RIMS1;SUN1;IGF2R;FNBP1;TFRC;STAM2;UBC;USO1;CLTA;SPAST;DNM3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4676959368661664,-0.9557377168403427,0.4909090909090909,0.9130488382913247,1.0,4/42,6.72%,GBP1;ISG15;OPTN;TMEM30A
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.6116729925652303,0.9553405741588104,0.6666666666666666,1.0,1.0,1/6,13.73%,MTHFD1L
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5015101692653157,-0.9551354868427286,0.5102040816326531,0.9131628989217736,1.0,3/35,4.04%,ZIC1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6167043719883156,0.9549074263716746,0.6470588235294118,1.0,1.0,4/6,22.90%,DICER1;SKI;PARD3;NF1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5507410813122101,0.9545103473092327,0.5370370370370371,1.0,1.0,4/8,32.64%,S1PR1;TEK;RBPJ;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.564161901240027,0.9544063201908192,0.574468085106383,1.0,1.0,3/7,31.98%,NRP1;DSCAM;GOLGA4
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.520981555898095,-0.9540718984116912,0.5555555555555556,0.9145310055520768,1.0,6/18,19.18%,SLC5A6;SLC2A3;BTD;PDXK;PCCA;CD320
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.587336163484837,-0.9539888556436318,0.5111111111111111,0.913616959733065,1.0,4/8,17.88%,PRKN;TFRC;CLU;OPA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.5378492516293969,0.9535324083497856,0.5238095238095238,1.0,1.0,3/14,9.08%,YAF2;PPP1R10;WAPL
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.485300108490411,-0.9533922340457898,0.4909090909090909,0.9137657492950997,1.0,3/29,6.00%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5690031729150999,0.9531333830416602,0.5192307692307693,1.0,1.0,1/9,0.96%,CRY1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5212173992136956,0.9528401268357813,0.5686274509803921,1.0,1.0,4/12,11.53%,CALR;KDM4C;CBFB;NCOA2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.5937509112627042,-0.9527782503503974,0.5849056603773585,0.913842771266875,1.0,1/6,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6153213074924061,0.9526366987415308,0.6274509803921569,1.0,1.0,1/6,6.11%,CHD7
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.4996179934269724,0.9525054373601711,0.48,1.0,1.0,2/15,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5900098721493692,0.9520389201934327,0.6041666666666666,1.0,1.0,3/6,33.31%,DST;KIF5B;DYNC1H1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.42527898146399357,0.9519974199757605,0.54,1.0,1.0,5/38,7.84%,TEAD4;COL4A2;IGFBP3;NCAM1;CKMT2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.49054772517184864,-0.9517972236368462,0.5357142857142857,0.9149661107684393,1.0,6/27,9.11%,MAP2;CTNNA2;NTNG1;ZDHHC17;MEF2A;S100A6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4729472340409958,-0.9513375672133828,0.5192307692307693,0.9150297306581114,1.0,9/34,17.80%,TMEM117;MAP3K5;SCN2A;ERO1A;PMAIP1;FHIT;ATM;DNAJC10;ZNF385B
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.49207556015095244,-0.950856733382898,0.5625,0.9150457467027611,1.0,1/19,1.57%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.45418815429826354,0.9506306272365211,0.5636363636363636,1.0,1.0,8/24,24.01%,UIMC1;PPP1R10;ERCC6;POT1;RNF168;RGCC;OTUD4;USP9X
prerank,PanglaoDB_Augmented_2021__Platelets,-0.44073808635929107,-0.9500575066424113,0.5471698113207547,0.9155832105286776,1.0,13/35,19.04%,CAVIN2;CD109;SERPINE1;LCP2;SLC2A3;ERO1A;HLA-E;SRGN;HLA-A;LRRC32;GIMAP8;MAPK14;WIPF1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.45997847338287623,-0.9490213182133713,0.5370370370370371,0.9165811753071534,1.0,2/26,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.558172705815384,0.9489074670107195,0.5918367346938775,1.0,1.0,5/11,28.07%,TLE4;CREBBP;EP300;CDC73;TCF7L2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5624006299186233,0.9484616800179212,0.6222222222222222,1.0,1.0,5/9,24.65%,DICER1;DIS3L2;SND1;AGO2;TUT7
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5691260739068574,0.9484236071203535,0.5178571428571429,1.0,1.0,5/9,23.29%,SLC2A13;RANBP9;EPHA4;ROCK2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.48028310261283536,-0.9482688082597197,0.5535714285714286,0.9168555581041167,1.0,3/18,9.46%,TNFSF10;MAP3K5;PMAIP1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5981783724701621,0.9479899240122344,0.6346153846153846,1.0,1.0,2/6,23.61%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5725559143866685,-0.947698993353374,0.5833333333333334,0.9170348300172149,1.0,8/11,28.37%,RPL7A;RPL10;RPL24;RPL11;RPL3;NPM1;RPL23A;RPL5
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5584826533263063,-0.9474145399757123,0.5686274509803921,0.9168361354474615,1.0,2/8,14.10%,STK39;HECW2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5597234227415986,0.9469099707237866,0.576271186440678,1.0,1.0,5/8,23.64%,ZEB2;CREBBP;EP300;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5597234227415986,0.9469099707237866,0.576271186440678,1.0,1.0,5/8,23.64%,ZEB2;CREBBP;EP300;ADAM17;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.5385330710308456,-0.946887919811058,0.5121951219512195,0.9168500281650382,1.0,7/23,19.31%,ATP9A;MAP2;MAPKAP1;HOMER2;STOM;STXBP1;KLHL5
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.5002199448282054,-0.9468681964963163,0.54,0.9158632166918532,1.0,2/25,6.77%,PPARG;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4671648122416145,0.9453789019913373,0.4666666666666667,1.0,1.0,3/20,10.89%,CALR;ACTB;ANXA2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4247078753409021,-0.9438304222476541,0.5573770491803278,0.9213698559748691,1.0,9/55,12.72%,RIMS1;TMSB4X;FN1;CD109;SERPINE1;ARHGAP17;ACTN1;CLU;SRGN
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5709658171636836,0.943772802100271,0.559322033898305,1.0,1.0,5/9,30.78%,YTHDF2;ROCK1;ROCK2;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.4462092342688482,0.9434866087901356,0.56,1.0,1.0,10/34,23.32%,CALR;PRKD1;ABL1;NRP1;RAC1;EDN1;PRKCA;ROCK2;NF1;TEK
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.44351400969649,0.9431258260572992,0.5882352941176471,1.0,1.0,6/33,12.54%,BTRC;HSP90AA1;LARP4;SAMD4A;CPEB3;EIF3E
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6062292137507795,-0.9426833545538565,0.575,0.9226237814310715,1.0,2/5,9.46%,TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5580394005026366,0.9423898051330736,0.5,1.0,1.0,5/9,36.60%,KLF2;HSPA5;ATF6;RBPJ;ATF3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.47303763343413957,0.9420731987412545,0.5319148936170213,1.0,1.0,7/21,25.82%,LRRK2;TPD52L1;EDN1;CDK12;PTPN1;NF1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5025316007101839,0.9420644980645314,0.5961538461538461,1.0,1.0,4/12,18.19%,KATNBL1;ANXA2;ANXA1;UVRAG
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.6323787170019899,0.9418770115064627,0.6382978723404256,1.0,1.0,3/5,20.56%,SERINC1;SPTLC1;MGST2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5970724840074635,0.9417268390979525,0.5849056603773585,1.0,1.0,1/6,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.48064624834270714,-0.9414367376048872,0.4897959183673469,0.9240391877618352,1.0,7/24,20.29%,TNFSF10;MAP3K5;PMAIP1;DELE1;CARD8;MAP2K5;NOD1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5758113888579146,-0.9413394925169236,0.5102040816326531,0.9232363039417677,1.0,3/9,21.67%,POLR2A;ZFP36;IFITM3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.38875343003586077,0.9412421409227071,0.631578947368421,1.0,1.0,10/67,7.76%,PNP;PSMD14;CALR;INSIG1;HSP90B1;ATP2A2;TES;P4HA1;SKAP2;NFYC
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5261918085010187,-0.9403550850843234,0.5471698113207547,0.9242264275942733,1.0,3/11,11.71%,CDC14A;ANAPC16;UBC
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48016784968375203,0.9401136503103968,0.49122807017543857,1.0,1.0,7/20,14.93%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3212105022744658,0.940018109834905,0.6470588235294118,1.0,1.0,27/199,9.14%,HDAC9;IRF2BP2;JAZF1;CRY1;MCPH1;CALR;BCL6;RARB;BMP6;MTDH;ATN1;BAG3;TAF1;ZBTB1;ZEB1;OTUD7B;CNOT2;TRPS1;ZNF608;CTBP2;YY1;URI1;TAF3;CBFB;KLF7;REST;ZEB2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5823952552146765,0.9395379184101138,0.5714285714285714,1.0,1.0,4/7,22.79%,CBFB;KLF7;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6398441543934029,0.9394917258674269,0.6326530612244898,1.0,1.0,2/5,20.48%,ABL1;DYRK1A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.391879770772697,0.9393426888833757,0.5,1.0,1.0,20/70,23.48%,PRKD1;TAF1;MORC3;CSNK1G3;STK38L;PRKX;LRRK2;GALNT2;PINK1;RPS6KA5;WNK1;PRKCA;ROCK1;TOP1;DYRK1A;EIF2AK3;CAMK1D;ROCK2;AKT3;MAST2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9242781987380567,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9242781987380567,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9242781987380567,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.41518424728408576,0.9384119874416577,0.5227272727272727,1.0,1.0,10/44,15.91%,PRKD1;FAM174B;YWHAZ;HACE1;ATP8B1;CLASP1;LRRK2;BET1;VMP1;CDC42
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5383987860481096,-0.9383983409954627,0.5714285714285714,0.9241438557632069,1.0,3/12,15.19%,VAV3;LARS1;RHOA
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6393361935981772,0.9379583430989392,0.6976744186046512,1.0,1.0,1/5,18.11%,AGPS
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5610734404012145,0.9372307197992475,0.5510204081632653,1.0,1.0,2/6,24.25%,CPT1A;ACACA
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4559312488936118,-0.9365873104584925,0.6078431372549019,0.9270718729554638,1.0,5/38,3.24%,CX3CL1;CYLD;TMSB4X;IRF1;UFL1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.5219236779546672,-0.9359596960558305,0.5476190476190477,0.9274580994327098,1.0,4/20,9.46%,DENND3;PRKN;NGLY1;PMAIP1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5559657761692586,0.9347386950000354,0.5862068965517241,1.0,1.0,8/11,41.81%,CCM2;RASA1;ADM;TGFBR3;RASIP1;ENG;SPRED1;SOX18
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.47473200415454425,-0.9346928199672324,0.5,0.9287380014392652,1.0,4/25,7.09%,PSMA1;PSMB9;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.39114935233517517,-0.9340803856303007,0.5964912280701754,0.9289010636886879,1.0,10/104,12.40%,CD74;SNX6;CDC37;RANBP17;VPS36;APPL2;RAB1A;COPA;USO1;STX17
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.558920800196247,0.9340666812820747,0.5483870967741935,1.0,1.0,1/7,15.22%,KHDRBS1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5366651941087199,0.9338605722948521,0.5510204081632653,1.0,1.0,2/8,10.49%,CCDC88A;RTN4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.4090840977471774,0.9329871968218955,0.5094339622641509,1.0,1.0,9/40,11.45%,RRAS2;PRKD1;RALA;BCR;CCDC88A;KRAS;TIAM2;ARHGAP31;RALB
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6033045614084156,0.9328639009161604,0.6792452830188679,1.0,1.0,3/5,23.85%,SLC8A1;RYR2;SPIDR
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5729995542206741,-0.9327499394368378,0.6428571428571429,0.9306170567638415,1.0,2/10,12.86%,AGPAT3;ENPP2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.573981779588972,-0.932435947204944,0.6,0.9302219091806848,1.0,3/8,18.01%,CAMKMT;GSPT1;PRMT2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5562224671956422,0.9320819527216043,0.5818181818181818,1.0,1.0,5/7,23.29%,RTN1;RTN4;ROCK1;RTN3;PICALM
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.4539274084586283,0.9320769851313415,0.54,1.0,1.0,7/28,14.93%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4820051493948932,0.9318806639435695,0.5625,1.0,1.0,4/14,17.29%,CDH2;ROBO2;NPTN;NECTIN3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5877353466637474,0.9318432746076728,0.6326530612244898,1.0,1.0,5/6,34.34%,MEF2C;SVIL;MYL6;BMPR2;PGM5
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5629036656893016,-0.9318169529816038,0.5227272727272727,0.9307413660831891,1.0,3/10,4.99%,FN1;ITGB5;COL8A1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.48286693890999377,-0.9315054223584164,0.5423728813559322,0.9303122861686636,1.0,2/25,2.07%,PPARG;TMSB4X
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.47217778336921223,0.9312929365273048,0.5135135135135135,1.0,1.0,3/30,4.83%,IL1R1;ITPR3;ITGA2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.509039019684429,0.9312535800332968,0.5510204081632653,1.0,1.0,1/10,1.04%,TEAD4
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5727739927401586,-0.9304784844714208,0.5121951219512195,0.9314075605442186,1.0,1/6,4.83%,NR3C2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4845282887526094,0.9302705286610028,0.6071428571428571,1.0,1.0,5/17,22.66%,WDPCP;PLCB1;CLASP1;PHLDB2;NIPBL
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.44429020320111484,-0.9293028264952322,0.574468085106383,0.932661841567444,1.0,2/42,1.20%,CYLD;RHOBTB1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.4347904988758535,-0.9290645154813317,0.6,0.9321053966179784,1.0,2/47,3.72%,CX3CL1;CASS4
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.5112143193476374,-0.9288652130059623,0.4864864864864865,0.9314006208378526,1.0,1/14,2.52%,IFI27
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5714899265619011,-0.9283050953668172,0.574468085106383,0.9312949004672371,1.0,2/6,17.88%,SPAST;OPA1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.5603857938970743,0.928070851022511,0.6363636363636364,1.0,1.0,5/8,28.31%,DPP10;ANK2;ANK3;KIF5B;DPP6
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.610100141040985,0.9280473864473789,0.6458333333333334,1.0,1.0,2/6,17.32%,GCNT2;WNK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5182446407297068,-0.9277221729507237,0.5925925925925926,0.9315911507876923,1.0,2/11,4.01%,SOD2;PRKN
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.31687809736133454,0.9277206116945691,0.7096774193548387,1.0,1.0,47/272,13.12%,HDAC9;IRF2BP2;JAZF1;CRY1;MCPH1;CALR;BCL6;RARB;BMP6;UIMC1;MTDH;ATN1;TAF1;ZBTB1;ZEB1;YAF2;PEX14;BTRC;OTUD7B;CNOT2;TRPS1;CCDC85B;ZNF608;CTBP2;PLCB1;YY1;CBFA2T2;URI1;TAF3;CBFB;KLF7;REST;ZEB2;PPM1F;ZMYND11;HIVEP1;ATP8B1;CPEB3;ID3;DNMT3A;YWHAQ;ZNF706;FOXO3;PHC2;DICER1;SKI;HSPA8
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.554905833633014,-0.9272120493434296,0.559322033898305,0.9316230432918472,1.0,1/11,4.86%,TIE1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5295819676000373,-0.9267835056252633,0.5192307692307693,0.9315059722629725,1.0,2/6,6.56%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5839986367085015,0.9260560503135111,0.6346153846153846,1.0,1.0,2/5,34.32%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5839986367085015,0.9260560503135111,0.6346153846153846,1.0,1.0,2/5,34.32%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.42141042165388476,-0.9259941399581184,0.6226415094339622,0.9322243481126067,1.0,8/63,6.27%,CX3CL1;ZIC1;DOK5;GRK5;SP100;GIT2;RGS6;ZDHHC17
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5867431163693992,0.9249934562493511,0.6122448979591837,1.0,1.0,4/6,21.17%,GLCE;EXT1;HS6ST3;NDST1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4741184133819788,-0.924971764747257,0.5272727272727272,0.9333183135208983,1.0,3/22,7.62%,NR4A1;TIE1;B2M
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.6279524557959164,-0.9246084773576767,0.6363636363636364,0.9329828804130794,1.0,1/5,3.29%,LYPLA1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.4697098836717104,0.92440994313321,0.5813953488372093,1.0,1.0,5/20,11.61%,GRM5;GRIA2;SNAP25;NRXN1;RBFOX1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.541808014435353,-0.9240348620298673,0.6041666666666666,0.9331157331958607,1.0,1/23,2.82%,OPTN
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5254557160304528,-0.9240171680113872,0.6440677966101694,0.9321091358569223,1.0,3/13,13.07%,STAT1;STAT5B;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.47376562535409994,-0.9235562600089919,0.49019607843137253,0.9320036773056132,1.0,1/27,1.57%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5509127510269252,0.9227615060938619,0.62,1.0,1.0,3/5,22.82%,MARCHF5;CDK6;AKT3
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.4341597293609271,-0.9227133763896094,0.6557377049180327,0.9327396119614961,1.0,4/29,11.21%,SNX6;SNX2;GOSR1;ANKFY1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.4707373886456322,-0.922417492668725,0.6,0.9323271203032361,1.0,3/22,4.94%,PPARG;SLC5A6;ACSL4
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.4321385410617963,-0.9223106995792587,0.6065573770491803,0.9314958351939846,1.0,5/51,7.12%,PPARG;FN1;PRKN;LAMA4;HMCN1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5920332206143786,-0.9219573005520012,0.6,0.9312781820923981,1.0,1/6,3.21%,CHKA
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4472745660564561,0.9218718426038198,0.5357142857142857,1.0,1.0,5/21,14.08%,YWHAB;MICALL2;YWHAZ;YWHAQ;PINK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.41530293265934576,-0.9217860314709678,0.5396825396825397,0.9305629869768832,1.0,7/59,5.21%,CLEC1A;FN1;ITGB5;CXCL12;LAMA4;MMRN2;CPQ
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.45239630088063826,-0.9212871214340015,0.5769230769230769,0.9307199052439465,1.0,4/33,8.61%,PSMA1;PSMB9;RFC3;TOPBP1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5592248944491622,0.9207647415617055,0.5333333333333333,1.0,1.0,1/8,7.01%,PIK3CA
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5895635545676154,-0.9203315983495695,0.574468085106383,0.9316106086721757,1.0,2/7,7.46%,TPM1;DMD
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.6040216340601269,-0.9203011150940339,0.64,0.9306717086926791,1.0,3/7,20.58%,ZDHHC17;ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.44272409518673406,-0.9201721938987186,0.5964912280701754,0.9298925935989635,1.0,7/33,12.70%,ISG15;FN1;ITGB5;CD47;ITGA10;ADAMTS1;ITGAV
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.45758481516614147,-0.9201586741444512,0.5573770491803278,0.9289124949336902,1.0,2/30,4.38%,GBP1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5361396319366614,-0.9193028825557203,0.5416666666666666,0.9295314236045745,1.0,5/12,29.06%,MSH2;ACVRL1;KMT2A;DACH1;XRCC5
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.6420850019385391,-0.9190414822176735,0.6744186046511628,0.9290256263024689,1.0,2/5,11.55%,ANKFY1;CCDC91
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5785584248770024,-0.9189552514662493,0.6222222222222222,0.9282403502068323,1.0,1/5,2.92%,CCDC68
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.570548677417335,-0.9183507775036336,0.5625,0.9282750888447384,1.0,1/7,1.12%,GBP1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5574730088551305,-0.9178931977153211,0.7058823529411765,0.9283993406187057,1.0,1/7,17.40%,NUP98
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5696976032823032,-0.9177462095760777,0.6041666666666666,0.9266914912715462,1.0,1/11,4.91%,PABPC1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5696976032823032,-0.9177462095760777,0.6041666666666666,0.9266914912715462,1.0,1/11,4.91%,PABPC1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5075670200644293,-0.9176487048862005,0.6140350877192983,0.9259351587347407,1.0,2/19,4.01%,DENND3;PRKN
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5735135453188331,-0.9174739764538083,0.6226415094339622,0.925280782982759,1.0,4/10,17.88%,SPG7;PMAIP1;MFN1;OPA1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.4818429055650145,-0.9171837824541182,0.5769230769230769,0.9248505735419137,1.0,3/29,4.01%,IFI27;ARIH2;PRKN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39102036218577485,0.9171108314777421,0.5531914893617021,1.0,1.0,11/53,17.74%,VAPB;COG6;MCFD2;BET1;TFG;CD59;ANK2;CAPZB;COG5;ARF4;ANK3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.508164808643234,-0.9169213028974794,0.6122448979591837,0.9243878881075633,1.0,3/18,3.72%,RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4532678899531452,-0.9168386870372274,0.4642857142857143,0.9235148907623493,1.0,5/31,13.23%,DENND3;ARHGAP17;MAPKAP1;ARHGEF28;JAK2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5813527292456733,-0.9165849092461448,0.6041666666666666,0.9229990621374468,1.0,2/7,10.70%,SP100;ACTN1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5285019004572191,-0.9164352527885411,0.6153846153846154,0.9223179299134473,1.0,3/15,7.62%,SNX6;PRKN;B2M
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5659145875981251,-0.9162334483853593,0.5283018867924528,0.9217933589722026,1.0,3/10,11.00%,TPM1;DMD;ARHGEF11
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5945579533307506,0.9162232302089484,0.5384615384615384,1.0,1.0,2/5,14.69%,DICER1;KPNA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.492242506638767,-0.9157952439280542,0.5384615384615384,0.921535549284236,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.6355712755618291,0.9157848189851301,0.6181818181818182,1.0,1.0,3/5,25.18%,ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5328706146561298,-0.9155431141026505,0.5869565217391305,0.9211787607577577,1.0,3/8,5.60%,CXCL12;LGALS3;SERPINE1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3565215756742259,0.9150283133893028,0.6486486486486487,1.0,1.0,20/105,18.75%,CALR;FOXN2;YAF2;GPBP1L1;CHD7;NFYC;ZNF708;REST;ABL1;RALY;ZMIZ1;NLK;NCOA2;TRIM22;RPS6KA5;BAZ2A;CREBBP;EP300;ZNF280D;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5911523077942293,-0.9149767883772992,0.6346153846153846,0.9213639762167551,1.0,2/5,13.44%,HLA-E;HLA-A
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.4395945909608474,0.914643130735009,0.5111111111111111,1.0,1.0,4/27,12.27%,BMP6;MT2A;MT1M;MT1E
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.4515615526790537,0.9139063375259282,0.5454545454545454,1.0,1.0,2/18,2.07%,HSD17B4;BMP6
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5685418295162823,0.9133896886210402,0.6545454545454545,1.0,1.0,2/5,11.00%,XPO1;PSIP1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.5919204093452921,0.9130302072495301,0.6086956521739131,1.0,1.0,3/5,22.90%,ROBO2;NIPBL;NF1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.5238788344694485,0.9128723937608847,0.5869565217391305,1.0,1.0,5/9,36.39%,LRRK2;GNPTAB;TMEM165;ARSB;ABCA1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.47763933831203753,-0.9125808468398916,0.575,0.9253998557028674,1.0,4/16,13.49%,NFKBIA;TANK;UBC;TBK1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.415173794225354,-0.9121215426187496,0.6379310344827587,0.9252936800232919,1.0,5/49,4.91%,PSMA1;PSMB9;CNOT8;ZC3HAV1;PABPC1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.46388227152083145,-0.9119890783084252,0.5384615384615384,0.9245490577411546,1.0,2/30,1.01%,NR4A1;PPARG
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.4728055837818076,0.9119334633032502,0.49122807017543857,1.0,1.0,2/12,6.11%,PBX3;CHD7
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.562769553354868,0.911640397141614,0.6170212765957447,1.0,1.0,2/7,8.18%,SMAD6;CHSY1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.44284248846629104,-0.9115491112869483,0.6666666666666666,0.9245319898885604,1.0,6/50,10.25%,EML1;SLC16A2;TPM1;LAMA4;LIMCH1;DIXDC1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.34564454839331704,0.9105371470504448,0.627906976744186,1.0,1.0,26/126,16.23%,AGTPBP1;VAPB;PRKD1;GABPB1;PEX14;BRWD1;WDPCP;FAM174B;YTHDF2;DIAPH1;PDZD8;LARP4;HACE1;DPYSL2;ATP8B1;RANBP9;DST;CLASP1;LRRK2;RAB7A;VMP1;PINK1;ZRANB1;CDC42;CAPZB;SSBP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.47762414512451634,-0.9104300673087661,0.5769230769230769,0.9257017264663049,1.0,1/22,1.01%,PPARG
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4757812652070212,-0.9103713736830628,0.5510204081632653,0.9247943444511251,1.0,4/16,9.59%,PPARG;DAB1;COL18A1;TRPM6
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5709540284088913,0.9095377433418067,0.64,1.0,1.0,1/5,8.47%,TPST2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.4590577014411673,-0.9094848772417885,0.6538461538461539,0.925643371631854,1.0,6/27,15.75%,PLK2;PRKN;GPC3;VSIR;HECW2;FOXO1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.5029675987516075,-0.9094538869087427,0.603448275862069,0.924726978281915,1.0,1/14,4.17%,SLC5A6
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5554414557358172,-0.908487898236685,0.6470588235294118,0.9256290308923549,1.0,4/11,22.55%,MAP2;SSH1;HIP1R;KANK3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.43336664617057175,-0.908425085880538,0.6296296296296297,0.9248238669245757,1.0,4/23,8.39%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5860293396354144,0.9079831754969153,0.6274509803921569,1.0,1.0,3/8,22.79%,CBFB;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.4673340571150292,-0.9078790573576652,0.6046511627906976,0.924784797597979,1.0,2/16,8.71%,TNIP1;TANK
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.4109570622941074,0.9070340754539374,0.6,1.0,1.0,7/35,16.68%,PRKD1;HSP90AA1;PPM1F;FNIP2;PINK1;ATP2B4;PTEN
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.5781244533990993,-0.9066508668173521,0.6981132075471698,0.9259130867578806,1.0,1/8,3.51%,ATP6V1E1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.5306956341169876,0.9065203721153297,0.62,1.0,1.0,4/10,17.56%,SLC38A9;CAPN2;CPEB3;CPEB4
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4648606287120999,0.906169484222073,0.5660377358490566,1.0,1.0,7/17,26.77%,RALB;LRRK2;PINK1;MTMR3;RAB3GAP2;RAB5A;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.4427323734435336,0.9061640320119185,0.6551724137931034,1.0,1.0,8/30,20.74%,CCNI;ABL1;ACTB;RALB;SLC8A1;CALM1;UVRAG;CDK12
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.37812908959224195,0.905681418268433,0.6136363636363636,1.0,1.0,6/56,8.07%,SMAD9;SOX5;BMP6;PRKD1;HSPB1;URI1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.48093038153635487,-0.9054533422527511,0.6274509803921569,0.9273768814228737,1.0,2/27,2.23%,RREB1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.36390677861533705,-0.9052376953303042,0.6833333333333333,0.9267583087747605,1.0,11/141,9.56%,HES1;TBX3;PPARG;IRF1;SNX6;FOXK1;SCML1;BHLHE40;JUN;CBX5;RCOR1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.496674036154107,0.9040281064966671,0.6481481481481481,1.0,1.0,3/15,15.91%,ITGA1;GRB2;CDC42
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5569119686199321,-0.9039772943358416,0.6304347826086957,0.9268286911581753,1.0,2/6,12.24%,SULF2;RORA
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5569119686199321,-0.9039772943358416,0.6304347826086957,0.9268286911581753,1.0,2/6,12.24%,SULF2;RORA
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5031609566020195,0.903955621347335,0.6481481481481481,1.0,1.0,1/12,1.78%,NREP
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5493860334560351,0.903854907079228,0.6222222222222222,1.0,1.0,3/8,8.87%,PCM1;ROBO2;REST
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.39915444221498164,0.9037158135070495,0.6976744186046512,1.0,1.0,6/33,8.15%,PSMD14;IL1R1;BTRC;ST18;PLCB1;TAB2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.536261446611631,0.9032885997021125,0.5531914893617021,1.0,1.0,1/10,1.25%,CALR
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5436429531433947,0.902968702751962,0.6222222222222222,1.0,1.0,2/10,5.82%,CCDC88A;CCDC186
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5678975959798319,0.9028090739602012,0.6666666666666666,1.0,1.0,3/8,4.94%,ERBB4;PHACTR4;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.557914783590227,0.9027362468152851,0.6122448979591837,1.0,1.0,1/6,4.49%,MED4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5669470177273362,0.9015963517698998,0.723404255319149,1.0,1.0,2/8,10.25%,PDZD8;MICU3
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4380951243267062,-0.9015962160793731,0.5849056603773585,0.9305863798399707,1.0,3/25,10.20%,RHOBTB1;ARHGAP17;BST2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.606347277458212,0.9014999153116816,0.6470588235294118,1.0,1.0,1/5,2.07%,BMP6
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5638454150654251,-0.9002863505033711,0.574468085106383,0.9321788072832368,1.0,2/9,7.46%,TPM1;DMD
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.53610282402153,0.900001863813894,0.7021276595744681,1.0,1.0,5/10,20.98%,EDN1;TOM1L2;RGCC;PHIP;CDK5RAP2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.458834925455763,-0.8999835584530942,0.5333333333333333,0.9316776207260773,1.0,6/21,13.09%,UFL1;PRKN;CALCOCO2;VIM;UBC;ATM
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.41089708292871135,0.899669979071705,0.4772727272727273,1.0,1.0,4/22,6.85%,CRY1;YWHAB;KCTD8;PLCB1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.5879154353288202,0.8995126865810585,0.7083333333333334,1.0,1.0,1/5,2.97%,TAF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.5879154353288202,0.8995126865810585,0.7083333333333334,1.0,1.0,1/5,2.97%,TAF1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3366765403636045,0.8992944344183219,0.6,1.0,1.0,35/102,29.14%,BCR;CCDC88A;PCM1;STK38L;DOCK4;ABL1;PPP4R2;RANBP9;RASA2;DST;CLASP1;SMC1A;CDC42;CAPZB;TIAM1;WASF2;ROCK1;PXN;CDK5RAP2;CLIP1;FSCN1;OPHN1;KIFAP3;NF1;GSN;MYO1E;YWHAE;ARAP3;MYH9;RASA1;KIF5B;WASL;AKAP13;ARFGEF1;MYH10
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.42593606282921026,0.8986253280478771,0.574468085106383,1.0,1.0,15/36,25.82%,CALR;PRKD1;HSPB1;ABL1;NRP1;RAC1;EDN1;PRKCA;ADAM17;ROCK2;AKT3;TEK;ETS1;NOS3;FGFR1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4044586162301798,0.8985102143608679,0.5,1.0,1.0,5/32,17.42%,PRAG1;YTHDF2;ZMIZ1;CREBBP;EP300
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.49411872625978026,-0.8966875620141425,0.6119402985074627,0.9361761712874576,1.0,2/18,6.67%,PLCG2;MEF2A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5009007256515411,0.896349304244702,0.5849056603773585,1.0,1.0,4/12,21.81%,CLASP1;PARD3;CDC42;OPHN1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.35100580642210444,0.8962885362445892,0.7878787878787878,1.0,1.0,16/93,11.90%,HDAC9;TEAD4;SOX5;RARB;TAF1;ZBTB1;MED4;ELL2;TAF3;CBFB;ERCC6;PGR;HDAC7;SETX;TFCP2;GTF2I
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5002993982002902,0.8961834874536695,0.5918367346938775,1.0,1.0,1/10,0.48%,GRIK2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.4380558104638013,-0.8961543929323692,0.5087719298245614,0.9362772033190191,1.0,5/37,9.08%,SOD2;TPM1;FOS;JUN;ERO1A
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5659142219794491,-0.8952727051564173,0.5333333333333333,0.936961098742055,1.0,2/6,6.91%,NGLY1;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.45811161907211645,0.8950793166230862,0.717948717948718,1.0,1.0,5/15,11.24%,CRY1;TAF1;IVNS1ABP;ABL1;SPOPL
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3390481974400794,0.8949723121786631,0.7096774193548387,1.0,1.0,16/91,12.08%,PSMD14;ERBB4;YWHAB;NRG2;DUSP6;KRAS;BTRC;NCAM1;PIK3CA;LRRC7;SETX;FRS2;PPP1CB;RANBP9;RASA2;LRRK2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.5424022113977834,0.89415540815126,0.6444444444444445,1.0,1.0,5/8,35.91%,MEF2C;SVIL;MYL6;FXR1;BASP1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.5417971163098123,0.8937231272765093,0.6785714285714286,1.0,1.0,2/7,22.90%,FOXO3;NF1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5535550788542756,-0.8933415422815525,0.5714285714285714,0.9383570291434123,1.0,1/5,9.85%,POLR2A
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5535550788542756,-0.8933415422815525,0.5714285714285714,0.9383570291434123,1.0,1/5,9.85%,POLR2A
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3035466490483837,0.8932453347385182,0.8,1.0,1.0,41/324,12.19%,PDK4;PSMD14;ABL2;PRKG1;CDH2;GOLM1;PRKD1;TAF1;HSP90B1;BCR;PRAG1;DCAF10;MORC3;MAPK10;YES1;COP1;UGCG;DUSP6;BTRC;FBXO7;IGFBP3;FEM1C;CTDSP2;CSNK1G3;STK38L;STT3B;PIGU;PXK;YWHAZ;ABL1;PPM1F;CDC14B;PGGT1B;PPP4R2;PPP1CB;ST8SIA4;NLK;PPP2CB;LRRK2;PPP3CA;GCNT2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5640605887105183,0.8930063728543722,0.625,1.0,1.0,1/7,9.93%,ACTB
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4858644350271264,-0.8927707537166697,0.6037735849056604,0.9384769552679026,1.0,5/13,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.43106488675722054,0.892677649338543,0.574468085106383,1.0,1.0,5/24,20.11%,BMP6;CLASP1;FRMD4A;EDN1;RGCC
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.44012329926907456,-0.8919768269899425,0.62,0.9390267815661796,1.0,4/31,7.28%,KIAA1217;CLIC5;SMARCA1;DSP
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.48484046145678883,0.8919119026547312,0.5686274509803921,1.0,1.0,5/12,24.89%,FGF12;HOMER1;ANK2;NEDD4L;YWHAE
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.49393094350010597,-0.8918534404968662,0.6226415094339622,0.9382863686769501,1.0,1/22,2.26%,PLK2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4772526946677548,-0.8914423469732884,0.5789473684210527,0.9380411213589831,1.0,3/21,8.55%,SNX2;GPM6A;TAOK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4245329276740183,0.8914245191953116,0.6122448979591837,1.0,1.0,8/26,25.42%,CALR;XPO1;XPO4;XPO7;WASHC4;SRSF7;SMURF1;SRSF11
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.48005608790087206,0.890318951535895,0.6326530612244898,1.0,1.0,5/11,18.19%,UBQLN1;ATP2A2;VMP1;CALM1;UVRAG
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.42493838846029997,-0.8901954947477457,0.6545454545454545,0.9394045007725271,1.0,4/24,8.39%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5055679287526809,0.8897543690482361,0.6,1.0,1.0,2/8,17.24%,REST;ANXA1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.43590130273867284,-0.8894134767772802,0.7021276595744681,0.9398012160274821,1.0,2/27,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5641670023184294,-0.889280367600879,0.5897435897435898,0.9390737182979979,1.0,1/6,8.29%,TMEM50B
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5224035717221567,0.8884888310907851,0.6226415094339622,1.0,1.0,1/8,2.02%,SLC26A3
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4670456844081182,-0.88843938328405,0.5769230769230769,0.9395554717275947,1.0,3/21,7.62%,LRPAP1;MAP2;B2M
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3801247370491021,0.8882702304073303,0.6842105263157895,1.0,1.0,8/29,14.08%,PRKD1;PIK3CA;ABL1;STX2;SETX;LRRK2;FOXO3;PINK1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5416650794050097,0.8881714333110682,0.7045454545454546,1.0,1.0,1/7,6.11%,CHD7
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.46728107771738964,-0.8878287505505439,0.5964912280701754,0.9397586359845437,1.0,4/27,6.56%,ABCA5;CHKA;SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5518371484598186,0.88761229242701,0.625,1.0,1.0,2/5,9.19%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5518371484598186,0.88761229242701,0.625,1.0,1.0,2/5,9.19%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.41724782115074754,-0.8872027041194053,0.6181818181818182,0.9399507230959504,1.0,2/31,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.4845240713593457,-0.8871177170788987,0.6346153846153846,0.9391727311747264,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5439126355966604,-0.8866180439828949,0.6739130434782609,0.9391627627061998,1.0,1/7,4.28%,SPG7
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.48177533339868805,-0.8865449093871043,0.6428571428571429,0.938302055356628,1.0,2/13,8.07%,PRKN;TRIM25
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.44953027501887033,0.886167764721616,0.6428571428571429,1.0,1.0,7/23,13.07%,BMP6;PRKD1;IL6R;SMAD6;REST;HDAC7;SKI
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.3697385439020345,0.8856297112253213,0.6530612244897959,1.0,1.0,7/51,13.86%,GRM5;IL6R;CCDC88A;HSP90AA1;TAB2;RALB;EPHA4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.47067618909276304,0.8855831576530134,0.5862068965517241,1.0,1.0,4/16,27.01%,INO80;ARID1A;BPTF;NAP1L4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5086267947016393,0.8854936892630939,0.6037735849056604,1.0,1.0,1/10,1.78%,NREP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5412648734415613,-0.8853265306683197,0.6521739130434783,0.9393553617070387,1.0,1/10,2.58%,HMGN1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.4983288642352115,0.8851794537537956,0.625,1.0,1.0,5/12,14.87%,SLC25A16;FBXO7;HSP90AA1;MFF;BCL2L1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3461566889083155,0.8845893935188368,0.6428571428571429,1.0,1.0,6/71,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.40902240351442065,0.8837966973151833,0.6808510638297872,1.0,1.0,7/23,21.86%,RALA;PPP1R10;PINK1;APPL1;IPO8;RYR2;HK1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5800622074074835,0.883639507665339,0.6862745098039216,1.0,1.0,1/5,5.84%,PPIG
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5800622074074835,0.883639507665339,0.6862745098039216,1.0,1.0,1/5,5.84%,PPIG
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.5965746985845579,-0.8836009679045939,0.6216216216216216,0.9417225766386674,1.0,1/5,3.45%,CARMIL1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4590206278405754,0.8834543298951502,0.6808510638297872,1.0,1.0,4/24,7.62%,ZNF160;TET2;PRKX;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5881875112223753,-0.8832537943971014,0.625,0.9413920144565158,1.0,2/7,14.42%,SRGAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3755740710295683,0.8829528390024385,0.6216216216216216,1.0,1.0,16/46,22.58%,INPP5A;PI4KA;PLCB1;PIK3CA;LRRK2;PPP3CA;PPP3CB;PLPPR4;CALM1;PTEN;LIMK2;TOP1;TAOK1;HK1;INPP4A;PPIP5K2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5728362492371546,0.8815230210643445,0.7115384615384616,1.0,1.0,3/5,28.50%,SLC8A1;MEF2C;AKAP13
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4019867611253351,0.8814284130406098,0.6888888888888889,1.0,1.0,12/37,18.99%,ACTG1;YES1;ACTB;CHN1;AP2B1;EPHA4;CDC42;PSEN1;TIAM1;RAC1;ROCK1;CRK
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5619820582907276,-0.8812349675610752,0.6382978723404256,0.9440278252780915,1.0,2/6,13.84%,VSIR;PGK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.4600057926712338,0.8811073973789213,0.6122448979591837,1.0,1.0,4/11,21.25%,ATP2A2;CACNA1C;ANK2;RYR2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4567011733121147,0.8809220228504522,0.625,1.0,1.0,5/18,13.49%,ADGRB3;S1PR1;ADGRL4;CALCRL;ADGRL2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5210217303404517,0.8807856508912252,0.5932203389830508,1.0,1.0,5/9,14.21%,RALA;DDHD1;PINK1;MARCHF5;MFF
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5660514010225901,0.8800795848636387,0.6744186046511628,1.0,1.0,3/6,24.12%,CEP290;SPIDR;GAPVD1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5624751491116923,0.8797852460262443,0.7021276595744681,1.0,1.0,1/6,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5525591393715514,-0.8796057484128218,0.6346153846153846,0.9459917378103664,1.0,1/6,8.37%,ACER2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5271725492223175,0.8793912938075156,0.7142857142857143,1.0,1.0,2/9,9.93%,ACTG1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41274742201377096,0.8792170025187807,0.5909090909090909,1.0,1.0,7/29,12.08%,RNF217;UBQLN1;TAF1;COP1;PIAS1;RNF180;LRRK2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5081256155171395,-0.8784609860392959,0.6730769230769231,0.9472012048364097,1.0,6/16,18.96%,YTHDC1;USP39;SRPK1;SRSF5;LUC7L;GCFC2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5582385827742371,-0.8781128197825031,0.625,0.9467714458646348,1.0,2/8,7.73%,CXCL12;STK39
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5652356130181728,0.8780998999264922,0.6666666666666666,1.0,1.0,3/6,12.08%,TRAK1;TRAK2;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.5937307941637873,0.8777957037596917,0.7068965517241379,1.0,1.0,2/5,18.38%,PPM1F;ADARB1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.4594853463864837,-0.8776238500636968,0.5849056603773585,0.9467961738834385,1.0,4/25,4.04%,TPM1;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.4427688300212981,0.877566941076861,0.5185185185185185,1.0,1.0,7/22,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;YWHAG;CEP290;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5746982599159528,0.8775507382758847,0.7254901960784313,1.0,1.0,1/6,8.87%,REST
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5514055712574943,0.8771368867598479,0.64,1.0,1.0,4/6,33.57%,NLGN1;KIF5B;RAB27A;SPG11
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.40095132005735346,-0.8768020934387754,0.6721311475409836,0.9475058854413508,1.0,4/48,5.39%,ZIC1;EML1;SMARCA1;CTNNA2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.49586693298595014,-0.8762320517063825,0.6909090909090909,0.947456132687848,1.0,4/14,8.15%,ITGB5;SLCO2B1;LCP2;FOS
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4609770224408415,-0.8760970005565376,0.66,0.946701774806992,1.0,6/27,11.61%,TPM1;ITGB5;DMD;MYL12A;ARHGEF11;VIM
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.4625614495591616,-0.8759735939284584,0.6379310344827587,0.9459384106278165,1.0,2/21,4.04%,CXCL12;LAMA4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.4463184438640614,-0.8757356123320004,0.5740740740740741,0.9453655112087471,1.0,4/19,8.74%,TPM1;CARMIL1;LIMCH1;CD47
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5250877763662322,0.875655195910736,0.5660377358490566,1.0,1.0,3/9,23.77%,ROCK1;ROCK2;ADD1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5615964798565207,0.8753554752614463,0.660377358490566,1.0,1.0,2/7,16.44%,CDH12;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5290199962021546,-0.8751431217774025,0.6818181818181818,0.9453180815786274,1.0,2/9,15.43%,CST3;PDE3B
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5735280343915645,-0.8749438028525883,0.675,0.9448412203917421,1.0,1/5,7.54%,RPL23
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5515579139821731,0.8748641204769436,0.6590909090909091,1.0,1.0,4/7,22.90%,CACNA1C;SKI;CEP290;NF1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.3787210038135137,0.8746752876999105,0.675,1.0,1.0,7/43,7.44%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PIK3CA;TTC7A;PIGU
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4584353534329064,-0.8745019441364604,0.6851851851851852,0.9447420751245696,1.0,3/24,3.72%,RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.5119467108478085,0.8744115536982513,0.6346153846153846,1.0,1.0,1/9,3.08%,ACTG1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.49450616782908713,-0.874319639620617,0.5416666666666666,0.9441726291046878,1.0,2/12,5.60%,CD109;SERPINE1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5253706942662313,-0.8739338058284654,0.6428571428571429,0.9438654383087002,1.0,4/8,25.18%,DSP;LSR;LAMA3;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5533308916130771,0.8736906419850917,0.74,1.0,1.0,4/6,31.87%,CYFIP1;WASF2;GSN;NCKAP1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4260557976300304,0.8736721801370003,0.6595744680851063,1.0,1.0,5/23,21.73%,NUP58;RANBP2;PSEN1;EP300;HDAC4
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.47006166955800865,-0.8735194599628372,0.6428571428571429,0.9437779859896078,1.0,2/15,8.98%,STAT1;STAT5B
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.37964019126388043,-0.8732170813847272,0.6065573770491803,0.9432528762081125,1.0,13/63,14.13%,ITIH5;NDRG1;GABARAPL1;TNFSF10;IGF2R;GBP4;SLC2A3;BHLHE40;PHTF2;RORA;ITGAV;ARL4A;IL18R1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.5266269689412877,0.8730768359270038,0.5813953488372093,1.0,1.0,2/6,31.45%,NLGN1;NDEL1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5346444098592558,0.8729937441177129,0.6530612244897959,1.0,1.0,2/6,24.25%,CPT1A;ACACA
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.4102552451086121,0.872463170432222,0.625,1.0,1.0,4/22,11.55%,HSD17B4;PEX14;IDE;ACOX1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.5534276694973743,0.8720589036159526,0.6666666666666666,1.0,1.0,2/5,18.30%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.5534276694973743,0.8720589036159526,0.6666666666666666,1.0,1.0,2/5,18.30%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.43347153881069955,-0.8718969451244075,0.6792452830188679,0.9446866804179659,1.0,17/45,20.03%,YTHDC1;GEMIN5;RPL38;USP39;RPS28;RPS19;RPS14;RPS15;RPL10;SRPK1;SRSF5;RPL24;LUC7L;RPL11;GCFC2;DHX29;RPS27
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.43760178686805845,-0.8718385455744608,0.6730769230769231,0.9439120144112392,1.0,5/15,10.73%,CX3CL1;IRF1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4951630716409522,0.8716518515083109,0.673469387755102,1.0,1.0,2/12,12.14%,CLASP1;RAB7A
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.33684701242464044,0.8713838117812516,0.7209302325581395,1.0,1.0,6/85,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5076886393339468,-0.8709779295952248,0.6326530612244898,0.9445212415080364,1.0,1/7,3.88%,MAP2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4311429433727185,0.870816384826874,0.7,1.0,1.0,9/28,22.47%,CDH2;MPDZ;PTPN21;ADGRL2;RAI14;FOXC1;MAGI1;BOC;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.536009518067777,-0.8707248108921006,0.6545454545454545,0.9440597673775182,1.0,3/8,20.27%,NFKB1;PDGFB;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.4498724756078339,0.8705723032158562,0.62,1.0,1.0,7/27,15.96%,SLC2A13;LARP4;SAMD4A;CPEB3;EIF3E;EPHA4;NSMAF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.49057233935302474,0.8702735351176125,0.66,1.0,1.0,5/11,21.25%,ATP2A2;CACNA1C;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.49913987997174347,0.8702568775649924,0.64,1.0,1.0,1/10,5.66%,SYNE2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.6200812592758532,0.869926041652639,0.7551020408163265,1.0,1.0,2/5,17.77%,CD59;RAC1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5599147390774527,0.8698961138221509,0.6170212765957447,1.0,1.0,3/5,14.98%,GLCE;EXT1;HS6ST3
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.5011295121339728,0.8693237259668138,0.6428571428571429,1.0,1.0,2/7,13.55%,ENTPD1;SND1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.44899971719764203,0.8685305795820747,0.7166666666666667,1.0,1.0,4/13,17.26%,HSP90AA1;NEK7;POT1;HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5826076034359791,0.8676957291535654,0.6949152542372882,1.0,1.0,2/5,22.10%,RALB;RAB3GAP2
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5540093999394896,0.8676697966305391,0.7169811320754716,1.0,1.0,2/6,11.85%,MAP4;CLASP1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.5213439624204468,-0.866828022206947,0.6470588235294118,0.9504041015416386,1.0,3/6,17.88%,SPG7;MFN1;OPA1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.48414302944572785,0.8666959309544057,0.6590909090909091,1.0,1.0,2/9,10.41%,BACH2;XPO1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.37078034608666444,0.8665248658976321,0.6829268292682927,1.0,1.0,4/42,2.97%,HDAC9;TEAD4;RARB;TAF1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.45033716388298944,-0.8662805167865687,0.7017543859649122,0.9505491855828726,1.0,8/25,19.39%,HGSNAT;RNF213;ZNHIT6;SPAST;OPA1;MICU1;PKD2;FUS
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.49177713923327027,0.8659220057876622,0.6595744680851063,1.0,1.0,2/7,14.08%,LRRK2;PINK1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.3781169756743369,0.8651207515660523,0.7804878048780488,1.0,1.0,22/66,19.12%,SEMA3F;ALCAM;NCAM1;PIK3CA;ROBO2;NRXN1;KLF7;GRB10;FRS2;RANBP9;NRXN3;NPTN;CHN1;EPHA4;NRP1;RPS6KA5;GRB2;UNC5C;CYFIP1;RAC1;PRKCA;RYK
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.44643642865286337,0.8649697661617667,0.6666666666666666,1.0,1.0,3/21,10.41%,PRPF8;STT3B;XPO1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.5477453434851759,0.8649102376838879,0.660377358490566,1.0,1.0,5/6,38.70%,PSEN1;INSR;PRNP;ARF1;APP
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.33406439667903187,0.8646474144296477,0.813953488372093,1.0,1.0,6/77,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5062182836409836,0.8635077736777149,0.6111111111111112,1.0,1.0,3/9,20.82%,CHD7;ANXA1;ADAM17
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5114044466790114,-0.8634153792985174,0.6909090909090909,0.9546591787282791,1.0,3/15,6.56%,SLC16A2;SLCO1A2;SLCO2B1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.46458710818462284,0.8633773454749223,0.6458333333333334,1.0,1.0,3/12,21.14%,MAN1A2;UGGT1;EDEM3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5177015103591591,-0.8630892101436786,0.6037735849056604,0.9544998684826603,1.0,3/12,15.91%,LIMA1;PAWR;SHROOM2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.4295268553727502,-0.8621554710533024,0.6607142857142857,0.9554051407365304,1.0,3/24,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5714801033790886,0.862132925807254,0.74,1.0,1.0,4/5,40.11%,SLC1A1;SLC1A2;SLC25A12;GJA1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.48444362708085825,-0.8617145691278099,0.6153846153846154,0.9553279937588139,1.0,2/10,10.44%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.33486956752278707,0.8615059822047443,0.75,1.0,1.0,16/109,15.62%,UBQLN1;ATP2A2;PACS2;PCM1;WDPCP;YTHDF2;AMBRA1;PARVA;CDC14B;RAB7A;INO80;VMP1;G3BP1;ABCC4;ATG2B;NEK7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5553730929284595,-0.8610196681762299,0.5892857142857143,0.9555500612494215,1.0,1/5,16.31%,PDGFB
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5439869220601187,-0.8606959446759088,0.5818181818181818,0.9551741513954464,1.0,4/8,29.11%,KPNB1;PIBF1;EML4;RAB11A
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.4406070141363885,0.860330898183398,0.6086956521739131,1.0,1.0,4/14,22.02%,GXYLT1;GALNT2;GALNT10;C1GALT1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4607595997833322,-0.8601937658337762,0.6,0.9552003795502848,1.0,7/17,17.74%,ISG15;RFC3;TRIM25;UBC;PRIMPOL;RFC1;POLK
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.4411219542472669,-0.8598922135423137,0.6111111111111112,0.9547946949783828,1.0,3/23,13.65%,PABPC1;SRSF5;SRRM1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4174041253248613,0.859304495908549,0.6739130434782609,1.0,1.0,6/24,13.31%,ITPR3;SNAP25;REST;CACNA1C;ITPR2;PPP3CB
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5368695364410287,0.8590696693391828,0.6140350877192983,1.0,1.0,1/5,22.28%,RC3H1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4963285094289921,-0.8590162062921032,0.5918367346938775,0.9556430346564918,1.0,1/9,2.58%,HMGN1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3836843617178581,-0.8582338925527293,0.6923076923076923,0.9561100153787743,1.0,4/59,4.01%,SLC6A6;RREB1;SHLD1;PRKN
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.36751840346119125,0.8580050288770468,0.7692307692307693,1.0,1.0,8/63,12.56%,ARHGEF4;SRGAP1;BCR;FAM13B;TIAM2;ARHGAP31;ARHGAP23;CHN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.5713204566500418,-0.8575682459360842,0.6666666666666666,0.9564838170995047,1.0,1/5,2.23%,PLCG2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.46104575624474087,0.8573163282159987,0.6595744680851063,1.0,1.0,4/12,9.22%,PRKD1;IL6R;HSPB1;PPM1F
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.48394923545031476,0.857312655771285,0.6923076923076923,1.0,1.0,4/8,36.81%,PHF14;KAT6A;LEF1;YEATS2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5353005616795142,-0.8569264646602545,0.7037037037037037,0.9567032557872265,1.0,2/6,8.74%,LGALS3;CD47
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.444734609113192,0.8557890135855971,0.6410256410256411,1.0,1.0,5/15,17.24%,PLEKHA1;ABL1;SETX;STK24;ANXA1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.3443156501424305,-0.8550013733250336,0.7777777777777778,0.9591325113027821,1.0,9/131,4.54%,KLHL20;PSMA1;PSMB9;IFI27;RNF213;RNF19A;ARIH2;PRKN;NUB1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.507287945728263,0.8548501302356439,0.6739130434782609,1.0,1.0,4/8,36.39%,LRRK2;GNPTAB;ARSB;ABCA1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.4938564472434943,-0.8547014987476557,0.6875,0.958643594989445,1.0,3/8,20.56%,PATJ;RHOA;MSN
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3584400315687277,0.854058697195139,0.723404255319149,1.0,1.0,7/50,7.54%,CALR;HSPG2;INPP5F;HSP90B1;HSPH1;SGIP1;HSP90AA1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.45432545755494547,-0.8539562716797793,0.6440677966101694,0.9590032875882543,1.0,4/22,11.77%,PLCG2;TNIP1;UBC;UBE2D2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5228242544017588,0.8538423155630087,0.6666666666666666,1.0,1.0,3/9,14.48%,CDH2;PIK3CA;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.554186236914472,-0.8532674279773885,0.6730769230769231,0.959137820392091,1.0,2/7,17.66%,B2M;MAP3K3
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.43134970252884075,0.8532197895006407,0.6739130434782609,1.0,1.0,3/24,2.79%,BTBD10;INPP5A;PRKD1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5162414449367404,-0.8530755177512845,0.7407407407407407,0.9586605078291623,1.0,5/10,29.38%,ATM;MDM2;KDM1A;XRCC5;WRN
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.4928066886855711,-0.8530755067528331,0.6578947368421053,0.9577360521803397,1.0,2/13,4.01%,OPTN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5817487921602301,0.8530515518193382,0.6808510638297872,1.0,1.0,2/5,16.44%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5229328442148671,-0.8526951431761909,0.6888888888888889,0.9575356930122089,1.0,1/10,0.13%,CD74
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4987175090081358,-0.8526132380635109,0.7222222222222222,0.9567563907456116,1.0,2/9,11.71%,TNIP1;UBC
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.538936286036606,-0.852558632967566,0.7017543859649122,0.9558567404575343,1.0,3/7,15.64%,ATM;DHX36;TNKS2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5453283859479623,0.8517868846730426,0.7090909090909091,1.0,1.0,4/6,22.50%,RTN1;RTN4;ROCK1;RTN3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.48002982238139635,-0.851490179050569,0.7254901960784313,0.9565413038197119,1.0,3/14,16.65%,TPM1;MSH2;DNAJC10
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.46896640419543323,-0.8514337242359383,0.7291666666666666,0.9556739899272394,1.0,6/19,20.19%,TNIP1;GCNT1;CHST12;CSGALNACT1;SERP1;ST3GAL6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5515169237035478,0.8506426948835574,0.68,1.0,1.0,4/6,22.55%,HSPA9;ZBTB16;CDC73;CDK6
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.568840500521193,0.8503928345862712,0.7321428571428571,1.0,1.0,1/5,2.68%,ATN1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.5087502876593553,-0.8499677665845013,0.6666666666666666,0.9573091361347077,1.0,3/7,17.88%,SPG7;MFN1;OPA1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.33575329891811856,-0.8492439564276847,0.7692307692307693,0.9576767766055853,1.0,8/108,8.07%,KLHL20;PSMA1;PSMB9;IFI27;PRKN;UBR2;ANAPC16;TRIM25
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5701620314941083,0.8490625465928894,0.6862745098039216,1.0,1.0,3/5,23.40%,PNPLA8;HADHB;PGS1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5336639207479044,0.8485379406243,0.7049180327868853,1.0,1.0,2/6,9.03%,PIK3CA;PARVA
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5242055903763,-0.8483864520055447,0.6170212765957447,0.9582963461275399,1.0,1/5,7.28%,DSP
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.47150744997188815,0.8481046092942629,0.6923076923076923,1.0,1.0,4/15,29.91%,PPP4R2;POT1;SPIDR;UBR5
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4310929761466051,-0.8476069195707405,0.6842105263157895,0.9585815746906583,1.0,4/42,6.67%,MX1;PRKN;SPG7;MEF2A
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.43428905539954293,0.8470805034849627,0.75,1.0,1.0,8/21,15.30%,BAG3;HSPH1;STT3B;HSPB1;HSP90AA1;HSPD1;HSPA8;HSPA9
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4014123512504987,-0.8468596023575058,0.631578947368421,0.9591890105137574,1.0,8/42,13.94%,KIAA1217;FN1;CXCL12;DSP;PKHD1L1;DUSP5;COBLL1;FBXO33
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5479452589705807,-0.8467319677604953,0.6538461538461539,0.9576320450318079,1.0,1/5,11.29%,MTMR2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.5479452589705807,-0.8467319677604953,0.6538461538461539,0.9576320450318079,1.0,1/5,11.29%,MTMR2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.4385482550588504,0.8459355970783146,0.6785714285714286,1.0,1.0,3/15,9.16%,PLCB1;NRCAM;ABL1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4492197076865672,-0.8453608165259688,0.6507936507936508,0.9590834532837594,1.0,6/19,13.28%,TDRD7;YTHDC1;GEMIN5;PARP9;RPL10;ZC3H7A
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.5095863337544733,-0.8451350518289676,0.7254901960784313,0.9585326237759887,1.0,1/9,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.4377342056738589,0.8450523388529934,0.6956521739130435,1.0,1.0,6/13,23.90%,GRM5;FOXO3;CYFIP1;ROCK1;PICALM;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.4522464535795015,-0.8450441978964991,0.6346153846153846,0.9578824608112679,1.0,2/15,8.37%,SERPINE1;ACER2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4405594007763157,-0.8449972665668041,0.5952380952380952,0.9570630476577474,1.0,2/19,7.62%,STAT1;B2M
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.45222878625230617,-0.8448506389339373,0.6666666666666666,0.956345379553595,1.0,1/16,1.30%,IFIH1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5516954692712353,0.844315231212181,0.7708333333333334,1.0,1.0,2/5,18.59%,CYFIP1;WASF2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5491786621882717,0.8441220787360448,0.7068965517241379,1.0,1.0,1/5,1.97%,INPP5F
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5213913834705505,-0.8434083909621004,0.6470588235294118,0.9577611001159735,1.0,1/8,5.39%,CTNNA2
prerank,MSigDB_Hallmark_2020__Coagulation,0.3946957170948518,0.8427759241013761,0.7209302325581395,1.0,1.0,5/30,8.84%,CRIP2;DUSP6;ITGA2;KLF7;CAPN2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.47710540455901257,-0.8425405580997064,0.6078431372549019,0.9583341357643081,1.0,2/12,10.17%,PMAIP1;RPS7
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5242280153680161,0.842433676634554,0.6296296296296297,1.0,1.0,4/8,23.29%,SLC2A13;EPHA4;ROCK2;PICALM
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.5611156751403145,-0.8422045825022351,0.7,0.9579669724011677,1.0,2/5,13.63%,CAMKMT;NMT2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.5487546883015311,-0.8421508951360763,0.6976744186046512,0.956277441336078,1.0,1/5,14.00%,PRKAR1A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.5487546883015311,-0.8421508951360763,0.6976744186046512,0.956277441336078,1.0,1/5,14.00%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.5028050521785724,0.8421234969085212,0.6792452830188679,1.0,1.0,3/9,23.64%,PICALM;NEDD4L;HSP90AB1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.48056123325039285,0.8413715671253529,0.6727272727272727,1.0,1.0,2/8,9.83%,MRTFA;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5188840917467904,-0.8412705548615965,0.7307692307692307,0.9568497142638338,1.0,2/9,7.73%,DMD;STK39
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.4791474113812373,-0.841249124978253,0.6458333333333334,0.9559876883147547,1.0,3/12,5.55%,ULK4;CTNNA2;NTNG1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5228086505067522,-0.840633834582756,0.7346938775510204,0.9563105677094113,1.0,1/6,3.88%,MAP2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.43946888561656344,-0.8398788055045265,0.6956521739130435,0.9566725763829971,1.0,2/24,2.12%,PPARG;STAT1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3884731311945591,0.8391245708555903,0.7547169811320755,1.0,1.0,6/36,12.54%,SLC25A37;HSPH1;LARP4;SAMD4A;CPEB3;EIF3E
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.46110723962880673,-0.839041561074826,0.6909090909090909,0.9572522513961051,1.0,2/8,10.57%,NFKB1;SPPL2A
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5158250131056548,0.8389191426789193,0.7454545454545455,1.0,1.0,3/5,24.01%,DIAPH2;IHO1;USP9X
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.48658656042266957,-0.8387633613808694,0.673469387755102,0.9568293687069905,1.0,3/11,16.02%,CHKA;ENPP2;MFSD2A
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.4612651200938351,-0.838440949884197,0.7450980392156863,0.9565360604623625,1.0,6/21,23.61%,CARMIL1;SSH1;HIP1R;KANK3;NCK1;CTTN
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5681774453980971,0.8376807914638449,0.7631578947368421,1.0,1.0,3/6,29.38%,SETX;SCAF8;PAPOLA
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.40447637879888587,-0.8375448624520201,0.6779661016949152,0.9574210390402642,1.0,3/42,6.00%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4264232521253127,-0.8375273860894691,0.6444444444444445,0.9565740158088252,1.0,3/30,5.60%,PPARG;STAT1;SERPINE1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5364286399571876,0.83698047962907,0.7115384615384616,1.0,1.0,3/6,23.64%,ENTPD1;ANO6;HSP90AB1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3521080259617978,0.8369073353128927,0.7222222222222222,1.0,1.0,14/57,18.78%,RRAS2;PRKD1;RALA;PHACTR4;KRAS;ELMO1;HACE1;RALB;G3BP1;GRB2;CYFIP1;TIAM1;RAC1;ROCK1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.5181666223875663,0.8368116700144169,0.7241379310344828,1.0,1.0,1/6,8.61%,ERCC6
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5518122504308668,0.8361704767703388,0.7843137254901961,1.0,1.0,1/8,2.20%,UIMC1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.45002572965153154,-0.8361597957814173,0.6382978723404256,0.9579512248508352,1.0,2/12,4.75%,SLC5A6;SLC38A3
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.5535688159842695,0.8354501672338506,0.7288135593220338,1.0,1.0,2/5,27.92%,ANK2;MDM4
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.48899300899221104,-0.8349969853746037,0.6792452830188679,0.959217298454169,1.0,2/10,6.51%,UFL1;SRARP
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.455122985142765,0.8343839308095227,0.6046511627906976,1.0,1.0,5/13,26.75%,BTRC;SPOPL;ITCH;TRAF3;ASPH
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.5639577536304555,0.8339195573821429,0.7045454545454546,1.0,1.0,1/7,14.26%,NRP1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.43058423879312596,0.8336286724959713,0.6808510638297872,1.0,1.0,4/14,9.93%,CLIC1;ACTG1;HSPB1;ACTB
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.4251683492478022,-0.8326514529107034,0.7192982456140351,0.9622558053496378,1.0,2/35,2.36%,SLC16A2;TPM1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5370825987644963,0.8326168981990185,0.7916666666666666,1.0,1.0,2/8,6.45%,SLCO2A1;MAP7
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5071341752857078,-0.8323037005890119,0.7169811320754716,0.9620280323026161,1.0,5/12,29.38%,ATM;MDM2;KDM1A;XRCC5;WRN
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5067809861705352,0.8319905973691623,0.6862745098039216,1.0,1.0,2/7,17.24%,REST;ANXA1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5640278149186614,-0.8318501002845577,0.7222222222222222,0.9620959320545458,1.0,4/5,33.65%,APC;CTNNB1;GSK3B;LRP6
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39720258542443543,0.8315502223663356,0.6545454545454545,1.0,1.0,9/28,17.80%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2;ATP2B4;ACVR2A
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.41115107992458316,-0.8312913909127133,0.7142857142857143,0.9622521973657403,1.0,11/39,18.27%,RFC3;RPL23;TOPBP1;MAPKAP1;RPS15;ATM;BRD7;RPL37;SMYD2;RPL11;MAPK14
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.4853205431711089,-0.83110033084174,0.7407407407407407,0.9616616012870308,1.0,4/12,14.18%,ABCA5;SCARF1;LBR;LSS
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4039539052687506,0.8305283106204918,0.6071428571428571,1.0,1.0,7/26,21.46%,CDH2;ACTG1;ACTB;CDH12;PRKCA;CTNND2;FSCN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.5450253149609305,0.8302303183002664,0.7333333333333333,1.0,1.0,1/5,5.95%,CNOT2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5337237539617297,0.8300998907805006,0.7291666666666666,1.0,1.0,2/7,8.05%,UBE2B;PEX5L
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.353502125139945,0.8298865115172789,0.7954545454545454,1.0,1.0,9/50,15.83%,COL4A2;NTM;GULP1;PARVA;MPDZ;PTPN21;ADGRL2;PDZRN3;ANK2
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.4361408227073286,-0.8298272738987591,0.6875,0.9630349367201194,1.0,3/17,8.69%,MAP2;PRKN;GOSR1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.4980004031332374,-0.8287945346543207,0.7166666666666667,0.9637487830870648,1.0,3/9,15.64%,ATM;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.48229902124607305,-0.8287391983633445,0.7254901960784313,0.9629331352034789,1.0,1/7,4.59%,RFC3
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.5071340873944381,-0.8277994240821468,0.6875,0.9626361543299985,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.5071340873944381,-0.8277994240821468,0.6875,0.9626361543299985,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.4573595442764037,-0.8267153258474944,0.6346153846153846,0.963621253863417,1.0,1/18,2.34%,CENATAC
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.5520057234202445,0.826679805681319,0.7586206896551724,1.0,1.0,1/5,6.14%,PKM
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.5196524715528457,-0.8265015565105889,0.775,0.9630527328375716,1.0,1/9,1.20%,RHOBTB1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.45312593280685665,0.8261818485595022,0.6792452830188679,1.0,1.0,3/13,23.64%,ITGA1;CALM1;HSP90AB1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.375976059191348,0.8252402733402131,0.7307692307692307,1.0,1.0,2/24,2.82%,CDH2;CADM2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.34070253775630327,0.8251783712688787,0.8,1.0,1.0,27/82,19.12%,SEMA3F;NCAM1;PIK3CA;HSP90AA1;ROBO2;NRCAM;NRXN1;KLF7;ACTB;GRB10;FRS2;RANBP9;NRXN3;NPTN;PPP3CB;EPHA4;NRP1;RPS6KA5;PARD3;GRB2;UNC5C;PLPPR4;PTEN;CYFIP1;ANK3;PRKCA;RYK
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.3595419068866923,-0.8249619684291951,0.8235294117647058,0.9648351887508476,1.0,6/85,4.54%,KLHL20;PSMA1;PSMB9;FN1;SHISA5;NUB1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4222935717628593,-0.8246351282241212,0.7090909090909091,0.9644516898403578,1.0,4/24,9.88%,PRKN;SRGAP2C;TFRC;CST3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.5597259663021696,-0.8238207343871432,0.7647058823529411,0.9649643118427781,1.0,2/5,20.58%,RAPGEF2;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.43065528810297826,-0.8236458569097365,0.7142857142857143,0.96434802912104,1.0,4/18,12.54%,SERPINE1;B2M;AHI1;CLU
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5047139587254119,-0.8227516034187049,0.7111111111111111,0.9649860963940764,1.0,1/6,2.36%,TPM1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5021372723006879,0.8222058807971833,0.7115384615384616,1.0,1.0,1/6,5.31%,PCM1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.48428504322027544,0.8220802859598796,0.6610169491525424,1.0,1.0,2/8,13.65%,NAA50;SMC1A
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5369554836701378,0.8214093727143323,0.7708333333333334,1.0,1.0,3/5,37.10%,WASL;ASAP1;SH3GLB1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.4849770598126478,-0.8212368095120893,0.7090909090909091,0.9667294661126458,1.0,1/14,2.82%,OPTN
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.4052037757783487,-0.8211265448380037,0.6825396825396826,0.9660259871408997,1.0,6/28,13.81%,MAP2;PRKN;ATXN7;LIMA1;CLU;SSH1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3586763391822464,0.8210618873490211,0.7567567567567568,1.0,1.0,4/47,2.97%,HDAC9;TEAD4;RARB;TAF1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5241047245728019,-0.8209140583067727,0.6829268292682927,0.9655272493755478,1.0,1/6,3.96%,ARIH2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.42829568334781587,0.8208830525637477,0.6938775510204082,1.0,1.0,3/17,10.36%,ARHGEF4;CCDC88A;S1PR1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.39502761807172165,-0.819827516797041,0.6935483870967742,0.9665103488678968,1.0,3/27,8.98%,PPARG;ACER2;STAT5B
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4910106657004629,0.8194165434917532,0.7090909090909091,1.0,1.0,3/8,12.08%,TRAK1;TRAK2;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.4589231552214463,-0.8190614657244347,0.660377358490566,0.9669210958989148,1.0,4/15,12.54%,MAP3K5;FOS;EFNB2;CLU
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.48424203889159984,-0.8178640694356415,0.7083333333333334,0.9679011212416682,1.0,3/12,12.70%,NFKB1;CLU;ITGAV
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.4246619204761576,0.8173250743776653,0.6976744186046512,1.0,1.0,1/13,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3664059963971018,-0.816692221114167,0.6923076923076923,0.9689951872573525,1.0,7/61,7.14%,PPARG;STAT1;SP100;TIE1;PLXND1;SERPINE1;WARS1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.42917515202139705,-0.8166171900970828,0.7540983606557377,0.9682645621814672,1.0,2/23,6.72%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.32551604227912445,0.8162711199359001,0.7560975609756098,1.0,1.0,12/71,9.88%,SOX5;BMP6;CDH2;PRKD1;IL6R;ZEB1;IGFBP3;PLCB1;NRCAM;REST;ABL1;WDFY2
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.37735599502355455,-0.8161360674471229,0.5681818181818182,0.9682097258284283,1.0,6/28,14.13%,STAT1;IRF1;JUN;IFNGR2;STAM2;IL18R1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5138420370823932,-0.8160872191832006,0.6808510638297872,0.9674426436233633,1.0,3/6,17.05%,RPL23;RPS7;RPL11
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41637568185602725,0.8159915587097344,0.6862745098039216,1.0,1.0,5/15,25.21%,LRRC7;PARD3;CDC42;OPHN1;MARK2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5141141707231334,0.815971717752414,0.7377049180327869,1.0,1.0,1/6,6.14%,PKM
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5104254711699,-0.8159300290165893,0.76,0.9668212215713043,1.0,1/8,6.40%,SRGAP2C
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3715942119301946,0.8159045156122975,0.7346938775510204,1.0,1.0,3/24,7.54%,PEX14;PPP1R10;HSP90AA1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5197736675949323,-0.8158471781312949,0.7307692307692307,0.9662009304056001,1.0,1/5,15.67%,PLEC
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.43068837367244706,-0.8158336801129165,0.6792452830188679,0.965332165964843,1.0,4/15,16.31%,MAP3K5;TAOK3;MAP3K4;PDGFB
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5196051740022962,0.8158147571088505,0.734375,1.0,1.0,1/5,8.61%,ERCC6
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.3464755493504939,0.8155824148999374,0.7560975609756098,1.0,1.0,15/56,21.65%,ERBB4;PRKD1;TAF1;PRKX;ABL1;LRRK2;EPHA4;PINK1;STK24;OXSR1;FES;TAOK1;DYRK1A;CDK12;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5367803454406107,-0.8146473932426038,0.7777777777777778,0.9663928353923793,1.0,3/7,18.43%,PRKAR1A;RAPGEF2;PKIG
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4762570875959268,0.8146192199317841,0.7288135593220338,1.0,1.0,4/10,14.08%,UBQLN1;HSP90AA1;ZMIZ1;PINK1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.40444022314570827,0.8142891690273444,0.7142857142857143,1.0,1.0,4/18,11.85%,CCDC88A;PCM1;DST;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.4148682126581847,-0.8140798019838302,0.7073170731707317,0.966426239651919,1.0,6/20,12.70%,PRKN;LGALS3;BST2;MTMR2;NDFIP1;ITGAV
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.42312739141371425,0.8131984052964762,0.75,1.0,1.0,4/15,12.88%,ACAT1;TPST2;LRRK2;AK3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.5311860037068737,0.8130945372429981,0.75,1.0,1.0,1/5,9.22%,PPM1F
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4687888277151989,-0.8126427934230734,0.74,0.9677999336409753,1.0,3/15,17.05%,FHIT;N4BP1;RPL11
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5142276260410678,-0.8122396012186746,0.7647058823529411,0.9674780882692133,1.0,3/5,24.99%,ATM;PIK3C3;SQSTM1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.5354268442193685,0.8119583826511989,0.7222222222222222,1.0,1.0,2/6,19.10%,WDR82;SETD3
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5105799426614174,0.8112071028670236,0.8214285714285714,1.0,1.0,2/7,2.07%,TRIM5;BMP6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.41982171288619385,-0.8110631267590519,0.7169811320754716,0.9683896271233515,1.0,1/16,2.23%,PLCG2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.48244381728613916,-0.8109388591972491,0.7321428571428571,0.9676954600697871,1.0,5/10,22.50%,PRKN;CLU;OPA1;HERPUD1;RACK1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.431677523171129,0.8107929890399226,0.7058823529411765,1.0,1.0,6/11,32.40%,ADAM15;GRAMD1A;SPIDR;CTNNA1;KLF9;ADCY2
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.38357715158508254,0.8097475792075617,0.76,1.0,1.0,3/27,7.28%,UBQLN1;HSP90B1;STT3B
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.4146770056732741,0.8092037887958098,0.6666666666666666,1.0,1.0,5/15,13.68%,CLIC1;ACTG1;HSPB1;ACTB;CD99
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.36696848123332826,-0.8082925226909543,0.7192982456140351,0.9711140012148985,1.0,6/63,9.27%,CX3CL1;ULK4;CTNNA2;NTNG1;KIDINS220;SCARF1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5124955086720925,0.8075819934651479,0.7843137254901961,1.0,1.0,1/5,19.36%,JARID2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.3549536895727064,0.8074457832369711,0.875,1.0,1.0,5/36,14.08%,UBQLN1;SLC38A9;PIK3CA;LRRK2;PINK1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3747408008162285,-0.8064914889238707,0.7419354838709677,0.9729442710176311,1.0,8/51,9.11%,MAP2;GPM6A;CTNNA2;NTNG1;ZDHHC17;MEF2A;TAOK3;S100A6
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.4771150983149854,-0.8063853101092069,0.6415094339622641,0.972209786267922,1.0,3/6,17.21%,BLCAP;ACIN1;KPNB1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.47969599566407517,0.8063573172028609,0.6545454545454545,1.0,1.0,2/6,12.88%,LRRK2;AK3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.47969599566407517,0.8063573172028609,0.6545454545454545,1.0,1.0,2/6,12.88%,LRRK2;AK3
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.44910502281902254,-0.8063337202485832,0.7358490566037735,0.9705546835525224,1.0,2/13,4.01%,GABARAPL1;PRKN
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.44910502281902254,-0.8063337202485832,0.7358490566037735,0.9705546835525224,1.0,2/13,4.01%,GABARAPL1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.4652295459048694,0.8060389832145118,0.7543859649122807,1.0,1.0,4/9,28.45%,PTEN;PHLDB2;BCAS3;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.4652295459048694,0.8060389832145118,0.7543859649122807,1.0,1.0,4/9,28.45%,PTEN;PHLDB2;BCAS3;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3994129668498591,0.8059225721616018,0.7272727272727273,1.0,1.0,8/21,21.33%,NAV3;HSP90AA1;CLASP1;PINK1;RAC1;FES;CDK5RAP2;CLIP1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.38557772516606825,0.8058821168754174,0.7,1.0,1.0,8/28,17.66%,TAF1;ABL1;IDE;RALB;PPP2CB;LRRK2;PSEN1;TIAM1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4105684670050621,-0.8058446597777462,0.7115384615384616,0.9704226051992102,1.0,2/17,2.26%,RIMS1;PLK2
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3872942234324129,-0.805682501766483,0.7142857142857143,0.9697879048704752,1.0,2/39,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.41251529700998146,0.8056194022677163,0.7321428571428571,1.0,1.0,5/14,17.56%,SLC38A9;CAPN2;CPEB3;SESN1;CPEB4
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5117104482884657,-0.8052670374757979,0.7021276595744681,0.9696567519528798,1.0,2/5,18.62%,RPL11;EPAS1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.536270418825903,0.8049381098210379,0.72,1.0,1.0,2/5,33.31%,RC3H1;DYNC1H1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5169732130077712,-0.8045919908643132,0.717391304347826,0.9697436648236318,1.0,2/5,21.54%,PARN;CHD1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5115235742959456,0.8043853199626672,0.8125,1.0,1.0,2/6,12.40%,HSP90AA1;HSPD1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.4957744569417144,-0.8043737876006531,0.7058823529411765,0.9692153655187867,1.0,1/9,5.50%,NGLY1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.32982053800123645,0.8043043330806237,0.9375,1.0,1.0,16/65,22.76%,VAPB;PRKD1;FAM174B;HACE1;ATP8B1;CLASP1;LRRK2;LEMD3;VMP1;CDC42;ANK3;TOR1AIP2;WASHC4;ATL2;EIF2AK3;TRAPPC8
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.4386674783336226,-0.8039093768269251,0.6808510638297872,0.9689810841292176,1.0,4/14,17.53%,AGPAT3;CBR4;LSS;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.36177222100693146,0.8035698956698594,0.8604651162790697,1.0,1.0,12/50,20.11%,SLC25A37;HSP90AA1;LARP4;ZEB2;SAMD4A;CPEB3;EIF3E;STARD4;APPL1;KLF2;EDN1;RGCC
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5435576075489352,-0.8034343661767862,0.7555555555555555,0.9688605675962236,1.0,4/5,28.58%,LARP1;RPTOR;CLEC16A;MTOR
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5136612786181802,0.802899636177662,0.7254901960784313,1.0,1.0,2/6,25.76%,PARG;SETD5
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.42129720982083874,0.8021286583579997,0.7317073170731707,1.0,1.0,3/14,17.95%,CBFB;EP300;CNOT4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.4563827395959944,-0.801674536085011,0.734375,0.9708636000238376,1.0,2/12,9.85%,TAF1D;POLR2A
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.48386932930675297,-0.801583462420208,0.7241379310344828,0.9701287580934749,1.0,6/9,33.25%,UNC13B;RACK1;ZBTB20;GAS6;PCK1;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4531628604109595,-0.8015468317545862,0.6491228070175439,0.9693104453992466,1.0,3/13,16.20%,PRKN;TMEFF2;TJP1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.5047715287803517,-0.8005005144576942,0.5952380952380952,0.9702253635524,1.0,2/5,22.92%,FOXO1;RHEB
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.418275794923032,0.8004011175783077,0.6808510638297872,1.0,1.0,1/15,2.07%,BMP6
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.3596991980035097,-0.799883089064087,0.8032786885245902,0.9702453269720615,1.0,2/42,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4371328603112263,-0.7993347059512255,0.6935483870967742,0.9701900944029147,1.0,2/16,2.23%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.45344210526427453,0.7992832790920993,0.7450980392156863,1.0,1.0,2/9,17.24%,REST;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.41522645881782433,0.798900865842996,0.75,1.0,1.0,4/13,20.82%,PLCB1;ANXA1;RGCC;ADAM17
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.49203578915967117,0.7982496982373629,0.6808510638297872,1.0,1.0,4/7,40.11%,CDK5RAP2;NDEL1;ITGB1;GJA1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.360534366559629,0.7978100363338407,0.7674418604651163,1.0,1.0,5/39,7.54%,PSMD14;AVEN;TUBB4B;PCM1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.498284791083077,-0.7974554516337224,0.6122448979591837,0.9722939026754172,1.0,1/6,1.54%,SOD2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5001258106318285,0.7974295259982396,0.7708333333333334,1.0,1.0,1/6,16.84%,BAZ2A
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.45451050525580616,-0.7973247853493931,0.75,0.9716648682496994,1.0,1/10,1.57%,RIMS1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4451522227544383,-0.7963332441877644,0.660377358490566,0.9723019067797615,1.0,2/7,6.56%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.448601686484277,-0.7962416707875953,0.7446808510638298,0.9715429161720662,1.0,6/20,12.96%,UFL1;NUB1;RPL23;RPS7;CLU;GNA12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.441526186891171,-0.7961590360131652,0.7551020408163265,0.97080397700136,1.0,1/12,0.56%,CYLD
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.5218836398724762,0.7960754722851404,0.74,1.0,1.0,2/5,17.24%,PPP3CA;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.45474891122854977,0.7957586908207249,0.6727272727272727,1.0,1.0,2/8,8.87%,PCM1;REST
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4392645733573318,-0.7954494551852391,0.7692307692307693,0.9711690761102277,1.0,5/19,12.62%,TPM1;MEF2A;DMD;NID1;LAMA2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3865933001051534,0.7954409750943513,0.7872340425531915,1.0,1.0,11/22,33.89%,CLASP1;INO80;SMC1A;NEK7;ZNF207;STARD9;TNKS;OFD1;STAG1;TOGARAM1;MAPRE2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.39825236350288906,-0.7948384822887552,0.6721311475409836,0.9712627591980292,1.0,7/29,16.04%,LRPAP1;PRKN;ACER2;CLU;TBK1;RAMP3;NPAS2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4256167414752383,-0.7938180273020482,0.717391304347826,0.9719719684710091,1.0,3/15,13.09%,NDRG1;ACER2;ATM
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5261106635421917,0.7929990835492694,0.7884615384615384,1.0,1.0,4/6,37.72%,PTEN;MAP4K4;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.5359800634861217,-0.7927143581839539,0.7446808510638298,0.9730713838300494,1.0,2/5,21.33%,MICU1;TGM2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4843493170679205,-0.7916123996830141,0.7142857142857143,0.973982615994935,1.0,2/7,5.92%,SP100;SUN1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4436973700913145,-0.791317985446638,0.7755102040816326,0.9736920258310043,1.0,2/12,5.60%,CD109;SERPINE1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.43457952702056935,0.7910033799077821,0.7291666666666666,1.0,1.0,8/16,21.33%,NAV3;ABL1;CLASP1;RAC1;FES;DYRK1A;CDK5RAP2;CLIP1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.37731961192177244,0.7893488753988307,0.7755102040816326,1.0,1.0,9/25,19.12%,NREP;NRCAM;KLF7;ACTB;RTN4;PARD3;PLPPR4;ANK3;RYK
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5075870872654573,0.7884029678777905,0.75,1.0,1.0,2/6,24.30%,SETD7;MECOM
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5152458605150129,0.7881717446596768,0.8292682926829268,1.0,1.0,2/6,25.82%,USP22;FGFR1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.41758180881590473,0.7880692419410723,0.7619047619047619,1.0,1.0,4/19,16.39%,ACTG1;MICALL2;PARD3;ESAM
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.4221374790562492,0.7875253768397201,0.75,1.0,1.0,4/15,24.12%,PPM1F;HSPA8;PTPN1;GAPVD1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.37529607734901443,0.7865873799371444,0.775,1.0,1.0,9/20,22.55%,CBFB;HSPA9;CREBBP;EP300;CNOT4;FES;ZBTB16;CDC73;CDK6
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4702589730268306,0.7863365495331731,0.7291666666666666,1.0,1.0,2/8,10.60%,MED4;SETX
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.506804041417433,0.785950162038593,0.8113207547169812,1.0,1.0,1/6,14.21%,MFF
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.40888974939603095,0.785877207513923,0.7555555555555555,1.0,1.0,10/30,24.75%,HSPB1;ABL1;PPM1F;SH3BP5;SLC8A1;ADARB1;YWHAG;PTPN1;NF1;GNAQ
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.44886461449722614,-0.7856213626317369,0.7307692307692307,0.9818890261496346,1.0,1/6,8.07%,TRIM25
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.42082852272609417,0.7851370963244833,0.7804878048780488,1.0,1.0,4/21,7.04%,SLC26A3;NTM;ITGA1;SGIP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4736927788418459,0.7847528295220875,0.7647058823529411,1.0,1.0,2/11,3.13%,CALR;IL6R
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.5077181670114775,0.7846510886429948,0.8269230769230769,1.0,1.0,1/5,6.16%,MRTFA
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5270935614508852,0.7836135960504814,0.76,1.0,1.0,1/7,6.56%,SLC25A46
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.4621759789434089,-0.7826880395418396,0.7894736842105263,0.9855763905335098,1.0,2/12,4.01%,OPTN;PRKN
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.37647196429626767,0.7816807738087178,0.8043478260869565,1.0,1.0,6/23,13.33%,DSE;CHSY1;CHST15;MAT2A;GLCE;PAPSS2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3585321394496604,0.7815712948866569,0.7777777777777778,1.0,1.0,8/29,19.71%,FBXO7;TRAK1;TRAK2;MFF;PARD3;NLGN1;ZDHHC14;SEC63
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.4218917540362016,0.781437489712874,0.7894736842105263,1.0,1.0,2/15,8.15%,MAPK10;TAB2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3802847017908809,-0.7803283005978714,0.7719298245614035,0.9882272524680563,1.0,5/32,12.93%,PLCG2;CCDC88C;DIXDC1;UBC;FZD6
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3121848135055862,-0.7800420039504172,0.84375,0.9876933932829366,1.0,5/113,5.05%,PARP14;BTG2;CNOT8;PRKN;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.3690542007192519,0.7798701821304813,0.8541666666666666,1.0,1.0,12/30,27.78%,DIAPH1;CAPN2;ZEB2;CLIC4;PINK1;MFF;EP300;TAOK1;ARMH3;MARK2;RHOT1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.36420793931766954,-0.7797066455612015,0.8148148148148148,0.9874754194204849,1.0,2/37,4.01%,PLK2;PRKN
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3364643433707151,0.7793211429159737,0.8048780487804879,1.0,1.0,12/50,13.20%,INSIG1;ZBTB10;ANKH;PIAS1;MAP7;ELL2;TNFAIP8;CDC14B;APPBP2;ZMIZ1;PTPN21;UBE2J1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.42333509084569887,0.7784833519911429,0.7592592592592593,1.0,1.0,2/14,6.85%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.42333509084569887,0.7784833519911429,0.7592592592592593,1.0,1.0,2/14,6.85%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.36792622284563553,0.7780707685113069,0.8,1.0,1.0,3/27,8.15%,MAPK10;BTRC;TAB2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.37771023801325954,-0.7778844810337584,0.8181818181818182,0.9894327712874862,1.0,9/29,13.49%,IFIH1;ISG15;HLA-B;EIF2AK2;CD47;BTNL9;AFAP1L2;SRGN;TBK1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.41417746295090396,0.7775444200162073,0.8085106382978723,1.0,1.0,3/15,17.42%,MORF4L1;ZZZ3;EP300
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.5054354353067243,-0.777436717636146,0.8245614035087719,0.988320485645137,1.0,1/6,14.42%,RAPGEF2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.5054354353067243,-0.777436717636146,0.8245614035087719,0.988320485645137,1.0,1/6,14.42%,RAPGEF2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4064385814006644,0.7769110039534742,0.8113207547169812,1.0,1.0,4/19,11.29%,FUT8;MAN1A2;STT3B;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.3700953225792934,0.776731115938423,0.8636363636363636,1.0,1.0,8/25,18.19%,AHCTF1;YTHDF2;SND1;BCL2L1;IHO1;CDC42;CALM1;UVRAG
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.5039286727226204,-0.7767283326900715,0.7115384615384616,0.9886658051244871,1.0,1/5,3.88%,MAP2
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.412481928356386,-0.7760755452704932,0.7142857142857143,0.9890197441729325,1.0,1/12,2.12%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.44848298104823225,0.7760507606819653,0.7142857142857143,1.0,1.0,1/8,5.29%,CCDC88A
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.446984244160518,-0.775960635341968,0.717391304347826,0.9883225897891065,1.0,1/7,3.88%,MAP2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3662923082935644,-0.7756758044557504,0.819672131147541,0.9879396776530911,1.0,5/42,4.54%,UFL1;RNF19A;ARIH2;PRKN;NUB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4579835663423036,-0.775229526595868,0.6964285714285714,0.9868909430765026,1.0,4/9,23.51%,PABPC1;DHX36;ZFP36;ZFP36L1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4579835663423036,-0.775229526595868,0.6964285714285714,0.9868909430765026,1.0,4/9,23.51%,PABPC1;DHX36;ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.4734866682161093,-0.775149928058497,0.7454545454545455,0.9860970555773134,1.0,1/11,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.4389984930259505,-0.7743228867315107,0.723404255319149,0.9864238573351751,1.0,2/17,6.27%,PIGC;ZDHHC17
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.39843673027622145,-0.7739988493223164,0.7358490566037735,0.9861450891179392,1.0,1/16,2.42%,CNOT8
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.36789951452399483,-0.7739142606930239,0.8571428571428571,0.9854271841695196,1.0,4/25,10.97%,PPARG;NFKBIA;AHI1;RAB1A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.36005722164222803,-0.7735782316697981,0.8333333333333334,0.9850491037411054,1.0,6/33,14.26%,LGALS3;EIF2AK2;WARS1;TFRC;CLU;RIOK3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.45312784654774496,-0.7735539960563779,0.6458333333333334,0.984232818960629,1.0,3/6,28.98%,SUCLG2;ACOT9;ACACB
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4651916081867863,0.7733101844781688,0.7547169811320755,1.0,1.0,2/6,13.55%,DIS3L2;SND1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.47517647487971204,-0.7731488772163616,0.8333333333333334,0.9839934506512945,1.0,3/10,13.07%,ABCA5;LBR;FAXDC2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.3788813324277396,-0.7728810946454314,0.8275862068965517,0.983471556260599,1.0,7/45,12.75%,POMP;SPAG1;RPL38;SMAD3;DMD;CLU;CLTA
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.40016003391212884,0.7727570475940156,0.8333333333333334,1.0,1.0,4/12,16.44%,RALA;NRP1;CDC42;NLGN1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.49975475693014104,-0.772627888280188,0.7291666666666666,0.9828958479798735,1.0,1/5,10.62%,LBR
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4398679244897329,-0.7725354318611368,0.82,0.982166240339205,1.0,1/13,0.93%,KIAA1217
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.4415923095960575,0.7721426636312495,0.75,1.0,1.0,4/11,32.51%,APPL1;C2CD5;INSR;PRKCI
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5007034172980215,-0.7714268884755168,0.7551020408163265,0.9830310009662097,1.0,4/8,21.12%,UBC;RNF111;XPC;CUL4A
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.3916473222606325,0.7712438794784846,0.8260869565217391,1.0,1.0,7/26,20.11%,CLASP1;GCNT2;PTEN;TIAM1;PHLDB2;FOXC1;RGCC
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.452583511709811,0.7712060390969832,0.7818181818181819,1.0,1.0,4/7,42.02%,AKAP12;ADCY2;ADCY9;GRM7
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.5445016703649702,-0.7711768042231913,0.8333333333333334,0.9825572118770743,1.0,2/5,9.19%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.31200652586249467,0.7709906829063277,0.9117647058823529,1.0,1.0,9/79,7.33%,PSMD14;RNF217;UBQLN1;TAF1;BTRC;FBXO7;FEM1C;RNF130;UBE2B
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.519078033277102,0.7707280802376245,0.8297872340425532,1.0,1.0,3/6,26.27%,ABL1;TOP1;TOP2B
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.31832059348445246,-0.7699394693687953,0.8793103448275862,0.983592816198648,1.0,11/104,9.38%,BTG2;UFL1;VAV3;RFC3;SAMHD1;ACER2;TAOK3;TOPBP1;TANK;BABAM2;CBX5
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.42941100659548326,-0.7690285172537696,0.7884615384615384,0.9842361993953134,1.0,5/10,21.99%,MYCBP2;EFNB2;PDGFB;PTPN2;USP14
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.5218311058984115,-0.7684165611346787,0.6976744186046512,0.9843250726724535,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5081433894605071,0.7681858870872066,0.803921568627451,1.0,1.0,3/5,14.08%,UBQLN1;REST;PINK1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.46284603410498026,0.7675794352833605,0.7547169811320755,1.0,1.0,1/5,9.22%,PPM1F
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.4764244852302085,0.7674480327849309,0.7450980392156863,1.0,1.0,2/6,18.30%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.31198797865836503,-0.7668996667559753,0.8947368421052632,0.9857462626471306,1.0,12/132,7.33%,KLHL20;IFIH1;ISG15;KLHL7;UFL1;RNF213;ARIH2;PRKN;NUB1;UBR2;ANAPC16;MYCBP2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.30662745327964525,0.7657615682123717,0.9761904761904762,1.0,1.0,18/88,21.81%,ARHGEF4;CCDC88A;PCM1;WDPCP;PARVA;CDC14B;S1PR1;NRP1;ABCC4;ANO6;CYFIP1;ARF4;RAC1;CC2D2A;BBS9;CEP290;FSCN1;OPHN1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.481316152035719,0.7656411436408543,0.8333333333333334,1.0,1.0,2/6,8.58%,BCL6;CBFB
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.47026045112740866,-0.7654295126118215,0.8043478260869565,0.9873733176888937,1.0,2/9,17.40%,DHX36;NUP98
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.46250972892046327,0.7652349615454949,0.8103448275862069,1.0,1.0,4/8,17.05%,MT2A;MT1M;MT1E;SLC39A10
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4814594594365133,-0.7649713869151419,0.8076923076923077,0.9873687854871549,1.0,3/11,19.15%,CD47;AFDN;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.38008843330195674,-0.7644357427770408,0.8518518518518519,0.9873009731016787,1.0,5/28,13.89%,EIF2AK2;MAP3K5;TAOK3;SH3RF3;MAP3K4
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.43913747609294584,-0.7642767331212554,0.6444444444444445,0.9867635398907032,1.0,1/6,3.88%,MAP2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.49030905777107536,0.7642114027299312,0.8076923076923077,1.0,1.0,3/8,12.27%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.49030905777107536,0.7642114027299312,0.8076923076923077,1.0,1.0,3/8,12.27%,MT2A;MT1M;MT1E
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3973268798413811,-0.764146042734604,0.8518518518518519,0.9861367685692106,1.0,2/35,2.79%,KIAA1217;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.41348616099190433,0.7639272686456917,0.8653846153846154,1.0,1.0,5/15,20.96%,GRM5;DOCK3;EPHA4;ADAM17;PTPN1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.4915506687339563,0.7635377750503043,0.7959183673469388,1.0,1.0,3/7,21.81%,ITGA2;NRP1;OPHN1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3192399792199989,-0.7634050736847015,0.967741935483871,0.986304649299844,1.0,10/119,5.87%,KLHL20;PSMA1;PSMB9;IFI27;RNF213;RNF19A;ARIH2;PRKN;HERC6;UBR2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.37762256877646255,-0.7630223612844006,0.803030303030303,0.9859496474326298,1.0,6/36,8.92%,PLCG2;PRKN;MEF2A;B2M;FOS;JUN
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.4002929139118785,0.7625632439835579,0.7333333333333333,1.0,1.0,1/11,4.81%,DUSP6
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4296101528858868,0.7620565476579773,0.8113207547169812,1.0,1.0,4/9,24.94%,NLGN1;CANX;OPHN1;RAB5A
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4040753069906539,0.7619614477901858,0.7843137254901961,1.0,1.0,9/19,35.43%,FOXC1;ROCK1;ROCK2;FGFR1;MEF2C;FBXL17;RBPJ;TGFBR3;LEF1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.44345960785892063,-0.7610554088127626,0.8679245283018868,0.9879809388991718,1.0,1/8,7.28%,DSP
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4224023696870365,0.7608382487999492,0.8,1.0,1.0,4/11,17.24%,PLEKHA1;ABL1;SETX;ANXA1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4458984115517466,-0.7606995768209885,0.782608695652174,0.9877780277379806,1.0,1/8,2.31%,KLF3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4141599824487029,0.7602975262867728,0.7592592592592593,1.0,1.0,7/16,28.45%,ACTG1;CLASP1;ROCK1;ROCK2;EFNA5;PTK2;CORO1C
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.41618492514475597,-0.7601918994233858,0.7884615384615384,0.9876922965042508,1.0,7/18,9.19%,HLA-F;HLA-B;HLA-C;TAP1;B2M;ERAP1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.4353001746295832,0.7600326590818576,0.7735849056603774,1.0,1.0,1/7,5.52%,BTRC
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.4805235168239307,-0.7600135577925787,0.7857142857142857,0.9872565054789673,1.0,1/8,8.74%,CD47
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5074587581272794,0.7598615199954527,0.7843137254901961,1.0,1.0,1/5,14.21%,MFF
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.42943073354523087,0.7598550144956524,0.76,1.0,1.0,1/9,7.04%,SGIP1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.482703984118611,0.759614152104735,0.8070175438596491,1.0,1.0,2/6,16.10%,SEMA3F;UNC5C
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.4930559635311478,-0.7591798781447235,0.7924528301886793,0.9876199630841166,1.0,1/5,19.73%,ACTR3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3935664180125911,-0.7589580041182208,0.8,0.9871222226500572,1.0,7/18,18.91%,UFL1;RPS19;RPS14;JAK2;ACIN1;CDIN1;PTPN2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4245345958113759,-0.757741369003283,0.8148148148148148,0.9879240598995493,1.0,1/10,1.20%,RHOBTB1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.37805216794777075,-0.7573638560872746,0.7708333333333334,0.9877222286925672,1.0,6/20,16.31%,RFC3;ATM;MAP3K4;PARN;TNKS2;PDGFB
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4557535323061931,-0.7572349505645268,0.72,0.9871720163552543,1.0,1/7,4.01%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.41158605329322645,-0.7569938049652131,0.78,0.9866227350032837,1.0,7/14,23.05%,PRKN;LIMA1;SSH1;TJP1;HIP1R;KANK3;SHANK3
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.3291856485495668,-0.7565459516089382,0.875,0.9864939276197153,1.0,8/81,8.63%,PPARG;GRK5;YTHDC1;SERPINE1;SMAD3;NFKB1;ICA1;BHLHE40
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3291691065512274,0.7555526490109754,0.8205128205128205,1.0,1.0,22/48,23.64%,BCL6;NREP;TRPS1;CBFB;REST;PLEKHB2;CLASP1;NLGN1;CREBBP;TIAM1;PHLDB2;ROCK1;CCN2;YWHAG;FES;MBOAT2;CDK5RAP2;BIRC2;NR1D2;CDK6;NF1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.44663962076351926,0.7554745270159802,0.782608695652174,1.0,1.0,1/9,4.81%,DUSP6
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.40564976196488933,0.7554039696797655,0.7735849056603774,1.0,1.0,3/12,11.85%,NAV3;PIK3CA;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3690724070707065,-0.7548911006704816,0.864406779661017,0.9880688586813751,1.0,4/29,4.54%,RNF19A;ARIH2;PRKN;NUB1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.4610727987377752,-0.7539553310145288,0.72,0.988749988545236,1.0,2/7,15.56%,CAPRIN1;DHX36
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.39330847251430284,0.7535683136003501,0.7608695652173914,1.0,1.0,1/16,1.09%,IL1R1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.42649310695580817,0.7535541729348907,0.803921568627451,1.0,1.0,1/10,2.92%,COG6
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.42983434148683464,0.753402091890238,0.7727272727272727,1.0,1.0,2/9,13.12%,RAB7A;HSPA8
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3907368485380933,-0.7531634122292086,0.7962962962962963,0.9890827170287743,1.0,1/19,2.26%,PLK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.4768890705418637,-0.753065927126841,0.7021276595744681,0.9882761436670973,1.0,1/5,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.32417906625991594,0.7527337338219593,0.9130434782608695,1.0,1.0,8/57,10.41%,PSMD14;YWHAB;FASTKD1;HSPB1;YTHDF2;YWHAZ;SAMD4A;XPO1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3472678619344379,0.7524691090996662,0.8148148148148148,1.0,1.0,6/23,20.82%,NAA50;HSPD1;GALNT2;ADAM10;PSEN1;ADAM17
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.43375694436266676,0.7523123509957121,0.7446808510638298,1.0,1.0,2/9,14.08%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4220170216889137,-0.7520440959484235,0.8269230769230769,0.9889731568782375,1.0,1/11,2.42%,CNOT8
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.49076585249376825,-0.7515790788053895,0.7777777777777778,0.9888963113919466,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.47883403599917507,0.7512773600888917,0.8363636363636363,1.0,1.0,2/6,16.47%,RPS6KA5;DIP2A
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.44788597585365014,-0.7511221683704686,0.75,0.9887574771425999,1.0,2/8,16.20%,DSP;TJP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.40647588144582913,0.750730668195152,0.8596491228070176,1.0,1.0,3/14,13.86%,GRM5;SH3BP5;EPHA4
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.31408204419457736,0.7506417033549906,0.925,1.0,1.0,9/53,12.22%,SOX5;TAF1;MED4;IVNS1ABP;TAF3;CBFB;ERCC6;SETX;FOXO3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.4937993362261074,0.7501057176028577,0.8,1.0,1.0,1/5,5.42%,BRWD1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.4937993362261074,0.7501057176028577,0.8,1.0,1.0,1/5,5.42%,BRWD1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3450495786626486,-0.7496362468855414,0.7818181818181819,0.9901705200080464,1.0,8/51,11.71%,PSMA1;PSMB9;CDC14A;ANAPC16;CEP57;CEP70;APPL2;UBC
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.46895717296615064,-0.7493113292618826,0.7755102040816326,0.9897827949733367,1.0,1/5,1.81%,HGSNAT
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3723979816840286,0.7492525176315251,0.7543859649122807,1.0,1.0,2/20,8.61%,UIMC1;ERCC6
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.4968655980765247,0.7488003670717815,0.875,1.0,1.0,2/5,26.40%,LRRK2;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.419317392695641,-0.7485605864122868,0.7818181818181819,0.9900861504120042,1.0,2/14,8.10%,MAP2;ATXN7
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.3738114243840958,0.747982389838414,0.88,1.0,1.0,4/23,12.59%,MAP7;TLE4;IDE;STRBP
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3705164922585436,0.74614602072986,0.86,1.0,1.0,4/16,17.26%,HSP90AA1;NEK7;POT1;HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.3907090363072281,-0.7460823058285273,0.7627118644067796,0.9931041853146054,1.0,6/22,24.99%,LGALS3;RAMP3;DLG1;RACK1;SPTBN1;SQSTM1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.4716933744143337,0.745426304789361,0.7924528301886793,1.0,1.0,2/6,22.79%,ROCK1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.473753417997554,-0.7450266192247702,0.7843137254901961,0.9937842385427348,1.0,5/10,24.14%,GRB14;APPL2;PTPN2;NCK1;TNS2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.30061085012312,-0.7444546212160297,0.9824561403508771,0.993809773811972,1.0,12/76,15.38%,BTG2;RFC3;TOPBP1;BABAM2;PARP9;MSH2;UBC;PWWP3A;ATM;PDS5B;PRIMPOL;XPC
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30982248898708875,0.7442510067559905,0.925,1.0,1.0,3/42,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.461619723908259,0.7440031796897816,0.7857142857142857,1.0,1.0,4/7,24.25%,ACAT1;PAM;FAR2;ACACA
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.33646556090400837,-0.7437409644263903,0.7884615384615384,0.9940734629324405,1.0,8/59,12.03%,BTG2;CNOT8;EIF2AK2;GEMIN5;CAPRIN1;VIM;UPF3A;RPL10
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4830933510666497,0.7430137066132831,0.7948717948717948,1.0,1.0,3/7,17.69%,ATP2B4;ATP1A1;KCNT2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3016265737532467,0.7429881199759638,0.9285714285714286,1.0,1.0,11/90,12.40%,ARHGEF4;BCL6;DUSP6;IGFBP3;TNFAIP8;REST;TIAM2;ABL1;LRRK2;FOXO3;HSPD1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.31746928010595576,-0.7429045747215381,0.8870967741935484,0.9945835242547407,1.0,9/61,13.60%,ZIC1;ACSL4;CTNNA2;PPP1R9A;SCN2A;NOL4;RORA;RNPC3;DNM3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.4769385887114174,-0.7428650487962937,0.8163265306122449,0.9938156650343521,1.0,6/7,28.37%,RPL10;RPL24;RPL11;RPL3;RPL23A;RPL5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.44907098197116596,0.7427856431838912,0.8076923076923077,1.0,1.0,6/10,23.88%,CACNA1C;SLC8A1;ANK2;CALM1;RYR2;AKAP6
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3699383274053549,-0.7423009747051847,0.8775510204081632,0.9938586890732367,1.0,3/40,3.88%,SLC16A2;DOK5;MAP2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3593695363654457,-0.7422155443439644,0.8947368421052632,0.9931102975004482,1.0,8/39,15.75%,PLK2;PRKN;NFKBIA;RAB1A;GPC3;CLU;HECW2;FOXO1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.4152421921998788,-0.7416992081485564,0.7446808510638298,0.9929869142627729,1.0,1/10,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.46438343649470154,-0.7415854373997433,0.8125,0.9923721629572714,1.0,4/10,19.28%,PRKN;PMAIP1;OPA1;HERPUD1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.39237976247358786,-0.7413239345681031,0.8363636363636363,0.9918724532589591,1.0,3/24,9.85%,TOPBP1;DDX24;POLR2A
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.46929415843982425,-0.7408086847859594,0.7659574468085106,0.991794222072585,1.0,1/5,12.32%,VSIR
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4226145371490857,0.7405769593017908,0.8793103448275862,1.0,1.0,3/9,17.74%,ANO6;ANK2;ANK3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.48416629158872987,0.7403997357971519,0.8,1.0,1.0,1/5,3.11%,WRNIP1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.4371443829592918,-0.740229078147677,0.7755102040816326,0.9917861706763887,1.0,2/12,9.88%,MAP2;CST3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.40904137453268696,-0.7402258435808307,0.7916666666666666,0.9909644754231356,1.0,1/11,1.57%,RIMS1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.2842158696014143,0.740225816193931,1.0,1.0,1.0,10/61,15.54%,MT2A;TENT4A;ABL1;XPO1;SS18;HSPA8;SMC1A;RPS6KA5;G3BP1;RAD23B
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4343836858453046,-0.7397031887521007,0.7450980392156863,0.9907822890418301,1.0,3/9,26.51%,UBC;UGGT2;RPS27A
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.3779779788220742,-0.7395889532776188,0.75,0.9901986157096718,1.0,3/28,4.04%,TPM1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.44867733970375956,-0.7386953717842921,0.7857142857142857,0.9905933658905756,1.0,2/7,19.07%,DMD;PKD2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.29207416575161815,-0.73849581544228,1.0,0.989324665545915,1.0,15/118,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.29207416575161815,-0.73849581544228,1.0,0.989324665545915,1.0,15/118,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4964502129802384,-0.7384287393391427,0.8035714285714286,0.9885700040895778,1.0,1/5,7.46%,DMD
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.41173777497239444,-0.738375003956927,0.7377049180327869,0.9878252844524212,1.0,2/15,3.24%,ISG15;UFL1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4064092079324924,0.7381717347932788,0.8627450980392157,1.0,1.0,5/12,37.03%,NCOR2;ADAM17;RBPJ;LEF1;PPARD
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.28913227615536224,-0.738081731478945,1.0,0.9873946809304013,1.0,15/120,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.35032804836940606,0.7377753820265697,0.8157894736842105,1.0,1.0,4/32,9.03%,ATRNL1;MICALL2;YTHDF2;PARVA
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4963764760924123,-0.737609155891965,0.7777777777777778,0.9872600500699892,1.0,1/5,7.46%,DMD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.40739277753345937,-0.7373527366012085,0.7454545454545455,0.986709139073367,1.0,6/19,24.99%,LGALS3;RAMP3;DLG1;SPTBN1;EPB41;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.4193999107126677,-0.73710013148864,0.8545454545454545,0.9861591326925024,1.0,3/20,10.07%,PRKN;TFRC;PARP9
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.4720151424290907,-0.7368655442271018,0.8372093023255814,0.9857486347135452,1.0,1/5,5.63%,CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.46300511975358416,-0.7368654823569727,0.7346938775510204,0.9849406440293538,1.0,1/5,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3585516522630022,0.7366748010570215,0.8431372549019608,1.0,1.0,8/26,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;CC2D2A;YWHAG;CEP290;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3592136551013266,-0.7365884103732626,0.9344262295081968,0.9845577624478896,1.0,4/29,4.54%,RNF19A;ARIH2;PRKN;NUB1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.46595818398814937,-0.7362072075717435,0.8333333333333334,0.9842964900326941,1.0,1/9,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.4020364592468867,-0.7361112423938948,0.8043478260869565,0.9836729940940135,1.0,3/12,14.87%,HEBP2;PMAIP1;PPA2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3865913568756034,0.7354839937189286,0.7555555555555555,1.0,1.0,6/15,17.80%,BMP6;ANKH;S1PR1;SLC8A1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.3494172994307335,-0.7350174048965905,0.8703703703703703,0.9844222875654102,1.0,2/48,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.402213777695879,-0.7347569489875696,0.8035714285714286,0.983894531786439,1.0,5/14,14.13%,ISG15;CD47;VSIR;HLA-A;IL18R1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.38351012703625775,0.734698994934736,0.8043478260869565,1.0,1.0,2/20,8.15%,EIF4G3;TAB2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2924117527387715,-0.7341352736283394,0.9838709677419355,0.9840050295832727,1.0,15/174,8.07%,KLHL20;PSMA1;PSMB9;ISG15;KLHL7;RNF213;RNF19A;ARIH2;PRKN;HERC6;NUB1;UBR2;ANAPC16;MYCBP2;TRIM25
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3742039275095328,0.7337836494476099,0.8409090909090909,1.0,1.0,5/17,14.26%,ACTG1;ACTB;LRRK2;PINK1;NRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.455188498123193,0.7336317205714175,0.8727272727272727,1.0,1.0,5/8,21.25%,CACNA1C;SLC8A1;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.47366356599674886,-0.7327741102737866,0.8076923076923077,0.9850964761981117,1.0,2/5,5.60%,TPM1;SERPINE1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.36388492833791763,0.7321933312114104,0.84,1.0,1.0,6/15,26.11%,FOXO3;SESN1;CPEB4;MTMR3;EIF2AK3;IFI16
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.498089941481238,0.7321912002953161,0.7708333333333334,1.0,1.0,1/5,16.92%,POT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.42652227119196506,-0.7321845263466663,0.8333333333333334,0.9849220355227111,1.0,1/19,2.39%,FN1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.42983407436048326,0.7316717281361571,0.7647058823529411,1.0,1.0,1/8,5.31%,PCM1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3827794200407738,-0.7314547447773444,0.8095238095238095,0.9851946829279697,1.0,4/19,4.01%,SOD2;HLA-F;SNX6;PRKN
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.35202294597398404,-0.7294627888071039,0.847457627118644,0.9872698216140847,1.0,4/25,15.19%,PLK2;CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3916192208716438,0.7293568653622842,0.8163265306122449,1.0,1.0,2/17,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3916192208716438,0.7293568653622842,0.8163265306122449,1.0,1.0,2/17,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4223934008279248,-0.7288798415513349,0.7446808510638298,0.9872999228317421,1.0,1/10,3.96%,ARIH2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4351357165187441,0.7288461957951866,0.8909090909090909,1.0,1.0,1/7,4.78%,UGCG
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.36263078445050295,-0.7285795719153743,0.7755102040816326,0.9867985443189276,1.0,7/26,18.22%,PATJ;TFRC;TRPM6;COBLL1;NEBL;FGD4;THRB
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.34388526169382205,0.7281469637746639,0.8048780487804879,1.0,1.0,8/32,15.64%,CRY1;UBQLN1;IVNS1ABP;HSP90AA1;SPOPL;LRRK2;PINK1;UBE3A
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.3913429677186566,-0.7277445053769921,0.7954545454545454,0.9873771078168052,1.0,5/21,13.84%,NDRG1;SCN2A;PMAIP1;RORA;PGK1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.41912651267511436,0.7267332863672129,0.75,1.0,1.0,3/8,21.81%,NLGN1;CANX;OPHN1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4045096498188158,0.7267240277593792,0.8636363636363636,1.0,1.0,4/13,23.61%,ADGRB3;CSMD3;CAMK1D;NEDD4L
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.35766210553313665,-0.7265952329857385,0.8909090909090909,0.9882542486793898,1.0,6/24,18.25%,RNF213;PRKN;UBE2D2;SH3RF3;NFX1;KLHL24
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.42746770979658505,0.7257225990930902,0.7777777777777778,1.0,1.0,4/7,31.47%,DICER1;AGO2;TUT7;TUT4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.47670454120721295,-0.724811086227253,0.7777777777777778,0.9896686596548118,1.0,1/7,4.01%,PRKN
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.31899776665277446,-0.724642647768503,0.8421052631578947,0.989124268641483,1.0,11/73,12.24%,SLC6A6;NDRG1;SERPINE1;SLC2A3;FOS;BHLHE40;JUN;ERO1A;WSB1;GPC3;RORA
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.37586985408543033,-0.7244003300478797,0.84,0.9886319787239205,1.0,7/20,22.79%,RFC3;TOPBP1;ATM;RFC1;ORC2;NAP1L1;REV3L
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4121085128475378,-0.7243781550627637,0.8076923076923077,0.9878589966221386,1.0,5/14,15.64%,ATM;MAP3K4;PARN;DHX36;TNKS2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4268943802745558,0.7236101268861302,0.7446808510638298,1.0,1.0,4/10,15.88%,YWHAZ;ABL1;EPHA4;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3491283412683003,0.7230461959217797,0.9111111111111111,1.0,1.0,4/31,9.16%,ABL2;CCDC88A;PIK3CA;ABL1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4247813332624762,-0.7230333269701513,0.7884615384615384,0.9889879000142329,1.0,2/5,22.90%,MSN;JAM2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.3888577350097411,-0.72293504536679,0.8301886792452831,0.9882840069507532,1.0,3/17,15.67%,FN1;ACTN1;PLEC
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3421872949180512,-0.7224422374920316,0.8837209302325582,0.9880407506697491,1.0,5/39,9.24%,PPARG;SNX6;CD109;SMAD3;SNX25
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.39062499431171266,0.7223067002770411,0.7843137254901961,1.0,1.0,5/15,16.68%,LRRK2;EPHA4;TANC2;NLGN1;PTEN
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4078556541053932,0.7200982062869115,0.8695652173913043,1.0,1.0,4/13,17.42%,ABL1;FNIP2;BCL2L1;EP300
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.38098785043106587,-0.7197709171086563,0.84,0.9905186707943978,1.0,5/17,17.05%,RPL23;RPS7;FHIT;N4BP1;RPL11
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4379670758355398,0.7197003522956571,0.7894736842105263,1.0,1.0,2/6,21.99%,RNF168;CDC73
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.3992683591852745,0.7191332072128523,0.8269230769230769,1.0,1.0,3/13,10.49%,NRCAM;ABL1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.46066660832868755,0.7184255172374794,0.8333333333333334,1.0,1.0,4/7,31.29%,ANK2;AKAP6;KIF5B;KCNMB4
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.42654642330028003,0.7176584620879543,0.8596491228070176,1.0,1.0,3/10,18.78%,LRRK2;EPHA4;ROCK1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.47612269205968294,0.7171387563219933,0.88,1.0,1.0,4/6,30.39%,BCL2L1;FGFR1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3770886107392006,0.7170912753872739,0.7924528301886793,1.0,1.0,8/14,21.25%,UGCG;SLC8A1;ANK2;ANXA1;YWHAG;CRK;PTPN1;RYR2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3261205078006312,0.7150710184124349,0.8695652173913043,1.0,1.0,9/44,14.50%,ABL2;PRKX;YTHDF2;FRMD5;ABL1;PPP1CB;PPP3CA;EPHA4;ADAM10
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.3922143485137851,-0.7150617932028142,0.875,0.9963398750022235,1.0,1/12,4.01%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.2911763559824007,0.7146070872789151,0.9629629629629629,1.0,1.0,15/95,17.66%,ARHGEF4;BCL6;DUSP6;IGFBP3;TNFAIP8;REST;TIAM2;ABL1;FOXO3;HSPD1;TPD52L1;ANO6;SHQ1;PSEN1;TIAM1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.4184638645654208,0.7145951238077065,0.8260869565217391,1.0,1.0,3/8,17.74%,LRRK2;PDZRN3;ANK3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4697143401393898,0.7144565182049849,0.7884615384615384,1.0,1.0,4/5,29.77%,EDN1;RGCC;PHIP;INSR
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4453410949525026,-0.7141112190726949,0.7647058823529411,0.9969565854006447,1.0,1/6,4.73%,PLA1A
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.3793520878758049,-0.7139320400942506,0.8771929824561403,0.9963933120597891,1.0,5/23,12.62%,CXCL12;LAMA4;HMCN1;ADAMTS1;LAMA2
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.35527746339088645,-0.7133506128620316,0.8656716417910447,0.9962716510114383,1.0,8/53,12.62%,TPM1;FN1;CXCL12;LAMA4;HMCN1;NOSTRIN;ACTN1;LAMA2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.40709798247269424,-0.7131542915100286,0.7346938775510204,0.9956759568997565,1.0,3/13,11.71%,PRKN;VIM;UBC
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.3636334025289036,-0.7131254085900454,0.8679245283018868,0.9949119859265122,1.0,7/34,15.59%,GABARAPL1;PRKN;VPS36;STAM2;STX17;MFN1;ATG12
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.46762541735794416,0.7130085500407333,0.864406779661017,1.0,1.0,2/5,29.88%,MDM4;BMPR2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.38736755510852244,-0.7118983682672604,0.8913043478260869,0.9955273707341278,1.0,3/23,4.38%,OPTN;HEBP2;LGALS3
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4556903030800091,-0.711622784168634,0.8636363636363636,0.9949674938583687,1.0,2/8,13.09%,MSH2;ATM
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.4205565363210274,-0.7115972021500948,0.88,0.9942228038340503,1.0,4/13,20.58%,ZDHHC17;FOXO1;ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.44182915729178684,-0.7115263929789627,0.75,0.993487737951602,1.0,3/5,26.91%,GSPT1;MRPL33;PTCD3
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3474453264332584,-0.7114567393421991,0.8596491228070176,0.9927875565975302,1.0,3/42,7.62%,LRPAP1;PRKN;B2M
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.44120116323164554,0.7109296082230524,0.8928571428571429,1.0,1.0,1/7,8.23%,SLTM
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3752466537445946,0.7108761661301253,0.9322033898305084,1.0,1.0,6/16,14.21%,RALA;FBXO7;DDHD1;PINK1;MARCHF5;MFF
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4800567019012425,-0.7104581364345315,0.8461538461538461,0.9930653382810496,1.0,1/6,10.39%,NNT
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.39742133942826163,-0.7102299140145508,0.8571428571428571,0.9925517256640118,1.0,1/10,9.88%,CST3
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.39845892390611665,-0.7101886827607019,0.8363636363636363,0.9918287389115575,1.0,2/12,9.46%,STAT5B;PMAIP1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.4479671184437891,0.709937711293629,0.8571428571428571,1.0,1.0,3/6,33.23%,LRRK2;MEF2C;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.4479671184437891,0.709937711293629,0.8571428571428571,1.0,1.0,3/6,33.23%,LRRK2;MEF2C;INSYN2A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4749252247561785,0.7090769924949805,0.8372093023255814,1.0,1.0,2/5,14.26%,DOCK4;NRP1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4037946181825163,-0.7088805556618534,0.8372093023255814,0.9927871006778318,1.0,2/11,6.99%,IL32;LCP2
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3716342842151593,-0.7084983064660553,0.88,0.9926107065809546,1.0,3/14,10.57%,NFKB1;ERAP1;SPPL2A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.4244324017149207,0.7083174304238127,0.7758620689655172,1.0,1.0,2/6,15.56%,PLCB1;GRB2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.4244324017149207,0.7083174304238127,0.7758620689655172,1.0,1.0,2/6,15.56%,PLCB1;GRB2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.40077686789047434,0.7068194613690232,0.8727272727272727,1.0,1.0,1/15,0.96%,CRY1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.38952112044251896,-0.7067204422288043,0.875,0.9942630993967372,1.0,2/17,2.79%,TPM1;CXCL12
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.41353596004199034,0.706198381556054,0.8695652173913043,1.0,1.0,1/10,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.39154969610192375,-0.7061496765024474,0.8653846153846154,0.9940941948514846,1.0,4/17,11.71%,PRKN;B2M;CST3;UBC
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.35794026453369704,0.7057341258349696,0.8367346938775511,1.0,1.0,2/20,7.01%,SLC38A9;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.38835366877233085,0.7054542775655371,0.8518518518518519,1.0,1.0,5/15,26.40%,CBFB;ROCK1;ROCK2;SETD5;MEF2C
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4658307364732476,-0.7039948604078081,0.8571428571428571,0.9959437746774515,1.0,4/8,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.3803767393051643,0.7038738985896361,0.8863636363636364,1.0,1.0,2/11,7.52%,IL1R1;ENTPD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.38954934627608917,-0.7038492572990673,0.8048780487804879,0.9952968467852631,1.0,2/12,14.24%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3577030368694575,0.7031979034146806,0.8823529411764706,1.0,1.0,4/23,15.91%,ITGA1;CCDC88A;GRB2;CDC42
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.415899602409774,-0.7031944994220738,0.8275862068965517,0.9955121346886178,1.0,3/10,22.52%,NFKB1;PDGFB;ZBTB20
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.4298004909435206,0.7030043536281934,0.8245614035087719,1.0,1.0,3/9,22.97%,CALM1;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3783503673186578,-0.7029347918737011,0.8666666666666667,0.9943138562549368,1.0,3/12,15.19%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.3783503673186578,-0.7029347918737011,0.8666666666666667,0.9943138562549368,1.0,3/12,15.19%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3927957611903573,0.7024547965812503,0.9047619047619048,1.0,1.0,3/12,31.10%,PTPN1;NF1;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.31644058505250383,0.7021581121016148,0.9803921568627451,1.0,1.0,10/41,18.67%,CALR;PRKD1;ABL1;PPM1F;RTN4;CLASP1;NRP1;RAC1;EDN1;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3548692765319004,0.7020862551090918,0.9333333333333333,1.0,1.0,6/26,22.90%,ABL1;SLC8A1;HEG1;PTEN;PTPN1;NF1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3069634470552802,0.7015823441148457,0.9534883720930233,1.0,1.0,14/48,21.59%,TUBB4B;PCM1;BTRC;PLCB1;HSP90AA1;PPP1CB;CLASP1;TPD52L1;KHDRBS1;YWHAG;TAF2;CEP290;CDK5RAP2;FBXL7
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3039683481714631,0.7015723546845524,0.9215686274509803,1.0,1.0,14/39,21.81%,CDH2;ACTG1;NRCAM;NRXN1;ACTB;CDH12;VMP1;CDC42;NLGN1;PTEN;RYK;CTNND2;FSCN1;OPHN1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3662488209234671,-0.7009385214824011,0.88,0.996030838731675,1.0,4/29,16.31%,FN1;JAK2;PPP1R16B;PDGFB
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3906237080665676,-0.7004611201247146,0.9,0.9958197987204546,1.0,1/12,2.23%,PLCG2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3289306130553403,-0.6993397661129137,0.9076923076923077,0.9962586842886438,1.0,11/50,14.77%,STAT1;NDRG1;PRKN;BCL2L14;ACER2;PMAIP1;ACTN1;CLU;ATM;JAK2;CHM
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3761988496725357,0.6993002748582792,0.7619047619047619,1.0,1.0,2/13,9.30%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.4148318678923051,0.6983363584136714,0.8461538461538461,1.0,1.0,1/6,7.25%,PRKX
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4732649298669269,-0.6978545353954044,0.8536585365853658,0.9972377788332621,1.0,1/6,8.92%,JUN
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3550129137111676,-0.6969590555809695,0.86,0.9975002417965103,1.0,1/20,1.57%,RIMS1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.3765932308026038,0.6965083287339047,0.7884615384615384,1.0,1.0,4/11,20.82%,BACE2;ADAM10;PSEN1;ADAM17
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.37396173031488106,-0.6964834076528046,0.8771929824561403,0.9972554760376023,1.0,8/25,21.12%,HMGN1;MSH2;UBC;PWWP3A;XPC;SAFB;TCF7L1;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.39463966455672167,0.6961000718142194,0.8,1.0,1.0,1/11,2.52%,VAPB
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.31228569816756185,-0.6957762138922983,0.8679245283018868,0.997368077803178,1.0,8/52,18.35%,SNX2;IGF2R;ICA1;USO1;CLTA;CLCN3;GNAS;SEC24D
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.4229494609448046,0.6955821836135567,0.9318181818181818,1.0,1.0,1/11,4.70%,YAF2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.4229494609448046,0.6955821836135567,0.9318181818181818,1.0,1.0,1/11,4.70%,YAF2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.40252032908825297,0.6953836063055763,0.7804878048780488,1.0,1.0,1/9,1.09%,IL1R1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.46897614403220805,-0.6941781578816568,0.8461538461538461,0.9980237732960142,1.0,4/6,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.46897614403220805,-0.6941781578816568,0.8461538461538461,0.9980237732960142,1.0,4/6,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.3793166930485011,0.6940661403383669,0.8780487804878049,1.0,1.0,3/11,18.59%,CLASP1;PHLDB2;WASF2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.4503118114092301,-0.6939378807184621,0.88,0.9976219994317376,1.0,3/6,20.74%,ATP2B1;ZDHHC21;ECE1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.41449874489861016,-0.6929989382205638,0.7804878048780488,0.998015341494347,1.0,1/7,4.38%,LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.44728078350833234,-0.6929418373461887,0.8863636363636364,0.9972999656314552,1.0,1/6,9.75%,RPS19
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.32722809108942885,0.6928227047075711,0.9591836734693877,1.0,1.0,2/19,7.12%,BACH2;PPP1R10
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.33873467666821405,0.692187389320483,0.9318181818181818,1.0,1.0,1/21,4.25%,TENT4A
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.30137085143991676,-0.6917714842991524,0.9491525423728814,0.9979077807258054,1.0,4/57,5.71%,PSMA1;RPL34;PABPC1;RPS6
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.34936200585618055,0.691622284000737,0.8571428571428571,1.0,1.0,4/20,19.71%,PEX14;PARD3;ZDHHC14;SEC63
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.3767681185814235,-0.690903094792236,0.8913043478260869,0.998052282151462,1.0,2/12,10.09%,TANK;NET1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3702923943085912,-0.6908761626424036,0.9215686274509803,0.997305553948446,1.0,6/24,23.16%,SEPTIN11;SPAST;RHOA;APC;SEPTIN2;SPTBN1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.40044515115331525,-0.6899522232681438,0.8771929824561403,0.9976563897716383,1.0,3/9,18.73%,DGKG;MGLL;DGKE
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.34526152884467587,-0.6899484448920333,0.9111111111111111,0.9968781866594919,1.0,4/26,16.65%,PRKN;WARS1;PRKRIP1;DNAJC10
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4171121451669352,-0.6895945210605825,0.8,0.9965785798446487,1.0,3/14,13.23%,STAT1;NFKB1;JAK2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.44045285640190296,0.6889369627075944,0.8571428571428571,1.0,1.0,1/8,4.94%,SEMA3F
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3647994367791595,0.6889328210473548,0.9074074074074074,1.0,1.0,5/13,22.90%,SBF2;SKI;PARD3;PLLP;NF1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3019479926939987,0.688669474761188,0.9777777777777777,1.0,1.0,9/30,22.55%,PLCB1;INO80;APPL1;PTEN;ANXA1;RGCC;ADAM17;CDC73;CDK6
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.347751479903508,-0.6871688433696639,0.82,0.9989687971076074,1.0,2/25,5.63%,OPTN;CALCOCO2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.43382504730627897,0.6870530528920612,0.8846153846153846,1.0,1.0,1/5,11.55%,ACOX1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.3501434690129555,0.6869165695847227,0.9512195121951219,1.0,1.0,6/20,17.64%,URI1;ROBO2;NCOA3;NCOA2;ATP1A1;NCOA1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3515181037481249,0.68554378944381,0.9024390243902439,1.0,1.0,3/23,9.03%,ATRNL1;MICALL2;PARVA
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.320093066526438,0.6853295430774958,0.9333333333333333,1.0,1.0,6/25,18.43%,UIMC1;COP1;INO80;GRB2;ANXA1;RNF168
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.437821526234523,0.6850248446704823,0.7966101694915254,1.0,1.0,2/5,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4170894915347335,-0.6849611791573257,0.8979591836734694,1.0,1.0,3/10,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.31923940206482365,0.6844194896516966,0.8888888888888888,1.0,1.0,4/17,15.64%,PGR;ZMIZ1;ARID1A;UBE3A
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4605819829219581,-0.6836271590280553,0.7962962962962963,1.0,1.0,4/6,32.32%,RIMKLB;DGLUCY;GLUD1;GLUL
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.44278793334619876,-0.6834213314777254,0.8541666666666666,1.0,1.0,2/7,23.11%,MAP3K4;GADD45B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.41234148541181703,-0.6829998465449691,0.8,1.0,1.0,1/9,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.39134678180054716,-0.6828363670147903,0.9016393442622951,0.9999847034081155,1.0,5/14,13.81%,GEMIN5;NFKBIA;NFKB1;RPL10;SSH1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.3587536313670873,-0.6822201833324268,0.9074074074074074,0.9998889662601502,1.0,3/29,4.04%,TPM1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.38455578237528176,0.68211714184927,0.8372093023255814,1.0,1.0,1/12,0.90%,INPP5A
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.3093977144809173,-0.6818348009746861,0.9,0.9994989067525251,1.0,7/53,11.29%,PLCG2;CHKA;AGPAT3;DGKG;INPP5D;PIK3C2B;MTMR2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.41313863353026153,0.6809306792322576,0.8333333333333334,1.0,1.0,2/8,11.26%,WAPL;PPHLN1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4246242503314291,-0.6791551608377401,0.9423076923076923,1.0,1.0,3/8,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.35097492786291346,0.6777397647168193,0.9148936170212766,1.0,1.0,5/14,16.57%,ITPR3;ITPR2;SLC8A1;SLC24A2;ATP2B4
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.37869462335849036,-0.6775320718230092,0.8518518518518519,1.0,1.0,1/9,4.73%,PLA1A
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.45503436629975935,-0.6770238342912661,0.82,1.0,1.0,2/7,13.23%,STAT5B;JAK2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.40144708283378,-0.6769842009770825,0.8148148148148148,1.0,1.0,1/10,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.40144708283378,-0.6769842009770825,0.8148148148148148,1.0,1.0,1/10,1.78%,ISG15
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.4166648577291619,-0.6755848349608353,0.8727272727272727,1.0,1.0,1/10,1.59%,SLC16A2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.30713738041399075,0.6755341950603179,1.0,1.0,1.0,14/47,21.59%,TUBB4B;PCM1;BTRC;PLCB1;HSP90AA1;PPP1CB;CLASP1;TPD52L1;KHDRBS1;YWHAG;TAF2;CEP290;CDK5RAP2;FBXL7
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.40266168489182097,-0.6752219780099248,0.7346938775510204,1.0,1.0,1/8,1.54%,SOD2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.43952725716291463,-0.6750727334622489,0.8936170212765957,1.0,1.0,2/5,6.56%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4127653952688129,0.6745842401093503,0.88,1.0,1.0,3/6,14.08%,FBXO7;REST;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.335218068512265,-0.6741198606542971,0.92,1.0,1.0,6/32,12.59%,MAP2;SMAD3;CDA;BST2;GNG4;SMARCA2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4361336111376094,-0.6726273539835809,0.7924528301886793,1.0,1.0,1/7,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.39795597716261666,0.6720467401477883,0.8048780487804879,1.0,1.0,3/9,32.51%,APPL1;INSR;PRKCI
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.3321740944673131,0.6720025966233075,0.8666666666666667,1.0,1.0,3/22,7.41%,GRM5;CCDC88A;HSPB1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3987766456727227,0.6718793093198672,0.8679245283018868,1.0,1.0,1/8,4.78%,UGCG
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.32508444675560455,-0.6718321209885811,0.9038461538461539,1.0,1.0,5/36,12.01%,CDK14;PRKN;APCDD1;GPC3;SULF2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3886736864121615,-0.6706558481036855,0.9285714285714286,1.0,1.0,3/13,29.38%,PRIMPOL;BOD1L1;WRN
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.3948019599945988,-0.6704352643180602,0.96,1.0,1.0,2/10,6.88%,GMPS;ADSS2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3790955528704904,0.6699066061242703,0.8076923076923077,1.0,1.0,2/9,9.30%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.35547657575624436,0.6691885912349798,0.9298245614035088,1.0,1.0,5/17,16.04%,ITGA1;RAB7A;GRB2;CDC42;CBLB
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.3931488856172944,-0.6691089966997283,0.8780487804878049,1.0,1.0,2/9,14.24%,MEF2A;PDE9A
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.27442022057541715,0.6677815187116342,0.9777777777777777,1.0,1.0,4/52,8.92%,MMRN1;CDH2;TET2;ELF1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.35539945023154274,0.6677720806836104,0.9454545454545454,1.0,1.0,5/15,16.49%,ACTB;GNB4;YWHAQ;CDC42;CALM1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.35702702894326316,0.6677105415198388,0.9302325581395349,1.0,1.0,1/18,0.72%,PSMD14
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.4429274272386737,0.6665975675072415,0.8666666666666667,1.0,1.0,1/5,16.52%,KLF2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3802036962814145,0.6665631189998122,0.875,1.0,1.0,2/10,20.98%,CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.38216566551648123,-0.6664624562169792,0.8269230769230769,1.0,1.0,2/15,10.44%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3816079362091005,-0.665519036755357,0.8979591836734694,1.0,1.0,1/9,1.81%,HGSNAT
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.4229991470833582,-0.6650600168377092,0.8163265306122449,1.0,1.0,1/7,7.46%,DMD
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.357354216690723,-0.6643115679487103,0.8909090909090909,1.0,1.0,2/15,8.66%,PRKN;CCDC88C
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.44584133954737387,0.6631898220647786,0.8627450980392157,1.0,1.0,1/5,7.89%,ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.44584133954737387,0.6631898220647786,0.8627450980392157,1.0,1.0,1/5,7.89%,ACAT1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.32424613540134584,0.6627995148544193,0.9347826086956522,1.0,1.0,5/21,21.25%,CACNA1C;CALCRL;SLC8A1;PSEN1;RYR2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.3789910731484738,0.6627676159979228,0.8936170212765957,1.0,1.0,3/11,20.03%,NAV3;CLASP1;TAOK1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.42616900645026307,-0.6627285810319749,0.8653846153846154,1.0,1.0,1/9,5.26%,GRB14
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.4174105006107016,-0.6609794537894911,0.8723404255319149,1.0,1.0,2/6,5.60%,CD109;SERPINE1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.3670862201123358,-0.6606476193664358,0.84,1.0,1.0,6/17,19.76%,SERPINE1;NFKB1;VIM;RHOA;MAPK14;ZFP36
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.4156057117541029,0.6604856258927064,0.8867924528301887,1.0,1.0,2/5,19.47%,CLASP1;LIMK2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.3670880343022629,0.6603425568100004,0.8604651162790697,1.0,1.0,4/14,17.24%,RAD23B;SSBP1;POT1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3680230718070695,0.6599318250264601,0.92,1.0,1.0,5/11,29.77%,EDN1;RGCC;PHIP;CDC16;INSR
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.29319480723057095,0.6594870219359277,1.0,1.0,1.0,9/57,15.99%,BCL6;CCDC85B;URI1;RTN4;CHPT1;INO80;ADAM10;CDC42;ST7L
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.4131849940155868,-0.6594539901762125,0.8333333333333334,1.0,1.0,1/5,11.95%,CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.4131849940155868,-0.6594539901762125,0.8333333333333334,1.0,1.0,1/5,11.95%,CLYBL
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3894604960509803,0.6588797972372691,0.8936170212765957,1.0,1.0,3/8,13.12%,PIK3CA;ABL1;HSPA8
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.33477928567364046,0.6580869294284759,0.9322033898305084,1.0,1.0,2/19,3.13%,BAG3;IL6R
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.4500299333581444,0.6576431973004617,0.8541666666666666,1.0,1.0,3/5,33.57%,KIF5B;RAB27A;SPG11
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.40091565960814324,0.6576254304692717,0.8723404255319149,1.0,1.0,3/8,29.77%,PSEN1;ARNT;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.40091565960814324,0.6576254304692717,0.8723404255319149,1.0,1.0,3/8,29.77%,PSEN1;ARNT;INSR
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.3660952080629859,0.6574868732544952,0.8392857142857143,1.0,1.0,4/8,34.13%,MYO1E;WASL;MYO1B;FNBP1L
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.4478920827254459,0.6567371213182658,0.8823529411764706,1.0,1.0,1/5,7.01%,PIK3CA
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.37017416032920525,0.6562968894391956,0.9523809523809523,1.0,1.0,3/15,25.15%,ANXA1;CANX;ARFGAP3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3852848182738878,0.6557851132262602,0.8478260869565217,1.0,1.0,2/7,7.49%,PRKG1;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.3812070855880377,0.6555140593746822,0.8076923076923077,1.0,1.0,1/12,2.34%,MCC
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.3856208526295549,-0.6554010137749601,0.8490566037735849,1.0,1.0,1/12,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.40835009079760476,-0.6549030537457022,0.8809523809523809,1.0,1.0,3/8,21.33%,ITGAV;JAK2;TGM2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3991961517977962,0.6532722263943074,0.864406779661017,1.0,1.0,3/8,17.77%,SEMA3F;NRP1;RAC1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.2878688552517073,0.6530324619194705,0.9787234042553191,1.0,1.0,15/46,24.41%,ZBTB1;KDM4C;BRWD1;KDM5A;INO80;ARID1A;BAZ1B;BAZ2A;SETD7;JARID2;TOP1;HDAC4;BPTF;MECOM;PBRM1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3664552526642929,0.6529791550528921,0.851063829787234,1.0,1.0,4/12,16.68%,PCM1;REST;RTN4;PTEN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3809782429709626,0.6529683673081651,0.9047619047619048,1.0,1.0,2/11,9.93%,CCNI;ACTB
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.3870441852238717,0.6525351241180127,0.9019607843137255,1.0,1.0,3/6,26.77%,PINK1;DYRK1A;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4122104481199456,0.6512044097805331,0.890625,1.0,1.0,1/7,18.78%,ROCK1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.3807495998269842,-0.6502764339818936,0.9056603773584906,1.0,1.0,1/17,5.26%,GRB14
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.4092401777527279,-0.6492285641994757,0.9090909090909091,1.0,1.0,1/12,2.12%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.36360237544315344,-0.6488055129483192,0.9433962264150944,1.0,1.0,4/12,15.64%,ATM;MAP3K4;PARN;TNKS2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.40154764305249535,-0.6485168962353832,0.8936170212765957,1.0,1.0,4/11,21.33%,SULF2;GNAS;SLC10A7;TGM2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3664071233703568,0.6483205211443533,0.88,1.0,1.0,3/13,17.42%,SMAD6;CDC42;EP300
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.44643917155725515,-0.6481456312337698,0.8461538461538461,1.0,1.0,1/5,12.24%,RORA
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.43143609107641373,0.646527640147189,0.82,1.0,1.0,3/5,27.09%,GCH1;SCP2;FDFT1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.386446142640891,-0.646510253813676,0.8823529411764706,1.0,1.0,4/14,23.51%,STAT5B;EEF1A1;ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.410586777310413,-0.6464536100208732,0.8367346938775511,1.0,1.0,3/5,34.29%,MAPK14;WWC2;VGLL4
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.32211796794480435,0.6463494861894505,0.8571428571428571,1.0,1.0,5/16,22.82%,IGFBP3;KLF7;PTPN1;CDK6;AKT3
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4187797399705154,-0.6463102407268513,0.8181818181818182,1.0,1.0,1/7,7.46%,DMD
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.2869155139051909,-0.6459177873534578,0.9836065573770492,1.0,1.0,5/72,8.82%,PLK2;CDK14;OPTN;CEP57;CEP70
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.38020905290730206,0.6459097500273492,0.9791666666666666,1.0,1.0,3/10,20.03%,NAV3;CLASP1;TAOK1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.4164814987944317,0.6446475937387407,0.9090909090909091,1.0,1.0,2/6,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3720424846379137,-0.6445350523210566,0.8541666666666666,1.0,1.0,2/17,5.58%,STAT1;PLXND1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3371532449796871,-0.6444356452289824,0.8936170212765957,1.0,1.0,6/16,19.07%,SMAD3;CD47;CLU;JAK2;CD34;PKD2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.40984304713138464,0.644357292545434,0.9272727272727272,1.0,1.0,1/5,23.88%,AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.40984304713138464,0.644357292545434,0.9272727272727272,1.0,1.0,1/5,23.88%,AKAP6
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.42415967366670404,-0.6440051050147029,0.84,1.0,1.0,1/5,8.37%,ACER2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2690170676138447,0.6437578658574289,1.0,1.0,1.0,17/78,23.82%,TUBB4B;PCM1;WDPCP;HSP90AA1;PARVA;CDC14B;CLASP1;ABCC4;ARF4;CC2D2A;YWHAG;BBS9;CEP290;CDK5RAP2;KIFAP3;GSN;NUDCD3
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3364856356192641,0.6437106195518242,0.9545454545454546,1.0,1.0,7/17,31.47%,YTHDF2;DIS3L2;RC3H1;TUT7;XRN2;HSPA1A;TUT4
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.41945008613069545,0.6426299977187802,0.9454545454545454,1.0,1.0,3/6,23.85%,ATP2B4;ROCK2;SPIDR
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.38968425801259776,-0.6424726536888861,0.9166666666666666,1.0,1.0,4/10,26.91%,EEF1A1;MRPL33;RACK1;PTCD3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.41159244401052053,-0.6420255982524968,0.8867924528301887,1.0,1.0,2/5,26.00%,GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.43055865271100946,0.6420142747037489,0.9038461538461539,1.0,1.0,2/5,16.20%,BCL2L1;APPL1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.39074294770198387,0.6416296981619966,0.8448275862068966,1.0,1.0,1/5,16.52%,KLF2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.363121750292163,-0.6411641594021146,0.96,1.0,1.0,5/14,20.24%,BRD7;PRMT2;PKD2;DLG1;APC
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3080189544064478,0.6406540339739101,0.9523809523809523,1.0,1.0,7/23,30.25%,PLCB1;ANXA1;RGCC;ADAM17;BRD4;CDC16;KMT2E
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3408028448971835,-0.6403012994154814,0.9215686274509803,1.0,1.0,2/24,4.38%,LRPAP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.3808882807971412,0.6402865048517402,0.9019607843137255,1.0,1.0,4/8,17.03%,CPEB3;TANC2;NLGN1;PSEN1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.38069003343247615,-0.640180747835533,0.9,1.0,1.0,1/10,3.88%,MAP2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3703718081449918,0.6383802191148769,0.88,1.0,1.0,5/12,30.94%,ACAT1;NOS3;HIBADH;AUH;GLS
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.3552483508431598,-0.6383320203027272,0.9285714285714286,1.0,1.0,4/20,12.99%,GRB14;NNT;GPC3;ATP7B
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.35612153318098394,0.6364363714857911,0.9361702127659575,1.0,1.0,3/14,20.85%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.35612153318098394,0.6364363714857911,0.9361702127659575,1.0,1.0,3/14,20.85%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.3957033967863738,-0.6351169759461415,0.9148936170212766,1.0,1.0,4/6,28.26%,MRPL33;RARS2;PTCD3;LARS2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3553765047977613,-0.6349130389574656,0.9333333333333333,1.0,1.0,2/10,14.24%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.35805503516561626,0.6345630760948898,0.9387755102040817,1.0,1.0,2/11,9.30%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.41367885633138246,0.6336142514978464,0.875,1.0,1.0,2/5,23.40%,PNPLA8;PGS1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3753730397642243,-0.6331636665541195,0.9,1.0,1.0,1/7,5.87%,UBR2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.40523546282037537,-0.6329272182649236,0.9387755102040817,1.0,1.0,3/5,23.61%,ATP2B1;ZDHHC21;CTTN
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.34669133545435576,-0.6326594683480424,0.9444444444444444,1.0,1.0,6/17,18.65%,B2M;TFRC;NDFIP1;IREB2;ACO1;FTH1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.40080185268524576,0.6311446845718119,0.8793103448275862,1.0,1.0,1/5,15.35%,SLC24A2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3632347055490872,-0.6310682509605718,0.8793103448275862,1.0,1.0,2/10,10.60%,RPS6;MAPKAP1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.33441437964971465,0.6307420879531009,0.9607843137254902,1.0,1.0,3/11,17.66%,ROBO2;TIAM2;TIAM1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.28910902976192615,0.6306350327008741,0.96,1.0,1.0,4/22,18.22%,CLASP1;INO80;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.39864218250802697,0.6304375500128978,0.8771929824561403,1.0,1.0,1/7,16.68%,PTEN
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3501496644318789,-0.6302799744787924,0.8936170212765957,1.0,1.0,3/15,12.40%,GABARAPL1;RPL23;STX17
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.39534435828132286,-0.6302624936164654,0.875,1.0,1.0,2/6,25.02%,ZIC2;MID1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3306164543200275,-0.6291490021346536,0.9491525423728814,1.0,1.0,6/26,14.26%,CARMIL1;LGALS3;MTMR2;CLU;TMEFF2;RIOK3
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2888572313519388,-0.6286939329293557,0.9814814814814815,1.0,1.0,9/30,23.51%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98;ZFP36;POM121C;NUP214;ZFP36L1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.35922844290803985,0.6266671789670841,0.9166666666666666,1.0,1.0,9/12,35.78%,CDC42;DIP2A;PTEN;CTNND2;WASL;INSR;FYN;PRNP;ARF1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.400410180398483,-0.6261236082371513,0.9215686274509803,1.0,1.0,2/8,8.37%,TFRC;ACER2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.41675266472973704,0.6258635741639476,0.9347826086956522,1.0,1.0,2/5,21.17%,EXT1;NDST1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.3149860222855644,-0.6258247896322333,0.9791666666666666,1.0,1.0,6/24,24.01%,TANK;NET1;ATM;MAPK14;MDM2;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3311808515378053,-0.6256732541318348,0.9387755102040817,1.0,1.0,3/20,10.92%,ACSL4;MYRIP;CD2AP
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.35092387776793477,0.6252062924990308,0.8958333333333334,1.0,1.0,4/11,14.71%,SETX;CELF2;PSIP1;SFSWAP
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3404698909217654,0.624804844260065,0.9591836734693877,1.0,1.0,3/20,16.39%,ACTG1;ACTB;ESAM
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3805595259315694,0.6243595324991564,0.88,1.0,1.0,2/8,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.3920484595962387,0.6239861513210542,0.9583333333333334,1.0,1.0,2/10,25.15%,CANX;ARFGAP3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.37046039271118236,-0.6235958438118421,0.9565217391304348,1.0,1.0,3/15,15.75%,SMAD3;RORA;FOXO1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.32407090358047547,0.6227726031295574,0.9333333333333333,1.0,1.0,7/27,19.12%,UGCG;PBX3;ERCC6;DTNB;IL1RAPL1;WNK1;RYK
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.3752258722028381,0.6226191673718056,0.9090909090909091,1.0,1.0,1/8,3.59%,PRAG1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.39813829787234045,-0.6224675753344521,0.8666666666666667,1.0,1.0,5/5,60.27%,PPP2R5A;PIK3R1;RBL2;PIK3R3;RB1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.36981537530872044,-0.6222413483545424,1.0,1.0,1.0,2/9,9.08%,PLCG2;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.36981537530872044,-0.6222413483545424,1.0,1.0,1.0,2/9,9.08%,PLCG2;ERO1A
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.39048283547739365,-0.6220186525558297,0.88,1.0,1.0,2/5,20.58%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.39048283547739365,-0.6220186525558297,0.88,1.0,1.0,2/5,20.58%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3085577619631369,0.6219154193815107,0.9545454545454546,1.0,1.0,14/33,20.11%,ACTG1;CCDC88A;ABL1;PPM1F;CLASP1;NRP1;CDC42;RAC1;PHLDB2;WASF2;ROCK1;CCN2;PXN;RGCC
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.3944462520150639,-0.6214438746196813,0.88,1.0,1.0,1/6,6.77%,SMAD3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.4298283185789722,-0.620969814634478,0.875,1.0,1.0,1/5,13.09%,ATM
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.4014930104615576,0.6208475701702182,0.9591836734693877,1.0,1.0,3/6,26.91%,SLC1A1;SLC23A2;SLC1A2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.41621658566216646,-0.6199350917585258,0.9444444444444444,1.0,1.0,2/6,18.27%,APPL2;MAPK14
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.404618558125732,0.619558425865039,0.9387755102040817,1.0,1.0,2/6,10.89%,INPP5F;ANXA2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.2908683176067307,0.6190105296450471,0.9767441860465116,1.0,1.0,7/27,16.57%,ATP2A2;MICU3;CACNA1C;SLC8A1;ANO6;SLC24A2;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.4015922292773952,0.6189741807630813,0.9016393442622951,1.0,1.0,1/5,10.33%,NCOA3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.42011406112542027,0.6188604934025248,0.9302325581395349,1.0,1.0,2/5,20.56%,ACOX1;MGST2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.369956494056688,-0.6186339755385157,0.9230769230769231,1.0,1.0,1/6,10.33%,AHI1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.43536242970773875,0.6176692996647773,0.9583333333333334,1.0,1.0,3/5,30.39%,BCL2L1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.43536242970773875,0.6176692996647773,0.9583333333333334,1.0,1.0,3/5,30.39%,BCL2L1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.3576734559850292,-0.6173325254081293,0.9361702127659575,1.0,1.0,3/18,12.83%,SMARCA1;SMARCA2;SMARCAD1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.3251249261598113,0.6171590283857309,0.9807692307692307,1.0,1.0,5/19,24.75%,HSPB1;PPM1F;YWHAG;NF1;GNAQ
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3425936534935041,0.6156786528615568,0.9607843137254902,1.0,1.0,7/16,26.19%,PDZD8;LARP4;ZRANB1;CAPZB;PHIP;FMNL2;EFNA5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36229268753838284,-0.6151825505267724,0.9183673469387755,1.0,1.0,1/11,4.97%,MMRN2
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.332864060907367,0.6144501909900051,0.9107142857142857,1.0,1.0,2/11,9.16%,CDH2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3623651009374307,0.6138392761857306,0.9310344827586207,1.0,1.0,1/8,7.41%,HSPB1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.3415924261182113,0.6138182689921673,0.9423076923076923,1.0,1.0,5/9,24.83%,CLASP1;ZNF207;CDK5RAP2;CLIP1;NAV1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.37631034965050836,0.6130612525831636,0.9411764705882353,1.0,1.0,2/6,24.62%,UGGT1;VCP
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.2650635185983641,0.6127100861750462,1.0,1.0,1.0,9/46,18.91%,IGFBP3;HSPB1;SMAD6;PPM1F;LRRK2;PARD3;CALM1;PTEN;YWHAG
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.36310665436454226,0.6110021161175406,0.8507462686567164,1.0,1.0,5/10,25.18%,SMAD6;ROBO2;ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.4017228063975651,-0.6106716700393038,0.8723404255319149,1.0,1.0,1/5,10.73%,APPL2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3456002366587162,0.6096140962441579,0.9636363636363636,1.0,1.0,2/11,17.24%,POT1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.33919609261265393,0.6095647995599595,0.9482758620689655,1.0,1.0,1/13,2.97%,TAF1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.3649094285241728,-0.6095149637173518,0.92,1.0,1.0,1/8,8.37%,ACER2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.35224005051971785,-0.6086233474551311,0.94,1.0,1.0,1/12,7.73%,STK39
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.35207763923129254,-0.6077854856389502,0.9361702127659575,1.0,1.0,2/12,10.73%,PLCG2;APPL2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.29174013298468493,0.6076650715550709,0.975,1.0,1.0,3/29,8.15%,IFNAR1;SMAD6;TAB2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3526244406103989,-0.6070177775994458,0.9803921568627451,1.0,1.0,1/19,1.54%,SOD2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.3812922659888273,0.6070017848087778,0.9069767441860465,1.0,1.0,2/8,23.69%,RSRC1;RBM17
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4057997747389935,0.6053040473744452,0.8775510204081632,1.0,1.0,2/5,14.26%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3799212735623244,-0.6052706305484831,0.9545454545454546,1.0,1.0,3/6,28.18%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3799212735623244,-0.6052706305484831,0.9545454545454546,1.0,1.0,3/6,28.18%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.26180030111517083,0.605054427512997,0.9787234042553191,1.0,1.0,8/40,19.73%,ERBB4;YES1;FRS2;EPHA4;ROR1;ACVR2A;RYK;FES
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.3967122677651683,-0.6020183992710176,0.9183673469387755,1.0,1.0,2/6,15.64%,MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.33047867899275024,-0.6015777859927299,0.896551724137931,1.0,1.0,3/16,12.48%,PABPC1;POLR2A;SRPK1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.32756814156142033,-0.6012842403882039,0.9818181818181818,1.0,1.0,1/15,4.01%,PRKN
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.32940080629376717,0.601037973434541,0.9347826086956522,1.0,1.0,6/15,19.12%,CDH2;NRCAM;NRXN1;NLGN1;PTEN;RYK
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.40809014002405447,0.6003454367918515,0.9347826086956522,1.0,1.0,1/5,11.74%,DST
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2796628833442673,-0.6002156063079892,1.0,1.0,1.0,5/29,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.393213557672465,-0.6001259543353182,0.9454545454545454,1.0,1.0,1/6,8.74%,CD47
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.30779875819911356,0.599132765556617,0.918918918918919,1.0,1.0,11/23,34.02%,ROBO2;ZMIZ1;CREBBP;EP300;NOS3;STAT3;AAK1;TSPAN14;RBPJ;PRKCI;YAP1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.4282131684480501,0.5988310222239281,0.9791666666666666,1.0,1.0,3/5,37.72%,MAP4K4;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.4075521907509102,-0.5984919614737939,0.9302325581395349,1.0,1.0,1/6,15.56%,DHX36
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3769880678133259,-0.5984593133500893,0.9318181818181818,1.0,1.0,1/5,5.87%,UBR2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.3614532625637642,-0.598224893199363,0.9545454545454546,1.0,1.0,1/5,13.39%,SERBP1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.33228386318887193,-0.5963719222592136,0.9411764705882353,1.0,1.0,4/17,15.64%,ATM;MAP3K4;PARN;TNKS2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.31599114731126154,0.5961070157617154,0.9772727272727273,1.0,1.0,3/15,18.22%,CLASP1;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.3471027679507248,0.5954711889925741,0.9375,1.0,1.0,2/12,8.10%,SMAD6;ROBO2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.28026846421897256,-0.5954710220811331,1.0,1.0,1.0,5/28,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.28026846421897256,-0.5954710220811331,1.0,1.0,1.0,5/28,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.3829953578249357,0.5953558890262176,0.9166666666666666,1.0,1.0,2/5,16.92%,SSBP1;POT1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.35503131160293266,-0.5943695630865583,0.8775510204081632,1.0,1.0,1/6,11.26%,MSH2
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3514899403283758,0.5922119647053712,0.9791666666666666,1.0,1.0,4/9,37.29%,MIS18BP1;RBBP4;POGZ;CENPC
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.33232526698178816,-0.5906364770159107,0.94,1.0,1.0,2/20,8.74%,SOD2;CD47
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.3274557147209128,0.5889503920228044,0.9333333333333333,1.0,1.0,4/14,20.98%,LRRK2;PINK1;LIMK2;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3620271886613903,0.5887554203624225,0.9038461538461539,1.0,1.0,4/7,42.36%,HSPA1A;DYNC1H1;HNRNPU;CLTC
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.34749023348068186,-0.5887368533927394,0.94,1.0,1.0,2/11,12.75%,SNX25;CLTA
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.33225782819900707,0.586828555843416,0.9302325581395349,1.0,1.0,2/12,16.20%,GRB10;APPL1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.32258452994331843,-0.5865077925760587,0.9622641509433962,1.0,1.0,7/19,24.41%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3083168403345261,-0.5863606915326167,0.9454545454545454,1.0,1.0,3/28,10.46%,VAV3;PLXND1;ARHGAP15
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.3675849255919971,0.5859248601329813,0.9411764705882353,1.0,1.0,2/7,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2761705961070359,-0.585672732212576,0.9591836734693877,1.0,1.0,6/38,14.32%,SNX6;CD109;SMAD3;SNX25;UBC;RNF111
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.3681395404888588,-0.585504275582954,0.9,1.0,1.0,2/8,20.16%,POLR2A;MTERF1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.3643183178271259,-0.584802373503899,0.9206349206349206,1.0,1.0,3/8,23.64%,NEBL;CCDC60;MYO5C
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.2762923065434728,0.5811864676771573,1.0,1.0,1.0,8/35,17.80%,URI1;ROBO2;NCOA3;NCOA2;LRRK2;IL1RAPL1;NCOA1;ACVR2A
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.3776117000121963,-0.5806935420641368,0.9019607843137255,1.0,1.0,1/6,7.46%,DMD
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3652746228486349,-0.5804961723414573,0.9333333333333333,1.0,1.0,1/5,7.28%,DSP
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.39398441046550947,-0.5797359363086396,0.9375,1.0,1.0,2/6,15.38%,MSH2;XPC
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.30834307564110586,0.5795724579888145,0.9607843137254902,1.0,1.0,4/15,20.11%,GCNT2;TIAM1;FOXC1;RGCC
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.34511279228918484,-0.579279534485793,0.8571428571428571,1.0,1.0,5/12,31.82%,CABIN1;NAP1L1;NPM1;MACROH2A1;NASP
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3056925316825567,-0.5779646666551845,1.0,1.0,1.0,1/19,2.90%,CAVIN2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.3844852065757176,0.5774449993192219,0.9574468085106383,1.0,1.0,1/6,11.85%,CLASP1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.33942349610389205,-0.5764990314092687,0.9459459459459459,1.0,1.0,1/8,7.28%,DSP
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3229655685666047,-0.576038627387713,0.9803921568627451,1.0,1.0,5/15,20.24%,BRD7;PRMT2;PKD2;DLG1;APC
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3668998668829083,0.5752850704511498,0.9622641509433962,1.0,1.0,3/7,17.03%,CPEB3;NLGN1;PSEN1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.2881055101489238,-0.5751119134210753,0.9830508474576272,1.0,1.0,3/28,7.46%,PRKN;WARS1;DMD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.39112586285240114,-0.5751061180436183,0.9534883720930233,1.0,1.0,2/6,15.19%,CD47;RHOA
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.3509571240248567,0.5748782928453527,0.8809523809523809,1.0,1.0,1/6,12.86%,DICER1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3480668664699677,-0.5746312266683057,0.9565217391304348,1.0,1.0,3/12,17.77%,MSH2;TNKS2;RAD21
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3208903602840226,-0.574163229973991,0.92,1.0,1.0,1/11,8.37%,ACER2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.3092171412390111,-0.5740848160076318,0.95,1.0,1.0,5/21,20.24%,PATJ;RHOA;AFDN;DLG1;APC
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.35789888767970945,0.570224500513387,1.0,1.0,1.0,2/6,13.92%,GLCE;EXT1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.335754296298627,-0.5699418797756877,0.9661016949152542,1.0,1.0,4/11,15.64%,ATM;MAP3K4;DHX36;TNKS2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3188017324943138,-0.5696570398577683,0.9591836734693877,1.0,1.0,2/15,13.28%,SMAD3;ZC3H7A
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.36675531914893617,-0.5666032446963019,0.9230769230769231,1.0,1.0,5/5,63.40%,KDM1A;N4BP2L2;FERMT2;GJA1;HNRNPU
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3498741156872579,0.5662616075495902,0.9795918367346939,1.0,1.0,1/6,15.09%,ARID1A
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3221763441765795,0.5657002487826285,0.9818181818181818,1.0,1.0,2/7,21.81%,CDC42;OPHN1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3477340936312895,-0.565354352690483,0.8666666666666667,1.0,1.0,3/7,24.36%,SHROOM2;AP1G1;KIF13A
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.31210586972998733,0.564863937702526,0.875,1.0,1.0,3/8,20.00%,DGKI;PLPPR4;MBOAT2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.35116069840478437,-0.5639482283555532,0.8846153846153846,1.0,1.0,2/7,18.01%,SMYD2;PRMT2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.33698140250094044,-0.5635413084895619,0.9215686274509803,1.0,1.0,3/12,14.42%,CAPRIN1;HECW2;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.3416025727326763,-0.5619789695250539,0.9777777777777777,1.0,1.0,2/11,12.96%,APPL2;GNA12
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.34135705176437225,-0.5617490552861655,0.8958333333333334,1.0,1.0,1/7,6.77%,SMAD3
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.36272421093298735,0.5608391761835205,0.9433962264150944,1.0,1.0,3/6,23.64%,HSP90AA1;PTEN;HSP90AB1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.2958496214850057,-0.5602120803628747,0.9508196721311475,1.0,1.0,4/17,20.24%,PATJ;AFDN;DLG1;APC
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.28037877492046837,0.5595810911786031,1.0,1.0,1.0,7/22,26.77%,PARD3;NECTIN3;ZDHHC14;SEC63;RAB3GAP2;RFTN1;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.33182846021334517,0.5591391117223861,0.9818181818181818,1.0,1.0,1/10,7.41%,HSPB1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.29056326579867636,-0.5587701598533348,0.9821428571428571,1.0,1.0,6/25,17.85%,GRK5;GNA12;GNA14;RAMP3;GNAS;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.33444974702050456,-0.5585232594074353,0.9019607843137255,1.0,1.0,2/6,18.27%,EFNB2;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36808510638297876,-0.5581972297922236,0.918918918918919,1.0,1.0,5/5,63.27%,SH3D19;SNX9;ADAM9;TNFRSF1B;NRDC
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.3366253945275072,0.5554235381273697,0.9807692307692307,1.0,1.0,4/9,26.80%,EPHA4;ROCK2;PICALM;STAT3
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2740827262222405,-0.5549672907514032,0.9830508474576272,1.0,1.0,2/22,9.85%,CEP57;POLR2A
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.3510562303578786,-0.5534034388115104,0.9069767441860465,1.0,1.0,3/8,10.97%,RPL23;RPS7;RAB1A
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.33003913792504885,-0.5529241179546445,0.9272727272727272,1.0,1.0,3/9,16.57%,DMD;RORA;NEBL
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3481159655065585,-0.5526638572477359,0.9215686274509803,1.0,1.0,3/5,29.11%,NPM1;MECP2;RAB11A
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.30062440271781643,0.5525116169097962,1.0,1.0,1.0,3/12,19.44%,HSPA8;HSPA9;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.34815616682640826,0.5523531971162842,0.9607843137254902,1.0,1.0,1/8,2.79%,PRKD1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.3191609078771138,-0.5522065066077456,0.9387755102040817,1.0,1.0,2/11,14.42%,PDE9A;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.2560169809297712,0.551512592224473,1.0,1.0,1.0,3/35,9.22%,HSPB1;TAB2;PPM1F
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.28201288860100815,0.550307962962084,1.0,1.0,1.0,5/21,20.82%,CCNI;ACTB;PTEN;RGCC;ADAM17
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.3532826178339225,-0.5499392824122217,0.9387755102040817,1.0,1.0,2/6,18.73%,DGKG;DGKE
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.2671198369684716,-0.5479075887999119,0.9782608695652174,1.0,1.0,2/22,12.48%,YTHDC1;SRPK1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3516643114840108,-0.5477414739388609,0.9607843137254902,1.0,1.0,2/5,31.82%,CABIN1;NASP
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3410523978518496,0.5442190351419042,0.9824561403508771,1.0,1.0,2/7,17.42%,REST;EP300
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.34750796371675335,-0.5441929006333015,0.9565217391304348,1.0,1.0,1/5,15.56%,DHX36
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.30146061838786653,0.5414970448100349,0.9795918367346939,1.0,1.0,2/12,14.69%,PPP4R2;KPNA1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.31364019567819973,0.539661200120878,1.0,1.0,1.0,5/10,32.40%,ROCK2;ADAM15;NR3C1;KLF9;ADCY2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.33297185163081733,-0.5396246043184076,0.9285714285714286,1.0,1.0,4/7,34.29%,MAPK14;IQCJ-SCHIP1;WWC2;VGLL4
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.2896647930680189,-0.5385469174616354,0.9696969696969697,1.0,1.0,2/17,11.69%,MAP2;GPC3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.30958570678846253,0.5383822609871182,0.9782608695652174,1.0,1.0,4/14,17.74%,FGF12;FGF14;WNK1;ANK3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.33491110149308656,-0.5358013190695721,0.9411764705882353,1.0,1.0,2/7,20.37%,BMP2K;HIP1R
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.24808843211556958,0.5355057180655346,1.0,1.0,1.0,8/32,20.21%,SMAD6;ID3;SMAD1;SKI;SMURF2;ID1;TRIM33;NCOR2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.31375797147876144,-0.5350528899496095,1.0,1.0,1.0,2/12,20.08%,UBC;FANCL
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.32658861384914706,0.534404655498691,1.0,1.0,1.0,4/6,36.57%,PTEN;LATS2;LATS1;IPO7
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.2770086319632036,-0.533729833095907,0.9811320754716981,1.0,1.0,3/21,13.36%,MAP3K5;TAOK3;SH3RF3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.3411206918172535,0.5337212424814902,0.8909090909090909,1.0,1.0,2/5,22.28%,CPEB3;RC3H1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.3243718920113141,0.5320379693984482,0.9655172413793104,1.0,1.0,2/6,21.81%,CDC42;OPHN1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.29532950714079964,-0.5312763678980819,0.9827586206896551,1.0,1.0,2/18,6.40%,GPM6A;SRGAP2C
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.26786632242022235,-0.5305077304361719,1.0,1.0,1.0,1/21,4.44%,GPM6A
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.297474917239353,-0.5293620097771619,0.9302325581395349,1.0,1.0,2/7,19.26%,FMNL3;DLG1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.32904268276246124,-0.5281945799542426,0.9411764705882353,1.0,1.0,4/5,27.84%,CBR4;PKD2;CPSF6;GRIN2B
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.2829283158106983,-0.5262369939698803,0.98,1.0,1.0,2/16,10.07%,TFRC;PARP9
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.34091407500990245,0.5259514648341488,1.0,1.0,1.0,1/5,17.61%,PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.3571035952390572,0.5249994253579593,0.98,1.0,1.0,1/5,16.49%,CALM1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.2653364174023995,-0.5233566031024819,0.9795918367346939,1.0,1.0,6/23,23.51%,SRSF5;SRRM1;ZFP36;POM121C;NUP214;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.32737865071341365,0.5219037328129664,0.9047619047619048,1.0,1.0,1/8,24.70%,ARMH3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.25359683249187587,0.5213441454950606,1.0,1.0,1.0,1/19,3.59%,PRAG1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.30180317181452654,-0.519490611861563,0.9629629629629629,1.0,1.0,1/11,4.57%,PATJ
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3236990368695376,0.5192433147199137,0.9811320754716981,1.0,1.0,3/8,23.64%,RGCC;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.30395299766343786,-0.5179543529634967,0.9375,1.0,1.0,2/11,14.42%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.26763152856656564,0.5176481828731945,1.0,1.0,1.0,5/20,22.79%,PHACTR4;CDC42;ROCK1;ADGRG1;ROCK2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.302840553216943,-0.516885622503195,1.0,1.0,1.0,5/12,22.50%,STAT5B;PDGFB;ACVRL1;MAP2K5;RACK1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.3156504596599763,0.5143983578189031,0.9649122807017544,1.0,1.0,3/8,24.99%,IDE;UVRAG;SMURF1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.30921929408249865,0.5111540222662414,1.0,1.0,1.0,3/8,26.40%,KLF2;MTSS1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3212452322686662,0.5093442215146315,1.0,1.0,1.0,4/7,36.57%,PTEN;LATS2;LATS1;IPO7
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.32102469174254017,0.5077152286702705,0.9423076923076923,1.0,1.0,2/5,22.66%,RPS6KA5;NIPBL
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.2664739997176539,-0.5071330489095928,0.9838709677419355,1.0,1.0,4/15,24.99%,SRGN;CD34;ALS2;SQSTM1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.3282367647181691,-0.5066153239751574,0.9302325581395349,1.0,1.0,2/5,23.51%,DHX36;ZFP36L1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.3016873906452218,-0.5050108809595307,0.9347826086956522,1.0,1.0,2/8,19.47%,RHOA;ACVRL1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.33452404121037893,-0.5043904544145115,0.9803921568627451,1.0,1.0,3/6,32.32%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.30794402344636185,-0.502967251139844,1.0,1.0,1.0,1/9,7.46%,DMD
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.2678685363189369,-0.5026009063411463,0.9787234042553191,1.0,1.0,3/17,16.20%,TIE1;RAPGEF2;TJP1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.31358099999099964,-0.49951685162868437,0.9622641509433962,1.0,1.0,4/7,25.60%,SRP14;SPCS3;MAN1A1;RAB3GAP1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.3073638324294584,0.49902576467793525,0.9591836734693877,1.0,1.0,2/8,22.90%,ANXA1;NF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.3307599841638813,0.49901571452812926,0.9772727272727273,1.0,1.0,3/7,23.88%,LRRK2;AKAP12;AKAP6
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.3339128591658015,0.49659401421303817,0.9795918367346939,1.0,1.0,2/5,36.65%,HSPA1A;HNRNPU
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.27517860873749617,0.4961070587078795,1.0,1.0,1.0,2/10,15.30%,HSPA8;HSPA9
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.2976063829787234,-0.4944027586549349,0.9622641509433962,1.0,1.0,5/5,70.31%,PKD2;GALNT11;NOTCH1;OFD1;RFX3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.24358654578647515,-0.49299037930626133,0.9830508474576272,1.0,1.0,5/24,17.77%,CDC14A;SPAST;RHOA;PDGFB;RAD21
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3017121257590551,0.4901408578948304,1.0,1.0,1.0,1/6,20.21%,NCOR2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.233272303861493,-0.4896661305823765,1.0,1.0,1.0,5/33,16.31%,TAOK3;MAPKAP1;JAK2;PRKAR1A;PDGFB
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2218165871438751,-0.4882896061768443,1.0,1.0,1.0,6/58,11.24%,CDC14A;RTTN;SCLT1;AHI1;RAB1A;SPAG16
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.28229122633882103,-0.48676503059225995,1.0,1.0,1.0,2/10,12.54%,SMAD3;CLU
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.28229122633882103,-0.48676503059225995,1.0,1.0,1.0,2/10,12.54%,SMAD3;CLU
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.32288061109401217,-0.48294299783244526,0.9807692307692307,1.0,1.0,1/5,10.97%,RAB1A
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.28867862152404805,0.4824310850990006,1.0,1.0,1.0,2/6,31.37%,RYR2;RBPJ
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.2611323093596054,0.4819329017548714,1.0,1.0,1.0,7/17,34.45%,ANK3;ROCK1;ROCK2;RASA1;MYH10;ECT2;TTC19
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2833814540994245,-0.48062911102993544,1.0,1.0,1.0,2/9,21.46%,HECW2;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.2790488221005319,-0.47817909295717687,1.0,1.0,1.0,1/10,13.71%,PPP1R16B
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.28448342835007784,0.4780338600968767,1.0,1.0,1.0,3/7,31.45%,MYH9;KIF5B;NDEL1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.26151085247894296,-0.47734273190054843,0.9782608695652174,1.0,1.0,1/15,7.73%,STK39
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.311436170212766,-0.4763627648262134,0.9777777777777777,1.0,1.0,5/5,68.92%,ACVR1;SMAD7;TGFBR2;TGFBR3;USP15
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.2750574310018489,-0.47511734148202295,0.98,1.0,1.0,1/6,19.20%,SYTL4
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.28713167056543193,-0.4690902224275026,1.0,1.0,1.0,2/7,18.41%,SRGN;BCOR
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.3011755687574912,0.4605458184427475,0.9782608695652174,1.0,1.0,3/5,27.78%,PXN;STAT3;PTK2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.2304825471130812,-0.45997901289000165,1.0,1.0,1.0,6/35,19.71%,SLC38A3;SHROOM2;TJP1;KIAA1549L;STXBP1;FARP1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.29801427814762305,0.4593739712781139,0.9782608695652174,1.0,1.0,1/6,15.41%,ATG2B
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.31382978723404253,-0.45771640760905796,0.9761904761904762,1.0,1.0,5/5,68.69%,ACVR1;DLL4;GALNT11;NOTCH1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.2874108035442392,-0.45121458261945363,0.98,1.0,1.0,4/7,26.61%,SEPTIN2;GLI3;KIAA0586;HIPK2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.2519957424161788,-0.451042089495012,1.0,1.0,1.0,7/7,74.87%,ACVRL1;ACVR1;NOTCH1;SMAD2;ENG;MDM4;NOS3
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),0.304641022224996,0.4510318605788634,1.0,1.0,1.0,1/5,18.09%,CCM2
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.31382978723404253,-0.4505129078338565,0.9791666666666666,1.0,1.0,5/5,68.69%,ACVRL1;DLL4;ENG;ADAMTS9;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.24082040962675982,-0.450096399593942,0.9803921568627451,1.0,1.0,7/23,24.41%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.29743619371046065,0.4494129978077234,1.0,1.0,1.0,2/5,25.18%,PRKCA;NOS3
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.24624628113598412,0.448534728890364,0.9629629629629629,1.0,1.0,1/8,19.36%,JARID2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2531114785825606,-0.44787809979128174,0.9565217391304348,1.0,1.0,5/14,32.54%,CARD8;MAP2K5;GAS6;XIAP;CAST
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.2519957424161788,-0.44585084570262185,0.9772727272727273,1.0,1.0,7/7,74.87%,ACVRL1;ACVR1;NOTCH1;TGFBR2;ENG;MDM4;NOS3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.2918102372956184,-0.44480175995344257,1.0,1.0,1.0,4/6,31.39%,BCOR;KDM1A;MTF2;MACROH2A1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.2551824935667733,-0.4433526641791043,1.0,0.9996149189452787,1.0,2/11,15.30%,STAT5B;RAMP3
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.2706446457112413,-0.44033821603410916,1.0,0.9993662693633601,1.0,11/11,73.04%,NAP1L1;NPM1;MACROH2A1;EZH1;RSF1;ATRX;SIRT1;SMARCA5;KAT6B;RBBP4;NAP1L4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.27588575509738733,0.43961486127074273,0.9591836734693877,1.0,1.0,2/5,26.40%,ANXA1;MEF2C
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.24849137539530386,0.43760251314696325,1.0,1.0,1.0,2/12,22.52%,DST;AP3B1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.2686591227831302,0.4374730040007816,0.9791666666666666,1.0,1.0,3/7,30.09%,ITCH;IFI16;MAPKBP1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.2817691479428571,-0.43681981296644623,0.9782608695652174,0.9992326625705297,1.0,2/7,19.07%,PDGFB;PKD2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.28791910590739755,-0.4365026601337694,0.9795918367346939,0.9986049065708269,1.0,7/7,71.29%,SENP6;TPR;CHMP4B;PDCD6IP;HNRNPU;DYNC1H1;HSPA1A
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.2630772984873919,0.43419291777475244,0.9803921568627451,1.0,1.0,2/7,22.90%,NIPBL;NF1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.2632344570948856,0.43362413970519065,0.9787234042553191,1.0,1.0,1/7,21.57%,AGO2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2632344570948856,0.43362413970519065,0.9787234042553191,1.0,1.0,1/7,21.57%,AGO2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.2866039364749618,0.4330646498817241,1.0,1.0,1.0,2/6,35.91%,MYO1E;BASP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2681564245810056,-0.4320515227700376,0.9622641509433962,0.9985650687060121,1.0,6/6,73.25%,ZFP36;PUM1;DHX9;PUM2;FXR1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.273133944692295,0.4313862726794854,0.9615384615384616,1.0,1.0,2/5,29.75%,SPEN;RFX3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.2538690304567126,0.42927128814802906,0.9787234042553191,1.0,1.0,2/7,24.57%,ITCH;TRAF3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.2520628160766569,-0.4262006858525429,0.9787234042553191,0.9985682118365671,1.0,8/8,74.87%,ACVRL1;FOXF1;ACVR1;NOTCH1;ENG;BMPR2;MDM4;NOS3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2791379826785384,0.42583700204038283,1.0,1.0,1.0,3/6,28.23%,NDUFS4;NDUFA12;UQCRC2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.2791379826785384,0.42583700204038283,1.0,1.0,1.0,3/6,28.23%,NDUFS4;NDUFA12;UQCRC2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.24500665778961384,-0.42068276597665283,1.0,0.9986785955881978,1.0,10/10,75.59%,SLC3A2;SLC36A4;SLC25A29;SLC38A5;SLC25A13;SLC7A1;SLC7A5;SLC25A12;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.24940047961630696,-0.41985398872075314,1.0,0.9981029271459986,1.0,12/12,75.17%,MAP2K5;GAS6;XIAP;DNAJB6;PAK2;DDX3X;KLF4;CSNK2A1;RAF1;USP47;RPS6KA3;YWHAE
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.22602030572743137,-0.41620119016410084,1.0,0.9977707968284482,1.0,4/17,21.09%,DIXDC1;FZD6;APC;TCF7L1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.2473270748034599,-0.4087165355939001,1.0,0.9980313341076328,1.0,2/10,19.47%,ZNF423;ACVRL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.22076800154689535,0.4066796119911062,1.0,1.0,1.0,5/13,29.88%,POT1;HMBOX1;RGCC;TNKS;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.21615138592750532,-0.4024453168342859,1.0,0.9979563931852816,1.0,13/13,78.49%,ZFP36;DDX5;EGFR;DDX6;RIPK1;PUM1;DHX9;MAP2K1;TNRC6B;PUM2;FXR1;STAT3;AGO2
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.252447416878012,0.39943540073876416,0.9803921568627451,1.0,1.0,2/7,25.76%,RPS6KA5;SETD5
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.2267526781455858,0.3838782809939356,1.0,1.0,1.0,4/9,37.48%,POT1;BMPR2;HNRNPU;DCP2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.23787959509856152,-0.3764361485758488,1.0,0.9991285223419213,1.0,11/11,76.31%,CABIN1;NPM1;NASP;RSF1;UBN1;ATRX;SMARCA5;CENPP;CENPC;RBBP4;MIS18BP1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.2202920811149709,0.374278074459291,1.0,1.0,1.0,4/10,32.40%,PDE7B;AKAP6;PDE7A;ADCY2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.20948827292110875,-0.368714939298015,1.0,0.9988464414141773,1.0,13/13,79.15%,CLCN3;ALS2;SQSTM1;HOOK3;USP8;TMCC1;ARFGEF2;SNX3;EEA1;RAB27A;CORO1C;DNAJC13;WASHC4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.2171078996498299,0.35847226731217124,1.0,1.0,1.0,3/7,35.94%,POT1;TNKS;ATR
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21373575989985055,0.33565012406835093,1.0,0.9999404163408185,1.0,4/7,37.48%,POT1;TNKS;HNRNPU;DCP2
